Sentence,Tags
"BACKGROUND : Calcitriol therapy suppresses serum levels of parathyroid hormone ( PTH ) in patients with renal failure but has several drawbacks , including hypercalcemia and / or marked suppression of bone turnover , which may lead to adynamic bone disease .","(('BACKGROUND', 'O'), (':', 'O'), ('Calcitriol', 'O'), ('therapy', 'O'), ('suppresses', 'O'), ('serum', 'O'), ('levels', 'O'), ('of', 'O'), ('parathyroid', 'O'), ('hormone', 'O'), ('(', 'O'), ('PTH', 'O'), (')', 'O'), ('in', 'O'), ('patients', 'O'), ('with', 'O'), ('renal', 'B'), ('failure', 'I'), ('but', 'O'), ('has', 'O'), ('several', 'O'), ('drawbacks', 'O'), (',', 'O'), ('including', 'O'), ('hypercalcemia', 'B'), ('and', 'O'), ('/', 'O'), ('or', 'O'), ('marked', 'O'), ('suppression', 'B'), ('of', 'I'), ('bone', 'I'), ('turnover', 'I'), (',', 'O'), ('which', 'O'), ('may', 'O'), ('lead', 'O'), ('to', 'O'), ('adynamic', 'B'), ('bone', 'I'), ('disease', 'I'), ('.', 'O'))$$$"
This study was undertaken to determine the effects of OCT on serum PTH levels and bone turnover in states of normal or impaired renal function .,"(('This', 'O'), ('study', 'O'), ('was', 'O'), ('undertaken', 'O'), ('to', 'O'), ('determine', 'O'), ('the', 'O'), ('effects', 'O'), ('of', 'O'), ('OCT', 'O'), ('on', 'O'), ('serum', 'O'), ('PTH', 'O'), ('levels', 'O'), ('and', 'O'), ('bone', 'O'), ('turnover', 'O'), ('in', 'O'), ('states', 'O'), ('of', 'O'), ('normal', 'O'), ('or', 'O'), ('impaired', 'B'), ('renal', 'I'), ('function', 'I'), ('.', 'O'))$$$"
"In Nx dogs , OCT reversed abnormal bone formation , such as woven osteoid and fibrosis , but did not significantly alter the level of bone turnover .","(('In', 'O'), ('Nx', 'O'), ('dogs', 'O'), (',', 'O'), ('OCT', 'O'), ('reversed', 'O'), ('abnormal', 'O'), ('bone', 'O'), ('formation', 'O'), (',', 'O'), ('such', 'O'), ('as', 'O'), ('woven', 'B'), ('osteoid', 'I'), ('and', 'O'), ('fibrosis', 'B'), (',', 'O'), ('but', 'O'), ('did', 'O'), ('not', 'O'), ('significantly', 'O'), ('alter', 'O'), ('the', 'O'), ('level', 'O'), ('of', 'O'), ('bone', 'O'), ('turnover', 'O'), ('.', 'O'))$$$"
"CONCLUSIONS : These results indicate that even though OCT does not completely prevent the occurrence of hypercalcemia in experimental dogs with renal insufficiency , it may be of use in the management of secondary hyperparathyroidism because it does not induce low bone turnover and , therefore , does not increase the risk of adynamic bone disease .","(('CONCLUSIONS', 'O'), (':', 'O'), ('These', 'O'), ('results', 'O'), ('indicate', 'O'), ('that', 'O'), ('even', 'O'), ('though', 'O'), ('OCT', 'O'), ('does', 'O'), ('not', 'O'), ('completely', 'O'), ('prevent', 'O'), ('the', 'O'), ('occurrence', 'O'), ('of', 'O'), ('hypercalcemia', 'B'), ('in', 'O'), ('experimental', 'O'), ('dogs', 'O'), ('with', 'O'), ('renal', 'B'), ('insufficiency', 'I'), (',', 'O'), ('it', 'O'), ('may', 'O'), ('be', 'O'), ('of', 'O'), ('use', 'O'), ('in', 'O'), ('the', 'O'), ('management', 'O'), ('of', 'O'), ('secondary', 'B'), ('hyperparathyroidism', 'I'), ('because', 'O'), ('it', 'O'), ('does', 'O'), ('not', 'O'), ('induce', 'O'), ('low', 'B'), ('bone', 'I'), ('turnover', 'I'), ('and', 'O'), (',', 'O'), ('therefore', 'O'), (',', 'O'), ('does', 'O'), ('not', 'O'), ('increase', 'O'), ('the', 'O'), ('risk', 'O'), ('of', 'O'), ('adynamic', 'B'), ('bone', 'I'), ('disease', 'I'), ('.', 'O'))$$$"
There was a history of ischemic cardiac disease 9 years earlier .,"(('There', 'O'), ('was', 'O'), ('a', 'O'), ('history', 'O'), ('of', 'O'), ('ischemic', 'B'), ('cardiac', 'B'), ('disease', 'I'), ('9', 'O'), ('years', 'O'), ('earlier', 'O'), ('.', 'O'))$$$"
Systemic toxicity following administration of sirolimus ( formerly rapamycin ) for psoriasis : association of capillary leak syndrome with apoptosis of lesional lymphocytes .,"(('Systemic', 'O'), ('toxicity', 'B'), ('following', 'O'), ('administration', 'O'), ('of', 'O'), ('sirolimus', 'O'), ('(', 'O'), ('formerly', 'O'), ('rapamycin', 'O'), (')', 'O'), ('for', 'O'), ('psoriasis', 'B'), (':', 'O'), ('association', 'O'), ('of', 'O'), ('capillary', 'B'), ('leak', 'I'), ('syndrome', 'I'), ('with', 'O'), ('apoptosis', 'O'), ('of', 'O'), ('lesional', 'O'), ('lymphocytes', 'O'), ('.', 'O'))$$$"
OBSERVATIONS : A keratome skin specimen from 1 patient with sirolimus - induced capillary leak syndrome had a 2 . 3 - fold increase in percentage of apoptotic cells ( to 48 % ) compared with an unaffected sirolimus - treated patient with psoriasis ( 21 % ) .,"(('OBSERVATIONS', 'O'), (':', 'O'), ('A', 'O'), ('keratome', 'O'), ('skin', 'O'), ('specimen', 'O'), ('from', 'O'), ('1', 'O'), ('patient', 'O'), ('with', 'O'), ('sirolimus', 'O'), ('-', 'O'), ('induced', 'O'), ('capillary', 'B'), ('leak', 'I'), ('syndrome', 'I'), ('had', 'O'), ('a', 'O'), ('2', 'O'), ('.', 'O'), ('3', 'O'), ('-', 'O'), ('fold', 'O'), ('increase', 'O'), ('in', 'O'), ('percentage', 'O'), ('of', 'O'), ('apoptotic', 'O'), ('cells', 'O'), ('(', 'O'), ('to', 'O'), ('48', 'O'), ('%', 'O'), (')', 'O'), ('compared', 'O'), ('with', 'O'), ('an', 'O'), ('unaffected', 'O'), ('sirolimus', 'O'), ('-', 'O'), ('treated', 'O'), ('patient', 'O'), ('with', 'O'), ('psoriasis', 'B'), ('(', 'O'), ('21', 'O'), ('%', 'O'), (')', 'O'), ('.', 'O'))$$$"
"Because patients with severe psoriasis may develop capillary leak from various systemic therapies , clinical monitoring is advisable for patients with inflammatory diseases who are treated with immune modulators .","(('Because', 'O'), ('patients', 'O'), ('with', 'O'), ('severe', 'O'), ('psoriasis', 'B'), ('may', 'O'), ('develop', 'O'), ('capillary', 'B'), ('leak', 'I'), ('from', 'O'), ('various', 'O'), ('systemic', 'O'), ('therapies', 'O'), (',', 'O'), ('clinical', 'O'), ('monitoring', 'O'), ('is', 'O'), ('advisable', 'O'), ('for', 'O'), ('patients', 'O'), ('with', 'O'), ('inflammatory', 'B'), ('diseases', 'I'), ('who', 'O'), ('are', 'O'), ('treated', 'O'), ('with', 'O'), ('immune', 'O'), ('modulators', 'O'), ('.', 'O'))$$$"
Severe immune hemolytic anemia associated with prophylactic use of cefotetan in obstetric and gynecologic procedures .,"(('Severe', 'O'), ('immune', 'O'), ('hemolytic', 'B'), ('anemia', 'I'), ('associated', 'O'), ('with', 'O'), ('prophylactic', 'O'), ('use', 'O'), ('of', 'O'), ('cefotetan', 'O'), ('in', 'O'), ('obstetric', 'O'), ('and', 'O'), ('gynecologic', 'O'), ('procedures', 'O'), ('.', 'O'))$$$"
"Second - and third - generation cephalosporins , especially cefotetan , are increasingly associated with severe , sometimes fatal immune hemolytic anemia .","(('Second', 'O'), ('-', 'O'), ('and', 'O'), ('third', 'O'), ('-', 'O'), ('generation', 'O'), ('cephalosporins', 'O'), (',', 'O'), ('especially', 'O'), ('cefotetan', 'O'), (',', 'O'), ('are', 'O'), ('increasingly', 'O'), ('associated', 'O'), ('with', 'O'), ('severe', 'O'), (',', 'O'), ('sometimes', 'O'), ('fatal', 'O'), ('immune', 'O'), ('hemolytic', 'B'), ('anemia', 'I'), ('.', 'O'))$$$"
Eight of these cases of severe immune hemolytic anemia are described .,"(('Eight', 'O'), ('of', 'O'), ('these', 'O'), ('cases', 'O'), ('of', 'O'), ('severe', 'O'), ('immune', 'O'), ('hemolytic', 'B'), ('anemia', 'I'), ('are', 'O'), ('described', 'O'), ('.', 'O'))$$$"
"Patients with aneurysmal subarachnoid hemorrhage ( SAH ) were randomized to receive either ketoprofen , 100 mg , three times a day ( ketoprofen group , n = 9 ) or a weak NSAID , acetaminophen , 1 g , three times a day ( acetaminophen group , n = 9 ) starting immediately after the diagnosis of aneurysmal SAH .","(('Patients', 'O'), ('with', 'O'), ('aneurysmal', 'B'), ('subarachnoid', 'I'), ('hemorrhage', 'I'), ('(', 'O'), ('SAH', 'B'), (')', 'O'), ('were', 'O'), ('randomized', 'O'), ('to', 'O'), ('receive', 'O'), ('either', 'O'), ('ketoprofen', 'O'), (',', 'O'), ('100', 'O'), ('mg', 'O'), (',', 'O'), ('three', 'O'), ('times', 'O'), ('a', 'O'), ('day', 'O'), ('(', 'O'), ('ketoprofen', 'O'), ('group', 'O'), (',', 'O'), ('n', 'O'), ('=', 'O'), ('9', 'O'), (')', 'O'), ('or', 'O'), ('a', 'O'), ('weak', 'O'), ('NSAID', 'O'), (',', 'O'), ('acetaminophen', 'O'), (',', 'O'), ('1', 'O'), ('g', 'O'), (',', 'O'), ('three', 'O'), ('times', 'O'), ('a', 'O'), ('day', 'O'), ('(', 'O'), ('acetaminophen', 'O'), ('group', 'O'), (',', 'O'), ('n', 'O'), ('=', 'O'), ('9', 'O'), (')', 'O'), ('starting', 'O'), ('immediately', 'O'), ('after', 'O'), ('the', 'O'), ('diagnosis', 'O'), ('of', 'O'), ('aneurysmal', 'B'), ('SAH', 'B'), ('.', 'O'))$$$"
One patient in the ketoprofen group developed a postoperative intracranial hematoma .,"(('One', 'O'), ('patient', 'O'), ('in', 'O'), ('the', 'O'), ('ketoprofen', 'O'), ('group', 'O'), ('developed', 'O'), ('a', 'O'), ('postoperative', 'O'), ('intracranial', 'O'), ('hematoma', 'B'), ('.', 'O'))$$$"
"If ketoprofen is used before surgery on cerebral artery aneurysms , it may pose an additional risk factor for hemorrhage .","(('If', 'O'), ('ketoprofen', 'O'), ('is', 'O'), ('used', 'O'), ('before', 'O'), ('surgery', 'O'), ('on', 'O'), ('cerebral', 'O'), ('artery', 'B'), ('aneurysms', 'I'), (',', 'O'), ('it', 'O'), ('may', 'O'), ('pose', 'O'), ('an', 'O'), ('additional', 'O'), ('risk', 'O'), ('factor', 'O'), ('for', 'O'), ('hemorrhage', 'B'), ('.', 'O'))$$$"
The specific aim was to elucidate whether an aura and / or an attack of migraine without aura could be induced .,"(('The', 'O'), ('specific', 'O'), ('aim', 'O'), ('was', 'O'), ('to', 'O'), ('elucidate', 'O'), ('whether', 'O'), ('an', 'O'), ('aura', 'O'), ('and', 'O'), ('/', 'O'), ('or', 'O'), ('an', 'O'), ('attack', 'O'), ('of', 'O'), ('migraine', 'B'), ('without', 'I'), ('aura', 'I'), ('could', 'O'), ('be', 'O'), ('induced', 'O'), ('.', 'O'))$$$"
"Since cortical spreading depression has been shown to liberate NO in animals , this finding may help our understanding of the coupling between cortical spreading depression and headache in migraine with aura .","(('Since', 'O'), ('cortical', 'O'), ('spreading', 'O'), ('depression', 'B'), ('has', 'O'), ('been', 'O'), ('shown', 'O'), ('to', 'O'), ('liberate', 'O'), ('NO', 'O'), ('in', 'O'), ('animals', 'O'), (',', 'O'), ('this', 'O'), ('finding', 'O'), ('may', 'O'), ('help', 'O'), ('our', 'O'), ('understanding', 'O'), ('of', 'O'), ('the', 'O'), ('coupling', 'O'), ('between', 'O'), ('cortical', 'O'), ('spreading', 'O'), ('depression', 'B'), ('and', 'O'), ('headache', 'B'), ('in', 'O'), ('migraine', 'B'), ('with', 'I'), ('aura', 'I'), ('.', 'O'))$$$"
"METHOD : We analyzed data from the Studies of Left Ventricular Dysfunction ( SOLVD ) , a randomized , double - blind , placebo - controlled trial of enalapril for the treatment of CHF .","(('METHOD', 'O'), (':', 'O'), ('We', 'O'), ('analyzed', 'O'), ('data', 'O'), ('from', 'O'), ('the', 'O'), ('Studies', 'O'), ('of', 'O'), ('Left', 'B'), ('Ventricular', 'I'), ('Dysfunction', 'I'), ('(', 'O'), ('SOLVD', 'O'), (')', 'O'), (',', 'O'), ('a', 'O'), ('randomized', 'O'), (',', 'O'), ('double', 'O'), ('-', 'O'), ('blind', 'O'), (',', 'O'), ('placebo', 'O'), ('-', 'O'), ('controlled', 'O'), ('trial', 'O'), ('of', 'O'), ('enalapril', 'O'), ('for', 'O'), ('the', 'O'), ('treatment', 'O'), ('of', 'O'), ('CHF', 'B'), ('.', 'O'))$$$"
"We used time - to - event analysis to identify potential predictors of decrease in renal function including age , baseline ejection fraction , baseline creatinine , low systolic blood pressure ( < 100 mm Hg ) , history of hypertension , diabetes , and use of antiplatelet , diuretic , and beta - blocker therapy .","(('We', 'O'), ('used', 'O'), ('time', 'O'), ('-', 'O'), ('to', 'O'), ('-', 'O'), ('event', 'O'), ('analysis', 'O'), ('to', 'O'), ('identify', 'O'), ('potential', 'O'), ('predictors', 'O'), ('of', 'O'), ('decrease', 'O'), ('in', 'O'), ('renal', 'O'), ('function', 'O'), ('including', 'O'), ('age', 'O'), (',', 'O'), ('baseline', 'O'), ('ejection', 'O'), ('fraction', 'O'), (',', 'O'), ('baseline', 'O'), ('creatinine', 'O'), (',', 'O'), ('low', 'O'), ('systolic', 'O'), ('blood', 'O'), ('pressure', 'O'), ('(', 'O'), ('<', 'O'), ('100', 'O'), ('mm', 'O'), ('Hg', 'O'), (')', 'O'), (',', 'O'), ('history', 'O'), ('of', 'O'), ('hypertension', 'B'), (',', 'O'), ('diabetes', 'B'), (',', 'O'), ('and', 'O'), ('use', 'O'), ('of', 'O'), ('antiplatelet', 'O'), (',', 'O'), ('diuretic', 'O'), (',', 'O'), ('and', 'O'), ('beta', 'O'), ('-', 'O'), ('blocker', 'O'), ('therapy', 'O'), ('.', 'O'))$$$"
We report a female patient with a diagnosis of a not otherwise specified psychotic disorder ( DSM - IV ) who developed hypomania shortly after the introduction of olanzapine treatment .,"(('We', 'O'), ('report', 'O'), ('a', 'O'), ('female', 'O'), ('patient', 'O'), ('with', 'O'), ('a', 'O'), ('diagnosis', 'O'), ('of', 'O'), ('a', 'O'), ('not', 'O'), ('otherwise', 'O'), ('specified', 'O'), ('psychotic', 'B'), ('disorder', 'I'), ('(', 'O'), ('DSM', 'O'), ('-', 'O'), ('IV', 'O'), (')', 'O'), ('who', 'O'), ('developed', 'O'), ('hypomania', 'B'), ('shortly', 'O'), ('after', 'O'), ('the', 'O'), ('introduction', 'O'), ('of', 'O'), ('olanzapine', 'O'), ('treatment', 'O'), ('.', 'O'))$$$"
"In patients with decompensated heart failure with hypotension after treatment with milrinone , low doses of vasopressin restored blood pressure without inhibiting the inotropic effect of milrinone .","(('In', 'O'), ('patients', 'O'), ('with', 'O'), ('decompensated', 'O'), ('heart', 'B'), ('failure', 'I'), ('with', 'O'), ('hypotension', 'B'), ('after', 'O'), ('treatment', 'O'), ('with', 'O'), ('milrinone', 'O'), (',', 'O'), ('low', 'O'), ('doses', 'O'), ('of', 'O'), ('vasopressin', 'O'), ('restored', 'O'), ('blood', 'O'), ('pressure', 'O'), ('without', 'O'), ('inhibiting', 'O'), ('the', 'O'), ('inotropic', 'O'), ('effect', 'O'), ('of', 'O'), ('milrinone', 'O'), ('.', 'O'))$$$"
"Indications for early conversion were neurotoxicity ( 20 ) , ( insulin - dependent ) diabetes mellitus ( IDDM ) ( 5 ) , nephrotoxicity ( 3 ) , gastrointestinal ( GI ) toxicity ( 6 ) , and cardiomyopathy ( 1 ) , and for late conversion were neurotoxicity ( 15 ) , IDDM ( 12 ) , nephrotoxicity ( 3 ) , GI toxicity ( 5 ) , hepatotoxicity ( 6 ) , post - transplant lmphoproliferate disease (","(('Indications', 'O'), ('for', 'O'), ('early', 'O'), ('conversion', 'O'), ('were', 'O'), ('neurotoxicity', 'B'), ('(', 'O'), ('20', 'O'), (')', 'O'), (',', 'O'), ('(', 'B'), ('insulin', 'I'), ('-', 'I'), ('dependent', 'I'), (')', 'I'), ('diabetes', 'I'), ('mellitus', 'I'), ('(', 'O'), ('IDDM', 'B'), (')', 'O'), ('(', 'O'), ('5', 'O'), (')', 'O'), (',', 'O'), ('nephrotoxicity', 'B'), ('(', 'O'), ('3', 'O'), (')', 'O'), (',', 'O'), ('gastrointestinal', 'B'), ('(', 'I'), ('GI', 'I'), (')', 'I'), ('toxicity', 'I'), ('(', 'O'), ('6', 'O'), (')', 'O'), (',', 'O'), ('and', 'O'), ('cardiomyopathy', 'B'), ('(', 'O'), ('1', 'O'), (')', 'O'), (',', 'O'), ('and', 'O'), ('for', 'O'), ('late', 'O'), ('conversion', 'O'), ('were', 'O'), ('neurotoxicity', 'B'), ('(', 'O'), ('15', 'O'), (')', 'O'), (',', 'O'), ('IDDM', 'B'), ('(', 'O'), ('12', 'O'), (')', 'O'), (',', 'O'), ('nephrotoxicity', 'B'), ('(', 'O'), ('3', 'O'), (')', 'O'), (',', 'O'), ('GI', 'B'), ('toxicity', 'I'), ('(', 'O'), ('5', 'O'), (')', 'O'), (',', 'O'), ('hepatotoxicity', 'B'), ('(', 'O'), ('6', 'O'), (')', 'O'), (',', 'O'), ('post', 'B'), ('-', 'I'), ('transplant', 'I'), ('lmphoproliferate', 'I'), ('disease', 'I'), ('(', 'O'))$$$"
"PTLD ) ( 2 ) , cardiomyopathy ( 1 ) , hemolytic anemia ( 1 ) , and pruritus ( 1 ) .","(('PTLD', 'B'), (')', 'O'), ('(', 'O'), ('2', 'O'), (')', 'O'), (',', 'O'), ('cardiomyopathy', 'B'), ('(', 'O'), ('1', 'O'), (')', 'O'), (',', 'O'), ('hemolytic', 'B'), ('anemia', 'I'), ('(', 'O'), ('1', 'O'), (')', 'O'), (',', 'O'), ('and', 'O'), ('pruritus', 'B'), ('(', 'O'), ('1', 'O'), (')', 'O'), ('.', 'O'))$$$"
"Forty - four percent of patients with uveitis had one or more identifiable signs or symptoms , such as red eye , ocular pain , decreased visual acuity , or photophobia , in order of decreasing frequency .","(('Forty', 'O'), ('-', 'O'), ('four', 'O'), ('percent', 'O'), ('of', 'O'), ('patients', 'O'), ('with', 'O'), ('uveitis', 'B'), ('had', 'O'), ('one', 'O'), ('or', 'O'), ('more', 'O'), ('identifiable', 'O'), ('signs', 'O'), ('or', 'O'), ('symptoms', 'O'), (',', 'O'), ('such', 'O'), ('as', 'O'), ('red', 'O'), ('eye', 'O'), (',', 'O'), ('ocular', 'B'), ('pain', 'I'), (',', 'O'), ('decreased', 'B'), ('visual', 'I'), ('acuity', 'I'), (',', 'O'), ('or', 'O'), ('photophobia', 'B'), (',', 'O'), ('in', 'O'), ('order', 'O'), ('of', 'O'), ('decreasing', 'O'), ('frequency', 'O'), ('.', 'O'))$$$"
Systemically administered corticosteroids were used in 75 of 210 cases ; a significant number of posterior subcapsular cataracts was found .,"(('Systemically', 'O'), ('administered', 'O'), ('corticosteroids', 'O'), ('were', 'O'), ('used', 'O'), ('in', 'O'), ('75', 'O'), ('of', 'O'), ('210', 'O'), ('cases', 'O'), (';', 'O'), ('a', 'O'), ('significant', 'O'), ('number', 'O'), ('of', 'O'), ('posterior', 'O'), ('subcapsular', 'O'), ('cataracts', 'B'), ('was', 'O'), ('found', 'O'), ('.', 'O'))$$$"
"CONCLUSIONS : Overall , these results indicate that this experimental model of CP - induced cystitis may be an interesting new behavioral model of inflammatory visceral pain , allowing a better understanding of these painful syndromes and thus a better therapeutic approach to them .","(('CONCLUSIONS', 'O'), (':', 'O'), ('Overall', 'O'), (',', 'O'), ('these', 'O'), ('results', 'O'), ('indicate', 'O'), ('that', 'O'), ('this', 'O'), ('experimental', 'O'), ('model', 'O'), ('of', 'O'), ('CP', 'O'), ('-', 'O'), ('induced', 'O'), ('cystitis', 'B'), ('may', 'O'), ('be', 'O'), ('an', 'O'), ('interesting', 'O'), ('new', 'O'), ('behavioral', 'O'), ('model', 'O'), ('of', 'O'), ('inflammatory', 'O'), ('visceral', 'B'), ('pain', 'I'), (',', 'O'), ('allowing', 'O'), ('a', 'O'), ('better', 'O'), ('understanding', 'O'), ('of', 'O'), ('these', 'O'), ('painful', 'B'), ('syndromes', 'I'), ('and', 'O'), ('thus', 'O'), ('a', 'O'), ('better', 'O'), ('therapeutic', 'O'), ('approach', 'O'), ('to', 'O'), ('them', 'O'), ('.', 'O'))$$$"
"On Day 8 , the nerve - evoked peak twitch tensions , tetanic tensions , and fatigability , and the dose - response curves of d - tubocurarine in the tibialis cranialis muscle were measured in vivo and related to muscle mass or expression of AChRs .","(('On', 'O'), ('Day', 'O'), ('8', 'O'), (',', 'O'), ('the', 'O'), ('nerve', 'O'), ('-', 'O'), ('evoked', 'O'), ('peak', 'O'), ('twitch', 'O'), ('tensions', 'O'), (',', 'O'), ('tetanic', 'B'), ('tensions', 'O'), (',', 'O'), ('and', 'O'), ('fatigability', 'O'), (',', 'O'), ('and', 'O'), ('the', 'O'), ('dose', 'O'), ('-', 'O'), ('response', 'O'), ('curves', 'O'), ('of', 'O'), ('d', 'O'), ('-', 'O'), ('tubocurarine', 'O'), ('in', 'O'), ('the', 'O'), ('tibialis', 'O'), ('cranialis', 'O'), ('muscle', 'O'), ('were', 'O'), ('measured', 'O'), ('in', 'O'), ('vivo', 'O'), ('and', 'O'), ('related', 'O'), ('to', 'O'), ('muscle', 'O'), ('mass', 'O'), ('or', 'O'), ('expression', 'O'), ('of', 'O'), ('AChRs', 'O'), ('.', 'O'))$$$"
"The evoked peak twitch and tetanic tensions were less in the P100 group than in the P10 or S groups , however , tension per milligram of muscle mass was greater in the P100 group than in the S group .","(('The', 'O'), ('evoked', 'O'), ('peak', 'O'), ('twitch', 'O'), ('and', 'O'), ('tetanic', 'B'), ('tensions', 'O'), ('were', 'O'), ('less', 'O'), ('in', 'O'), ('the', 'O'), ('P100', 'O'), ('group', 'O'), ('than', 'O'), ('in', 'O'), ('the', 'O'), ('P10', 'O'), ('or', 'O'), ('S', 'O'), ('groups', 'O'), (',', 'O'), ('however', 'O'), (',', 'O'), ('tension', 'O'), ('per', 'O'), ('milligram', 'O'), ('of', 'O'), ('muscle', 'O'), ('mass', 'O'), ('was', 'O'), ('greater', 'O'), ('in', 'O'), ('the', 'O'), ('P100', 'O'), ('group', 'O'), ('than', 'O'), ('in', 'O'), ('the', 'O'), ('S', 'O'), ('group', 'O'), ('.', 'O'))$$$"
"The main side effects of subcutaneous apomorphine treatment are related to cutaneous tolerability problems , whereas sedation and psychiatric complications play a lesser role .","(('The', 'O'), ('main', 'O'), ('side', 'O'), ('effects', 'O'), ('of', 'O'), ('subcutaneous', 'O'), ('apomorphine', 'O'), ('treatment', 'O'), ('are', 'O'), ('related', 'O'), ('to', 'O'), ('cutaneous', 'O'), ('tolerability', 'O'), ('problems', 'O'), (',', 'O'), ('whereas', 'O'), ('sedation', 'O'), ('and', 'O'), ('psychiatric', 'B'), ('complications', 'O'), ('play', 'O'), ('a', 'O'), ('lesser', 'O'), ('role', 'O'), ('.', 'O'))$$$"
"OBJECTIVE : The pharmacological response to drugs that act on the cholinergic system of the iris has been used to predict deficits in central cholinergic functioning due to diseases such as Alzheimer ' s disease , yet correlations between central and peripheral responses have not been properly studied .","(('OBJECTIVE', 'O'), (':', 'O'), ('The', 'O'), ('pharmacological', 'O'), ('response', 'O'), ('to', 'O'), ('drugs', 'O'), ('that', 'O'), ('act', 'O'), ('on', 'O'), ('the', 'O'), ('cholinergic', 'O'), ('system', 'O'), ('of', 'O'), ('the', 'O'), ('iris', 'O'), ('has', 'O'), ('been', 'O'), ('used', 'O'), ('to', 'O'), ('predict', 'O'), ('deficits', 'O'), ('in', 'O'), ('central', 'O'), ('cholinergic', 'O'), ('functioning', 'O'), ('due', 'O'), ('to', 'O'), ('diseases', 'O'), ('such', 'O'), ('as', 'O'), ('Alzheimer', 'B'), (""'"", 'I'), ('s', 'I'), ('disease', 'I'), (',', 'O'), ('yet', 'O'), ('correlations', 'O'), ('between', 'O'), ('central', 'O'), ('and', 'O'), ('peripheral', 'O'), ('responses', 'O'), ('have', 'O'), ('not', 'O'), ('been', 'O'), ('properly', 'O'), ('studied', 'O'), ('.', 'O'))$$$"
This study was designed to describe pain tolerance and analgesic response in a sample of opioid addicts stabilized in methadone - maintenance ( MM ) treatment ( n = 60 ) in comparison to matched nondependent control subjects ( n = 60 ) .,"(('This', 'O'), ('study', 'O'), ('was', 'O'), ('designed', 'O'), ('to', 'O'), ('describe', 'O'), ('pain', 'B'), ('tolerance', 'O'), ('and', 'O'), ('analgesic', 'O'), ('response', 'O'), ('in', 'O'), ('a', 'O'), ('sample', 'O'), ('of', 'O'), ('opioid', 'B'), ('addicts', 'I'), ('stabilized', 'O'), ('in', 'O'), ('methadone', 'O'), ('-', 'O'), ('maintenance', 'O'), ('(', 'O'), ('MM', 'O'), (')', 'O'), ('treatment', 'O'), ('(', 'O'), ('n', 'O'), ('=', 'O'), ('60', 'O'), (')', 'O'), ('in', 'O'), ('comparison', 'O'), ('to', 'O'), ('matched', 'O'), ('nondependent', 'O'), ('control', 'O'), ('subjects', 'O'), ('(', 'O'), ('n', 'O'), ('=', 'O'), ('60', 'O'), (')', 'O'), ('.', 'O'))$$$"
"By using a placebo - controlled , two - way factorial design , tolerance to cold - pressor ( CP ) pain was examined , both before and after oral administration of therapeutic doses of common opioid ( hydromorphone 2 mg ) and nonsteroidal anti - inflammatory ( ketorolac 10 mg ) analgesic agents .","(('By', 'O'), ('using', 'O'), ('a', 'O'), ('placebo', 'O'), ('-', 'O'), ('controlled', 'O'), (',', 'O'), ('two', 'O'), ('-', 'O'), ('way', 'O'), ('factorial', 'O'), ('design', 'O'), (',', 'O'), ('tolerance', 'O'), ('to', 'O'), ('cold', 'O'), ('-', 'O'), ('pressor', 'O'), ('(', 'O'), ('CP', 'O'), (')', 'O'), ('pain', 'B'), ('was', 'O'), ('examined', 'O'), (',', 'O'), ('both', 'O'), ('before', 'O'), ('and', 'O'), ('after', 'O'), ('oral', 'O'), ('administration', 'O'), ('of', 'O'), ('therapeutic', 'O'), ('doses', 'O'), ('of', 'O'), ('common', 'O'), ('opioid', 'O'), ('(', 'O'), ('hydromorphone', 'O'), ('2', 'O'), ('mg', 'O'), (')', 'O'), ('and', 'O'), ('nonsteroidal', 'O'), ('anti', 'O'), ('-', 'O'), ('inflammatory', 'O'), ('(', 'O'), ('ketorolac', 'O'), ('10', 'O'), ('mg', 'O'), (')', 'O'), ('analgesic', 'O'), ('agents', 'O'), ('.', 'O'))$$$"
"Results showed that MM individuals were significantly less tolerant of CP pain than control subjects , replicating previous work .","(('Results', 'O'), ('showed', 'O'), ('that', 'O'), ('MM', 'O'), ('individuals', 'O'), ('were', 'O'), ('significantly', 'O'), ('less', 'O'), ('tolerant', 'O'), ('of', 'O'), ('CP', 'O'), ('pain', 'B'), ('than', 'O'), ('control', 'O'), ('subjects', 'O'), (',', 'O'), ('replicating', 'O'), ('previous', 'O'), ('work', 'O'), ('.', 'O'))$$$"
These data indicate that MM opioid abusers represent a pain - intolerant subset of clinical patients .,"(('These', 'O'), ('data', 'O'), ('indicate', 'O'), ('that', 'O'), ('MM', 'O'), ('opioid', 'O'), ('abusers', 'O'), ('represent', 'O'), ('a', 'O'), ('pain', 'B'), ('-', 'I'), ('intolerant', 'I'), ('subset', 'O'), ('of', 'O'), ('clinical', 'O'), ('patients', 'O'), ('.', 'O'))$$$"
"Because of the National Acute Spinal Cord Injury Studies ( NASCIS ) , high - dose methylprednisolone became the standard of care for the acute spinal cord injury .","(('Because', 'O'), ('of', 'O'), ('the', 'O'), ('National', 'O'), ('Acute', 'O'), ('Spinal', 'B'), ('Cord', 'I'), ('Injury', 'I'), ('Studies', 'O'), ('(', 'O'), ('NASCIS', 'O'), (')', 'O'), (',', 'O'), ('high', 'O'), ('-', 'O'), ('dose', 'O'), ('methylprednisolone', 'O'), ('became', 'O'), ('the', 'O'), ('standard', 'O'), ('of', 'O'), ('care', 'O'), ('for', 'O'), ('the', 'O'), ('acute', 'O'), ('spinal', 'B'), ('cord', 'I'), ('injury', 'I'), ('.', 'O'))$$$"
We hypothesize that it may cause some damage to the muscle of spinal cord injury patients .,"(('We', 'O'), ('hypothesize', 'O'), ('that', 'O'), ('it', 'O'), ('may', 'O'), ('cause', 'O'), ('some', 'O'), ('damage', 'B'), ('to', 'I'), ('the', 'I'), ('muscle', 'I'), ('of', 'O'), ('spinal', 'B'), ('cord', 'I'), ('injury', 'I'), ('patients', 'O'), ('.', 'O'))$$$"
"Five patients developed pneumonia ( two Pneumocystis carinii pneumonia , one infectious mononucleosis with polyclonal PTLD lung infiltrate ) and two had bronchiolitis obliterans .","(('Five', 'O'), ('patients', 'O'), ('developed', 'O'), ('pneumonia', 'B'), ('(', 'O'), ('two', 'O'), ('Pneumocystis', 'B'), ('carinii', 'I'), ('pneumonia', 'I'), (',', 'O'), ('one', 'O'), ('infectious', 'B'), ('mononucleosis', 'I'), ('with', 'O'), ('polyclonal', 'O'), ('PTLD', 'B'), ('lung', 'O'), ('infiltrate', 'O'), (')', 'O'), ('and', 'O'), ('two', 'O'), ('had', 'O'), ('bronchiolitis', 'B'), ('obliterans', 'I'), ('.', 'O'))$$$"
"However , when converting patients to RAPA drug levels should be monitored to avoid over - immunosuppression and adequate antiviral and Pneumocystis carinii pneumonia prophylaxis should be given .","(('However', 'O'), (',', 'O'), ('when', 'O'), ('converting', 'O'), ('patients', 'O'), ('to', 'O'), ('RAPA', 'O'), ('drug', 'O'), ('levels', 'O'), ('should', 'O'), ('be', 'O'), ('monitored', 'O'), ('to', 'O'), ('avoid', 'O'), ('over', 'O'), ('-', 'O'), ('immunosuppression', 'O'), ('and', 'O'), ('adequate', 'O'), ('antiviral', 'O'), ('and', 'O'), ('Pneumocystis', 'B'), ('carinii', 'I'), ('pneumonia', 'I'), ('prophylaxis', 'O'), ('should', 'O'), ('be', 'O'), ('given', 'O'), ('.', 'O'))$$$"
The aim of the present study is to examine whether myocardial ischemia due to coronary spasm is induced by dobutamine .,"(('The', 'O'), ('aim', 'O'), ('of', 'O'), ('the', 'O'), ('present', 'O'), ('study', 'O'), ('is', 'O'), ('to', 'O'), ('examine', 'O'), ('whether', 'O'), ('myocardial', 'B'), ('ischemia', 'I'), ('due', 'O'), ('to', 'O'), ('coronary', 'B'), ('spasm', 'I'), ('is', 'O'), ('induced', 'O'), ('by', 'O'), ('dobutamine', 'O'), ('.', 'O'))$$$"
All patients had anginal attacks at rest with ST elevation on the electrocardiogram ( variant angina ) .,"(('All', 'O'), ('patients', 'O'), ('had', 'O'), ('anginal', 'B'), ('attacks', 'O'), ('at', 'O'), ('rest', 'O'), ('with', 'O'), ('ST', 'O'), ('elevation', 'O'), ('on', 'O'), ('the', 'O'), ('electrocardiogram', 'O'), ('(', 'O'), ('variant', 'B'), ('angina', 'I'), (')', 'O'), ('.', 'O'))$$$"
"Coronary spasm was induced by intracoronary injection of acetylcholine , and no fixed coronary artery stenosis was documented on angiograms in all patients .","(('Coronary', 'O'), ('spasm', 'O'), ('was', 'O'), ('induced', 'O'), ('by', 'O'), ('intracoronary', 'O'), ('injection', 'O'), ('of', 'O'), ('acetylcholine', 'O'), (',', 'O'), ('and', 'O'), ('no', 'O'), ('fixed', 'O'), ('coronary', 'B'), ('artery', 'I'), ('stenosis', 'I'), ('was', 'O'), ('documented', 'O'), ('on', 'O'), ('angiograms', 'O'), ('in', 'O'), ('all', 'O'), ('patients', 'O'), ('.', 'O'))$$$"
"We found significant positive correlations between the preoperative levodopa responsiveness of motor signs and the levodopa responsiveness of scores in timed tests ( Core Assessment Program for Intracerebral Transplantations ) in the contralateral limbs and the improvement in these scores after surgery , whereas there was no correlation with the improvement in LID .","(('We', 'O'), ('found', 'O'), ('significant', 'O'), ('positive', 'O'), ('correlations', 'O'), ('between', 'O'), ('the', 'O'), ('preoperative', 'O'), ('levodopa', 'O'), ('responsiveness', 'O'), ('of', 'O'), ('motor', 'O'), ('signs', 'O'), ('and', 'O'), ('the', 'O'), ('levodopa', 'O'), ('responsiveness', 'O'), ('of', 'O'), ('scores', 'O'), ('in', 'O'), ('timed', 'O'), ('tests', 'O'), ('(', 'O'), ('Core', 'O'), ('Assessment', 'O'), ('Program', 'O'), ('for', 'O'), ('Intracerebral', 'O'), ('Transplantations', 'O'), (')', 'O'), ('in', 'O'), ('the', 'O'), ('contralateral', 'O'), ('limbs', 'O'), ('and', 'O'), ('the', 'O'), ('improvement', 'O'), ('in', 'O'), ('these', 'O'), ('scores', 'O'), ('after', 'O'), ('surgery', 'O'), (',', 'O'), ('whereas', 'O'), ('there', 'O'), ('was', 'O'), ('no', 'O'), ('correlation', 'O'), ('with', 'O'), ('the', 'O'), ('improvement', 'O'), ('in', 'O'), ('LID', 'B'), ('.', 'O'))$$$"
"We also found a highly significant correlation ( P : < 0 . 0001 , r = 0 . 8 ) between the volume of the ventral lesion in the GPi and the improvement in LID in the contralateral limbs , whereas there was no correlation between the ventral volume and the improvement in parkinsonian ' off ' signs .","(('We', 'O'), ('also', 'O'), ('found', 'O'), ('a', 'O'), ('highly', 'O'), ('significant', 'O'), ('correlation', 'O'), ('(', 'O'), ('P', 'O'), (':', 'O'), ('<', 'O'), ('0', 'O'), ('.', 'O'), ('0001', 'O'), (',', 'O'), ('r', 'O'), ('=', 'O'), ('0', 'O'), ('.', 'O'), ('8', 'O'), (')', 'O'), ('between', 'O'), ('the', 'O'), ('volume', 'O'), ('of', 'O'), ('the', 'O'), ('ventral', 'O'), ('lesion', 'O'), ('in', 'O'), ('the', 'O'), ('GPi', 'O'), ('and', 'O'), ('the', 'O'), ('improvement', 'O'), ('in', 'O'), ('LID', 'B'), ('in', 'O'), ('the', 'O'), ('contralateral', 'O'), ('limbs', 'O'), (',', 'O'), ('whereas', 'O'), ('there', 'O'), ('was', 'O'), ('no', 'O'), ('correlation', 'O'), ('between', 'O'), ('the', 'O'), ('ventral', 'O'), ('volume', 'O'), ('and', 'O'), ('the', 'O'), ('improvement', 'O'), ('in', 'O'), ('parkinsonian', 'B'), (""'"", 'O'), ('off', 'O'), (""'"", 'O'), ('signs', 'O'), ('.', 'O'))$$$"
The differential predictive value of levodopa responsiveness for the outcome of parkinsonian ' off ' signs and LID and the different correlations of ventral lesion volume with dyskinesias and parkinsonian ' off ' signs indicate that different anatomical or pathophysiological substrates may be responsible for the generation of parkinsonian ' off ' signs and dyskinesias .,"(('The', 'O'), ('differential', 'O'), ('predictive', 'O'), ('value', 'O'), ('of', 'O'), ('levodopa', 'O'), ('responsiveness', 'O'), ('for', 'O'), ('the', 'O'), ('outcome', 'O'), ('of', 'O'), ('parkinsonian', 'B'), (""'"", 'O'), ('off', 'O'), (""'"", 'O'), ('signs', 'O'), ('and', 'O'), ('LID', 'B'), ('and', 'O'), ('the', 'O'), ('different', 'O'), ('correlations', 'O'), ('of', 'O'), ('ventral', 'O'), ('lesion', 'O'), ('volume', 'O'), ('with', 'O'), ('dyskinesias', 'B'), ('and', 'O'), ('parkinsonian', 'B'), (""'"", 'O'), ('off', 'O'), (""'"", 'O'), ('signs', 'O'), ('indicate', 'O'), ('that', 'O'), ('different', 'O'), ('anatomical', 'O'), ('or', 'O'), ('pathophysiological', 'O'), ('substrates', 'O'), ('may', 'O'), ('be', 'O'), ('responsible', 'O'), ('for', 'O'), ('the', 'O'), ('generation', 'O'), ('of', 'O'), ('parkinsonian', 'B'), (""'"", 'O'), ('off', 'O'), (""'"", 'O'), ('signs', 'O'), ('and', 'O'), ('dyskinesias', 'B'), ('.', 'O'))$$$"
"Patient demographics , history of underlying drug or alcohol - related seizure disorder , estimated time from seizure to sample collection , history or suspicion of cocaine or amphetamine abuse , results of clinical urine testing for drugs of abuse , and assay results were recorded without patient identifiers .","(('Patient', 'O'), ('demographics', 'O'), (',', 'O'), ('history', 'O'), ('of', 'O'), ('underlying', 'O'), ('drug', 'O'), ('or', 'O'), ('alcohol', 'O'), ('-', 'O'), ('related', 'O'), ('seizure', 'B'), ('disorder', 'O'), (',', 'O'), ('estimated', 'O'), ('time', 'O'), ('from', 'O'), ('seizure', 'B'), ('to', 'O'), ('sample', 'O'), ('collection', 'O'), (',', 'O'), ('history', 'O'), ('or', 'O'), ('suspicion', 'O'), ('of', 'O'), ('cocaine', 'B'), ('or', 'I'), ('amphetamine', 'I'), ('abuse', 'I'), (',', 'O'), ('results', 'O'), ('of', 'O'), ('clinical', 'O'), ('urine', 'O'), ('testing', 'O'), ('for', 'O'), ('drugs', 'O'), ('of', 'O'), ('abuse', 'O'), (',', 'O'), ('and', 'O'), ('assay', 'O'), ('results', 'O'), ('were', 'O'), ('recorded', 'O'), ('without', 'O'), ('patient', 'O'), ('identifiers', 'O'), ('.', 'O'))$$$"
Contribution of sodium valproate to the syndrome of inappropriate secretion of antidiuretic hormone .,"(('Contribution', 'O'), ('of', 'O'), ('sodium', 'O'), ('valproate', 'O'), ('to', 'O'), ('the', 'O'), ('syndrome', 'B'), ('of', 'I'), ('inappropriate', 'I'), ('secretion', 'I'), ('of', 'I'), ('antidiuretic', 'I'), ('hormone', 'I'), ('.', 'O'))$$$"
We report the case of a 62 - year - old man who was administered sodium valproate ( VPA ) and who subsequently developed the syndrome of inappropriate secretion of antidiuretic hormone ( SIADH ) .,"(('We', 'O'), ('report', 'O'), ('the', 'O'), ('case', 'O'), ('of', 'O'), ('a', 'O'), ('62', 'O'), ('-', 'O'), ('year', 'O'), ('-', 'O'), ('old', 'O'), ('man', 'O'), ('who', 'O'), ('was', 'O'), ('administered', 'O'), ('sodium', 'O'), ('valproate', 'O'), ('(', 'O'), ('VPA', 'O'), (')', 'O'), ('and', 'O'), ('who', 'O'), ('subsequently', 'O'), ('developed', 'O'), ('the', 'O'), ('syndrome', 'B'), ('of', 'I'), ('inappropriate', 'I'), ('secretion', 'I'), ('of', 'I'), ('antidiuretic', 'I'), ('hormone', 'I'), ('(', 'O'), ('SIADH', 'B'), (')', 'O'), ('.', 'O'))$$$"
He had been taking VPA for treatment of idiopathic generalized tonic - clonic convulsions since he was 56 years old .,"(('He', 'O'), ('had', 'O'), ('been', 'O'), ('taking', 'O'), ('VPA', 'O'), ('for', 'O'), ('treatment', 'O'), ('of', 'O'), ('idiopathic', 'O'), ('generalized', 'O'), ('tonic', 'B'), ('-', 'I'), ('clonic', 'I'), ('convulsions', 'I'), ('since', 'O'), ('he', 'O'), ('was', 'O'), ('56', 'O'), ('years', 'O'), ('old', 'O'), ('.', 'O'))$$$"
In the IPRK phenylephrine and acetylcholine related responses were significantly impaired in the ADR - nephropathy group .,"(('In', 'O'), ('the', 'O'), ('IPRK', 'O'), ('phenylephrine', 'O'), ('and', 'O'), ('acetylcholine', 'O'), ('related', 'O'), ('responses', 'O'), ('were', 'O'), ('significantly', 'O'), ('impaired', 'O'), ('in', 'O'), ('the', 'O'), ('ADR', 'O'), ('-', 'O'), ('nephropathy', 'B'), ('group', 'O'), ('.', 'O'))$$$"
"Cardiotoxicity was defined by reductions in left - ventricular ejection fraction , assessed by serial multigated radionuclide angiography scans , or congestive heart failure ( CHF ) .","(('Cardiotoxicity', 'B'), ('was', 'O'), ('defined', 'O'), ('by', 'O'), ('reductions', 'O'), ('in', 'O'), ('left', 'O'), ('-', 'O'), ('ventricular', 'O'), ('ejection', 'O'), ('fraction', 'O'), (',', 'O'), ('assessed', 'O'), ('by', 'O'), ('serial', 'O'), ('multigated', 'O'), ('radionuclide', 'O'), ('angiography', 'O'), ('scans', 'O'), (',', 'O'), ('or', 'O'), ('congestive', 'B'), ('heart', 'I'), ('failure', 'I'), ('(', 'O'), ('CHF', 'B'), (')', 'O'), ('.', 'O'))$$$"
RESULTS : Six percent of MC patients versus 21 % ( including five cases of CHF ) of AC patients developed cardiotoxicity ( P = . 0002 ) .,"(('RESULTS', 'O'), (':', 'O'), ('Six', 'O'), ('percent', 'O'), ('of', 'O'), ('MC', 'O'), ('patients', 'O'), ('versus', 'O'), ('21', 'O'), ('%', 'O'), ('(', 'O'), ('including', 'O'), ('five', 'O'), ('cases', 'O'), ('of', 'O'), ('CHF', 'B'), (')', 'O'), ('of', 'O'), ('AC', 'O'), ('patients', 'O'), ('developed', 'O'), ('cardiotoxicity', 'B'), ('(', 'O'), ('P', 'O'), ('=', 'O'), ('.', 'O'), ('0002', 'O'), (')', 'O'), ('.', 'O'))$$$"
Erythropoietin restores the anemia - induced reduction in cyclophosphamide cytotoxicity in rat tumors .,"(('Erythropoietin', 'O'), ('restores', 'O'), ('the', 'O'), ('anemia', 'B'), ('-', 'O'), ('induced', 'O'), ('reduction', 'O'), ('in', 'O'), ('cyclophosphamide', 'O'), ('cytotoxicity', 'B'), ('in', 'O'), ('rat', 'O'), ('tumors', 'B'), ('.', 'O'))$$$"
The aim of this study was to examine the impact of anemia prevention by recombinant human erythropoietin ( rHuEPO ) treatment on the cytotoxicity of cyclophosphamide in solid experimental tumors .,"(('The', 'O'), ('aim', 'O'), ('of', 'O'), ('this', 'O'), ('study', 'O'), ('was', 'O'), ('to', 'O'), ('examine', 'O'), ('the', 'O'), ('impact', 'O'), ('of', 'O'), ('anemia', 'B'), ('prevention', 'O'), ('by', 'O'), ('recombinant', 'O'), ('human', 'O'), ('erythropoietin', 'O'), ('(', 'O'), ('rHuEPO', 'O'), (')', 'O'), ('treatment', 'O'), ('on', 'O'), ('the', 'O'), ('cytotoxicity', 'B'), ('of', 'O'), ('cyclophosphamide', 'O'), ('in', 'O'), ('solid', 'O'), ('experimental', 'O'), ('tumors', 'B'), ('.', 'O'))$$$"
"Four days after carboplatin treatment , tumors ( DS - sarcoma of the rat ) were implanted s . c . onto the hind food dorsum .","(('Four', 'O'), ('days', 'O'), ('after', 'O'), ('carboplatin', 'O'), ('treatment', 'O'), (',', 'O'), ('tumors', 'B'), ('(', 'O'), ('DS', 'O'), ('-', 'O'), ('sarcoma', 'B'), ('of', 'O'), ('the', 'O'), ('rat', 'O'), (')', 'O'), ('were', 'O'), ('implanted', 'O'), ('s', 'O'), ('.', 'O'), ('c', 'O'), ('.', 'O'), ('onto', 'O'), ('the', 'O'), ('hind', 'O'), ('food', 'O'), ('dorsum', 'O'), ('.', 'O'))$$$"
"In the anemia group , the growth delay was significantly shorter compared with nonanemic controls ( 13 . 3 days versus 8 . 6 days ) .","(('In', 'O'), ('the', 'O'), ('anemia', 'B'), ('group', 'O'), (',', 'O'), ('the', 'O'), ('growth', 'O'), ('delay', 'O'), ('was', 'O'), ('significantly', 'O'), ('shorter', 'O'), ('compared', 'O'), ('with', 'O'), ('nonanemic', 'O'), ('controls', 'O'), ('(', 'O'), ('13', 'O'), ('.', 'O'), ('3', 'O'), ('days', 'O'), ('versus', 'O'), ('8', 'O'), ('.', 'O'), ('6', 'O'), ('days', 'O'), (')', 'O'), ('.', 'O'))$$$"
"In the group where anemia was prevented by rHuEPO treatment , growth delay was comparable with that of nonanemic controls ( 13 . 3 days ) .","(('In', 'O'), ('the', 'O'), ('group', 'O'), ('where', 'O'), ('anemia', 'B'), ('was', 'O'), ('prevented', 'O'), ('by', 'O'), ('rHuEPO', 'O'), ('treatment', 'O'), (',', 'O'), ('growth', 'O'), ('delay', 'O'), ('was', 'O'), ('comparable', 'O'), ('with', 'O'), ('that', 'O'), ('of', 'O'), ('nonanemic', 'O'), ('controls', 'O'), ('(', 'O'), ('13', 'O'), ('.', 'O'), ('3', 'O'), ('days', 'O'), (')', 'O'), ('.', 'O'))$$$"
"These results suggest that chemotherapy - induced anemia reduces cytotoxicity of cyclophosphamide in tumors , whereas correction of anemia by rHuEPO treatment ( epoetin alpha ) increases the sensitivity , probably as a result of an improved oxygen supply to tumor tissue .","(('These', 'O'), ('results', 'O'), ('suggest', 'O'), ('that', 'O'), ('chemotherapy', 'O'), ('-', 'O'), ('induced', 'O'), ('anemia', 'B'), ('reduces', 'O'), ('cytotoxicity', 'B'), ('of', 'O'), ('cyclophosphamide', 'O'), ('in', 'O'), ('tumors', 'B'), (',', 'O'), ('whereas', 'O'), ('correction', 'O'), ('of', 'O'), ('anemia', 'B'), ('by', 'O'), ('rHuEPO', 'O'), ('treatment', 'O'), ('(', 'O'), ('epoetin', 'O'), ('alpha', 'O'), (')', 'O'), ('increases', 'O'), ('the', 'O'), ('sensitivity', 'O'), (',', 'O'), ('probably', 'O'), ('as', 'O'), ('a', 'O'), ('result', 'O'), ('of', 'O'), ('an', 'O'), ('improved', 'O'), ('oxygen', 'O'), ('supply', 'O'), ('to', 'O'), ('tumor', 'B'), ('tissue', 'O'), ('.', 'O'))$$$"
Fatal haemorrhagic myocarditis secondary to cyclophosphamide therapy .,"(('Fatal', 'O'), ('haemorrhagic', 'B'), ('myocarditis', 'I'), ('secondary', 'O'), ('to', 'O'), ('cyclophosphamide', 'O'), ('therapy', 'O'), ('.', 'O'))$$$"
Haemorrhagic myocarditis is a rare but important complication of cyclophosphamide therapy .,"(('Haemorrhagic', 'B'), ('myocarditis', 'I'), ('is', 'O'), ('a', 'O'), ('rare', 'O'), ('but', 'O'), ('important', 'O'), ('complication', 'O'), ('of', 'O'), ('cyclophosphamide', 'O'), ('therapy', 'O'), ('.', 'O'))$$$"
"CASE SUMMARY : A 68 - year - old white woman with Candida glabrata isolated from a presacral abscess developed TDP eight days after commencing oral fluconazole The patient had no other risk factors for TDP , including coronary artery disease , cardiomyopathy , congestive heart failure , and electrolyte abnormalities There was a temporal association between the initiation of fluconazole and TDP .","(('CASE', 'O'), ('SUMMARY', 'O'), (':', 'O'), ('A', 'O'), ('68', 'O'), ('-', 'O'), ('year', 'O'), ('-', 'O'), ('old', 'O'), ('white', 'O'), ('woman', 'O'), ('with', 'O'), ('Candida', 'O'), ('glabrata', 'O'), ('isolated', 'O'), ('from', 'O'), ('a', 'O'), ('presacral', 'O'), ('abscess', 'O'), ('developed', 'O'), ('TDP', 'B'), ('eight', 'O'), ('days', 'O'), ('after', 'O'), ('commencing', 'O'), ('oral', 'O'), ('fluconazole', 'O'), ('The', 'O'), ('patient', 'O'), ('had', 'O'), ('no', 'O'), ('other', 'O'), ('risk', 'O'), ('factors', 'O'), ('for', 'O'), ('TDP', 'B'), (',', 'O'), ('including', 'O'), ('coronary', 'B'), ('artery', 'I'), ('disease', 'I'), (',', 'O'), ('cardiomyopathy', 'B'), (',', 'O'), ('congestive', 'B'), ('heart', 'I'), ('failure', 'I'), (',', 'O'), ('and', 'O'), ('electrolyte', 'O'), ('abnormalities', 'O'), ('There', 'O'), ('was', 'O'), ('a', 'O'), ('temporal', 'O'), ('association', 'O'), ('between', 'O'), ('the', 'O'), ('initiation', 'O'), ('of', 'O'), ('fluconazole', 'O'), ('and', 'O'), ('TDP', 'B'), ('.', 'O'))$$$"
The possible mechanism is depression of rapidly activating delayed rectifier potassium currents .,"(('The', 'O'), ('possible', 'O'), ('mechanism', 'O'), ('is', 'O'), ('depression', 'B'), ('of', 'O'), ('rapidly', 'O'), ('activating', 'O'), ('delayed', 'O'), ('rectifier', 'O'), ('potassium', 'O'), ('currents', 'O'), ('.', 'O'))$$$"
"CONCLUSIONS : Clinicians should be aware that fluconazole , even at low doses , may cause prolongation of the QT interval , leading to TDP .","(('CONCLUSIONS', 'O'), (':', 'O'), ('Clinicians', 'O'), ('should', 'O'), ('be', 'O'), ('aware', 'O'), ('that', 'O'), ('fluconazole', 'O'), (',', 'O'), ('even', 'O'), ('at', 'O'), ('low', 'O'), ('doses', 'O'), (',', 'O'), ('may', 'O'), ('cause', 'O'), ('prolongation', 'B'), ('of', 'I'), ('the', 'I'), ('QT', 'I'), ('interval', 'I'), (',', 'O'), ('leading', 'O'), ('to', 'O'), ('TDP', 'B'), ('.', 'O'))$$$"
"A 67 - year - old man who was treated with oxacillin for one week because of Staphylococcus aureus bacteremia , developed renal failure and diffuse , symmetric , palpable purpuric lesions on his feet .","(('A', 'O'), ('67', 'O'), ('-', 'O'), ('year', 'O'), ('-', 'O'), ('old', 'O'), ('man', 'O'), ('who', 'O'), ('was', 'O'), ('treated', 'O'), ('with', 'O'), ('oxacillin', 'O'), ('for', 'O'), ('one', 'O'), ('week', 'O'), ('because', 'O'), ('of', 'O'), ('Staphylococcus', 'B'), ('aureus', 'I'), ('bacteremia', 'I'), (',', 'O'), ('developed', 'O'), ('renal', 'B'), ('failure', 'I'), ('and', 'O'), ('diffuse', 'O'), (',', 'O'), ('symmetric', 'O'), (',', 'O'), ('palpable', 'O'), ('purpuric', 'B'), ('lesions', 'I'), ('on', 'O'), ('his', 'O'), ('feet', 'O'), ('.', 'O'))$$$"
"Leucocytoclastic vasculitis presents as palpable purpura of the lower extremities often accompanied by abdominal pain , arthralgia , and renal involvement .","(('Leucocytoclastic', 'B'), ('vasculitis', 'I'), ('presents', 'O'), ('as', 'O'), ('palpable', 'O'), ('purpura', 'B'), ('of', 'O'), ('the', 'O'), ('lower', 'O'), ('extremities', 'O'), ('often', 'O'), ('accompanied', 'O'), ('by', 'O'), ('abdominal', 'B'), ('pain', 'I'), (',', 'O'), ('arthralgia', 'B'), (',', 'O'), ('and', 'O'), ('renal', 'B'), ('involvement', 'I'), ('.', 'O'))$$$"
"A percutaneous liver biopsy was obtained showing marked cholestasis , with portal edema , ductular proliferation , and acute inflammation .","(('A', 'O'), ('percutaneous', 'O'), ('liver', 'O'), ('biopsy', 'O'), ('was', 'O'), ('obtained', 'O'), ('showing', 'O'), ('marked', 'O'), ('cholestasis', 'B'), (',', 'O'), ('with', 'O'), ('portal', 'O'), ('edema', 'B'), (',', 'O'), ('ductular', 'O'), ('proliferation', 'O'), (',', 'O'), ('and', 'O'), ('acute', 'O'), ('inflammation', 'B'), ('.', 'O'))$$$"
OBJECTIVE : To report a case of multiple episodes of seizure activity in an AIDS patent following amphotericin B infusion .,"(('OBJECTIVE', 'O'), (':', 'O'), ('To', 'O'), ('report', 'O'), ('a', 'O'), ('case', 'O'), ('of', 'O'), ('multiple', 'O'), ('episodes', 'O'), ('of', 'O'), ('seizure', 'B'), ('activity', 'O'), ('in', 'O'), ('an', 'O'), ('AIDS', 'B'), ('patent', 'O'), ('following', 'O'), ('amphotericin', 'O'), ('B', 'O'), ('infusion', 'O'), ('.', 'O'))$$$"
"CASE SUMMARY : A 46 - year - old African - American man experienced recurrent grand mal seizures during intravenous infusion of amphotericin B , then petit mal seizures as the infusion was stopped and the drug concentrations decreased with time .","(('CASE', 'O'), ('SUMMARY', 'O'), (':', 'O'), ('A', 'O'), ('46', 'O'), ('-', 'O'), ('year', 'O'), ('-', 'O'), ('old', 'O'), ('African', 'O'), ('-', 'O'), ('American', 'O'), ('man', 'O'), ('experienced', 'O'), ('recurrent', 'O'), ('grand', 'B'), ('mal', 'I'), ('seizures', 'I'), ('during', 'O'), ('intravenous', 'O'), ('infusion', 'O'), ('of', 'O'), ('amphotericin', 'O'), ('B', 'O'), (',', 'O'), ('then', 'O'), ('petit', 'O'), ('mal', 'O'), ('seizures', 'B'), ('as', 'O'), ('the', 'O'), ('infusion', 'O'), ('was', 'O'), ('stopped', 'O'), ('and', 'O'), ('the', 'O'), ('drug', 'O'), ('concentrations', 'O'), ('decreased', 'O'), ('with', 'O'), ('time', 'O'), ('.', 'O'))$$$"
The patient had a history of alcohol abuse ; alcohol intake as well as withdrawal can also cause seizures .,"(('The', 'O'), ('patient', 'O'), ('had', 'O'), ('a', 'O'), ('history', 'O'), ('of', 'O'), ('alcohol', 'B'), ('abuse', 'I'), (';', 'O'), ('alcohol', 'O'), ('intake', 'O'), ('as', 'O'), ('well', 'O'), ('as', 'O'), ('withdrawal', 'O'), ('can', 'O'), ('also', 'O'), ('cause', 'O'), ('seizures', 'B'), ('.', 'O'))$$$"
The time course of events suggested that amphotericin B was the cause of the seizures in this AIDS patient .,"(('The', 'O'), ('time', 'O'), ('course', 'O'), ('of', 'O'), ('events', 'O'), ('suggested', 'O'), ('that', 'O'), ('amphotericin', 'O'), ('B', 'O'), ('was', 'O'), ('the', 'O'), ('cause', 'O'), ('of', 'O'), ('the', 'O'), ('seizures', 'B'), ('in', 'O'), ('this', 'O'), ('AIDS', 'B'), ('patient', 'O'), ('.', 'O'))$$$"
"Furthermore , 18 . 28 % of patients with a history of chronic urticaria and 11 . 8 % of subjects with an history of NSAID - induced urticaria / angioedema or angioedema alone ( with or without chronic urticaria ) resulted to be intolerant to alternative drugs .","(('Furthermore', 'O'), (',', 'O'), ('18', 'O'), ('.', 'O'), ('28', 'O'), ('%', 'O'), ('of', 'O'), ('patients', 'O'), ('with', 'O'), ('a', 'O'), ('history', 'O'), ('of', 'O'), ('chronic', 'O'), ('urticaria', 'B'), ('and', 'O'), ('11', 'O'), ('.', 'O'), ('8', 'O'), ('%', 'O'), ('of', 'O'), ('subjects', 'O'), ('with', 'O'), ('an', 'O'), ('history', 'O'), ('of', 'O'), ('NSAID', 'O'), ('-', 'O'), ('induced', 'O'), ('urticaria', 'B'), ('/', 'O'), ('angioedema', 'B'), ('or', 'O'), ('angioedema', 'B'), ('alone', 'O'), ('(', 'O'), ('with', 'O'), ('or', 'O'), ('without', 'O'), ('chronic', 'O'), ('urticaria', 'B'), (')', 'O'), ('resulted', 'O'), ('to', 'O'), ('be', 'O'), ('intolerant', 'O'), ('to', 'O'), ('alternative', 'O'), ('drugs', 'O'), ('.', 'O'))$$$"
"METHODS : Forty - three Caucasian patients with primary open - angle glaucoma or ocular hypertension with a mean ( + / - SD ) age of 63 ( + / - 8 ) years were randomized and crossed over in a double - masked manner to 14 days of treatment with placebo ( morning and evening in both eyes ) , timolol solution ( morning and evening in both eyes ) , or timolol gellan ( morning in both eyes with placebo in the evening ) .","(('METHODS', 'O'), (':', 'O'), ('Forty', 'O'), ('-', 'O'), ('three', 'O'), ('Caucasian', 'O'), ('patients', 'O'), ('with', 'O'), ('primary', 'O'), ('open', 'B'), ('-', 'I'), ('angle', 'I'), ('glaucoma', 'I'), ('or', 'O'), ('ocular', 'B'), ('hypertension', 'I'), ('with', 'O'), ('a', 'O'), ('mean', 'O'), ('(', 'O'), ('+', 'O'), ('/', 'O'), ('-', 'O'), ('SD', 'O'), (')', 'O'), ('age', 'O'), ('of', 'O'), ('63', 'O'), ('(', 'O'), ('+', 'O'), ('/', 'O'), ('-', 'O'), ('8', 'O'), (')', 'O'), ('years', 'O'), ('were', 'O'), ('randomized', 'O'), ('and', 'O'), ('crossed', 'O'), ('over', 'O'), ('in', 'O'), ('a', 'O'), ('double', 'O'), ('-', 'O'), ('masked', 'O'), ('manner', 'O'), ('to', 'O'), ('14', 'O'), ('days', 'O'), ('of', 'O'), ('treatment', 'O'), ('with', 'O'), ('placebo', 'O'), ('(', 'O'), ('morning', 'O'), ('and', 'O'), ('evening', 'O'), ('in', 'O'), ('both', 'O'), ('eyes', 'O'), (')', 'O'), (',', 'O'), ('timolol', 'O'), ('solution', 'O'), ('(', 'O'), ('morning', 'O'), ('and', 'O'), ('evening', 'O'), ('in', 'O'), ('both', 'O'), ('eyes', 'O'), (')', 'O'), (',', 'O'), ('or', 'O'), ('timolol', 'O'), ('gellan', 'O'), ('(', 'O'), ('morning', 'O'), ('in', 'O'), ('both', 'O'), ('eyes', 'O'), ('with', 'O'), ('placebo', 'O'), ('in', 'O'), ('the', 'O'), ('evening', 'O'), (')', 'O'), ('.', 'O'))$$$"
"BACKGROUND : Preclinical studies of intrathecal adenosine suggest it may be effective in the treatment of acute and chronic pain in humans , and preliminary studies in volunteers and patients with a Swedish formulation of adenosine suggests it may be effective in hypersensitivity states but not with acute noxious stimulation .","(('BACKGROUND', 'O'), (':', 'O'), ('Preclinical', 'O'), ('studies', 'O'), ('of', 'O'), ('intrathecal', 'O'), ('adenosine', 'O'), ('suggest', 'O'), ('it', 'O'), ('may', 'O'), ('be', 'O'), ('effective', 'O'), ('in', 'O'), ('the', 'O'), ('treatment', 'O'), ('of', 'O'), ('acute', 'B'), ('and', 'I'), ('chronic', 'I'), ('pain', 'I'), ('in', 'O'), ('humans', 'O'), (',', 'O'), ('and', 'O'), ('preliminary', 'O'), ('studies', 'O'), ('in', 'O'), ('volunteers', 'O'), ('and', 'O'), ('patients', 'O'), ('with', 'O'), ('a', 'O'), ('Swedish', 'O'), ('formulation', 'O'), ('of', 'O'), ('adenosine', 'O'), ('suggests', 'O'), ('it', 'O'), ('may', 'O'), ('be', 'O'), ('effective', 'O'), ('in', 'O'), ('hypersensitivity', 'B'), ('states', 'O'), ('but', 'O'), ('not', 'O'), ('with', 'O'), ('acute', 'O'), ('noxious', 'O'), ('stimulation', 'O'), ('.', 'O'))$$$"
"Cerebrospinal fluid was obtained for pharmacokinetic analysis , and pain ratings in response to acute heat stimuli and areas of mechanical hyperalgesia and allodynia after intradermal capsaicin injection were determined .","(('Cerebrospinal', 'O'), ('fluid', 'O'), ('was', 'O'), ('obtained', 'O'), ('for', 'O'), ('pharmacokinetic', 'O'), ('analysis', 'O'), (',', 'O'), ('and', 'O'), ('pain', 'B'), ('ratings', 'O'), ('in', 'O'), ('response', 'O'), ('to', 'O'), ('acute', 'O'), ('heat', 'O'), ('stimuli', 'O'), ('and', 'O'), ('areas', 'O'), ('of', 'O'), ('mechanical', 'B'), ('hyperalgesia', 'I'), ('and', 'O'), ('allodynia', 'B'), ('after', 'O'), ('intradermal', 'O'), ('capsaicin', 'O'), ('injection', 'O'), ('were', 'O'), ('determined', 'O'), ('.', 'O'))$$$"
RESULTS : Adenosine produced no effect on pain report to acute noxious thermal or chemical stimulation but reduced mechanical hyperalgesia and allodynia from intradermal capsaicin injection for at least 24 h .,"(('RESULTS', 'O'), (':', 'O'), ('Adenosine', 'O'), ('produced', 'O'), ('no', 'O'), ('effect', 'O'), ('on', 'O'), ('pain', 'B'), ('report', 'O'), ('to', 'O'), ('acute', 'O'), ('noxious', 'O'), ('thermal', 'O'), ('or', 'O'), ('chemical', 'O'), ('stimulation', 'O'), ('but', 'O'), ('reduced', 'O'), ('mechanical', 'B'), ('hyperalgesia', 'I'), ('and', 'O'), ('allodynia', 'B'), ('from', 'O'), ('intradermal', 'O'), ('capsaicin', 'O'), ('injection', 'O'), ('for', 'O'), ('at', 'O'), ('least', 'O'), ('24', 'O'), ('h', 'O'), ('.', 'O'))$$$"
The long - lasting effect is consistent with that observed in preliminary reports of patients with chronic neuropathic pain and is not due to prolonged residence of adenosine in cerebrospinal fluid .,"(('The', 'O'), ('long', 'O'), ('-', 'O'), ('lasting', 'O'), ('effect', 'O'), ('is', 'O'), ('consistent', 'O'), ('with', 'O'), ('that', 'O'), ('observed', 'O'), ('in', 'O'), ('preliminary', 'O'), ('reports', 'O'), ('of', 'O'), ('patients', 'O'), ('with', 'O'), ('chronic', 'O'), ('neuropathic', 'B'), ('pain', 'I'), ('and', 'O'), ('is', 'O'), ('not', 'O'), ('due', 'O'), ('to', 'O'), ('prolonged', 'O'), ('residence', 'O'), ('of', 'O'), ('adenosine', 'O'), ('in', 'O'), ('cerebrospinal', 'O'), ('fluid', 'O'), ('.', 'O'))$$$"
PATIENTS : 14 patients seen over a 3 - year period in whom heparin - induced thrombocytopenia became apparent on delayed presentation with thromboembolic complications .,"(('PATIENTS', 'O'), (':', 'O'), ('14', 'O'), ('patients', 'O'), ('seen', 'O'), ('over', 'O'), ('a', 'O'), ('3', 'O'), ('-', 'O'), ('year', 'O'), ('period', 'O'), ('in', 'O'), ('whom', 'O'), ('heparin', 'O'), ('-', 'O'), ('induced', 'O'), ('thrombocytopenia', 'B'), ('became', 'O'), ('apparent', 'O'), ('on', 'O'), ('delayed', 'O'), ('presentation', 'O'), ('with', 'O'), ('thromboembolic', 'B'), ('complications', 'O'), ('.', 'O'))$$$"
"RESULTS : Patients went home after hospitalizations that had included heparin exposure - - in most cases , with no thrombocytopenia recognized - - only to return to the hospital ( median , day 14 ) with thromboembolic complications .","(('RESULTS', 'O'), (':', 'O'), ('Patients', 'O'), ('went', 'O'), ('home', 'O'), ('after', 'O'), ('hospitalizations', 'O'), ('that', 'O'), ('had', 'O'), ('included', 'O'), ('heparin', 'O'), ('exposure', 'O'), ('-', 'O'), ('-', 'O'), ('in', 'O'), ('most', 'O'), ('cases', 'O'), (',', 'O'), ('with', 'O'), ('no', 'O'), ('thrombocytopenia', 'B'), ('recognized', 'O'), ('-', 'O'), ('-', 'O'), ('only', 'O'), ('to', 'O'), ('return', 'O'), ('to', 'O'), ('the', 'O'), ('hospital', 'O'), ('(', 'O'), ('median', 'O'), (',', 'O'), ('day', 'O'), ('14', 'O'), (')', 'O'), ('with', 'O'), ('thromboembolic', 'B'), ('complications', 'O'), ('.', 'O'))$$$"
"Thromboemboli were venous ( 12 patients , 7 with pulmonary emboli ) or arterial ( 4 patients ) or both .","(('Thromboemboli', 'B'), ('were', 'O'), ('venous', 'O'), ('(', 'O'), ('12', 'O'), ('patients', 'O'), (',', 'O'), ('7', 'O'), ('with', 'O'), ('pulmonary', 'B'), ('emboli', 'I'), (')', 'O'), ('or', 'O'), ('arterial', 'O'), ('(', 'O'), ('4', 'O'), ('patients', 'O'), (')', 'O'), ('or', 'O'), ('both', 'O'), ('.', 'O'))$$$"
Chronically elevated prolactin levels in children with prolactinomas may be associated with arrested growth and development resulting in either delayed puberty or short stature .,"(('Chronically', 'O'), ('elevated', 'O'), ('prolactin', 'O'), ('levels', 'O'), ('in', 'O'), ('children', 'O'), ('with', 'O'), ('prolactinomas', 'B'), ('may', 'O'), ('be', 'O'), ('associated', 'O'), ('with', 'O'), ('arrested', 'O'), ('growth', 'O'), ('and', 'O'), ('development', 'O'), ('resulting', 'O'), ('in', 'O'), ('either', 'O'), ('delayed', 'B'), ('puberty', 'I'), ('or', 'O'), ('short', 'O'), ('stature', 'O'), ('.', 'O'))$$$"
Torsade de pointes induced by metoclopramide in an elderly woman with preexisting complete left bundle branch block .,"(('Torsade', 'B'), ('de', 'I'), ('pointes', 'I'), ('induced', 'O'), ('by', 'O'), ('metoclopramide', 'O'), ('in', 'O'), ('an', 'O'), ('elderly', 'O'), ('woman', 'O'), ('with', 'O'), ('preexisting', 'O'), ('complete', 'O'), ('left', 'B'), ('bundle', 'I'), ('branch', 'I'), ('block', 'I'), ('.', 'O'))$$$"
We report on a 92 - year - old woman with preexisting complete left bundle branch block who developed torsade de pointes after intravenous and oral administration of metoclopramide .,"(('We', 'O'), ('report', 'O'), ('on', 'O'), ('a', 'O'), ('92', 'O'), ('-', 'O'), ('year', 'O'), ('-', 'O'), ('old', 'O'), ('woman', 'O'), ('with', 'O'), ('preexisting', 'O'), ('complete', 'O'), ('left', 'B'), ('bundle', 'I'), ('branch', 'I'), ('block', 'I'), ('who', 'O'), ('developed', 'O'), ('torsade', 'B'), ('de', 'I'), ('pointes', 'I'), ('after', 'O'), ('intravenous', 'O'), ('and', 'O'), ('oral', 'O'), ('administration', 'O'), ('of', 'O'), ('metoclopramide', 'O'), ('.', 'O'))$$$"
Excitotoxicity leading to neuronal cell death in the affected areas is a major consequence of seizures at the cellular level .,"(('Excitotoxicity', 'B'), ('leading', 'O'), ('to', 'O'), ('neuronal', 'O'), ('cell', 'O'), ('death', 'O'), ('in', 'O'), ('the', 'O'), ('affected', 'O'), ('areas', 'O'), ('is', 'O'), ('a', 'O'), ('major', 'O'), ('consequence', 'O'), ('of', 'O'), ('seizures', 'B'), ('at', 'O'), ('the', 'O'), ('cellular', 'O'), ('level', 'O'), ('.', 'O'))$$$"
"In this respect , little is known about the role of DA receptors in the occurrence of epilepsy - induced neuronal cell death .","(('In', 'O'), ('this', 'O'), ('respect', 'O'), (',', 'O'), ('little', 'O'), ('is', 'O'), ('known', 'O'), ('about', 'O'), ('the', 'O'), ('role', 'O'), ('of', 'O'), ('DA', 'O'), ('receptors', 'O'), ('in', 'O'), ('the', 'O'), ('occurrence', 'O'), ('of', 'O'), ('epilepsy', 'B'), ('-', 'O'), ('induced', 'O'), ('neuronal', 'O'), ('cell', 'O'), ('death', 'O'), ('.', 'O'))$$$"
"However , pilocarpine - induced seizures result in a more widespread neuronal death in both WT and D2R - / - brains in comparison to KA .","(('However', 'O'), (',', 'O'), ('pilocarpine', 'O'), ('-', 'O'), ('induced', 'O'), ('seizures', 'B'), ('result', 'O'), ('in', 'O'), ('a', 'O'), ('more', 'O'), ('widespread', 'O'), ('neuronal', 'O'), ('death', 'O'), ('in', 'O'), ('both', 'O'), ('WT', 'O'), ('and', 'O'), ('D2R', 'O'), ('-', 'O'), ('/', 'O'), ('-', 'O'), ('brains', 'O'), ('in', 'O'), ('comparison', 'O'), ('to', 'O'), ('KA', 'O'), ('.', 'O'))$$$"
Selective distal tubular epithelial toxicity seems to be responsible for the profound potassium wasting that is a major clinical side effect of treatment with AmB .,"(('Selective', 'O'), ('distal', 'O'), ('tubular', 'O'), ('epithelial', 'O'), ('toxicity', 'B'), ('seems', 'O'), ('to', 'O'), ('be', 'O'), ('responsible', 'O'), ('for', 'O'), ('the', 'O'), ('profound', 'O'), ('potassium', 'O'), ('wasting', 'O'), ('that', 'O'), ('is', 'O'), ('a', 'O'), ('major', 'O'), ('clinical', 'O'), ('side', 'O'), ('effect', 'O'), ('of', 'O'), ('treatment', 'O'), ('with', 'O'), ('AmB', 'O'), ('.', 'O'))$$$"
Potassium depletion also potentiates the tubular toxicity of AmB .,"(('Potassium', 'O'), ('depletion', 'O'), ('also', 'O'), ('potentiates', 'O'), ('the', 'O'), ('tubular', 'O'), ('toxicity', 'B'), ('of', 'O'), ('AmB', 'O'), ('.', 'O'))$$$"
Erectile dysfunction occurs following substantia nigra lesions in the rat .,"(('Erectile', 'B'), ('dysfunction', 'I'), ('occurs', 'O'), ('following', 'O'), ('substantia', 'O'), ('nigra', 'O'), ('lesions', 'O'), ('in', 'O'), ('the', 'O'), ('rat', 'O'), ('.', 'O'))$$$"
A pathological increase of forces was seen in ON - state in Parkinson ' s disease + LID only .,"(('A', 'O'), ('pathological', 'O'), ('increase', 'O'), ('of', 'O'), ('forces', 'O'), ('was', 'O'), ('seen', 'O'), ('in', 'O'), ('ON', 'O'), ('-', 'O'), ('state', 'O'), ('in', 'O'), ('Parkinson', 'B'), (""'"", 'I'), ('s', 'I'), ('disease', 'I'), ('+', 'O'), ('LID', 'B'), ('only', 'O'), ('.', 'O'))$$$"
"In Parkinson ' s disease + LID , the force involved in pressing down the object before lifting was significantly increased by levodopa ( by 61 % , P < 0 . 05 ) .","(('In', 'O'), ('Parkinson', 'B'), (""'"", 'I'), ('s', 'I'), ('disease', 'I'), ('+', 'O'), ('LID', 'B'), (',', 'O'), ('the', 'O'), ('force', 'O'), ('involved', 'O'), ('in', 'O'), ('pressing', 'O'), ('down', 'O'), ('the', 'O'), ('object', 'O'), ('before', 'O'), ('lifting', 'O'), ('was', 'O'), ('significantly', 'O'), ('increased', 'O'), ('by', 'O'), ('levodopa', 'O'), ('(', 'O'), ('by', 'O'), ('61', 'O'), ('%', 'O'), (',', 'O'), ('P', 'O'), ('<', 'O'), ('0', 'O'), ('.', 'O'), ('05', 'O'), (')', 'O'), ('.', 'O'))$$$"
"In contrast , no excessive force was found in Parkinson ' s disease - LID .","(('In', 'O'), ('contrast', 'O'), (',', 'O'), ('no', 'O'), ('excessive', 'O'), ('force', 'O'), ('was', 'O'), ('found', 'O'), ('in', 'O'), ('Parkinson', 'B'), (""'"", 'I'), ('s', 'I'), ('disease', 'I'), ('-', 'O'), ('LID', 'B'), ('.', 'O'))$$$"
"Peak grip force in ON - state was 140 % ( P < 0 . 05 ) higher in Parkinson ' s disease + LID than in Parkinson ' s disease - LID , while static grip force was increased by 138 % ( P < 0 . 01 ) between groups .","(('Peak', 'O'), ('grip', 'O'), ('force', 'O'), ('in', 'O'), ('ON', 'O'), ('-', 'O'), ('state', 'O'), ('was', 'O'), ('140', 'O'), ('%', 'O'), ('(', 'O'), ('P', 'O'), ('<', 'O'), ('0', 'O'), ('.', 'O'), ('05', 'O'), (')', 'O'), ('higher', 'O'), ('in', 'O'), ('Parkinson', 'B'), (""'"", 'I'), ('s', 'I'), ('disease', 'I'), ('+', 'O'), ('LID', 'B'), ('than', 'O'), ('in', 'O'), ('Parkinson', 'B'), (""'"", 'I'), ('s', 'I'), ('disease', 'I'), ('-', 'O'), ('LID', 'B'), (',', 'O'), ('while', 'O'), ('static', 'O'), ('grip', 'O'), ('force', 'O'), ('was', 'O'), ('increased', 'O'), ('by', 'O'), ('138', 'O'), ('%', 'O'), ('(', 'O'), ('P', 'O'), ('<', 'O'), ('0', 'O'), ('.', 'O'), ('01', 'O'), (')', 'O'), ('between', 'O'), ('groups', 'O'), ('.', 'O'))$$$"
Force excess was only observed in patients with LID and motor fluctuations .,"(('Force', 'O'), ('excess', 'O'), ('was', 'O'), ('only', 'O'), ('observed', 'O'), ('in', 'O'), ('patients', 'O'), ('with', 'O'), ('LID', 'B'), ('and', 'O'), ('motor', 'O'), ('fluctuations', 'O'), ('.', 'O'))$$$"
"This study focuses on behavioral syndromes that may used as models for Parkinson ' s disease , or tardive dyskinesia , and its response after glutamatergic blockage .","(('This', 'O'), ('study', 'O'), ('focuses', 'O'), ('on', 'O'), ('behavioral', 'O'), ('syndromes', 'O'), ('that', 'O'), ('may', 'O'), ('used', 'O'), ('as', 'O'), ('models', 'O'), ('for', 'O'), ('Parkinson', 'B'), (""'"", 'I'), ('s', 'I'), ('disease', 'I'), (',', 'O'), ('or', 'O'), ('tardive', 'B'), ('dyskinesia', 'I'), (',', 'O'), ('and', 'O'), ('its', 'O'), ('response', 'O'), ('after', 'O'), ('glutamatergic', 'O'), ('blockage', 'O'), ('.', 'O'))$$$"
"Reserpine ( 1 mg / kg ) , administered 90 min before the test and followed by apomophine injection ( 0 . 1 mg / kg ) 5 min before the test , did not produce oral dyskinesia in mice .","(('Reserpine', 'O'), ('(', 'O'), ('1', 'O'), ('mg', 'O'), ('/', 'O'), ('kg', 'O'), (')', 'O'), (',', 'O'), ('administered', 'O'), ('90', 'O'), ('min', 'O'), ('before', 'O'), ('the', 'O'), ('test', 'O'), ('and', 'O'), ('followed', 'O'), ('by', 'O'), ('apomophine', 'O'), ('injection', 'O'), ('(', 'O'), ('0', 'O'), ('.', 'O'), ('1', 'O'), ('mg', 'O'), ('/', 'O'), ('kg', 'O'), (')', 'O'), ('5', 'O'), ('min', 'O'), ('before', 'O'), ('the', 'O'), ('test', 'O'), (',', 'O'), ('did', 'O'), ('not', 'O'), ('produce', 'O'), ('oral', 'B'), ('dyskinesia', 'I'), ('in', 'O'), ('mice', 'O'), ('.', 'O'))$$$"
"These results show that reserpine produces different and abnormal movements , which are related to dose and schedule employed and can be considered as parkinsonian - like and tardive dsykinesia signs .","(('These', 'O'), ('results', 'O'), ('show', 'O'), ('that', 'O'), ('reserpine', 'O'), ('produces', 'O'), ('different', 'O'), ('and', 'O'), ('abnormal', 'B'), ('movements', 'I'), (',', 'O'), ('which', 'O'), ('are', 'O'), ('related', 'O'), ('to', 'O'), ('dose', 'O'), ('and', 'O'), ('schedule', 'O'), ('employed', 'O'), ('and', 'O'), ('can', 'O'), ('be', 'O'), ('considered', 'O'), ('as', 'O'), ('parkinsonian', 'B'), ('-', 'O'), ('like', 'O'), ('and', 'O'), ('tardive', 'B'), ('dsykinesia', 'I'), ('signs', 'O'), ('.', 'O'))$$$"
"Two schizophrenic patients , who had a prior history of LSD abuse and who had previously developed EPS with classic antipsychotics , were successfully treated with risperidone .","(('Two', 'O'), ('schizophrenic', 'B'), ('patients', 'O'), (',', 'O'), ('who', 'O'), ('had', 'O'), ('a', 'O'), ('prior', 'O'), ('history', 'O'), ('of', 'O'), ('LSD', 'O'), ('abuse', 'O'), ('and', 'O'), ('who', 'O'), ('had', 'O'), ('previously', 'O'), ('developed', 'O'), ('EPS', 'B'), ('with', 'O'), ('classic', 'O'), ('antipsychotics', 'O'), (',', 'O'), ('were', 'O'), ('successfully', 'O'), ('treated', 'O'), ('with', 'O'), ('risperidone', 'O'), ('.', 'O'))$$$"
"This imagery resembled visual disturbances previously experienced as "" flashbacks "" related to prior LSD consumption .","(('This', 'O'), ('imagery', 'O'), ('resembled', 'O'), ('visual', 'B'), ('disturbances', 'I'), ('previously', 'O'), ('experienced', 'O'), ('as', 'O'), ('""', 'O'), ('flashbacks', 'O'), ('""', 'O'), ('related', 'O'), ('to', 'O'), ('prior', 'O'), ('LSD', 'O'), ('consumption', 'O'), ('.', 'O'))$$$"
Topiramate is a recently developed antiepileptic medication that is becoming more widely prescribed because of its efficacy in treating refractory seizures .,"(('Topiramate', 'O'), ('is', 'O'), ('a', 'O'), ('recently', 'O'), ('developed', 'O'), ('antiepileptic', 'O'), ('medication', 'O'), ('that', 'O'), ('is', 'O'), ('becoming', 'O'), ('more', 'O'), ('widely', 'O'), ('prescribed', 'O'), ('because', 'O'), ('of', 'O'), ('its', 'O'), ('efficacy', 'O'), ('in', 'O'), ('treating', 'O'), ('refractory', 'B'), ('seizures', 'I'), ('.', 'O'))$$$"
"Diazepam , unless contraindicated or risky , remains the only necessary complementary drug to ketamine as it buffers its cardiovascular response and decreases the duration and intensity of operative and postoperative hallucinations .","(('Diazepam', 'O'), (',', 'O'), ('unless', 'O'), ('contraindicated', 'O'), ('or', 'O'), ('risky', 'O'), (',', 'O'), ('remains', 'O'), ('the', 'O'), ('only', 'O'), ('necessary', 'O'), ('complementary', 'O'), ('drug', 'O'), ('to', 'O'), ('ketamine', 'O'), ('as', 'O'), ('it', 'O'), ('buffers', 'O'), ('its', 'O'), ('cardiovascular', 'O'), ('response', 'O'), ('and', 'O'), ('decreases', 'O'), ('the', 'O'), ('duration', 'O'), ('and', 'O'), ('intensity', 'O'), ('of', 'O'), ('operative', 'O'), ('and', 'O'), ('postoperative', 'O'), ('hallucinations', 'B'), ('.', 'O'))$$$"
"There are no approved antiviral agents with proven efficacy for the treatment of severe adenovirus disease , nor are there any prospective randomized , controlled trials of potentially useful anti - adenovirus therapies .","(('There', 'O'), ('are', 'O'), ('no', 'O'), ('approved', 'O'), ('antiviral', 'O'), ('agents', 'O'), ('with', 'O'), ('proven', 'O'), ('efficacy', 'O'), ('for', 'O'), ('the', 'O'), ('treatment', 'O'), ('of', 'O'), ('severe', 'O'), ('adenovirus', 'B'), ('disease', 'I'), (',', 'O'), ('nor', 'O'), ('are', 'O'), ('there', 'O'), ('any', 'O'), ('prospective', 'O'), ('randomized', 'O'), (',', 'O'), ('controlled', 'O'), ('trials', 'O'), ('of', 'O'), ('potentially', 'O'), ('useful', 'O'), ('anti', 'O'), ('-', 'O'), ('adenovirus', 'O'), ('therapies', 'O'), ('.', 'O'))$$$"
Intravenous ribavirin is the treatment of choice for infection with hemorrhagic fever viruses .,"(('Intravenous', 'O'), ('ribavirin', 'O'), ('is', 'O'), ('the', 'O'), ('treatment', 'O'), ('of', 'O'), ('choice', 'O'), ('for', 'O'), ('infection', 'B'), ('with', 'I'), ('hemorrhagic', 'I'), ('fever', 'I'), ('viruses', 'I'), ('.', 'O'))$$$"
"Two patients developed adenovirus hemorrhagic cystitis after cardiac and bone marrow transplants , respectively .","(('Two', 'O'), ('patients', 'O'), ('developed', 'O'), ('adenovirus', 'O'), ('hemorrhagic', 'B'), ('cystitis', 'I'), ('after', 'O'), ('cardiac', 'O'), ('and', 'O'), ('bone', 'O'), ('marrow', 'O'), ('transplants', 'O'), (',', 'O'), ('respectively', 'O'), ('.', 'O'))$$$"
"An additional 3 children developed adenovirus pneumonia ; 2 were neonates , 1 of whom had partial DiGeorge syndrome .","(('An', 'O'), ('additional', 'O'), ('3', 'O'), ('children', 'O'), ('developed', 'O'), ('adenovirus', 'B'), ('pneumonia', 'I'), (';', 'O'), ('2', 'O'), ('were', 'O'), ('neonates', 'O'), (',', 'O'), ('1', 'O'), ('of', 'O'), ('whom', 'O'), ('had', 'O'), ('partial', 'O'), ('DiGeorge', 'B'), ('syndrome', 'I'), ('.', 'O'))$$$"
RESULTS : Complete clinical recovery followed later by viral clearance was observed in 2 children : the cardiac transplant recipient with adenovirus hemorrhagic cystitis and the immunocompetent neonate with adenovirus pneumonia .,"(('RESULTS', 'O'), (':', 'O'), ('Complete', 'O'), ('clinical', 'O'), ('recovery', 'O'), ('followed', 'O'), ('later', 'O'), ('by', 'O'), ('viral', 'O'), ('clearance', 'O'), ('was', 'O'), ('observed', 'O'), ('in', 'O'), ('2', 'O'), ('children', 'O'), (':', 'O'), ('the', 'O'), ('cardiac', 'O'), ('transplant', 'O'), ('recipient', 'O'), ('with', 'O'), ('adenovirus', 'O'), ('hemorrhagic', 'B'), ('cystitis', 'I'), ('and', 'O'), ('the', 'O'), ('immunocompetent', 'O'), ('neonate', 'O'), ('with', 'O'), ('adenovirus', 'B'), ('pneumonia', 'I'), ('.', 'O'))$$$"
Use of cidofovir in 1 child was associated with progressive renal failure and neutropenia .,"(('Use', 'O'), ('of', 'O'), ('cidofovir', 'O'), ('in', 'O'), ('1', 'O'), ('child', 'O'), ('was', 'O'), ('associated', 'O'), ('with', 'O'), ('progressive', 'B'), ('renal', 'I'), ('failure', 'I'), ('and', 'O'), ('neutropenia', 'B'), ('.', 'O'))$$$"
"Although intravenous ribavirin was not effective for all children with severe adenovirus disease in this series or in the literature , therapy is unlikely to be of benefit if begun late in the course of the infection .","(('Although', 'O'), ('intravenous', 'O'), ('ribavirin', 'O'), ('was', 'O'), ('not', 'O'), ('effective', 'O'), ('for', 'O'), ('all', 'O'), ('children', 'O'), ('with', 'O'), ('severe', 'O'), ('adenovirus', 'B'), ('disease', 'I'), ('in', 'O'), ('this', 'O'), ('series', 'O'), ('or', 'O'), ('in', 'O'), ('the', 'O'), ('literature', 'O'), (',', 'O'), ('therapy', 'O'), ('is', 'O'), ('unlikely', 'O'), ('to', 'O'), ('be', 'O'), ('of', 'O'), ('benefit', 'O'), ('if', 'O'), ('begun', 'O'), ('late', 'O'), ('in', 'O'), ('the', 'O'), ('course', 'O'), ('of', 'O'), ('the', 'O'), ('infection', 'B'), ('.', 'O'))$$$"
Delayed asystolic cardiac arrest after diltiazem overdose ; resuscitation with high dose intravenous calcium .,"(('Delayed', 'O'), ('asystolic', 'B'), ('cardiac', 'B'), ('arrest', 'I'), ('after', 'O'), ('diltiazem', 'O'), ('overdose', 'B'), (';', 'O'), ('resuscitation', 'O'), ('with', 'O'), ('high', 'O'), ('dose', 'O'), ('intravenous', 'O'), ('calcium', 'O'), ('.', 'O'))$$$"
"The patient remained unresponsive with junctional bradycardia , unrecordable blood pressure , and then became asystolic .","(('The', 'O'), ('patient', 'O'), ('remained', 'O'), ('unresponsive', 'O'), ('with', 'O'), ('junctional', 'O'), ('bradycardia', 'B'), (',', 'O'), ('unrecordable', 'O'), ('blood', 'O'), ('pressure', 'O'), (',', 'O'), ('and', 'O'), ('then', 'O'), ('became', 'O'), ('asystolic', 'B'), ('.', 'O'))$$$"
"Immunohistochemical study on inducible type of nitric oxide ( iNOS ) , basic fibroblast growth factor ( bFGF ) and tumor growth factor - beta1 ( TGF - beta1 ) in arteritis induced in rats by fenoldopam and theophylline , vasodilators .","(('Immunohistochemical', 'O'), ('study', 'O'), ('on', 'O'), ('inducible', 'O'), ('type', 'O'), ('of', 'O'), ('nitric', 'O'), ('oxide', 'O'), ('(', 'O'), ('iNOS', 'O'), (')', 'O'), (',', 'O'), ('basic', 'O'), ('fibroblast', 'O'), ('growth', 'O'), ('factor', 'O'), ('(', 'O'), ('bFGF', 'O'), (')', 'O'), ('and', 'O'), ('tumor', 'B'), ('growth', 'O'), ('factor', 'O'), ('-', 'O'), ('beta1', 'O'), ('(', 'O'), ('TGF', 'O'), ('-', 'O'), ('beta1', 'O'), (')', 'O'), ('in', 'O'), ('arteritis', 'B'), ('induced', 'O'), ('in', 'O'), ('rats', 'O'), ('by', 'O'), ('fenoldopam', 'O'), ('and', 'O'), ('theophylline', 'O'), (',', 'O'), ('vasodilators', 'O'), ('.', 'O'))$$$"
"Arteritis induced in rats by vasodilators , fenoldopam and theophylline , was examined immunohistochemically for expressions of inducible type of nitric oxide synthase ( iNOS ) , basic fibroblast growth factor ( bFGF ) and tumor growth factor - beta1 ( TGF - beta1 ) .","(('Arteritis', 'B'), ('induced', 'O'), ('in', 'O'), ('rats', 'O'), ('by', 'O'), ('vasodilators', 'O'), (',', 'O'), ('fenoldopam', 'O'), ('and', 'O'), ('theophylline', 'O'), (',', 'O'), ('was', 'O'), ('examined', 'O'), ('immunohistochemically', 'O'), ('for', 'O'), ('expressions', 'O'), ('of', 'O'), ('inducible', 'O'), ('type', 'O'), ('of', 'O'), ('nitric', 'O'), ('oxide', 'O'), ('synthase', 'O'), ('(', 'O'), ('iNOS', 'O'), (')', 'O'), (',', 'O'), ('basic', 'O'), ('fibroblast', 'O'), ('growth', 'O'), ('factor', 'O'), ('(', 'O'), ('bFGF', 'O'), (')', 'O'), ('and', 'O'), ('tumor', 'B'), ('growth', 'O'), ('factor', 'O'), ('-', 'O'), ('beta1', 'O'), ('(', 'O'), ('TGF', 'O'), ('-', 'O'), ('beta1', 'O'), (')', 'O'), ('.', 'O'))$$$"
"Haloperidol ( 1 mg / kg ip ) induced parkinsonian - like muscle rigidity , measured as an increased resistance of a rat ' s hind foot to passive flexion and extension at the ankle joint .","(('Haloperidol', 'O'), ('(', 'O'), ('1', 'O'), ('mg', 'O'), ('/', 'O'), ('kg', 'O'), ('ip', 'O'), (')', 'O'), ('induced', 'O'), ('parkinsonian', 'B'), ('-', 'O'), ('like', 'O'), ('muscle', 'B'), ('rigidity', 'I'), (',', 'O'), ('measured', 'O'), ('as', 'O'), ('an', 'O'), ('increased', 'O'), ('resistance', 'O'), ('of', 'O'), ('a', 'O'), ('rat', 'O'), (""'"", 'O'), ('s', 'O'), ('hind', 'O'), ('foot', 'O'), ('to', 'O'), ('passive', 'O'), ('flexion', 'O'), ('and', 'O'), ('extension', 'O'), ('at', 'O'), ('the', 'O'), ('ankle', 'O'), ('joint', 'O'), ('.', 'O'))$$$"
Liver biopsy showed evidence of nonspecific drug - induced acute liver injury .,"(('Liver', 'O'), ('biopsy', 'O'), ('showed', 'O'), ('evidence', 'O'), ('of', 'O'), ('nonspecific', 'O'), ('drug', 'B'), ('-', 'I'), ('induced', 'I'), ('acute', 'I'), ('liver', 'I'), ('injury', 'I'), ('.', 'O'))$$$"
CONCLUSIONS : Clinicians should be aware of the possibility of acute liver insult induced by bupropion given concurrently with other hepatotoxic drugs .,"(('CONCLUSIONS', 'O'), (':', 'O'), ('Clinicians', 'O'), ('should', 'O'), ('be', 'O'), ('aware', 'O'), ('of', 'O'), ('the', 'O'), ('possibility', 'O'), ('of', 'O'), ('acute', 'B'), ('liver', 'I'), ('insult', 'I'), ('induced', 'O'), ('by', 'O'), ('bupropion', 'O'), ('given', 'O'), ('concurrently', 'O'), ('with', 'O'), ('other', 'O'), ('hepatotoxic', 'B'), ('drugs', 'O'), ('.', 'O'))$$$"
Levodopa - induced oromandibular dystonia in progressive supranuclear palsy .,"(('Levodopa', 'O'), ('-', 'O'), ('induced', 'O'), ('oromandibular', 'O'), ('dystonia', 'B'), ('in', 'O'), ('progressive', 'B'), ('supranuclear', 'I'), ('palsy', 'I'), ('.', 'O'))$$$"
Cranial dystonias are rare in patients with progressive supranuclear palsy ( PSP ) .,"(('Cranial', 'O'), ('dystonias', 'B'), ('are', 'O'), ('rare', 'O'), ('in', 'O'), ('patients', 'O'), ('with', 'O'), ('progressive', 'B'), ('supranuclear', 'I'), ('palsy', 'I'), ('(', 'O'), ('PSP', 'B'), (')', 'O'), ('.', 'O'))$$$"
"Since 1989 , she had been suffering from systemic lupus erythematosus ( SLE ) with renal involvement and undergone periods of treatment with azathioprine and cyclophosphamide .","(('Since', 'O'), ('1989', 'O'), (',', 'O'), ('she', 'O'), ('had', 'O'), ('been', 'O'), ('suffering', 'O'), ('from', 'O'), ('systemic', 'B'), ('lupus', 'I'), ('erythematosus', 'I'), ('(', 'O'), ('SLE', 'B'), (')', 'O'), ('with', 'O'), ('renal', 'B'), ('involvement', 'I'), ('and', 'O'), ('undergone', 'O'), ('periods', 'O'), ('of', 'O'), ('treatment', 'O'), ('with', 'O'), ('azathioprine', 'O'), ('and', 'O'), ('cyclophosphamide', 'O'), ('.', 'O'))$$$"
"Thus , muscle biopsy of the deltoid muscle was performed in order to exclude polymyositis or toxic myopathy .","(('Thus', 'O'), (',', 'O'), ('muscle', 'O'), ('biopsy', 'O'), ('of', 'O'), ('the', 'O'), ('deltoid', 'O'), ('muscle', 'O'), ('was', 'O'), ('performed', 'O'), ('in', 'O'), ('order', 'O'), ('to', 'O'), ('exclude', 'O'), ('polymyositis', 'B'), ('or', 'O'), ('toxic', 'O'), ('myopathy', 'B'), ('.', 'O'))$$$"
Seizure associated with sleep deprivation and sustained - release bupropion .,"(('Seizure', 'B'), ('associated', 'O'), ('with', 'O'), ('sleep', 'B'), ('deprivation', 'I'), ('and', 'O'), ('sustained', 'O'), ('-', 'O'), ('release', 'O'), ('bupropion', 'O'), ('.', 'O'))$$$"
This case report describes a generalized seizure associated with sustained - release bupropion use and sleep deprivation .,"(('This', 'O'), ('case', 'O'), ('report', 'O'), ('describes', 'O'), ('a', 'O'), ('generalized', 'O'), ('seizure', 'B'), ('associated', 'O'), ('with', 'O'), ('sustained', 'O'), ('-', 'O'), ('release', 'O'), ('bupropion', 'O'), ('use', 'O'), ('and', 'O'), ('sleep', 'B'), ('deprivation', 'I'), ('.', 'O'))$$$"
"After 5 weeks of bupropion use , the subject experienced a generalized tonic clonic seizure after staying up nearly all night packing and moving to a new residence .","(('After', 'O'), ('5', 'O'), ('weeks', 'O'), ('of', 'O'), ('bupropion', 'O'), ('use', 'O'), (',', 'O'), ('the', 'O'), ('subject', 'O'), ('experienced', 'O'), ('a', 'O'), ('generalized', 'O'), ('tonic', 'O'), ('clonic', 'O'), ('seizure', 'B'), ('after', 'O'), ('staying', 'O'), ('up', 'O'), ('nearly', 'O'), ('all', 'O'), ('night', 'O'), ('packing', 'O'), ('and', 'O'), ('moving', 'O'), ('to', 'O'), ('a', 'O'), ('new', 'O'), ('residence', 'O'), ('.', 'O'))$$$"
We suggest that sleep deprivation may add to the risk of bupropion - associated seizures .,"(('We', 'O'), ('suggest', 'O'), ('that', 'O'), ('sleep', 'B'), ('deprivation', 'I'), ('may', 'O'), ('add', 'O'), ('to', 'O'), ('the', 'O'), ('risk', 'O'), ('of', 'O'), ('bupropion', 'O'), ('-', 'O'), ('associated', 'O'), ('seizures', 'B'), ('.', 'O'))$$$"
"In addition , interleukin - 6 ( IL - 6 ) as an early marker of inflammation was assessed in a subgroup of 10 patients pretreated with saline .","(('In', 'O'), ('addition', 'O'), (',', 'O'), ('interleukin', 'O'), ('-', 'O'), ('6', 'O'), ('(', 'O'), ('IL', 'O'), ('-', 'O'), ('6', 'O'), (')', 'O'), ('as', 'O'), ('an', 'O'), ('early', 'O'), ('marker', 'O'), ('of', 'O'), ('inflammation', 'B'), ('was', 'O'), ('assessed', 'O'), ('in', 'O'), ('a', 'O'), ('subgroup', 'O'), ('of', 'O'), ('10', 'O'), ('patients', 'O'), ('pretreated', 'O'), ('with', 'O'), ('saline', 'O'), ('.', 'O'))$$$"
"Furthermore , there was no significant relationship between postoperative myalgia and time course of interleukin - 6 concentrations , a marker of inflammation .","(('Furthermore', 'O'), (',', 'O'), ('there', 'O'), ('was', 'O'), ('no', 'O'), ('significant', 'O'), ('relationship', 'O'), ('between', 'O'), ('postoperative', 'B'), ('myalgia', 'I'), ('and', 'O'), ('time', 'O'), ('course', 'O'), ('of', 'O'), ('interleukin', 'O'), ('-', 'O'), ('6', 'O'), ('concentrations', 'O'), (',', 'O'), ('a', 'O'), ('marker', 'O'), ('of', 'O'), ('inflammation', 'B'), ('.', 'O'))$$$"
"Similarly , when the P450 - mediated metabolism of lindane was blocked by cobalt chloride incidence of convulsions was increased in animals treated with lindane indicating that lindane per se or its metabolites formed by PB or ethanol inducible P450 isoenzymes are involved in its neurobehavioral toxicity .","(('Similarly', 'O'), (',', 'O'), ('when', 'O'), ('the', 'O'), ('P450', 'O'), ('-', 'O'), ('mediated', 'O'), ('metabolism', 'O'), ('of', 'O'), ('lindane', 'O'), ('was', 'O'), ('blocked', 'O'), ('by', 'O'), ('cobalt', 'O'), ('chloride', 'O'), ('incidence', 'O'), ('of', 'O'), ('convulsions', 'B'), ('was', 'O'), ('increased', 'O'), ('in', 'O'), ('animals', 'O'), ('treated', 'O'), ('with', 'O'), ('lindane', 'O'), ('indicating', 'O'), ('that', 'O'), ('lindane', 'O'), ('per', 'O'), ('se', 'O'), ('or', 'O'), ('its', 'O'), ('metabolites', 'O'), ('formed', 'O'), ('by', 'O'), ('PB', 'O'), ('or', 'O'), ('ethanol', 'O'), ('inducible', 'O'), ('P450', 'O'), ('isoenzymes', 'O'), ('are', 'O'), ('involved', 'O'), ('in', 'O'), ('its', 'O'), ('neurobehavioral', 'O'), ('toxicity', 'B'), ('.', 'O'))$$$"
"Objectives of the current study were to compare results between Sprague - Dawley ( SD ) and Wistar strains when ASA is administered on GD 9 , 10 , or 11 ; to compare the malformation patterns following single and multiple dosings during organogenesis in SD rats ; and to test the hypothesis that maternal gastrointestinal toxicity confounds the detection of low incidence malformations with ASA when a multiple dosing paradigm is used .","(('Objectives', 'O'), ('of', 'O'), ('the', 'O'), ('current', 'O'), ('study', 'O'), ('were', 'O'), ('to', 'O'), ('compare', 'O'), ('results', 'O'), ('between', 'O'), ('Sprague', 'O'), ('-', 'O'), ('Dawley', 'O'), ('(', 'O'), ('SD', 'O'), (')', 'O'), ('and', 'O'), ('Wistar', 'O'), ('strains', 'O'), ('when', 'O'), ('ASA', 'O'), ('is', 'O'), ('administered', 'O'), ('on', 'O'), ('GD', 'O'), ('9', 'O'), (',', 'O'), ('10', 'O'), (',', 'O'), ('or', 'O'), ('11', 'O'), (';', 'O'), ('to', 'O'), ('compare', 'O'), ('the', 'O'), ('malformation', 'O'), ('patterns', 'O'), ('following', 'O'), ('single', 'O'), ('and', 'O'), ('multiple', 'O'), ('dosings', 'O'), ('during', 'O'), ('organogenesis', 'O'), ('in', 'O'), ('SD', 'O'), ('rats', 'O'), (';', 'O'), ('and', 'O'), ('to', 'O'), ('test', 'O'), ('the', 'O'), ('hypothesis', 'O'), ('that', 'O'), ('maternal', 'O'), ('gastrointestinal', 'B'), ('toxicity', 'I'), ('confounds', 'O'), ('the', 'O'), ('detection', 'O'), ('of', 'O'), ('low', 'O'), ('incidence', 'O'), ('malformations', 'B'), ('with', 'O'), ('ASA', 'O'), ('when', 'O'), ('a', 'O'), ('multiple', 'O'), ('dosing', 'O'), ('paradigm', 'O'), ('is', 'O'), ('used', 'O'), ('.', 'O'))$$$"
"RESULTS : The literature evaluation suggested that NSAIDs induce ventricular septal defects ( VSDs ) and midline defects ( MDs ) in rats and diaphragmatic hernia ( DH ) , MDs , and VSDs in rabbits ( Cook JC et al . , 2003 ) ; hence , the present study focused on these malformations , even though ASA induces several other low - incidence malformations .","(('RESULTS', 'O'), (':', 'O'), ('The', 'O'), ('literature', 'O'), ('evaluation', 'O'), ('suggested', 'O'), ('that', 'O'), ('NSAIDs', 'O'), ('induce', 'O'), ('ventricular', 'B'), ('septal', 'I'), ('defects', 'I'), ('(', 'O'), ('VSDs', 'B'), (')', 'O'), ('and', 'O'), ('midline', 'B'), ('defects', 'I'), ('(', 'O'), ('MDs', 'B'), (')', 'O'), ('in', 'O'), ('rats', 'O'), ('and', 'O'), ('diaphragmatic', 'B'), ('hernia', 'I'), ('(', 'O'), ('DH', 'B'), (')', 'O'), (',', 'O'), ('MDs', 'B'), (',', 'O'), ('and', 'O'), ('VSDs', 'B'), ('in', 'O'), ('rabbits', 'O'), ('(', 'O'), ('Cook', 'O'), ('JC', 'O'), ('et', 'O'), ('al', 'O'), ('.', 'O'), (',', 'O'), ('2003', 'O'), (')', 'O'), (';', 'O'), ('hence', 'O'), (',', 'O'), ('the', 'O'), ('present', 'O'), ('study', 'O'), ('focused', 'O'), ('on', 'O'), ('these', 'O'), ('malformations', 'B'), (',', 'O'), ('even', 'O'), ('though', 'O'), ('ASA', 'O'), ('induces', 'O'), ('several', 'O'), ('other', 'O'), ('low', 'O'), ('-', 'O'), ('incidence', 'O'), ('malformations', 'B'), ('.', 'O'))$$$"
CONCLUSIONS : High concordance in major developmental anomalies between Wistar and SD rats were noted with the exception of VSD in the SD rats and hydrocephalus in the Wistar rats .,"(('CONCLUSIONS', 'O'), (':', 'O'), ('High', 'O'), ('concordance', 'O'), ('in', 'O'), ('major', 'O'), ('developmental', 'B'), ('anomalies', 'I'), ('between', 'O'), ('Wistar', 'O'), ('and', 'O'), ('SD', 'O'), ('rats', 'O'), ('were', 'O'), ('noted', 'O'), ('with', 'O'), ('the', 'O'), ('exception', 'O'), ('of', 'O'), ('VSD', 'B'), ('in', 'O'), ('the', 'O'), ('SD', 'O'), ('rats', 'O'), ('and', 'O'), ('hydrocephalus', 'B'), ('in', 'O'), ('the', 'O'), ('Wistar', 'O'), ('rats', 'O'), ('.', 'O'))$$$"
An 82 - year - old man with treatment - resistant depression and early Alzheimer ' s disease was started on methylphenidate .,"(('An', 'O'), ('82', 'O'), ('-', 'O'), ('year', 'O'), ('-', 'O'), ('old', 'O'), ('man', 'O'), ('with', 'O'), ('treatment', 'B'), ('-', 'I'), ('resistant', 'I'), ('depression', 'I'), ('and', 'O'), ('early', 'O'), ('Alzheimer', 'B'), (""'"", 'I'), ('s', 'I'), ('disease', 'I'), ('was', 'O'), ('started', 'O'), ('on', 'O'), ('methylphenidate', 'O'), ('.', 'O'))$$$"
"Renal function significantly deteriorated in the group pretreated with furosemide ( p < 0 . 005 by ANOVA ) , with a rise in serum creatinine from 145 + / - 13 to 182 + / - 16 mumol / l at 24 h , while no change occurred in the control group ( from 141 + / - 6 to 142 + / - 7 mumol / l ) .","(('Renal', 'B'), ('function', 'I'), ('significantly', 'I'), ('deteriorated', 'I'), ('in', 'O'), ('the', 'O'), ('group', 'O'), ('pretreated', 'O'), ('with', 'O'), ('furosemide', 'O'), ('(', 'O'), ('p', 'O'), ('<', 'O'), ('0', 'O'), ('.', 'O'), ('005', 'O'), ('by', 'O'), ('ANOVA', 'O'), (')', 'O'), (',', 'O'), ('with', 'O'), ('a', 'O'), ('rise', 'O'), ('in', 'O'), ('serum', 'O'), ('creatinine', 'O'), ('from', 'O'), ('145', 'O'), ('+', 'O'), ('/', 'O'), ('-', 'O'), ('13', 'O'), ('to', 'O'), ('182', 'O'), ('+', 'O'), ('/', 'O'), ('-', 'O'), ('16', 'O'), ('mumol', 'O'), ('/', 'O'), ('l', 'O'), ('at', 'O'), ('24', 'O'), ('h', 'O'), (',', 'O'), ('while', 'O'), ('no', 'O'), ('change', 'O'), ('occurred', 'O'), ('in', 'O'), ('the', 'O'), ('control', 'O'), ('group', 'O'), ('(', 'O'), ('from', 'O'), ('141', 'O'), ('+', 'O'), ('/', 'O'), ('-', 'O'), ('6', 'O'), ('to', 'O'), ('142', 'O'), ('+', 'O'), ('/', 'O'), ('-', 'O'), ('7', 'O'), ('mumol', 'O'), ('/', 'O'), ('l', 'O'), (')', 'O'), ('.', 'O'))$$$"
Thromboembolic and other complications of oral contraceptive therapy in relationship to pretreatment levels of blood coagulation factors : summary report of a ten - year study .,"(('Thromboembolic', 'B'), ('and', 'O'), ('other', 'O'), ('complications', 'O'), ('of', 'O'), ('oral', 'O'), ('contraceptive', 'O'), ('therapy', 'O'), ('in', 'O'), ('relationship', 'O'), ('to', 'O'), ('pretreatment', 'O'), ('levels', 'O'), ('of', 'O'), ('blood', 'B'), ('coagulation', 'I'), ('factors', 'O'), (':', 'O'), ('summary', 'O'), ('report', 'O'), ('of', 'O'), ('a', 'O'), ('ten', 'O'), ('-', 'O'), ('year', 'O'), ('study', 'O'), ('.', 'O'))$$$"
"All four had an abnormal blood coagulation profile , suggesting "" hypercoagulability "" before initiation of therapy .","(('All', 'O'), ('four', 'O'), ('had', 'O'), ('an', 'O'), ('abnormal', 'O'), ('blood', 'B'), ('coagulation', 'I'), ('profile', 'O'), (',', 'O'), ('suggesting', 'O'), ('""', 'O'), ('hypercoagulability', 'B'), ('""', 'O'), ('before', 'O'), ('initiation', 'O'), ('of', 'O'), ('therapy', 'O'), ('.', 'O'))$$$"
Previous studies suggested the possiblility of increased propensity for thromboembolic episodes in patients possessing the A antigen .,"(('Previous', 'O'), ('studies', 'O'), ('suggested', 'O'), ('the', 'O'), ('possiblility', 'O'), ('of', 'O'), ('increased', 'O'), ('propensity', 'O'), ('for', 'O'), ('thromboembolic', 'B'), ('episodes', 'I'), ('in', 'O'), ('patients', 'O'), ('possessing', 'O'), ('the', 'O'), ('A', 'O'), ('antigen', 'O'), ('.', 'O'))$$$"
An elderly woman developed an Alzheimer - like subacute dementia as a result of propranolol toxicity .,"(('An', 'O'), ('elderly', 'O'), ('woman', 'O'), ('developed', 'O'), ('an', 'O'), ('Alzheimer', 'B'), ('-', 'O'), ('like', 'O'), ('subacute', 'O'), ('dementia', 'B'), ('as', 'O'), ('a', 'O'), ('result', 'O'), ('of', 'O'), ('propranolol', 'O'), ('toxicity', 'B'), ('.', 'O'))$$$"
There is evidence that cerebral reactions to drug toxicity can exhibit patterns that suggest highly selective involvement of functional subdivisions of the brain .,"(('There', 'O'), ('is', 'O'), ('evidence', 'O'), ('that', 'O'), ('cerebral', 'O'), ('reactions', 'O'), ('to', 'O'), ('drug', 'O'), ('toxicity', 'B'), ('can', 'O'), ('exhibit', 'O'), ('patterns', 'O'), ('that', 'O'), ('suggest', 'O'), ('highly', 'O'), ('selective', 'O'), ('involvement', 'O'), ('of', 'O'), ('functional', 'O'), ('subdivisions', 'O'), ('of', 'O'), ('the', 'O'), ('brain', 'O'), ('.', 'O'))$$$"
"These observations , in conjunction with clinical and laboratory evidence of extravascular hemolysis , are consistent with drug - induced hemolytic anemia , possibly involving both drug - adsorption and autoantibody formation mechanisms .","(('These', 'O'), ('observations', 'O'), (',', 'O'), ('in', 'O'), ('conjunction', 'O'), ('with', 'O'), ('clinical', 'O'), ('and', 'O'), ('laboratory', 'O'), ('evidence', 'O'), ('of', 'O'), ('extravascular', 'O'), ('hemolysis', 'B'), (',', 'O'), ('are', 'O'), ('consistent', 'O'), ('with', 'O'), ('drug', 'O'), ('-', 'O'), ('induced', 'O'), ('hemolytic', 'B'), ('anemia', 'I'), (',', 'O'), ('possibly', 'O'), ('involving', 'O'), ('both', 'O'), ('drug', 'O'), ('-', 'O'), ('adsorption', 'O'), ('and', 'O'), ('autoantibody', 'O'), ('formation', 'O'), ('mechanisms', 'O'), ('.', 'O'))$$$"
"Fever and subsequent multiple painful erythematous nodules over extremities developed on D11 , D16 , D17 , and D19 , respectively , after ATRA therapy .","(('Fever', 'B'), ('and', 'O'), ('subsequent', 'O'), ('multiple', 'O'), ('painful', 'B'), ('erythematous', 'B'), ('nodules', 'I'), ('over', 'O'), ('extremities', 'O'), ('developed', 'O'), ('on', 'O'), ('D11', 'O'), (',', 'O'), ('D16', 'O'), (',', 'O'), ('D17', 'O'), (',', 'O'), ('and', 'O'), ('D19', 'O'), (',', 'O'), ('respectively', 'O'), (',', 'O'), ('after', 'O'), ('ATRA', 'O'), ('therapy', 'O'), ('.', 'O'))$$$"
BACKGROUND : Doxorubicin induces a self - perpetuating nephropathy characterized by early glomerular and late - onset tubular lesions in rats .,"(('BACKGROUND', 'O'), (':', 'O'), ('Doxorubicin', 'O'), ('induces', 'O'), ('a', 'O'), ('self', 'O'), ('-', 'O'), ('perpetuating', 'O'), ('nephropathy', 'B'), ('characterized', 'O'), ('by', 'O'), ('early', 'O'), ('glomerular', 'B'), ('and', 'I'), ('late', 'I'), ('-', 'I'), ('onset', 'I'), ('tubular', 'I'), ('lesions', 'I'), ('in', 'O'), ('rats', 'O'), ('.', 'O'))$$$"
"In ' short - term ' rats , there were fewer tubular lesions , but similar numbers of glomerular lesions activity .","(('In', 'O'), (""'"", 'O'), ('short', 'O'), ('-', 'O'), ('term', 'O'), (""'"", 'O'), ('rats', 'O'), (',', 'O'), ('there', 'O'), ('were', 'O'), ('fewer', 'O'), ('tubular', 'B'), ('lesions', 'I'), (',', 'O'), ('but', 'O'), ('similar', 'O'), ('numbers', 'O'), ('of', 'O'), ('glomerular', 'B'), ('lesions', 'I'), ('activity', 'O'), ('.', 'O'))$$$"
Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition ?,"(('Does', 'O'), ('hormone', 'O'), ('therapy', 'O'), ('for', 'O'), ('the', 'O'), ('treatment', 'O'), ('of', 'O'), ('breast', 'B'), ('cancer', 'I'), ('have', 'O'), ('a', 'O'), ('detrimental', 'B'), ('effect', 'I'), ('on', 'I'), ('memory', 'I'), ('and', 'I'), ('cognition', 'I'), ('?', 'O'))$$$"
The results showed specific impairments in processing speed and verbal memory in women receiving hormonal therapy for the treatment of breast cancer .,"(('The', 'O'), ('results', 'O'), ('showed', 'O'), ('specific', 'O'), ('impairments', 'O'), ('in', 'O'), ('processing', 'O'), ('speed', 'O'), ('and', 'O'), ('verbal', 'O'), ('memory', 'O'), ('in', 'O'), ('women', 'O'), ('receiving', 'O'), ('hormonal', 'O'), ('therapy', 'O'), ('for', 'O'), ('the', 'O'), ('treatment', 'O'), ('of', 'O'), ('breast', 'B'), ('cancer', 'I'), ('.', 'O'))$$$"
Atrial fibrillation following chemotherapy for stage IIIE diffuse large B - cell gastric lymphoma in a patient with myotonic dystrophy ( Steinert ' s disease ) .,"(('Atrial', 'B'), ('fibrillation', 'I'), ('following', 'O'), ('chemotherapy', 'O'), ('for', 'O'), ('stage', 'O'), ('IIIE', 'O'), ('diffuse', 'O'), ('large', 'O'), ('B', 'O'), ('-', 'O'), ('cell', 'O'), ('gastric', 'B'), ('lymphoma', 'I'), ('in', 'O'), ('a', 'O'), ('patient', 'O'), ('with', 'O'), ('myotonic', 'B'), ('dystrophy', 'I'), ('(', 'O'), ('Steinert', 'B'), (""'"", 'I'), ('s', 'I'), ('disease', 'I'), (')', 'O'), ('.', 'O'))$$$"
"The authors describe the unusual association between diffuse B - cell gastric lymphoma and myotonic dystrophy , the most common form of adult muscular dystrophy , and sudden atrial fibrillation following one cycle of doxorubicin - based chemotherapy in the same patient .","(('The', 'O'), ('authors', 'O'), ('describe', 'O'), ('the', 'O'), ('unusual', 'O'), ('association', 'O'), ('between', 'O'), ('diffuse', 'O'), ('B', 'O'), ('-', 'O'), ('cell', 'O'), ('gastric', 'B'), ('lymphoma', 'I'), ('and', 'O'), ('myotonic', 'B'), ('dystrophy', 'I'), (',', 'O'), ('the', 'O'), ('most', 'O'), ('common', 'O'), ('form', 'O'), ('of', 'O'), ('adult', 'O'), ('muscular', 'B'), ('dystrophy', 'I'), (',', 'O'), ('and', 'O'), ('sudden', 'O'), ('atrial', 'B'), ('fibrillation', 'I'), ('following', 'O'), ('one', 'O'), ('cycle', 'O'), ('of', 'O'), ('doxorubicin', 'O'), ('-', 'O'), ('based', 'O'), ('chemotherapy', 'O'), ('in', 'O'), ('the', 'O'), ('same', 'O'), ('patient', 'O'), ('.', 'O'))$$$"
Hypersensitivity immune reaction as a mechanism for dilevalol - associated hepatitis .,"(('Hypersensitivity', 'B'), ('immune', 'O'), ('reaction', 'O'), ('as', 'O'), ('a', 'O'), ('mechanism', 'O'), ('for', 'O'), ('dilevalol', 'O'), ('-', 'O'), ('associated', 'O'), ('hepatitis', 'B'), ('.', 'O'))$$$"
"Stimulation often produces an improvement in the hyper - or dyskinetic upper limbs , but increases the "" freezing "" phenomenon in the lower limbs at the same time .","(('Stimulation', 'O'), ('often', 'O'), ('produces', 'O'), ('an', 'O'), ('improvement', 'O'), ('in', 'O'), ('the', 'O'), ('hyper', 'B'), ('-', 'I'), ('or', 'I'), ('dyskinetic', 'I'), ('upper', 'O'), ('limbs', 'O'), (',', 'O'), ('but', 'O'), ('increases', 'O'), ('the', 'O'), ('""', 'O'), ('freezing', 'O'), ('""', 'O'), ('phenomenon', 'O'), ('in', 'O'), ('the', 'O'), ('lower', 'O'), ('limbs', 'O'), ('at', 'O'), ('the', 'O'), ('same', 'O'), ('time', 'O'), ('.', 'O'))$$$"
Effects of the cyclooxygenase - 2 specific inhibitor valdecoxib versus nonsteroidal antiinflammatory agents and placebo on cardiovascular thrombotic events in patients with arthritis .,"(('Effects', 'O'), ('of', 'O'), ('the', 'O'), ('cyclooxygenase', 'O'), ('-', 'O'), ('2', 'O'), ('specific', 'O'), ('inhibitor', 'O'), ('valdecoxib', 'O'), ('versus', 'O'), ('nonsteroidal', 'O'), ('antiinflammatory', 'O'), ('agents', 'O'), ('and', 'O'), ('placebo', 'O'), ('on', 'O'), ('cardiovascular', 'O'), ('thrombotic', 'B'), ('events', 'O'), ('in', 'O'), ('patients', 'O'), ('with', 'O'), ('arthritis', 'B'), ('.', 'O'))$$$"
There have been concerns that the risk of cardiovascular thrombotic events may be higher with cyclooxygenase ( COX ) - 2 - specific inhibitors than nonselective nonsteroidal antiinflammatory drugs ( NSAIDs ) .,"(('There', 'O'), ('have', 'O'), ('been', 'O'), ('concerns', 'O'), ('that', 'O'), ('the', 'O'), ('risk', 'O'), ('of', 'O'), ('cardiovascular', 'O'), ('thrombotic', 'B'), ('events', 'O'), ('may', 'O'), ('be', 'O'), ('higher', 'O'), ('with', 'O'), ('cyclooxygenase', 'O'), ('(', 'O'), ('COX', 'O'), (')', 'O'), ('-', 'O'), ('2', 'O'), ('-', 'O'), ('specific', 'O'), ('inhibitors', 'O'), ('than', 'O'), ('nonselective', 'O'), ('nonsteroidal', 'O'), ('antiinflammatory', 'O'), ('drugs', 'O'), ('(', 'O'), ('NSAIDs', 'O'), (')', 'O'), ('.', 'O'))$$$"
"The incidence of cardiovascular thrombotic events ( cardiac , cerebrovascular and peripheral vascular , or arterial thrombotic ) was determined by analyzing pooled valdecoxib ( 10 - 80 mg daily ) , nonselective NSAID ( diclofenac 75 mg bid , ibuprofen 800 mg tid , or naproxen 500 mg bid ) and placebo data from 10 randomized osteoarthritis and rheumatoid arthritis trials that were 6 - 52 weeks in duration .","(('The', 'O'), ('incidence', 'O'), ('of', 'O'), ('cardiovascular', 'O'), ('thrombotic', 'B'), ('events', 'O'), ('(', 'O'), ('cardiac', 'O'), (',', 'O'), ('cerebrovascular', 'O'), ('and', 'O'), ('peripheral', 'O'), ('vascular', 'O'), (',', 'O'), ('or', 'O'), ('arterial', 'O'), ('thrombotic', 'B'), (')', 'O'), ('was', 'O'), ('determined', 'O'), ('by', 'O'), ('analyzing', 'O'), ('pooled', 'O'), ('valdecoxib', 'O'), ('(', 'O'), ('10', 'O'), ('-', 'O'), ('80', 'O'), ('mg', 'O'), ('daily', 'O'), (')', 'O'), (',', 'O'), ('nonselective', 'O'), ('NSAID', 'O'), ('(', 'O'), ('diclofenac', 'O'), ('75', 'O'), ('mg', 'O'), ('bid', 'O'), (',', 'O'), ('ibuprofen', 'O'), ('800', 'O'), ('mg', 'O'), ('tid', 'O'), (',', 'O'), ('or', 'O'), ('naproxen', 'O'), ('500', 'O'), ('mg', 'O'), ('bid', 'O'), (')', 'O'), ('and', 'O'), ('placebo', 'O'), ('data', 'O'), ('from', 'O'), ('10', 'O'), ('randomized', 'O'), ('osteoarthritis', 'B'), ('and', 'O'), ('rheumatoid', 'B'), ('arthritis', 'I'), ('trials', 'O'), ('that', 'O'), ('were', 'O'), ('6', 'O'), ('-', 'O'), ('52', 'O'), ('weeks', 'O'), ('in', 'O'), ('duration', 'O'), ('.', 'O'))$$$"
Short - and intermediate - term treatment with therapeutic ( 10 or 20 mg daily ) and supratherapeutic ( 40 or 80 mg daily ) valdecoxib doses was not associated with an increased incidence of thrombotic events relative to nonselective NSAIDs or placebo in osteoarthritis and rheumatoid arthritis patients in controlled clinical trials .,"(('Short', 'O'), ('-', 'O'), ('and', 'O'), ('intermediate', 'O'), ('-', 'O'), ('term', 'O'), ('treatment', 'O'), ('with', 'O'), ('therapeutic', 'O'), ('(', 'O'), ('10', 'O'), ('or', 'O'), ('20', 'O'), ('mg', 'O'), ('daily', 'O'), (')', 'O'), ('and', 'O'), ('supratherapeutic', 'O'), ('(', 'O'), ('40', 'O'), ('or', 'O'), ('80', 'O'), ('mg', 'O'), ('daily', 'O'), (')', 'O'), ('valdecoxib', 'O'), ('doses', 'O'), ('was', 'O'), ('not', 'O'), ('associated', 'O'), ('with', 'O'), ('an', 'O'), ('increased', 'O'), ('incidence', 'O'), ('of', 'O'), ('thrombotic', 'B'), ('events', 'O'), ('relative', 'O'), ('to', 'O'), ('nonselective', 'O'), ('NSAIDs', 'O'), ('or', 'O'), ('placebo', 'O'), ('in', 'O'), ('osteoarthritis', 'B'), ('and', 'O'), ('rheumatoid', 'B'), ('arthritis', 'I'), ('patients', 'O'), ('in', 'O'), ('controlled', 'O'), ('clinical', 'O'), ('trials', 'O'), ('.', 'O'))$$$"
Hypersensitivity myocarditis complicating hypertrophic cardiomyopathy heart .,"(('Hypersensitivity', 'B'), ('myocarditis', 'B'), ('complicating', 'O'), ('hypertrophic', 'B'), ('cardiomyopathy', 'I'), ('heart', 'O'), ('.', 'O'))$$$"
The present report describes a case of eosinophilic myocarditis complicating hypertrophic cardiomyopathy .,"(('The', 'O'), ('present', 'O'), ('report', 'O'), ('describes', 'O'), ('a', 'O'), ('case', 'O'), ('of', 'O'), ('eosinophilic', 'B'), ('myocarditis', 'I'), ('complicating', 'O'), ('hypertrophic', 'B'), ('cardiomyopathy', 'I'), ('.', 'O'))$$$"
Myocarditis is rare and eosinophilic myocarditis is rarer .,"(('Myocarditis', 'B'), ('is', 'O'), ('rare', 'O'), ('and', 'O'), ('eosinophilic', 'B'), ('myocarditis', 'I'), ('is', 'O'), ('rarer', 'O'), ('.', 'O'))$$$"
It is likely that the hypersensitivity ( eosinophilic ) myocarditis was related to dobutamine infusion therapy .,"(('It', 'O'), ('is', 'O'), ('likely', 'O'), ('that', 'O'), ('the', 'O'), ('hypersensitivity', 'B'), ('(', 'O'), ('eosinophilic', 'B'), (')', 'O'), ('myocarditis', 'B'), ('was', 'O'), ('related', 'O'), ('to', 'O'), ('dobutamine', 'O'), ('infusion', 'O'), ('therapy', 'O'), ('.', 'O'))$$$"
Eosinophilic myocarditis has been reported with an incidence of 2 . 4 % to 7 . 2 % in explanted hearts and may be related to multidrug therapy .,"(('Eosinophilic', 'B'), ('myocarditis', 'I'), ('has', 'O'), ('been', 'O'), ('reported', 'O'), ('with', 'O'), ('an', 'O'), ('incidence', 'O'), ('of', 'O'), ('2', 'O'), ('.', 'O'), ('4', 'O'), ('%', 'O'), ('to', 'O'), ('7', 'O'), ('.', 'O'), ('2', 'O'), ('%', 'O'), ('in', 'O'), ('explanted', 'O'), ('hearts', 'O'), ('and', 'O'), ('may', 'O'), ('be', 'O'), ('related', 'O'), ('to', 'O'), ('multidrug', 'O'), ('therapy', 'O'), ('.', 'O'))$$$"
Yohimbine treatment of sexual side effects induced by serotonin reuptake blockers .,"(('Yohimbine', 'O'), ('treatment', 'O'), ('of', 'O'), ('sexual', 'B'), ('side', 'I'), ('effects', 'I'), ('induced', 'O'), ('by', 'O'), ('serotonin', 'O'), ('reuptake', 'O'), ('blockers', 'O'), ('.', 'O'))$$$"
A single case report suggests that yohimbine may be used to treat the sexual side effects of clomipramine .,"(('A', 'O'), ('single', 'O'), ('case', 'O'), ('report', 'O'), ('suggests', 'O'), ('that', 'O'), ('yohimbine', 'O'), ('may', 'O'), ('be', 'O'), ('used', 'O'), ('to', 'O'), ('treat', 'O'), ('the', 'O'), ('sexual', 'B'), ('side', 'I'), ('effects', 'I'), ('of', 'O'), ('clomipramine', 'O'), ('.', 'O'))$$$"
This study evaluated yohimbine as a treatment for the sexual side effects caused by serotonin reuptake blockers .,"(('This', 'O'), ('study', 'O'), ('evaluated', 'O'), ('yohimbine', 'O'), ('as', 'O'), ('a', 'O'), ('treatment', 'O'), ('for', 'O'), ('the', 'O'), ('sexual', 'B'), ('side', 'I'), ('effects', 'I'), ('caused', 'O'), ('by', 'O'), ('serotonin', 'O'), ('reuptake', 'O'), ('blockers', 'O'), ('.', 'O'))$$$"
"METHOD : Six patients with either obsessive compulsive disorder , trichotillomania , anxiety , or affective disorders who suffered sexual side effects after treatment with serotonin reuptake blockers were given yohimbine on a p . r . n . basis in an open clinical trial .","(('METHOD', 'O'), (':', 'O'), ('Six', 'O'), ('patients', 'O'), ('with', 'O'), ('either', 'O'), ('obsessive', 'B'), ('compulsive', 'I'), ('disorder', 'I'), (',', 'O'), ('trichotillomania', 'B'), (',', 'O'), ('anxiety', 'B'), (',', 'O'), ('or', 'O'), ('affective', 'B'), ('disorders', 'I'), ('who', 'O'), ('suffered', 'O'), ('sexual', 'B'), ('side', 'I'), ('effects', 'I'), ('after', 'O'), ('treatment', 'O'), ('with', 'O'), ('serotonin', 'O'), ('reuptake', 'O'), ('blockers', 'O'), ('were', 'O'), ('given', 'O'), ('yohimbine', 'O'), ('on', 'O'), ('a', 'O'), ('p', 'O'), ('.', 'O'), ('r', 'O'), ('.', 'O'), ('n', 'O'), ('.', 'O'), ('basis', 'O'), ('in', 'O'), ('an', 'O'), ('open', 'O'), ('clinical', 'O'), ('trial', 'O'), ('.', 'O'))$$$"
"Side effects of yohimbine included excessive sweating , increased anxiety , and a wound - up feeling in some patients .","(('Side', 'O'), ('effects', 'O'), ('of', 'O'), ('yohimbine', 'O'), ('included', 'O'), ('excessive', 'O'), ('sweating', 'O'), (',', 'O'), ('increased', 'O'), ('anxiety', 'B'), (',', 'O'), ('and', 'O'), ('a', 'O'), ('wound', 'O'), ('-', 'O'), ('up', 'O'), ('feeling', 'O'), ('in', 'O'), ('some', 'O'), ('patients', 'O'), ('.', 'O'))$$$"
CONCLUSION : The results of this study indicate that yohimbine may be an effective treatment for the sexual side effects caused by serotonin reuptake blockers .,"(('CONCLUSION', 'O'), (':', 'O'), ('The', 'O'), ('results', 'O'), ('of', 'O'), ('this', 'O'), ('study', 'O'), ('indicate', 'O'), ('that', 'O'), ('yohimbine', 'O'), ('may', 'O'), ('be', 'O'), ('an', 'O'), ('effective', 'O'), ('treatment', 'O'), ('for', 'O'), ('the', 'O'), ('sexual', 'B'), ('side', 'I'), ('effects', 'I'), ('caused', 'O'), ('by', 'O'), ('serotonin', 'O'), ('reuptake', 'O'), ('blockers', 'O'), ('.', 'O'))$$$"
The number of deaths related to cardiac toxicity is low .,"(('The', 'O'), ('number', 'O'), ('of', 'O'), ('deaths', 'O'), ('related', 'O'), ('to', 'O'), ('cardiac', 'B'), ('toxicity', 'I'), ('is', 'O'), ('low', 'O'), ('.', 'O'))$$$"
Optical coherence tomography can measure axonal loss in patients with ethambutol - induced optic neuropathy .,"(('Optical', 'O'), ('coherence', 'O'), ('tomography', 'O'), ('can', 'O'), ('measure', 'O'), ('axonal', 'O'), ('loss', 'O'), ('in', 'O'), ('patients', 'O'), ('with', 'O'), ('ethambutol', 'O'), ('-', 'O'), ('induced', 'O'), ('optic', 'B'), ('neuropathy', 'I'), ('.', 'O'))$$$"
"A serious complication of ethambutol is an optic neuropathy that impairs visual acuity , contrast sensitivity , and color vision .","(('A', 'O'), ('serious', 'O'), ('complication', 'O'), ('of', 'O'), ('ethambutol', 'O'), ('is', 'O'), ('an', 'O'), ('optic', 'B'), ('neuropathy', 'I'), ('that', 'O'), ('impairs', 'O'), ('visual', 'O'), ('acuity', 'O'), (',', 'O'), ('contrast', 'O'), ('sensitivity', 'O'), (',', 'O'), ('and', 'O'), ('color', 'O'), ('vision', 'O'), ('.', 'O'))$$$"
"In all subjects with history of EMB - induced optic neuropathy , there was a mean loss of 72 % nerve fiber layer thickness in the temporal quadrant ( patient A , with eventual recovery of visual acuity and fields , 58 % loss ; patient B , with intermediate visual deficits , 68 % loss ; patient C , with chronic visual deficits , 90 % loss ) , with an average mean optic nerve thickness of 26 + / - 16 microm .","(('In', 'O'), ('all', 'O'), ('subjects', 'O'), ('with', 'O'), ('history', 'O'), ('of', 'O'), ('EMB', 'O'), ('-', 'O'), ('induced', 'O'), ('optic', 'B'), ('neuropathy', 'I'), (',', 'O'), ('there', 'O'), ('was', 'O'), ('a', 'O'), ('mean', 'O'), ('loss', 'O'), ('of', 'O'), ('72', 'O'), ('%', 'O'), ('nerve', 'O'), ('fiber', 'O'), ('layer', 'O'), ('thickness', 'O'), ('in', 'O'), ('the', 'O'), ('temporal', 'O'), ('quadrant', 'O'), ('(', 'O'), ('patient', 'O'), ('A', 'O'), (',', 'O'), ('with', 'O'), ('eventual', 'O'), ('recovery', 'O'), ('of', 'O'), ('visual', 'O'), ('acuity', 'O'), ('and', 'O'), ('fields', 'O'), (',', 'O'), ('58', 'O'), ('%', 'O'), ('loss', 'O'), (';', 'O'), ('patient', 'O'), ('B', 'O'), (',', 'O'), ('with', 'O'), ('intermediate', 'O'), ('visual', 'B'), ('deficits', 'I'), (',', 'O'), ('68', 'O'), ('%', 'O'), ('loss', 'O'), (';', 'O'), ('patient', 'O'), ('C', 'O'), (',', 'O'), ('with', 'O'), ('chronic', 'O'), ('visual', 'B'), ('deficits', 'I'), (',', 'O'), ('90', 'O'), ('%', 'O'), ('loss', 'O'), (')', 'O'), (',', 'O'), ('with', 'O'), ('an', 'O'), ('average', 'O'), ('mean', 'O'), ('optic', 'O'), ('nerve', 'O'), ('thickness', 'O'), ('of', 'O'), ('26', 'O'), ('+', 'O'), ('/', 'O'), ('-', 'O'), ('16', 'O'), ('microm', 'O'), ('.', 'O'))$$$"
This is consistent with prior histopathological studies that show predominant loss of parvo - cellular axons ( or small - caliber axons ) within the papillo - macular bundle in toxic or hereditary optic neuropathies .,"(('This', 'O'), ('is', 'O'), ('consistent', 'O'), ('with', 'O'), ('prior', 'O'), ('histopathological', 'O'), ('studies', 'O'), ('that', 'O'), ('show', 'O'), ('predominant', 'O'), ('loss', 'O'), ('of', 'O'), ('parvo', 'O'), ('-', 'O'), ('cellular', 'O'), ('axons', 'O'), ('(', 'O'), ('or', 'O'), ('small', 'O'), ('-', 'O'), ('caliber', 'O'), ('axons', 'O'), (')', 'O'), ('within', 'O'), ('the', 'O'), ('papillo', 'O'), ('-', 'O'), ('macular', 'O'), ('bundle', 'O'), ('in', 'O'), ('toxic', 'O'), ('or', 'O'), ('hereditary', 'O'), ('optic', 'B'), ('neuropathies', 'I'), ('.', 'O'))$$$"
Hypoxia in renal disease with proteinuria and / or glomerular hypertension .,"(('Hypoxia', 'B'), ('in', 'O'), ('renal', 'B'), ('disease', 'I'), ('with', 'O'), ('proteinuria', 'B'), ('and', 'O'), ('/', 'O'), ('or', 'O'), ('glomerular', 'O'), ('hypertension', 'B'), ('.', 'O'))$$$"
"In this study , we developed a new hypoxia - responsive reporter vector using a hypoxia - responsive element of the 5 ' vascular endothelial growth factor untranslated region and generated a novel hypoxia - sensing transgenic rat .","(('In', 'O'), ('this', 'O'), ('study', 'O'), (',', 'O'), ('we', 'O'), ('developed', 'O'), ('a', 'O'), ('new', 'O'), ('hypoxia', 'B'), ('-', 'O'), ('responsive', 'O'), ('reporter', 'O'), ('vector', 'O'), ('using', 'O'), ('a', 'O'), ('hypoxia', 'B'), ('-', 'O'), ('responsive', 'O'), ('element', 'O'), ('of', 'O'), ('the', 'O'), ('5', 'O'), (""'"", 'O'), ('vascular', 'O'), ('endothelial', 'O'), ('growth', 'O'), ('factor', 'O'), ('untranslated', 'O'), ('region', 'O'), ('and', 'O'), ('generated', 'O'), ('a', 'O'), ('novel', 'O'), ('hypoxia', 'B'), ('-', 'O'), ('sensing', 'O'), ('transgenic', 'O'), ('rat', 'O'), ('.', 'O'))$$$"
We then applied this animal model to the detection of tubulointerstitial hypoxia in the diseased kidney .,"(('We', 'O'), ('then', 'O'), ('applied', 'O'), ('this', 'O'), ('animal', 'O'), ('model', 'O'), ('to', 'O'), ('the', 'O'), ('detection', 'O'), ('of', 'O'), ('tubulointerstitial', 'O'), ('hypoxia', 'B'), ('in', 'O'), ('the', 'O'), ('diseased', 'B'), ('kidney', 'I'), ('.', 'O'))$$$"
We propose here a possible pathological tie between chronic tubulointerstitial hypoxia and progressive glomerular diseases .,"(('We', 'O'), ('propose', 'O'), ('here', 'O'), ('a', 'O'), ('possible', 'O'), ('pathological', 'O'), ('tie', 'O'), ('between', 'O'), ('chronic', 'O'), ('tubulointerstitial', 'O'), ('hypoxia', 'B'), ('and', 'O'), ('progressive', 'O'), ('glomerular', 'B'), ('diseases', 'I'), ('.', 'O'))$$$"
Relation of perfusion defects observed with myocardial contrast echocardiography to the severity of coronary stenosis : correlation with thallium - 201 single - photon emission tomography .,"(('Relation', 'O'), ('of', 'O'), ('perfusion', 'O'), ('defects', 'O'), ('observed', 'O'), ('with', 'O'), ('myocardial', 'O'), ('contrast', 'O'), ('echocardiography', 'O'), ('to', 'O'), ('the', 'O'), ('severity', 'O'), ('of', 'O'), ('coronary', 'B'), ('stenosis', 'I'), (':', 'O'), ('correlation', 'O'), ('with', 'O'), ('thallium', 'O'), ('-', 'O'), ('201', 'O'), ('single', 'O'), ('-', 'O'), ('photon', 'O'), ('emission', 'O'), ('tomography', 'O'), ('.', 'O'))$$$"
It has been previously shown that myocardial contrast echocardiography is a valuable technique for delineating regions of myocardial underperfusion secondary to coronary occlusion and to critical coronary stenoses in the presence of hyperemic stimulation .,"(('It', 'O'), ('has', 'O'), ('been', 'O'), ('previously', 'O'), ('shown', 'O'), ('that', 'O'), ('myocardial', 'O'), ('contrast', 'O'), ('echocardiography', 'O'), ('is', 'O'), ('a', 'O'), ('valuable', 'O'), ('technique', 'O'), ('for', 'O'), ('delineating', 'O'), ('regions', 'O'), ('of', 'O'), ('myocardial', 'O'), ('underperfusion', 'O'), ('secondary', 'O'), ('to', 'O'), ('coronary', 'B'), ('occlusion', 'I'), ('and', 'O'), ('to', 'O'), ('critical', 'O'), ('coronary', 'B'), ('stenoses', 'I'), ('in', 'O'), ('the', 'O'), ('presence', 'O'), ('of', 'O'), ('hyperemic', 'B'), ('stimulation', 'O'), ('.', 'O'))$$$"
The aim of this study was to determine whether myocardial contrast echocardiography performed with a stable solution of sonicated albumin could detect regions of myocardial underperfusion resulting from various degrees of coronary stenosis .,"(('The', 'O'), ('aim', 'O'), ('of', 'O'), ('this', 'O'), ('study', 'O'), ('was', 'O'), ('to', 'O'), ('determine', 'O'), ('whether', 'O'), ('myocardial', 'O'), ('contrast', 'O'), ('echocardiography', 'O'), ('performed', 'O'), ('with', 'O'), ('a', 'O'), ('stable', 'O'), ('solution', 'O'), ('of', 'O'), ('sonicated', 'O'), ('albumin', 'O'), ('could', 'O'), ('detect', 'O'), ('regions', 'O'), ('of', 'O'), ('myocardial', 'O'), ('underperfusion', 'O'), ('resulting', 'O'), ('from', 'O'), ('various', 'O'), ('degrees', 'O'), ('of', 'O'), ('coronary', 'B'), ('stenosis', 'I'), ('.', 'O'))$$$"
"During a transient ( 20 - s ) coronary occlusion , a perfusion defect was observed with contrast echocardiography in 14 of the 15 dogs in which the occlusion was produced .","(('During', 'O'), ('a', 'O'), ('transient', 'O'), ('(', 'O'), ('20', 'O'), ('-', 'O'), ('s', 'O'), (')', 'O'), ('coronary', 'B'), ('occlusion', 'I'), (',', 'O'), ('a', 'O'), ('perfusion', 'O'), ('defect', 'O'), ('was', 'O'), ('observed', 'O'), ('with', 'O'), ('contrast', 'O'), ('echocardiography', 'O'), ('in', 'O'), ('14', 'O'), ('of', 'O'), ('the', 'O'), ('15', 'O'), ('dogs', 'O'), ('in', 'O'), ('which', 'O'), ('the', 'O'), ('occlusion', 'O'), ('was', 'O'), ('produced', 'O'), ('.', 'O'))$$$"
"During dipyridamole - induced hyperemia , 12 of the 16 dogs with a partial coronary stenosis had a visible area of hypoperfusion by contrast echocardiography .","(('During', 'O'), ('dipyridamole', 'O'), ('-', 'O'), ('induced', 'O'), ('hyperemia', 'B'), (',', 'O'), ('12', 'O'), ('of', 'O'), ('the', 'O'), ('16', 'O'), ('dogs', 'O'), ('with', 'O'), ('a', 'O'), ('partial', 'O'), ('coronary', 'B'), ('stenosis', 'I'), ('had', 'O'), ('a', 'O'), ('visible', 'O'), ('area', 'O'), ('of', 'O'), ('hypoperfusion', 'O'), ('by', 'O'), ('contrast', 'O'), ('echocardiography', 'O'), ('.', 'O'))$$$"
The four dogs without a perfusion defect had a stenosis that resulted in a mild ( 0 % to 50 % ) reduction in dipyridamole - induced hyperemia .,"(('The', 'O'), ('four', 'O'), ('dogs', 'O'), ('without', 'O'), ('a', 'O'), ('perfusion', 'O'), ('defect', 'O'), ('had', 'O'), ('a', 'O'), ('stenosis', 'O'), ('that', 'O'), ('resulted', 'O'), ('in', 'O'), ('a', 'O'), ('mild', 'O'), ('(', 'O'), ('0', 'O'), ('%', 'O'), ('to', 'O'), ('50', 'O'), ('%', 'O'), (')', 'O'), ('reduction', 'O'), ('in', 'O'), ('dipyridamole', 'O'), ('-', 'O'), ('induced', 'O'), ('hyperemia', 'B'), ('.', 'O'))$$$"
The activation of spinal N - methyl - D - aspartate receptors may contribute to degeneration of spinal motor neurons induced by neuraxial morphine after a noninjurious interval of spinal cord ischemia .,"(('The', 'O'), ('activation', 'O'), ('of', 'O'), ('spinal', 'O'), ('N', 'O'), ('-', 'O'), ('methyl', 'O'), ('-', 'O'), ('D', 'O'), ('-', 'O'), ('aspartate', 'O'), ('receptors', 'O'), ('may', 'O'), ('contribute', 'O'), ('to', 'O'), ('degeneration', 'O'), ('of', 'O'), ('spinal', 'O'), ('motor', 'O'), ('neurons', 'O'), ('induced', 'O'), ('by', 'O'), ('neuraxial', 'O'), ('morphine', 'O'), ('after', 'O'), ('a', 'O'), ('noninjurious', 'O'), ('interval', 'O'), ('of', 'O'), ('spinal', 'B'), ('cord', 'I'), ('ischemia', 'I'), ('.', 'O'))$$$"
We investigated the relationship between the degeneration of spinal motor neurons and activation of N - methyl - d - aspartate ( NMDA ) receptors after neuraxial morphine following a noninjurious interval of aortic occlusion in rats .,"(('We', 'O'), ('investigated', 'O'), ('the', 'O'), ('relationship', 'O'), ('between', 'O'), ('the', 'O'), ('degeneration', 'O'), ('of', 'O'), ('spinal', 'O'), ('motor', 'O'), ('neurons', 'O'), ('and', 'O'), ('activation', 'O'), ('of', 'O'), ('N', 'O'), ('-', 'O'), ('methyl', 'O'), ('-', 'O'), ('d', 'O'), ('-', 'O'), ('aspartate', 'O'), ('(', 'O'), ('NMDA', 'O'), (')', 'O'), ('receptors', 'O'), ('after', 'O'), ('neuraxial', 'O'), ('morphine', 'O'), ('following', 'O'), ('a', 'O'), ('noninjurious', 'O'), ('interval', 'O'), ('of', 'O'), ('aortic', 'B'), ('occlusion', 'I'), ('in', 'O'), ('rats', 'O'), ('.', 'O'))$$$"
Spinal cord ischemia was induced by aortic occlusion for 6 min with a balloon catheter .,"(('Spinal', 'B'), ('cord', 'I'), ('ischemia', 'I'), ('was', 'O'), ('induced', 'O'), ('by', 'O'), ('aortic', 'B'), ('occlusion', 'I'), ('for', 'O'), ('6', 'O'), ('min', 'O'), ('with', 'O'), ('a', 'O'), ('balloon', 'O'), ('catheter', 'O'), ('.', 'O'))$$$"
Acute low back pain during intravenous administration of amiodarone : a report of two cases .,"(('Acute', 'O'), ('low', 'B'), ('back', 'I'), ('pain', 'I'), ('during', 'O'), ('intravenous', 'O'), ('administration', 'O'), ('of', 'O'), ('amiodarone', 'O'), (':', 'O'), ('a', 'O'), ('report', 'O'), ('of', 'O'), ('two', 'O'), ('cases', 'O'), ('.', 'O'))$$$"
"To examine the relationship between quantitative stimulant drug levels , catecholamines , and psychotic symptoms , nineteen patients in a psychiatric emergency service with a diagnosis of amphetamine - or cocaine - induced psychosis were interviewed , and plasma and urine were collected for quantitative assays of stimulant drug and catecholamine metabolite levels .","(('To', 'O'), ('examine', 'O'), ('the', 'O'), ('relationship', 'O'), ('between', 'O'), ('quantitative', 'O'), ('stimulant', 'O'), ('drug', 'O'), ('levels', 'O'), (',', 'O'), ('catecholamines', 'O'), (',', 'O'), ('and', 'O'), ('psychotic', 'B'), ('symptoms', 'I'), (',', 'O'), ('nineteen', 'O'), ('patients', 'O'), ('in', 'O'), ('a', 'O'), ('psychiatric', 'B'), ('emergency', 'O'), ('service', 'O'), ('with', 'O'), ('a', 'O'), ('diagnosis', 'O'), ('of', 'O'), ('amphetamine', 'O'), ('-', 'O'), ('or', 'O'), ('cocaine', 'O'), ('-', 'O'), ('induced', 'O'), ('psychosis', 'B'), ('were', 'O'), ('interviewed', 'O'), (',', 'O'), ('and', 'O'), ('plasma', 'O'), ('and', 'O'), ('urine', 'O'), ('were', 'O'), ('collected', 'O'), ('for', 'O'), ('quantitative', 'O'), ('assays', 'O'), ('of', 'O'), ('stimulant', 'O'), ('drug', 'O'), ('and', 'O'), ('catecholamine', 'O'), ('metabolite', 'O'), ('levels', 'O'), ('.', 'O'))$$$"
"Although many other factors such as sensitization may play a role , intensity of stimulant - induced psychotic symptoms and stereotypies appears to be at least in part dose - related .","(('Although', 'O'), ('many', 'O'), ('other', 'O'), ('factors', 'O'), ('such', 'O'), ('as', 'O'), ('sensitization', 'O'), ('may', 'O'), ('play', 'O'), ('a', 'O'), ('role', 'O'), (',', 'O'), ('intensity', 'O'), ('of', 'O'), ('stimulant', 'O'), ('-', 'O'), ('induced', 'O'), ('psychotic', 'B'), ('symptoms', 'I'), ('and', 'O'), ('stereotypies', 'B'), ('appears', 'O'), ('to', 'O'), ('be', 'O'), ('at', 'O'), ('least', 'O'), ('in', 'O'), ('part', 'O'), ('dose', 'O'), ('-', 'O'), ('related', 'O'), ('.', 'O'))$$$"
"Exclusion criteria were asphyxia , malformations , major surgical interventions , small for gestational age , intraventricular haemorrhage grades III and IV , periventricular leukomalacia , and severe psychomotor retardation .","(('Exclusion', 'O'), ('criteria', 'O'), ('were', 'O'), ('asphyxia', 'B'), (',', 'O'), ('malformations', 'B'), (',', 'O'), ('major', 'O'), ('surgical', 'O'), ('interventions', 'O'), (',', 'O'), ('small', 'O'), ('for', 'O'), ('gestational', 'O'), ('age', 'O'), (',', 'O'), ('intraventricular', 'O'), ('haemorrhage', 'B'), ('grades', 'O'), ('III', 'O'), ('and', 'O'), ('IV', 'O'), (',', 'O'), ('periventricular', 'B'), ('leukomalacia', 'I'), (',', 'O'), ('and', 'O'), ('severe', 'O'), ('psychomotor', 'B'), ('retardation', 'I'), ('.', 'O'))$$$"
Assessment of perinatal hepatitis B and rubella prevention in New Hampshire delivery hospitals .,"(('Assessment', 'O'), ('of', 'O'), ('perinatal', 'O'), ('hepatitis', 'B'), ('B', 'I'), ('and', 'O'), ('rubella', 'B'), ('prevention', 'O'), ('in', 'O'), ('New', 'O'), ('Hampshire', 'O'), ('delivery', 'O'), ('hospitals', 'O'), ('.', 'O'))$$$"
OBJECTIVE : To evaluate current performance on recommended perinatal hepatitis B and rubella prevention practices in New Hampshire .,"(('OBJECTIVE', 'O'), (':', 'O'), ('To', 'O'), ('evaluate', 'O'), ('current', 'O'), ('performance', 'O'), ('on', 'O'), ('recommended', 'O'), ('perinatal', 'O'), ('hepatitis', 'B'), ('B', 'I'), ('and', 'O'), ('rubella', 'B'), ('prevention', 'O'), ('practices', 'O'), ('in', 'O'), ('New', 'O'), ('Hampshire', 'O'), ('.', 'O'))$$$"
"Assessment was done on the following : prenatal screening for hepatitis B and rubella , administration of the hepatitis B vaccine birth dose to all infants , administration of hepatitis B immune globulin to infants who were born to hepatitis B surface antigen - positive mothers , rubella immunity , and administration of in - hospital postpartum rubella vaccine to rubella nonimmune women .","(('Assessment', 'O'), ('was', 'O'), ('done', 'O'), ('on', 'O'), ('the', 'O'), ('following', 'O'), (':', 'O'), ('prenatal', 'O'), ('screening', 'O'), ('for', 'O'), ('hepatitis', 'B'), ('B', 'I'), ('and', 'O'), ('rubella', 'B'), (',', 'O'), ('administration', 'O'), ('of', 'O'), ('the', 'O'), ('hepatitis', 'B'), ('B', 'I'), ('vaccine', 'O'), ('birth', 'O'), ('dose', 'O'), ('to', 'O'), ('all', 'O'), ('infants', 'O'), (',', 'O'), ('administration', 'O'), ('of', 'O'), ('hepatitis', 'B'), ('B', 'I'), ('immune', 'O'), ('globulin', 'O'), ('to', 'O'), ('infants', 'O'), ('who', 'O'), ('were', 'O'), ('born', 'O'), ('to', 'O'), ('hepatitis', 'O'), ('B', 'O'), ('surface', 'O'), ('antigen', 'O'), ('-', 'O'), ('positive', 'O'), ('mothers', 'O'), (',', 'O'), ('rubella', 'B'), ('immunity', 'O'), (',', 'O'), ('and', 'O'), ('administration', 'O'), ('of', 'O'), ('in', 'O'), ('-', 'O'), ('hospital', 'O'), ('postpartum', 'O'), ('rubella', 'B'), ('vaccine', 'O'), ('to', 'O'), ('rubella', 'B'), ('nonimmune', 'O'), ('women', 'O'), ('.', 'O'))$$$"
All infants who were born to hepatitis B surface antigen - positive mothers also received hepatitis B immune globulin .,"(('All', 'O'), ('infants', 'O'), ('who', 'O'), ('were', 'O'), ('born', 'O'), ('to', 'O'), ('hepatitis', 'O'), ('B', 'O'), ('surface', 'O'), ('antigen', 'O'), ('-', 'O'), ('positive', 'O'), ('mothers', 'O'), ('also', 'O'), ('received', 'O'), ('hepatitis', 'B'), ('B', 'I'), ('immune', 'O'), ('globulin', 'O'), ('.', 'O'))$$$"
CONCLUSION : This study documents good compliance in New Hampshire ' s birthing hospitals with national guidelines for perinatal hepatitis B and rubella prevention and highlights potential areas for improvement .,"(('CONCLUSION', 'O'), (':', 'O'), ('This', 'O'), ('study', 'O'), ('documents', 'O'), ('good', 'O'), ('compliance', 'O'), ('in', 'O'), ('New', 'O'), ('Hampshire', 'O'), (""'"", 'O'), ('s', 'O'), ('birthing', 'O'), ('hospitals', 'O'), ('with', 'O'), ('national', 'O'), ('guidelines', 'O'), ('for', 'O'), ('perinatal', 'O'), ('hepatitis', 'B'), ('B', 'I'), ('and', 'O'), ('rubella', 'B'), ('prevention', 'O'), ('and', 'O'), ('highlights', 'O'), ('potential', 'O'), ('areas', 'O'), ('for', 'O'), ('improvement', 'O'), ('.', 'O'))$$$"
"Here , we describe a case of severe masseter muscle rigidity ( jaw of steel ) after succinylcholine ( Sch ) administration during general anesthetic management for rigid bronchoscopic removal of a tracheal foreign body .","(('Here', 'O'), (',', 'O'), ('we', 'O'), ('describe', 'O'), ('a', 'O'), ('case', 'O'), ('of', 'O'), ('severe', 'O'), ('masseter', 'B'), ('muscle', 'I'), ('rigidity', 'I'), ('(', 'O'), ('jaw', 'B'), ('of', 'I'), ('steel', 'I'), (')', 'O'), ('after', 'O'), ('succinylcholine', 'O'), ('(', 'O'), ('Sch', 'O'), (')', 'O'), ('administration', 'O'), ('during', 'O'), ('general', 'O'), ('anesthetic', 'O'), ('management', 'O'), ('for', 'O'), ('rigid', 'O'), ('bronchoscopic', 'O'), ('removal', 'O'), ('of', 'O'), ('a', 'O'), ('tracheal', 'O'), ('foreign', 'O'), ('body', 'O'), ('.', 'O'))$$$"
"EXPERIMENTAL DESIGN : Because of their widespread use , the hematologic toxicity following coadministration of dexrazoxane and these three structurally different DNA cleavage enhancers was investigated : Sensitivity of human and murine blood progenitor cells to etoposide , daunorubicin , and doxorubicin + / - dexrazoxane was determined in granulocyte - macrophage colony forming assays .","(('EXPERIMENTAL', 'O'), ('DESIGN', 'O'), (':', 'O'), ('Because', 'O'), ('of', 'O'), ('their', 'O'), ('widespread', 'O'), ('use', 'O'), (',', 'O'), ('the', 'O'), ('hematologic', 'B'), ('toxicity', 'I'), ('following', 'O'), ('coadministration', 'O'), ('of', 'O'), ('dexrazoxane', 'O'), ('and', 'O'), ('these', 'O'), ('three', 'O'), ('structurally', 'O'), ('different', 'O'), ('DNA', 'O'), ('cleavage', 'O'), ('enhancers', 'O'), ('was', 'O'), ('investigated', 'O'), (':', 'O'), ('Sensitivity', 'O'), ('of', 'O'), ('human', 'O'), ('and', 'O'), ('murine', 'O'), ('blood', 'O'), ('progenitor', 'O'), ('cells', 'O'), ('to', 'O'), ('etoposide', 'O'), (',', 'O'), ('daunorubicin', 'O'), (',', 'O'), ('and', 'O'), ('doxorubicin', 'O'), ('+', 'O'), ('/', 'O'), ('-', 'O'), ('dexrazoxane', 'O'), ('was', 'O'), ('determined', 'O'), ('in', 'O'), ('granulocyte', 'O'), ('-', 'O'), ('macrophage', 'O'), ('colony', 'O'), ('forming', 'O'), ('assays', 'O'), ('.', 'O'))$$$"
"RESULTS : Nontoxic doses of dexrazoxane reduced myelosuppression and weight loss from daunorubicin and etoposide in mice and antagonized their antiproliferative effects in the colony assay ; however , dexrazoxane neither reduced myelosuppression , weight loss , nor the in vitro cytotoxicity from doxorubicin .","(('RESULTS', 'O'), (':', 'O'), ('Nontoxic', 'O'), ('doses', 'O'), ('of', 'O'), ('dexrazoxane', 'O'), ('reduced', 'O'), ('myelosuppression', 'B'), ('and', 'O'), ('weight', 'B'), ('loss', 'I'), ('from', 'O'), ('daunorubicin', 'O'), ('and', 'O'), ('etoposide', 'O'), ('in', 'O'), ('mice', 'O'), ('and', 'O'), ('antagonized', 'O'), ('their', 'O'), ('antiproliferative', 'O'), ('effects', 'O'), ('in', 'O'), ('the', 'O'), ('colony', 'O'), ('assay', 'O'), (';', 'O'), ('however', 'O'), (',', 'O'), ('dexrazoxane', 'O'), ('neither', 'O'), ('reduced', 'O'), ('myelosuppression', 'B'), (',', 'O'), ('weight', 'B'), ('loss', 'I'), (',', 'O'), ('nor', 'O'), ('the', 'O'), ('in', 'O'), ('vitro', 'O'), ('cytotoxicity', 'B'), ('from', 'O'), ('doxorubicin', 'O'), ('.', 'O'))$$$"
Clinical trials in patients with brain metastases combining dexrazoxane and high doses of etoposide is ongoing with the aim of improving efficacy without aggravating hematologic toxicity .,"(('Clinical', 'O'), ('trials', 'O'), ('in', 'O'), ('patients', 'O'), ('with', 'O'), ('brain', 'O'), ('metastases', 'B'), ('combining', 'O'), ('dexrazoxane', 'O'), ('and', 'O'), ('high', 'O'), ('doses', 'O'), ('of', 'O'), ('etoposide', 'O'), ('is', 'O'), ('ongoing', 'O'), ('with', 'O'), ('the', 'O'), ('aim', 'O'), ('of', 'O'), ('improving', 'O'), ('efficacy', 'O'), ('without', 'O'), ('aggravating', 'O'), ('hematologic', 'B'), ('toxicity', 'I'), ('.', 'O'))$$$"
The mean highest BIS score corresponding to the inability to repeat words was 81 . 5 ( 95 % CI = 78 . 1 to 84 . 8 ) .,"(('The', 'O'), ('mean', 'O'), ('highest', 'O'), ('BIS', 'O'), ('score', 'O'), ('corresponding', 'O'), ('to', 'O'), ('the', 'O'), ('inability', 'B'), ('to', 'I'), ('repeat', 'I'), ('words', 'I'), ('was', 'O'), ('81', 'O'), ('.', 'O'), ('5', 'O'), ('(', 'O'), ('95', 'O'), ('%', 'O'), ('CI', 'O'), ('=', 'O'), ('78', 'O'), ('.', 'O'), ('1', 'O'), ('to', 'O'), ('84', 'O'), ('.', 'O'), ('8', 'O'), (')', 'O'), ('.', 'O'))$$$"
The pulmonary toxicity of amiodarone is thought to result from direct injury related to the intracellular accumulation of phospholipid and T cell - mediated hypersensitivity pneumonitis .,"(('The', 'O'), ('pulmonary', 'B'), ('toxicity', 'I'), ('of', 'O'), ('amiodarone', 'O'), ('is', 'O'), ('thought', 'O'), ('to', 'O'), ('result', 'O'), ('from', 'O'), ('direct', 'O'), ('injury', 'O'), ('related', 'O'), ('to', 'O'), ('the', 'O'), ('intracellular', 'O'), ('accumulation', 'O'), ('of', 'O'), ('phospholipid', 'O'), ('and', 'O'), ('T', 'O'), ('cell', 'O'), ('-', 'O'), ('mediated', 'O'), ('hypersensitivity', 'B'), ('pneumonitis', 'I'), ('.', 'O'))$$$"
"Leukocytoclastic vasculitis ( LV ) is primarily a cutaneous small vessel vasculitis , though systemic involvement may be encountered .","(('Leukocytoclastic', 'B'), ('vasculitis', 'I'), ('(', 'O'), ('LV', 'B'), (')', 'O'), ('is', 'O'), ('primarily', 'O'), ('a', 'O'), ('cutaneous', 'B'), ('small', 'I'), ('vessel', 'I'), ('vasculitis', 'I'), (',', 'O'), ('though', 'O'), ('systemic', 'O'), ('involvement', 'O'), ('may', 'O'), ('be', 'O'), ('encountered', 'O'), ('.', 'O'))$$$"
"The results of skin lesion biopsies were available in 3 patients , confirming LV Cutaneous lesions resolved in all patients after warfarin was discontinued .","(('The', 'O'), ('results', 'O'), ('of', 'O'), ('skin', 'B'), ('lesion', 'I'), ('biopsies', 'O'), ('were', 'O'), ('available', 'O'), ('in', 'O'), ('3', 'O'), ('patients', 'O'), (',', 'O'), ('confirming', 'O'), ('LV', 'B'), ('Cutaneous', 'I'), ('lesions', 'I'), ('resolved', 'O'), ('in', 'O'), ('all', 'O'), ('patients', 'O'), ('after', 'O'), ('warfarin', 'O'), ('was', 'O'), ('discontinued', 'O'), ('.', 'O'))$$$"
Cocaine - induced brainstem seizures and behavior .,"(('Cocaine', 'O'), ('-', 'O'), ('induced', 'O'), ('brainstem', 'O'), ('seizures', 'B'), ('and', 'O'), ('behavior', 'O'), ('.', 'O'))$$$"
"The abnormal behaviors were yawning , retrocollis , hyperactivity , hypersensitivity , "" beating drum "" behavior , squealing , head bobbing , circling , sniffing , abnormal posturing , and facial twitching .","(('The', 'O'), ('abnormal', 'O'), ('behaviors', 'O'), ('were', 'O'), ('yawning', 'O'), (',', 'O'), ('retrocollis', 'O'), (',', 'O'), ('hyperactivity', 'B'), (',', 'O'), ('hypersensitivity', 'B'), (',', 'O'), ('""', 'O'), ('beating', 'O'), ('drum', 'O'), ('""', 'O'), ('behavior', 'O'), (',', 'O'), ('squealing', 'O'), (',', 'O'), ('head', 'O'), ('bobbing', 'O'), (',', 'O'), ('circling', 'O'), (',', 'O'), ('sniffing', 'O'), (',', 'O'), ('abnormal', 'O'), ('posturing', 'O'), (',', 'O'), ('and', 'O'), ('facial', 'O'), ('twitching', 'O'), ('.', 'O'))$$$"
"rTMS at 1 Hz was observed to markedly reduce drug - induced dyskinesias , whereas 5 - Hz rTMS induced a slight but not significant increase .","(('rTMS', 'O'), ('at', 'O'), ('1', 'O'), ('Hz', 'O'), ('was', 'O'), ('observed', 'O'), ('to', 'O'), ('markedly', 'O'), ('reduce', 'O'), ('drug', 'B'), ('-', 'I'), ('induced', 'I'), ('dyskinesias', 'I'), (',', 'O'), ('whereas', 'O'), ('5', 'O'), ('-', 'O'), ('Hz', 'O'), ('rTMS', 'O'), ('induced', 'O'), ('a', 'O'), ('slight', 'O'), ('but', 'O'), ('not', 'O'), ('significant', 'O'), ('increase', 'O'), ('.', 'O'))$$$"
Human malignant brain tumors have a poor prognosis in spite of surgery and radiation therapy .,"(('Human', 'O'), ('malignant', 'O'), ('brain', 'B'), ('tumors', 'I'), ('have', 'O'), ('a', 'O'), ('poor', 'O'), ('prognosis', 'O'), ('in', 'O'), ('spite', 'O'), ('of', 'O'), ('surgery', 'O'), ('and', 'O'), ('radiation', 'O'), ('therapy', 'O'), ('.', 'O'))$$$"
A total of 12 patients with a recurrence of a glioblastoma multiforme underwent re - resection and received an intracavitary application of paclitaxel and carboplatin cubic phases in different dosages .,"(('A', 'O'), ('total', 'O'), ('of', 'O'), ('12', 'O'), ('patients', 'O'), ('with', 'O'), ('a', 'O'), ('recurrence', 'O'), ('of', 'O'), ('a', 'O'), ('glioblastoma', 'B'), ('multiforme', 'O'), ('underwent', 'O'), ('re', 'O'), ('-', 'O'), ('resection', 'O'), ('and', 'O'), ('received', 'O'), ('an', 'O'), ('intracavitary', 'O'), ('application', 'O'), ('of', 'O'), ('paclitaxel', 'O'), ('and', 'O'), ('carboplatin', 'O'), ('cubic', 'O'), ('phases', 'O'), ('in', 'O'), ('different', 'O'), ('dosages', 'O'), ('.', 'O'))$$$"
CONCLUSION : No quantitative evidence for narrowing of large cerebral arteries or qualitative angiographic evidence for distal narrowing or vasculitis could be found in patients who underwent angiography after aneurysmal SAH associated with cocaine use .,"(('CONCLUSION', 'O'), (':', 'O'), ('No', 'O'), ('quantitative', 'O'), ('evidence', 'O'), ('for', 'O'), ('narrowing', 'O'), ('of', 'O'), ('large', 'O'), ('cerebral', 'O'), ('arteries', 'O'), ('or', 'O'), ('qualitative', 'O'), ('angiographic', 'O'), ('evidence', 'O'), ('for', 'O'), ('distal', 'O'), ('narrowing', 'O'), ('or', 'O'), ('vasculitis', 'B'), ('could', 'O'), ('be', 'O'), ('found', 'O'), ('in', 'O'), ('patients', 'O'), ('who', 'O'), ('underwent', 'O'), ('angiography', 'O'), ('after', 'O'), ('aneurysmal', 'B'), ('SAH', 'B'), ('associated', 'O'), ('with', 'O'), ('cocaine', 'O'), ('use', 'O'), ('.', 'O'))$$$"
"However , there are two case reports that show tic - like symptoms , including motor and phonic variants , occurring during treatment with quetiapine or clozapine .","(('However', 'O'), (',', 'O'), ('there', 'O'), ('are', 'O'), ('two', 'O'), ('case', 'O'), ('reports', 'O'), ('that', 'O'), ('show', 'O'), ('tic', 'B'), ('-', 'I'), ('like', 'I'), ('symptoms', 'I'), (',', 'O'), ('including', 'O'), ('motor', 'O'), ('and', 'O'), ('phonic', 'O'), ('variants', 'O'), (',', 'O'), ('occurring', 'O'), ('during', 'O'), ('treatment', 'O'), ('with', 'O'), ('quetiapine', 'O'), ('or', 'O'), ('clozapine', 'O'), ('.', 'O'))$$$"
The tic - like symptoms resolved completely after we reduced the dose of amisulpride down to 800 mg per day .,"(('The', 'O'), ('tic', 'B'), ('-', 'I'), ('like', 'I'), ('symptoms', 'I'), ('resolved', 'O'), ('completely', 'O'), ('after', 'O'), ('we', 'O'), ('reduced', 'O'), ('the', 'O'), ('dose', 'O'), ('of', 'O'), ('amisulpride', 'O'), ('down', 'O'), ('to', 'O'), ('800', 'O'), ('mg', 'O'), ('per', 'O'), ('day', 'O'), ('.', 'O'))$$$"
No more tic - like symptoms or other side effects have been reported .,"(('No', 'O'), ('more', 'O'), ('tic', 'B'), ('-', 'I'), ('like', 'I'), ('symptoms', 'I'), ('or', 'O'), ('other', 'O'), ('side', 'O'), ('effects', 'O'), ('have', 'O'), ('been', 'O'), ('reported', 'O'), ('.', 'O'))$$$"
"Together with previously reported cases , our patient suggests that tic - like symptoms might occur in certain vulnerable individuals during treatment with atypical antipsychotics such as quetiapine , clozapine , or amisulpride .","(('Together', 'O'), ('with', 'O'), ('previously', 'O'), ('reported', 'O'), ('cases', 'O'), (',', 'O'), ('our', 'O'), ('patient', 'O'), ('suggests', 'O'), ('that', 'O'), ('tic', 'B'), ('-', 'I'), ('like', 'I'), ('symptoms', 'I'), ('might', 'O'), ('occur', 'O'), ('in', 'O'), ('certain', 'O'), ('vulnerable', 'O'), ('individuals', 'O'), ('during', 'O'), ('treatment', 'O'), ('with', 'O'), ('atypical', 'O'), ('antipsychotics', 'O'), ('such', 'O'), ('as', 'O'), ('quetiapine', 'O'), (',', 'O'), ('clozapine', 'O'), (',', 'O'), ('or', 'O'), ('amisulpride', 'O'), ('.', 'O'))$$$"
"A 27 - year old African woman with history of regular chloroquine ingestion presented with progressive deterioration of vision , easy fatiguability , dyspnoea , dizziness progressing to syncopal attacks .","(('A', 'O'), ('27', 'O'), ('-', 'O'), ('year', 'O'), ('old', 'O'), ('African', 'O'), ('woman', 'O'), ('with', 'O'), ('history', 'O'), ('of', 'O'), ('regular', 'O'), ('chloroquine', 'O'), ('ingestion', 'O'), ('presented', 'O'), ('with', 'O'), ('progressive', 'O'), ('deterioration', 'B'), ('of', 'I'), ('vision', 'I'), (',', 'O'), ('easy', 'O'), ('fatiguability', 'B'), (',', 'O'), ('dyspnoea', 'B'), (',', 'O'), ('dizziness', 'B'), ('progressing', 'O'), ('to', 'O'), ('syncopal', 'B'), ('attacks', 'I'), ('.', 'O'))$$$"
"Ophthalmological assessment revealed features of chloroquine retinopathy , cardiac assessment revealed features of heart failure and a complete heart block with right bundle branch block pattern .","(('Ophthalmological', 'O'), ('assessment', 'O'), ('revealed', 'O'), ('features', 'O'), ('of', 'O'), ('chloroquine', 'O'), ('retinopathy', 'B'), (',', 'O'), ('cardiac', 'O'), ('assessment', 'O'), ('revealed', 'O'), ('features', 'O'), ('of', 'O'), ('heart', 'B'), ('failure', 'I'), ('and', 'O'), ('a', 'O'), ('complete', 'O'), ('heart', 'B'), ('block', 'I'), ('with', 'O'), ('right', 'B'), ('bundle', 'I'), ('branch', 'I'), ('block', 'I'), ('pattern', 'O'), ('.', 'O'))$$$"
"In summary , suprofen causes acute declines in renal function , most likely by directly altering the intrarenal distribution of uric acid .","(('In', 'O'), ('summary', 'O'), (',', 'O'), ('suprofen', 'O'), ('causes', 'O'), ('acute', 'B'), ('declines', 'I'), ('in', 'I'), ('renal', 'I'), ('function', 'I'), (',', 'O'), ('most', 'O'), ('likely', 'O'), ('by', 'O'), ('directly', 'O'), ('altering', 'O'), ('the', 'O'), ('intrarenal', 'O'), ('distribution', 'O'), ('of', 'O'), ('uric', 'O'), ('acid', 'O'), ('.', 'O'))$$$"
"Palpable purpura is a concerning clinical finding in pediatric patients and can have many causes , including infectious and autoimmune processes .","(('Palpable', 'O'), ('purpura', 'B'), ('is', 'O'), ('a', 'O'), ('concerning', 'O'), ('clinical', 'O'), ('finding', 'O'), ('in', 'O'), ('pediatric', 'O'), ('patients', 'O'), ('and', 'O'), ('can', 'O'), ('have', 'O'), ('many', 'O'), ('causes', 'O'), (',', 'O'), ('including', 'O'), ('infectious', 'O'), ('and', 'O'), ('autoimmune', 'O'), ('processes', 'O'), ('.', 'O'))$$$"
The most common side effect was dry month in 5 cases ( 16 . 7 % ) with 2 cases reporting a moderate degree and 1 case with severe degree .,"(('The', 'O'), ('most', 'O'), ('common', 'O'), ('side', 'O'), ('effect', 'O'), ('was', 'O'), ('dry', 'B'), ('month', 'I'), ('in', 'O'), ('5', 'O'), ('cases', 'O'), ('(', 'O'), ('16', 'O'), ('.', 'O'), ('7', 'O'), ('%', 'O'), (')', 'O'), ('with', 'O'), ('2', 'O'), ('cases', 'O'), ('reporting', 'O'), ('a', 'O'), ('moderate', 'O'), ('degree', 'O'), ('and', 'O'), ('1', 'O'), ('case', 'O'), ('with', 'O'), ('severe', 'O'), ('degree', 'O'), ('.', 'O'))$$$"
"Although 3 , 4 - methylenedioxymethamphetamine ( MDMA or ecstasy ) has been shown to damage brain serotonin ( 5 - HT ) neurons in animals and possibly humans , little is known about the long - term consequences of MDMA - induced 5 - HT neurotoxic lesions on functions in which 5 - HT is involved , such as cognitive function .","(('Although', 'O'), ('3', 'O'), (',', 'O'), ('4', 'O'), ('-', 'O'), ('methylenedioxymethamphetamine', 'O'), ('(', 'O'), ('MDMA', 'O'), ('or', 'O'), ('ecstasy', 'O'), (')', 'O'), ('has', 'O'), ('been', 'O'), ('shown', 'O'), ('to', 'O'), ('damage', 'O'), ('brain', 'O'), ('serotonin', 'O'), ('(', 'O'), ('5', 'O'), ('-', 'O'), ('HT', 'O'), (')', 'O'), ('neurons', 'O'), ('in', 'O'), ('animals', 'O'), ('and', 'O'), ('possibly', 'O'), ('humans', 'O'), (',', 'O'), ('little', 'O'), ('is', 'O'), ('known', 'O'), ('about', 'O'), ('the', 'O'), ('long', 'O'), ('-', 'O'), ('term', 'O'), ('consequences', 'O'), ('of', 'O'), ('MDMA', 'O'), ('-', 'O'), ('induced', 'O'), ('5', 'O'), ('-', 'O'), ('HT', 'O'), ('neurotoxic', 'B'), ('lesions', 'I'), ('on', 'O'), ('functions', 'O'), ('in', 'O'), ('which', 'O'), ('5', 'O'), ('-', 'O'), ('HT', 'O'), ('is', 'O'), ('involved', 'O'), (',', 'O'), ('such', 'O'), ('as', 'O'), ('cognitive', 'O'), ('function', 'O'), ('.', 'O'))$$$"
The protective role of mangiferin was analyzed by triphenyl tetrazolium chloride ( TTC ) test used for macroscopic enzyme mapping assay of the ischemic myocardium .,"(('The', 'O'), ('protective', 'O'), ('role', 'O'), ('of', 'O'), ('mangiferin', 'O'), ('was', 'O'), ('analyzed', 'O'), ('by', 'O'), ('triphenyl', 'O'), ('tetrazolium', 'O'), ('chloride', 'O'), ('(', 'O'), ('TTC', 'O'), (')', 'O'), ('test', 'O'), ('used', 'O'), ('for', 'O'), ('macroscopic', 'O'), ('enzyme', 'O'), ('mapping', 'O'), ('assay', 'O'), ('of', 'O'), ('the', 'O'), ('ischemic', 'B'), ('myocardium', 'I'), ('.', 'O'))$$$"
Pilocarpine seizures cause age - dependent impairment in auditory location discrimination .,"(('Pilocarpine', 'O'), ('seizures', 'B'), ('cause', 'O'), ('age', 'O'), ('-', 'O'), ('dependent', 'O'), ('impairment', 'B'), ('in', 'I'), ('auditory', 'I'), ('location', 'I'), ('discrimination', 'I'), ('.', 'O'))$$$"
This impairment may explain one cause of impaired auditory location discrimination in humans .,"(('This', 'O'), ('impairment', 'O'), ('may', 'O'), ('explain', 'O'), ('one', 'O'), ('cause', 'O'), ('of', 'O'), ('impaired', 'B'), ('auditory', 'I'), ('location', 'I'), ('discrimination', 'I'), ('in', 'O'), ('humans', 'O'), ('.', 'O'))$$$"
Definition and management of anemia in patients infected with hepatitis C virus .,"(('Definition', 'O'), ('and', 'O'), ('management', 'O'), ('of', 'O'), ('anemia', 'B'), ('in', 'O'), ('patients', 'O'), ('infected', 'B'), ('with', 'I'), ('hepatitis', 'I'), ('C', 'I'), ('virus', 'I'), ('.', 'O'))$$$"
"Chronic infection with hepatitis C virus ( HCV ) can progress to cirrhosis , hepatocellular carcinoma , and end - stage liver disease .","(('Chronic', 'B'), ('infection', 'I'), ('with', 'I'), ('hepatitis', 'I'), ('C', 'I'), ('virus', 'I'), ('(', 'O'), ('HCV', 'O'), (')', 'O'), ('can', 'O'), ('progress', 'O'), ('to', 'O'), ('cirrhosis', 'B'), (',', 'O'), ('hepatocellular', 'B'), ('carcinoma', 'I'), (',', 'O'), ('and', 'O'), ('end', 'B'), ('-', 'I'), ('stage', 'I'), ('liver', 'I'), ('disease', 'I'), ('.', 'O'))$$$"
This study examined the utility of biometry for detecting alcohol - related fetal growth impairment .,"(('This', 'O'), ('study', 'O'), ('examined', 'O'), ('the', 'O'), ('utility', 'O'), ('of', 'O'), ('biometry', 'O'), ('for', 'O'), ('detecting', 'O'), ('alcohol', 'O'), ('-', 'O'), ('related', 'O'), ('fetal', 'O'), ('growth', 'B'), ('impairment', 'I'), ('.', 'O'))$$$"
CLINICAL PICTURE : Three patients with ethambutol - associated toxic optic neuropathy are described .,"(('CLINICAL', 'O'), ('PICTURE', 'O'), (':', 'O'), ('Three', 'O'), ('patients', 'O'), ('with', 'O'), ('ethambutol', 'O'), ('-', 'O'), ('associated', 'O'), ('toxic', 'O'), ('optic', 'B'), ('neuropathy', 'I'), ('are', 'O'), ('described', 'O'), ('.', 'O'))$$$"
"All 3 patients had loss of central visual acuity , colour vision ( Ishihara ) and visual field .","(('All', 'O'), ('3', 'O'), ('patients', 'O'), ('had', 'O'), ('loss', 'B'), ('of', 'I'), ('central', 'I'), ('visual', 'I'), ('acuity', 'I'), (',', 'I'), ('colour', 'I'), ('vision', 'I'), ('(', 'I'), ('Ishihara', 'I'), (')', 'I'), ('and', 'I'), ('visual', 'I'), ('field', 'I'), ('.', 'O'))$$$"
"A 74 - year - old man with depressive symptoms was admitted to a psychiatric hospital due to insomnia , loss of appetite , exhaustion , and agitation .","(('A', 'O'), ('74', 'O'), ('-', 'O'), ('year', 'O'), ('-', 'O'), ('old', 'O'), ('man', 'O'), ('with', 'O'), ('depressive', 'B'), ('symptoms', 'I'), ('was', 'O'), ('admitted', 'O'), ('to', 'O'), ('a', 'O'), ('psychiatric', 'B'), ('hospital', 'O'), ('due', 'O'), ('to', 'O'), ('insomnia', 'B'), (',', 'O'), ('loss', 'B'), ('of', 'I'), ('appetite', 'I'), (',', 'O'), ('exhaustion', 'O'), (',', 'O'), ('and', 'O'), ('agitation', 'B'), ('.', 'O'))$$$"
"On the 10th day of paroxetine and alprazolam treatment , the patient exhibited marked psychomotor retardation , disorientation , and severe muscle rigidity with tremors .","(('On', 'O'), ('the', 'O'), ('10th', 'O'), ('day', 'O'), ('of', 'O'), ('paroxetine', 'O'), ('and', 'O'), ('alprazolam', 'O'), ('treatment', 'O'), (',', 'O'), ('the', 'O'), ('patient', 'O'), ('exhibited', 'O'), ('marked', 'O'), ('psychomotor', 'B'), ('retardation', 'I'), (',', 'O'), ('disorientation', 'O'), (',', 'O'), ('and', 'O'), ('severe', 'O'), ('muscle', 'B'), ('rigidity', 'I'), ('with', 'O'), ('tremors', 'B'), ('.', 'O'))$$$"
"This patient presented with symptoms of neuroleptic malignant syndrome ( NMS ) , thus demonstrating that NMS - like symptoms can occur after combined paroxetine and alprazolam treatment .","(('This', 'O'), ('patient', 'O'), ('presented', 'O'), ('with', 'O'), ('symptoms', 'O'), ('of', 'O'), ('neuroleptic', 'B'), ('malignant', 'I'), ('syndrome', 'I'), ('(', 'O'), ('NMS', 'B'), (')', 'O'), (',', 'O'), ('thus', 'O'), ('demonstrating', 'O'), ('that', 'O'), ('NMS', 'B'), ('-', 'O'), ('like', 'O'), ('symptoms', 'O'), ('can', 'O'), ('occur', 'O'), ('after', 'O'), ('combined', 'O'), ('paroxetine', 'O'), ('and', 'O'), ('alprazolam', 'O'), ('treatment', 'O'), ('.', 'O'))$$$"
"Several risk factors for NMS should be noted in elderly depressive patients whose symptoms often include dehydration , agitation , malnutrition , and exhaustion .","(('Several', 'O'), ('risk', 'O'), ('factors', 'O'), ('for', 'O'), ('NMS', 'B'), ('should', 'O'), ('be', 'O'), ('noted', 'O'), ('in', 'O'), ('elderly', 'O'), ('depressive', 'B'), ('patients', 'O'), ('whose', 'O'), ('symptoms', 'O'), ('often', 'O'), ('include', 'O'), ('dehydration', 'B'), (',', 'O'), ('agitation', 'B'), (',', 'O'), ('malnutrition', 'B'), (',', 'O'), ('and', 'O'), ('exhaustion', 'O'), ('.', 'O'))$$$"
"The central nervous system toxicity of high - dose cytosine arabinoside is well recognized , but the toxicity of cytosine arabinoside in the peripheral nervous system has been infrequently reported .","(('The', 'O'), ('central', 'O'), ('nervous', 'O'), ('system', 'O'), ('toxicity', 'B'), ('of', 'O'), ('high', 'O'), ('-', 'O'), ('dose', 'O'), ('cytosine', 'O'), ('arabinoside', 'O'), ('is', 'O'), ('well', 'O'), ('recognized', 'O'), (',', 'O'), ('but', 'O'), ('the', 'O'), ('toxicity', 'B'), ('of', 'O'), ('cytosine', 'O'), ('arabinoside', 'O'), ('in', 'O'), ('the', 'O'), ('peripheral', 'O'), ('nervous', 'O'), ('system', 'O'), ('has', 'O'), ('been', 'O'), ('infrequently', 'O'), ('reported', 'O'), ('.', 'O'))$$$"
"Although the mechanisms of peripheral neuropathy are still unclear , high - dose cytosine arabinoside is a therapy that is potentially toxic to the peripheral nervous system , and auto / alloimmunity may play an important role in these mechanisms .","(('Although', 'O'), ('the', 'O'), ('mechanisms', 'O'), ('of', 'O'), ('peripheral', 'B'), ('neuropathy', 'I'), ('are', 'O'), ('still', 'O'), ('unclear', 'O'), (',', 'O'), ('high', 'O'), ('-', 'O'), ('dose', 'O'), ('cytosine', 'O'), ('arabinoside', 'O'), ('is', 'O'), ('a', 'O'), ('therapy', 'O'), ('that', 'O'), ('is', 'O'), ('potentially', 'O'), ('toxic', 'O'), ('to', 'O'), ('the', 'O'), ('peripheral', 'O'), ('nervous', 'O'), ('system', 'O'), (',', 'O'), ('and', 'O'), ('auto', 'O'), ('/', 'O'), ('alloimmunity', 'O'), ('may', 'O'), ('play', 'O'), ('an', 'O'), ('important', 'O'), ('role', 'O'), ('in', 'O'), ('these', 'O'), ('mechanisms', 'O'), ('.', 'O'))$$$"
Methamphetamine ( MA ) - induced dopaminergic neurotoxicity is believed to be associated with the increased formation of free radicals .,"(('Methamphetamine', 'O'), ('(', 'O'), ('MA', 'O'), (')', 'O'), ('-', 'O'), ('induced', 'O'), ('dopaminergic', 'O'), ('neurotoxicity', 'B'), ('is', 'O'), ('believed', 'O'), ('to', 'O'), ('be', 'O'), ('associated', 'O'), ('with', 'O'), ('the', 'O'), ('increased', 'O'), ('formation', 'O'), ('of', 'O'), ('free', 'O'), ('radicals', 'O'), ('.', 'O'))$$$"
alpha - TC and DFO attenuated the MA - induced hyperthermia as well as the alterations in the locomotor activity .,"(('alpha', 'O'), ('-', 'O'), ('TC', 'O'), ('and', 'O'), ('DFO', 'O'), ('attenuated', 'O'), ('the', 'O'), ('MA', 'O'), ('-', 'O'), ('induced', 'O'), ('hyperthermia', 'B'), ('as', 'O'), ('well', 'O'), ('as', 'O'), ('the', 'O'), ('alterations', 'O'), ('in', 'O'), ('the', 'O'), ('locomotor', 'O'), ('activity', 'O'), ('.', 'O'))$$$"
Sustained clinical improvement of a patient with decompensated hepatitis B virus - related cirrhosis after treatment with lamivudine monotherapy .,"(('Sustained', 'O'), ('clinical', 'O'), ('improvement', 'O'), ('of', 'O'), ('a', 'O'), ('patient', 'O'), ('with', 'O'), ('decompensated', 'O'), ('hepatitis', 'B'), ('B', 'I'), ('virus', 'O'), ('-', 'O'), ('related', 'O'), ('cirrhosis', 'B'), ('after', 'O'), ('treatment', 'O'), ('with', 'O'), ('lamivudine', 'O'), ('monotherapy', 'O'), ('.', 'O'))$$$"
"Hepatitis B virus ( HBV ) infection , which causes liver cirrhosis and hepatocellular carcinoma , remains a major health problem in Asian countries .","(('Hepatitis', 'B'), ('B', 'I'), ('virus', 'I'), ('(', 'I'), ('HBV', 'I'), (')', 'I'), ('infection', 'I'), (',', 'O'), ('which', 'O'), ('causes', 'O'), ('liver', 'B'), ('cirrhosis', 'I'), ('and', 'O'), ('hepatocellular', 'B'), ('carcinoma', 'I'), (',', 'O'), ('remains', 'O'), ('a', 'O'), ('major', 'O'), ('health', 'O'), ('problem', 'O'), ('in', 'O'), ('Asian', 'O'), ('countries', 'O'), ('.', 'O'))$$$"
"In this report , we encountered a patient with decompensated HBV - related cirrhosis who exhibited the dramatic improvements after antiviral therapy .","(('In', 'O'), ('this', 'O'), ('report', 'O'), (',', 'O'), ('we', 'O'), ('encountered', 'O'), ('a', 'O'), ('patient', 'O'), ('with', 'O'), ('decompensated', 'O'), ('HBV', 'O'), ('-', 'O'), ('related', 'O'), ('cirrhosis', 'B'), ('who', 'O'), ('exhibited', 'O'), ('the', 'O'), ('dramatic', 'O'), ('improvements', 'O'), ('after', 'O'), ('antiviral', 'O'), ('therapy', 'O'), ('.', 'O'))$$$"
"Adrenaline arrhythmia , which is suppressed by Ca channel blockers , was induced by adrenaline infusion in halothane - anesthetized dogs .","(('Adrenaline', 'B'), ('arrhythmia', 'I'), (',', 'O'), ('which', 'O'), ('is', 'O'), ('suppressed', 'O'), ('by', 'O'), ('Ca', 'O'), ('channel', 'O'), ('blockers', 'O'), (',', 'O'), ('was', 'O'), ('induced', 'O'), ('by', 'O'), ('adrenaline', 'O'), ('infusion', 'O'), ('in', 'O'), ('halothane', 'O'), ('-', 'O'), ('anesthetized', 'O'), ('dogs', 'O'), ('.', 'O'))$$$"
AIM : Widespread use of mannitol to reduce brain edema and lower elevated ICP in brain tumor patients continues to be afflicted by the so - called rebound phenomenon .,"(('AIM', 'O'), (':', 'O'), ('Widespread', 'O'), ('use', 'O'), ('of', 'O'), ('mannitol', 'O'), ('to', 'O'), ('reduce', 'O'), ('brain', 'B'), ('edema', 'I'), ('and', 'O'), ('lower', 'O'), ('elevated', 'B'), ('ICP', 'I'), ('in', 'O'), ('brain', 'B'), ('tumor', 'I'), ('patients', 'O'), ('continues', 'O'), ('to', 'O'), ('be', 'O'), ('afflicted', 'O'), ('by', 'O'), ('the', 'O'), ('so', 'O'), ('-', 'O'), ('called', 'O'), ('rebound', 'O'), ('phenomenon', 'O'), ('.', 'O'))$$$"
"METHODS : Mannitol ( 18 % solution ; 1 g / kg ) was administered as a bolus to patients ( ten had malignant glioma , seven brain metastases and four meningioma ) about 30 minutes before craniotomy .","(('METHODS', 'O'), (':', 'O'), ('Mannitol', 'O'), ('(', 'O'), ('18', 'O'), ('%', 'O'), ('solution', 'O'), (';', 'O'), ('1', 'O'), ('g', 'O'), ('/', 'O'), ('kg', 'O'), (')', 'O'), ('was', 'O'), ('administered', 'O'), ('as', 'O'), ('a', 'O'), ('bolus', 'O'), ('to', 'O'), ('patients', 'O'), ('(', 'O'), ('ten', 'O'), ('had', 'O'), ('malignant', 'B'), ('glioma', 'I'), (',', 'O'), ('seven', 'O'), ('brain', 'O'), ('metastases', 'B'), ('and', 'O'), ('four', 'O'), ('meningioma', 'B'), (')', 'O'), ('about', 'O'), ('30', 'O'), ('minutes', 'O'), ('before', 'O'), ('craniotomy', 'O'), ('.', 'O'))$$$"
"CONCLUSIONS : The results of our study show that even after a single bolus , mannitol may leak through the altered BBB near gliomas , reversing the initial plasma - to - blood osmotic gradient , aggravating peritumoral edema and promoting rebound of ICP .","(('CONCLUSIONS', 'O'), (':', 'O'), ('The', 'O'), ('results', 'O'), ('of', 'O'), ('our', 'O'), ('study', 'O'), ('show', 'O'), ('that', 'O'), ('even', 'O'), ('after', 'O'), ('a', 'O'), ('single', 'O'), ('bolus', 'O'), (',', 'O'), ('mannitol', 'O'), ('may', 'O'), ('leak', 'O'), ('through', 'O'), ('the', 'O'), ('altered', 'O'), ('BBB', 'O'), ('near', 'O'), ('gliomas', 'B'), (',', 'O'), ('reversing', 'O'), ('the', 'O'), ('initial', 'O'), ('plasma', 'O'), ('-', 'O'), ('to', 'O'), ('-', 'O'), ('blood', 'O'), ('osmotic', 'O'), ('gradient', 'O'), (',', 'O'), ('aggravating', 'O'), ('peritumoral', 'O'), ('edema', 'B'), ('and', 'O'), ('promoting', 'O'), ('rebound', 'O'), ('of', 'O'), ('ICP', 'O'), ('.', 'O'))$$$"
"Extrapyramidal symptoms were evaluated using the Simpson - Angus Scale ( SAS ) , the Barnes Akathisia Rating Scale ( BARS ) , adverse event reports and anticholinergic drug usage .","(('Extrapyramidal', 'B'), ('symptoms', 'I'), ('were', 'O'), ('evaluated', 'O'), ('using', 'O'), ('the', 'O'), ('Simpson', 'O'), ('-', 'O'), ('Angus', 'O'), ('Scale', 'O'), ('(', 'O'), ('SAS', 'O'), (')', 'O'), (',', 'O'), ('the', 'O'), ('Barnes', 'O'), ('Akathisia', 'O'), ('Rating', 'O'), ('Scale', 'O'), ('(', 'O'), ('BARS', 'O'), (')', 'O'), (',', 'O'), ('adverse', 'O'), ('event', 'O'), ('reports', 'O'), ('and', 'O'), ('anticholinergic', 'O'), ('drug', 'O'), ('usage', 'O'), ('.', 'O'))$$$"
"RESULTS : The incidence of EPS - related adverse events , including akathisia , was no different with quetiapine monotherapy ( 12 . 9 % ) than with placebo ( 13 . 1 % ) .","(('RESULTS', 'O'), (':', 'O'), ('The', 'O'), ('incidence', 'O'), ('of', 'O'), ('EPS', 'B'), ('-', 'O'), ('related', 'O'), ('adverse', 'O'), ('events', 'O'), (',', 'O'), ('including', 'O'), ('akathisia', 'B'), (',', 'O'), ('was', 'O'), ('no', 'O'), ('different', 'O'), ('with', 'O'), ('quetiapine', 'O'), ('monotherapy', 'O'), ('(', 'O'), ('12', 'O'), ('.', 'O'), ('9', 'O'), ('%', 'O'), (')', 'O'), ('than', 'O'), ('with', 'O'), ('placebo', 'O'), ('(', 'O'), ('13', 'O'), ('.', 'O'), ('1', 'O'), ('%', 'O'), (')', 'O'), ('.', 'O'))$$$"
"Similarly , EPS - related adverse events with QTP + Li / DVP ( 21 . 4 % ) were no different than with PBO + Li / DVP ( 19 . 2 % ) .","(('Similarly', 'O'), (',', 'O'), ('EPS', 'B'), ('-', 'O'), ('related', 'O'), ('adverse', 'O'), ('events', 'O'), ('with', 'O'), ('QTP', 'O'), ('+', 'O'), ('Li', 'O'), ('/', 'O'), ('DVP', 'O'), ('(', 'O'), ('21', 'O'), ('.', 'O'), ('4', 'O'), ('%', 'O'), (')', 'O'), ('were', 'O'), ('no', 'O'), ('different', 'O'), ('than', 'O'), ('with', 'O'), ('PBO', 'O'), ('+', 'O'), ('Li', 'O'), ('/', 'O'), ('DVP', 'O'), ('(', 'O'), ('19', 'O'), ('.', 'O'), ('2', 'O'), ('%', 'O'), (')', 'O'), ('.', 'O'))$$$"
"Lithium was associated with a significantly higher incidence ( p < 0 . 05 ) of tremor ( 18 . 4 % ) than quetiapine ( 5 . 6 % ) ; cerebellar tremor , which is a known adverse effect of lithium , may have contributed to the elevated rate of tremor in patients receiving lithium therapy .","(('Lithium', 'O'), ('was', 'O'), ('associated', 'O'), ('with', 'O'), ('a', 'O'), ('significantly', 'O'), ('higher', 'O'), ('incidence', 'O'), ('(', 'O'), ('p', 'O'), ('<', 'O'), ('0', 'O'), ('.', 'O'), ('05', 'O'), (')', 'O'), ('of', 'O'), ('tremor', 'B'), ('(', 'O'), ('18', 'O'), ('.', 'O'), ('4', 'O'), ('%', 'O'), (')', 'O'), ('than', 'O'), ('quetiapine', 'O'), ('(', 'O'), ('5', 'O'), ('.', 'O'), ('6', 'O'), ('%', 'O'), (')', 'O'), (';', 'O'), ('cerebellar', 'O'), ('tremor', 'B'), (',', 'O'), ('which', 'O'), ('is', 'O'), ('a', 'O'), ('known', 'O'), ('adverse', 'O'), ('effect', 'O'), ('of', 'O'), ('lithium', 'O'), (',', 'O'), ('may', 'O'), ('have', 'O'), ('contributed', 'O'), ('to', 'O'), ('the', 'O'), ('elevated', 'O'), ('rate', 'O'), ('of', 'O'), ('tremor', 'B'), ('in', 'O'), ('patients', 'O'), ('receiving', 'O'), ('lithium', 'O'), ('therapy', 'O'), ('.', 'O'))$$$"
The cardiac depressant actions of phenytoin and hypothermia can be additive .,"(('The', 'O'), ('cardiac', 'O'), ('depressant', 'O'), ('actions', 'O'), ('of', 'O'), ('phenytoin', 'O'), ('and', 'O'), ('hypothermia', 'B'), ('can', 'O'), ('be', 'O'), ('additive', 'O'), ('.', 'O'))$$$"
Administration of phenytoin in the presence of hypothermia may lead to an adverse cardiac event in children .,"(('Administration', 'O'), ('of', 'O'), ('phenytoin', 'O'), ('in', 'O'), ('the', 'O'), ('presence', 'O'), ('of', 'O'), ('hypothermia', 'B'), ('may', 'O'), ('lead', 'O'), ('to', 'O'), ('an', 'O'), ('adverse', 'O'), ('cardiac', 'O'), ('event', 'O'), ('in', 'O'), ('children', 'O'), ('.', 'O'))$$$"
Valproate - induced chorea and encephalopathy in atypical nonketotic hyperglycinemia .,"(('Valproate', 'O'), ('-', 'O'), ('induced', 'O'), ('chorea', 'B'), ('and', 'O'), ('encephalopathy', 'B'), ('in', 'O'), ('atypical', 'O'), ('nonketotic', 'B'), ('hyperglycinemia', 'I'), ('.', 'O'))$$$"
Nonketotic hyperglycinemia is a disorder of amino acid metabolism in which a defect in the glycine cleavage system leads to an accumulation of glycine in the brain and other body compartments .,"(('Nonketotic', 'B'), ('hyperglycinemia', 'I'), ('is', 'O'), ('a', 'O'), ('disorder', 'B'), ('of', 'I'), ('amino', 'I'), ('acid', 'I'), ('metabolism', 'I'), ('in', 'O'), ('which', 'O'), ('a', 'O'), ('defect', 'O'), ('in', 'O'), ('the', 'O'), ('glycine', 'O'), ('cleavage', 'O'), ('system', 'O'), ('leads', 'O'), ('to', 'O'), ('an', 'O'), ('accumulation', 'O'), ('of', 'O'), ('glycine', 'O'), ('in', 'O'), ('the', 'O'), ('brain', 'O'), ('and', 'O'), ('other', 'O'), ('body', 'O'), ('compartments', 'O'), ('.', 'O'))$$$"
"This report describes a patient with mild language delay and mental retardation , who was found to have nonketotic hyperglycinemia following her presentation with acute encephalopathy and chorea shortly after initiation of valproate therapy .","(('This', 'O'), ('report', 'O'), ('describes', 'O'), ('a', 'O'), ('patient', 'O'), ('with', 'O'), ('mild', 'O'), ('language', 'B'), ('delay', 'I'), ('and', 'O'), ('mental', 'B'), ('retardation', 'I'), (',', 'O'), ('who', 'O'), ('was', 'O'), ('found', 'O'), ('to', 'O'), ('have', 'O'), ('nonketotic', 'B'), ('hyperglycinemia', 'I'), ('following', 'O'), ('her', 'O'), ('presentation', 'O'), ('with', 'O'), ('acute', 'O'), ('encephalopathy', 'B'), ('and', 'O'), ('chorea', 'B'), ('shortly', 'O'), ('after', 'O'), ('initiation', 'O'), ('of', 'O'), ('valproate', 'O'), ('therapy', 'O'), ('.', 'O'))$$$"
Delayed institution of hypertension during focal cerebral ischemia : effect on brain edema .,"(('Delayed', 'O'), ('institution', 'O'), ('of', 'O'), ('hypertension', 'B'), ('during', 'O'), ('focal', 'O'), ('cerebral', 'B'), ('ischemia', 'I'), (':', 'O'), ('effect', 'O'), ('on', 'O'), ('brain', 'B'), ('edema', 'I'), ('.', 'O'))$$$"
The effect of induced hypertension instituted after a 2 - h delay following middle cerebral artery occlusion ( MCAO ) on brain edema formation and histochemical injury was studied .,"(('The', 'O'), ('effect', 'O'), ('of', 'O'), ('induced', 'O'), ('hypertension', 'B'), ('instituted', 'O'), ('after', 'O'), ('a', 'O'), ('2', 'O'), ('-', 'O'), ('h', 'O'), ('delay', 'O'), ('following', 'O'), ('middle', 'B'), ('cerebral', 'I'), ('artery', 'I'), ('occlusion', 'I'), ('(', 'O'), ('MCAO', 'B'), (')', 'O'), ('on', 'O'), ('brain', 'B'), ('edema', 'I'), ('formation', 'O'), ('and', 'O'), ('histochemical', 'O'), ('injury', 'O'), ('was', 'O'), ('studied', 'O'), ('.', 'O'))$$$"
"In the hypertensive group ( n = 7 ) , the MAP was elevated by 25 - 30 mm Hg beginning 2 h after MCAO .","(('In', 'O'), ('the', 'O'), ('hypertensive', 'B'), ('group', 'O'), ('(', 'O'), ('n', 'O'), ('=', 'O'), ('7', 'O'), (')', 'O'), (',', 'O'), ('the', 'O'), ('MAP', 'O'), ('was', 'O'), ('elevated', 'O'), ('by', 'O'), ('25', 'O'), ('-', 'O'), ('30', 'O'), ('mm', 'O'), ('Hg', 'O'), ('beginning', 'O'), ('2', 'O'), ('h', 'O'), ('after', 'O'), ('MCAO', 'B'), ('.', 'O'))$$$"
The brains were sectioned along coronal planes spanning the distribution of ischemia produced by MCAO .,"(('The', 'O'), ('brains', 'O'), ('were', 'O'), ('sectioned', 'O'), ('along', 'O'), ('coronal', 'O'), ('planes', 'O'), ('spanning', 'O'), ('the', 'O'), ('distribution', 'O'), ('of', 'O'), ('ischemia', 'B'), ('produced', 'O'), ('by', 'O'), ('MCAO', 'B'), ('.', 'O'))$$$"
Specific gravity ( SG ) was determined in the subcortex and in two sites in the cortex ( core and periphery of the ischemic territory ) .,"(('Specific', 'O'), ('gravity', 'O'), ('(', 'O'), ('SG', 'O'), (')', 'O'), ('was', 'O'), ('determined', 'O'), ('in', 'O'), ('the', 'O'), ('subcortex', 'O'), ('and', 'O'), ('in', 'O'), ('two', 'O'), ('sites', 'O'), ('in', 'O'), ('the', 'O'), ('cortex', 'O'), ('(', 'O'), ('core', 'O'), ('and', 'O'), ('periphery', 'O'), ('of', 'O'), ('the', 'O'), ('ischemic', 'B'), ('territory', 'O'), (')', 'O'), ('.', 'O'))$$$"
"In the ischemic core , there was no difference in SG in the subcortex and cortex in the two groups .","(('In', 'O'), ('the', 'O'), ('ischemic', 'B'), ('core', 'O'), (',', 'O'), ('there', 'O'), ('was', 'O'), ('no', 'O'), ('difference', 'O'), ('in', 'O'), ('SG', 'O'), ('in', 'O'), ('the', 'O'), ('subcortex', 'O'), ('and', 'O'), ('cortex', 'O'), ('in', 'O'), ('the', 'O'), ('two', 'O'), ('groups', 'O'), ('.', 'O'))$$$"
"In the periphery of the ischemic territory , SG in the cortex was greater ( less edema accumulation ) in the hypertensive group ( 1 . 041 + / - 0 . 001 vs 1 . 039 + / - 0 . 001 , P less than 0 . 05 ) .","(('In', 'O'), ('the', 'O'), ('periphery', 'O'), ('of', 'O'), ('the', 'O'), ('ischemic', 'B'), ('territory', 'O'), (',', 'O'), ('SG', 'O'), ('in', 'O'), ('the', 'O'), ('cortex', 'O'), ('was', 'O'), ('greater', 'O'), ('(', 'O'), ('less', 'O'), ('edema', 'B'), ('accumulation', 'O'), (')', 'O'), ('in', 'O'), ('the', 'O'), ('hypertensive', 'B'), ('group', 'O'), ('(', 'O'), ('1', 'O'), ('.', 'O'), ('041', 'O'), ('+', 'O'), ('/', 'O'), ('-', 'O'), ('0', 'O'), ('.', 'O'), ('001', 'O'), ('vs', 'O'), ('1', 'O'), ('.', 'O'), ('039', 'O'), ('+', 'O'), ('/', 'O'), ('-', 'O'), ('0', 'O'), ('.', 'O'), ('001', 'O'), (',', 'O'), ('P', 'O'), ('less', 'O'), ('than', 'O'), ('0', 'O'), ('.', 'O'), ('05', 'O'), (')', 'O'), ('.', 'O'))$$$"
"The data indicate that phenylephrine - induced hypertension instituted 2 h after MCAO does not aggravate edema in the ischemic core , that it improves edema in the periphery of the ischemic territory , and that it reduces the area of histochemical neuronal dysfunction .","(('The', 'O'), ('data', 'O'), ('indicate', 'O'), ('that', 'O'), ('phenylephrine', 'O'), ('-', 'O'), ('induced', 'O'), ('hypertension', 'B'), ('instituted', 'O'), ('2', 'O'), ('h', 'O'), ('after', 'O'), ('MCAO', 'B'), ('does', 'O'), ('not', 'O'), ('aggravate', 'O'), ('edema', 'B'), ('in', 'O'), ('the', 'O'), ('ischemic', 'B'), ('core', 'O'), (',', 'O'), ('that', 'O'), ('it', 'O'), ('improves', 'O'), ('edema', 'B'), ('in', 'O'), ('the', 'O'), ('periphery', 'O'), ('of', 'O'), ('the', 'O'), ('ischemic', 'B'), ('territory', 'O'), (',', 'O'), ('and', 'O'), ('that', 'O'), ('it', 'O'), ('reduces', 'O'), ('the', 'O'), ('area', 'O'), ('of', 'O'), ('histochemical', 'O'), ('neuronal', 'B'), ('dysfunction', 'I'), ('.', 'O'))$$$"
"Chronic exposure to PCPA alone significantly decreased locomotor activity and increased irritability but had no effect on sexual behavior , partner preference , or aggression .","(('Chronic', 'O'), ('exposure', 'O'), ('to', 'O'), ('PCPA', 'O'), ('alone', 'O'), ('significantly', 'O'), ('decreased', 'O'), ('locomotor', 'O'), ('activity', 'O'), ('and', 'O'), ('increased', 'O'), ('irritability', 'B'), ('but', 'O'), ('had', 'O'), ('no', 'O'), ('effect', 'O'), ('on', 'O'), ('sexual', 'O'), ('behavior', 'O'), (',', 'O'), ('partner', 'O'), ('preference', 'O'), (',', 'O'), ('or', 'O'), ('aggression', 'B'), ('.', 'O'))$$$"
"Her symptoms improved within the next 24 hours , and repeat CT after 72 hours revealed marked improvement in stomach and small bowel thickening and resolution of ascites .","(('Her', 'O'), ('symptoms', 'O'), ('improved', 'O'), ('within', 'O'), ('the', 'O'), ('next', 'O'), ('24', 'O'), ('hours', 'O'), (',', 'O'), ('and', 'O'), ('repeat', 'O'), ('CT', 'O'), ('after', 'O'), ('72', 'O'), ('hours', 'O'), ('revealed', 'O'), ('marked', 'O'), ('improvement', 'O'), ('in', 'O'), ('stomach', 'O'), ('and', 'O'), ('small', 'O'), ('bowel', 'O'), ('thickening', 'O'), ('and', 'O'), ('resolution', 'O'), ('of', 'O'), ('ascites', 'B'), ('.', 'O'))$$$"
"A patient with sinus bradycardia and atrioventricular block , induced by carbamazepine , prompted an extensive literature review of all previously reported cases .","(('A', 'O'), ('patient', 'O'), ('with', 'O'), ('sinus', 'O'), ('bradycardia', 'B'), ('and', 'O'), ('atrioventricular', 'B'), ('block', 'I'), (',', 'O'), ('induced', 'O'), ('by', 'O'), ('carbamazepine', 'O'), (',', 'O'), ('prompted', 'O'), ('an', 'O'), ('extensive', 'O'), ('literature', 'O'), ('review', 'O'), ('of', 'O'), ('all', 'O'), ('previously', 'O'), ('reported', 'O'), ('cases', 'O'), ('.', 'O'))$$$"
"The second group consisted almost exclusively of elderly women who developed potentially life - threatening bradyarrhythmias or atrioventricular conduction delay , associated with either therapeutic or modestly elevated carbamazepine serum levels .","(('The', 'O'), ('second', 'O'), ('group', 'O'), ('consisted', 'O'), ('almost', 'O'), ('exclusively', 'O'), ('of', 'O'), ('elderly', 'O'), ('women', 'O'), ('who', 'O'), ('developed', 'O'), ('potentially', 'O'), ('life', 'O'), ('-', 'O'), ('threatening', 'O'), ('bradyarrhythmias', 'B'), ('or', 'O'), ('atrioventricular', 'B'), ('conduction', 'I'), ('delay', 'I'), (',', 'O'), ('associated', 'O'), ('with', 'O'), ('either', 'O'), ('therapeutic', 'O'), ('or', 'O'), ('modestly', 'O'), ('elevated', 'O'), ('carbamazepine', 'O'), ('serum', 'O'), ('levels', 'O'), ('.', 'O'))$$$"
"Because carbamazepine is widely used in the treatment of many neurologic and psychiatric conditions , the recognition of the latter syndrome has important implications for the use of this drug in elderly patients .","(('Because', 'O'), ('carbamazepine', 'O'), ('is', 'O'), ('widely', 'O'), ('used', 'O'), ('in', 'O'), ('the', 'O'), ('treatment', 'O'), ('of', 'O'), ('many', 'O'), ('neurologic', 'O'), ('and', 'O'), ('psychiatric', 'B'), ('conditions', 'O'), (',', 'O'), ('the', 'O'), ('recognition', 'O'), ('of', 'O'), ('the', 'O'), ('latter', 'O'), ('syndrome', 'O'), ('has', 'O'), ('important', 'O'), ('implications', 'O'), ('for', 'O'), ('the', 'O'), ('use', 'O'), ('of', 'O'), ('this', 'O'), ('drug', 'O'), ('in', 'O'), ('elderly', 'O'), ('patients', 'O'), ('.', 'O'))$$$"
"The degree of vacuolar degeneration of myocardial cells was analyzed in relation to the duration of adriamycin treatment ( 2 mg / kg , once a week ) .","(('The', 'O'), ('degree', 'O'), ('of', 'O'), ('vacuolar', 'B'), ('degeneration', 'I'), ('of', 'I'), ('myocardial', 'I'), ('cells', 'I'), ('was', 'O'), ('analyzed', 'O'), ('in', 'O'), ('relation', 'O'), ('to', 'O'), ('the', 'O'), ('duration', 'O'), ('of', 'O'), ('adriamycin', 'O'), ('treatment', 'O'), ('(', 'O'), ('2', 'O'), ('mg', 'O'), ('/', 'O'), ('kg', 'O'), (',', 'O'), ('once', 'O'), ('a', 'O'), ('week', 'O'), (')', 'O'), ('.', 'O'))$$$"
The appearance of impaired cardiac adrenergic neuron activity in the presence of slight myocardial impairment ( scattered or focal vacuolar degeneration ) indicates that MIBG scintigraphy may be a useful method for detection of adriamycin - induced cardiomyopathy .,"(('The', 'O'), ('appearance', 'O'), ('of', 'O'), ('impaired', 'O'), ('cardiac', 'O'), ('adrenergic', 'O'), ('neuron', 'O'), ('activity', 'O'), ('in', 'O'), ('the', 'O'), ('presence', 'O'), ('of', 'O'), ('slight', 'O'), ('myocardial', 'B'), ('impairment', 'I'), ('(', 'O'), ('scattered', 'O'), ('or', 'O'), ('focal', 'O'), ('vacuolar', 'B'), ('degeneration', 'I'), (')', 'O'), ('indicates', 'O'), ('that', 'O'), ('MIBG', 'O'), ('scintigraphy', 'O'), ('may', 'O'), ('be', 'O'), ('a', 'O'), ('useful', 'O'), ('method', 'O'), ('for', 'O'), ('detection', 'O'), ('of', 'O'), ('adriamycin', 'O'), ('-', 'O'), ('induced', 'O'), ('cardiomyopathy', 'B'), ('.', 'O'))$$$"
Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen .,"(('Syncope', 'B'), ('and', 'O'), ('QT', 'B'), ('prolongation', 'I'), ('among', 'O'), ('patients', 'O'), ('treated', 'O'), ('with', 'O'), ('methadone', 'O'), ('for', 'O'), ('heroin', 'O'), ('dependence', 'O'), ('in', 'O'), ('the', 'O'), ('city', 'O'), ('of', 'O'), ('Copenhagen', 'O'), ('.', 'O'))$$$"
We describe a case of neuroleptic malignant syndrome ( NMS ) associated with the use of ziprasidone .,"(('We', 'O'), ('describe', 'O'), ('a', 'O'), ('case', 'O'), ('of', 'O'), ('neuroleptic', 'B'), ('malignant', 'I'), ('syndrome', 'I'), ('(', 'O'), ('NMS', 'B'), (')', 'O'), ('associated', 'O'), ('with', 'O'), ('the', 'O'), ('use', 'O'), ('of', 'O'), ('ziprasidone', 'O'), ('.', 'O'))$$$"
Peripheral iron dextran induced degeneration of dopaminergic neurons in rat substantia nigra .,"(('Peripheral', 'O'), ('iron', 'O'), ('dextran', 'O'), ('induced', 'O'), ('degeneration', 'B'), ('of', 'I'), ('dopaminergic', 'I'), ('neurons', 'I'), ('in', 'O'), ('rat', 'O'), ('substantia', 'O'), ('nigra', 'O'), ('.', 'O'))$$$"
"To demonstrate the relationship between peripheral iron overload and dopaminergic neuron loss in rat substantia nigra ( SN ) , in the present study we used fast cyclic voltammetry , tyrosine hydroxylase ( TH ) immunohistochemistry , Perls ' iron staining , and high performance liquid chromatography - electrochemical detection to study the degeneration of dopaminergic neurons and increased iron content in the SN of iron dextran overloaded animals .","(('To', 'O'), ('demonstrate', 'O'), ('the', 'O'), ('relationship', 'O'), ('between', 'O'), ('peripheral', 'O'), ('iron', 'O'), ('overload', 'O'), ('and', 'O'), ('dopaminergic', 'O'), ('neuron', 'O'), ('loss', 'O'), ('in', 'O'), ('rat', 'O'), ('substantia', 'O'), ('nigra', 'O'), ('(', 'O'), ('SN', 'O'), (')', 'O'), (',', 'O'), ('in', 'O'), ('the', 'O'), ('present', 'O'), ('study', 'O'), ('we', 'O'), ('used', 'O'), ('fast', 'O'), ('cyclic', 'O'), ('voltammetry', 'O'), (',', 'O'), ('tyrosine', 'O'), ('hydroxylase', 'O'), ('(', 'O'), ('TH', 'O'), (')', 'O'), ('immunohistochemistry', 'O'), (',', 'O'), ('Perls', 'O'), (""'"", 'O'), ('iron', 'O'), ('staining', 'O'), (',', 'O'), ('and', 'O'), ('high', 'O'), ('performance', 'O'), ('liquid', 'O'), ('chromatography', 'O'), ('-', 'O'), ('electrochemical', 'O'), ('detection', 'O'), ('to', 'O'), ('study', 'O'), ('the', 'O'), ('degeneration', 'B'), ('of', 'I'), ('dopaminergic', 'I'), ('neurons', 'I'), ('and', 'O'), ('increased', 'O'), ('iron', 'O'), ('content', 'O'), ('in', 'O'), ('the', 'O'), ('SN', 'O'), ('of', 'O'), ('iron', 'O'), ('dextran', 'O'), ('overloaded', 'O'), ('animals', 'O'), ('.', 'O'))$$$"
"These results suggest that peripheral iron dextran can increase the iron level in the SN , where excessive iron causes the degeneration of dopaminergic neurons .","(('These', 'O'), ('results', 'O'), ('suggest', 'O'), ('that', 'O'), ('peripheral', 'O'), ('iron', 'O'), ('dextran', 'O'), ('can', 'O'), ('increase', 'O'), ('the', 'O'), ('iron', 'O'), ('level', 'O'), ('in', 'O'), ('the', 'O'), ('SN', 'O'), (',', 'O'), ('where', 'O'), ('excessive', 'O'), ('iron', 'O'), ('causes', 'O'), ('the', 'O'), ('degeneration', 'B'), ('of', 'I'), ('dopaminergic', 'I'), ('neurons', 'I'), ('.', 'O'))$$$"
"For this reason , each clinician should recognize this entity in the differential diagnosis of PB - related asymptomatic chronic hepatic enzyme dysfunction .","(('For', 'O'), ('this', 'O'), ('reason', 'O'), (',', 'O'), ('each', 'O'), ('clinician', 'O'), ('should', 'O'), ('recognize', 'O'), ('this', 'O'), ('entity', 'O'), ('in', 'O'), ('the', 'O'), ('differential', 'O'), ('diagnosis', 'O'), ('of', 'O'), ('PB', 'O'), ('-', 'O'), ('related', 'O'), ('asymptomatic', 'O'), ('chronic', 'B'), ('hepatic', 'I'), ('enzyme', 'I'), ('dysfunction', 'I'), ('.', 'O'))$$$"
Delayed leukoencephalopathy with stroke - like presentation in chemotherapy recipients .,"(('Delayed', 'O'), ('leukoencephalopathy', 'B'), ('with', 'O'), ('stroke', 'B'), ('-', 'O'), ('like', 'O'), ('presentation', 'O'), ('in', 'O'), ('chemotherapy', 'O'), ('recipients', 'O'), ('.', 'O'))$$$"
METHODS : We reviewed the medical literature for single reports and case series of patients presenting with stroke - like episodes while receiving systemic or intrathecal chemotherapy .,"(('METHODS', 'O'), (':', 'O'), ('We', 'O'), ('reviewed', 'O'), ('the', 'O'), ('medical', 'O'), ('literature', 'O'), ('for', 'O'), ('single', 'O'), ('reports', 'O'), ('and', 'O'), ('case', 'O'), ('series', 'O'), ('of', 'O'), ('patients', 'O'), ('presenting', 'O'), ('with', 'O'), ('stroke', 'B'), ('-', 'O'), ('like', 'O'), ('episodes', 'O'), ('while', 'O'), ('receiving', 'O'), ('systemic', 'O'), ('or', 'O'), ('intrathecal', 'O'), ('chemotherapy', 'O'), ('.', 'O'))$$$"
"Diffusion weighted imaging ( DWI ) of all patients revealed well demarcated hyperintense lesions within the subcortical white matter of the cerebral hemispheres and the corpus callosum , corresponding to areas of decreased proton diffusion on apparent diffusion coefficient ( ADC ) maps ( available in 21 / 27 patients ) .","(('Diffusion', 'O'), ('weighted', 'O'), ('imaging', 'O'), ('(', 'O'), ('DWI', 'O'), (')', 'O'), ('of', 'O'), ('all', 'O'), ('patients', 'O'), ('revealed', 'O'), ('well', 'O'), ('demarcated', 'O'), ('hyperintense', 'O'), ('lesions', 'B'), ('within', 'I'), ('the', 'I'), ('subcortical', 'I'), ('white', 'I'), ('matter', 'I'), ('of', 'O'), ('the', 'O'), ('cerebral', 'O'), ('hemispheres', 'O'), ('and', 'O'), ('the', 'O'), ('corpus', 'O'), ('callosum', 'O'), (',', 'O'), ('corresponding', 'O'), ('to', 'O'), ('areas', 'O'), ('of', 'O'), ('decreased', 'O'), ('proton', 'O'), ('diffusion', 'O'), ('on', 'O'), ('apparent', 'O'), ('diffusion', 'O'), ('coefficient', 'O'), ('(', 'O'), ('ADC', 'O'), (')', 'O'), ('maps', 'O'), ('(', 'O'), ('available', 'O'), ('in', 'O'), ('21', 'O'), ('/', 'O'), ('27', 'O'), ('patients', 'O'), (')', 'O'), ('.', 'O'))$$$"
DWI findings in this cohort are indicative of cytotoxic oedema within cerebral white matter and lend support to an at least partially reversible metabolic derangement as the basis for this syndrome .,"(('DWI', 'O'), ('findings', 'O'), ('in', 'O'), ('this', 'O'), ('cohort', 'O'), ('are', 'O'), ('indicative', 'O'), ('of', 'O'), ('cytotoxic', 'B'), ('oedema', 'I'), ('within', 'I'), ('cerebral', 'I'), ('white', 'I'), ('matter', 'I'), ('and', 'O'), ('lend', 'O'), ('support', 'O'), ('to', 'O'), ('an', 'O'), ('at', 'O'), ('least', 'O'), ('partially', 'O'), ('reversible', 'O'), ('metabolic', 'O'), ('derangement', 'O'), ('as', 'O'), ('the', 'O'), ('basis', 'O'), ('for', 'O'), ('this', 'O'), ('syndrome', 'O'), ('.', 'O'))$$$"
Prenatal exposure to fluoxetine induces fetal pulmonary hypertension in the rat .,"(('Prenatal', 'O'), ('exposure', 'O'), ('to', 'O'), ('fluoxetine', 'O'), ('induces', 'O'), ('fetal', 'B'), ('pulmonary', 'I'), ('hypertension', 'I'), ('in', 'O'), ('the', 'O'), ('rat', 'O'), ('.', 'O'))$$$"
"As compared with controls , fluoxetine exposure resulted in fetal pulmonary hypertension as evidenced by an increase in the weight ratio of the right ventricle to the left ventricle plus septum ( P = 0 . 02 ) and by an increase in pulmonary arterial medial thickness ( P < 0 . 01 ) .","(('As', 'O'), ('compared', 'O'), ('with', 'O'), ('controls', 'O'), (',', 'O'), ('fluoxetine', 'O'), ('exposure', 'O'), ('resulted', 'O'), ('in', 'O'), ('fetal', 'B'), ('pulmonary', 'I'), ('hypertension', 'I'), ('as', 'O'), ('evidenced', 'O'), ('by', 'O'), ('an', 'O'), ('increase', 'O'), ('in', 'O'), ('the', 'O'), ('weight', 'O'), ('ratio', 'O'), ('of', 'O'), ('the', 'O'), ('right', 'O'), ('ventricle', 'O'), ('to', 'O'), ('the', 'O'), ('left', 'O'), ('ventricle', 'O'), ('plus', 'O'), ('septum', 'O'), ('(', 'O'), ('P', 'O'), ('=', 'O'), ('0', 'O'), ('.', 'O'), ('02', 'O'), (')', 'O'), ('and', 'O'), ('by', 'O'), ('an', 'O'), ('increase', 'O'), ('in', 'O'), ('pulmonary', 'O'), ('arterial', 'O'), ('medial', 'O'), ('thickness', 'O'), ('(', 'O'), ('P', 'O'), ('<', 'O'), ('0', 'O'), ('.', 'O'), ('01', 'O'), (')', 'O'), ('.', 'O'))$$$"
AIM : To report a case of optic and peripheral neuropathy after chronic use of disulfiram for alcohol dependence management .,"(('AIM', 'O'), (':', 'O'), ('To', 'O'), ('report', 'O'), ('a', 'O'), ('case', 'O'), ('of', 'O'), ('optic', 'B'), ('and', 'I'), ('peripheral', 'I'), ('neuropathy', 'I'), ('after', 'O'), ('chronic', 'O'), ('use', 'O'), ('of', 'O'), ('disulfiram', 'O'), ('for', 'O'), ('alcohol', 'B'), ('dependence', 'I'), ('management', 'O'), ('.', 'O'))$$$"
RESULTS : A 57 - year - old male presented with gradual loss of vision in both eyes with intermittent headaches for 2 months .,"(('RESULTS', 'O'), (':', 'O'), ('A', 'O'), ('57', 'O'), ('-', 'O'), ('year', 'O'), ('-', 'O'), ('old', 'O'), ('male', 'O'), ('presented', 'O'), ('with', 'O'), ('gradual', 'O'), ('loss', 'B'), ('of', 'I'), ('vision', 'I'), ('in', 'O'), ('both', 'O'), ('eyes', 'O'), ('with', 'O'), ('intermittent', 'O'), ('headaches', 'B'), ('for', 'O'), ('2', 'O'), ('months', 'O'), ('.', 'O'))$$$"
OBJECTIVE : To report the incidence and management of elevated intraocular pressure ( IOP ) in patients with uveitis treated with the fluocinolone acetonide ( FA ) intravitreal implant .,"(('OBJECTIVE', 'O'), (':', 'O'), ('To', 'O'), ('report', 'O'), ('the', 'O'), ('incidence', 'O'), ('and', 'O'), ('management', 'O'), ('of', 'O'), ('elevated', 'B'), ('intraocular', 'I'), ('pressure', 'I'), ('(', 'O'), ('IOP', 'O'), (')', 'O'), ('in', 'O'), ('patients', 'O'), ('with', 'O'), ('uveitis', 'B'), ('treated', 'O'), ('with', 'O'), ('the', 'O'), ('fluocinolone', 'O'), ('acetonide', 'O'), ('(', 'O'), ('FA', 'O'), (')', 'O'), ('intravitreal', 'O'), ('implant', 'O'), ('.', 'O'))$$$"
"In contrast , AZT - treated FasL Tg mice developed cardiac dilation and depressed cardiac function in a dose - dependent manner , with concomitant inflammatory infiltration of both ventricles .","(('In', 'O'), ('contrast', 'O'), (',', 'O'), ('AZT', 'O'), ('-', 'O'), ('treated', 'O'), ('FasL', 'O'), ('Tg', 'O'), ('mice', 'O'), ('developed', 'O'), ('cardiac', 'B'), ('dilation', 'I'), ('and', 'O'), ('depressed', 'O'), ('cardiac', 'O'), ('function', 'O'), ('in', 'O'), ('a', 'O'), ('dose', 'O'), ('-', 'O'), ('dependent', 'O'), ('manner', 'O'), (',', 'O'), ('with', 'O'), ('concomitant', 'O'), ('inflammatory', 'O'), ('infiltration', 'O'), ('of', 'O'), ('both', 'O'), ('ventricles', 'O'), ('.', 'O'))$$$"
"General safety was also assessed , including adjudicated thrombotic cardiovascular event data .","(('General', 'O'), ('safety', 'O'), ('was', 'O'), ('also', 'O'), ('assessed', 'O'), (',', 'O'), ('including', 'O'), ('adjudicated', 'O'), ('thrombotic', 'B'), ('cardiovascular', 'I'), ('event', 'O'), ('data', 'O'), ('.', 'O'))$$$"
CONCLUSION : This appears to be the first reported case documenting a possible association between CC and myocardial infarction .,"(('CONCLUSION', 'O'), (':', 'O'), ('This', 'O'), ('appears', 'O'), ('to', 'O'), ('be', 'O'), ('the', 'O'), ('first', 'O'), ('reported', 'O'), ('case', 'O'), ('documenting', 'O'), ('a', 'O'), ('possible', 'O'), ('association', 'O'), ('between', 'O'), ('CC', 'O'), ('and', 'O'), ('myocardial', 'B'), ('infarction', 'I'), ('.', 'O'))$$$"
Reverse or inverted left ventricular apical ballooning syndrome ( reverse Takotsubo cardiomyopathy ) in a young woman in the setting of amphetamine use .,"(('Reverse', 'O'), ('or', 'O'), ('inverted', 'O'), ('left', 'B'), ('ventricular', 'I'), ('apical', 'I'), ('ballooning', 'I'), ('syndrome', 'I'), ('(', 'O'), ('reverse', 'O'), ('Takotsubo', 'B'), ('cardiomyopathy', 'I'), (')', 'O'), ('in', 'O'), ('a', 'O'), ('young', 'O'), ('woman', 'O'), ('in', 'O'), ('the', 'O'), ('setting', 'O'), ('of', 'O'), ('amphetamine', 'O'), ('use', 'O'), ('.', 'O'))$$$"
"Peripheral edema was reported in 8 . 5 % patients ( 9 / 106 ) in the T + A group compared with 13 . 5 % ( 14 / 104 ) in the A group , and cough was reported in 3 . 8 % patients ( 4 / 106 ) in the T + A group and 1 . 0 % ( 1 / 104 ) patients in the A group ; these differences did not reach statistical significance .","(('Peripheral', 'O'), ('edema', 'B'), ('was', 'O'), ('reported', 'O'), ('in', 'O'), ('8', 'O'), ('.', 'O'), ('5', 'O'), ('%', 'O'), ('patients', 'O'), ('(', 'O'), ('9', 'O'), ('/', 'O'), ('106', 'O'), (')', 'O'), ('in', 'O'), ('the', 'O'), ('T', 'O'), ('+', 'O'), ('A', 'O'), ('group', 'O'), ('compared', 'O'), ('with', 'O'), ('13', 'O'), ('.', 'O'), ('5', 'O'), ('%', 'O'), ('(', 'O'), ('14', 'O'), ('/', 'O'), ('104', 'O'), (')', 'O'), ('in', 'O'), ('the', 'O'), ('A', 'O'), ('group', 'O'), (',', 'O'), ('and', 'O'), ('cough', 'B'), ('was', 'O'), ('reported', 'O'), ('in', 'O'), ('3', 'O'), ('.', 'O'), ('8', 'O'), ('%', 'O'), ('patients', 'O'), ('(', 'O'), ('4', 'O'), ('/', 'O'), ('106', 'O'), (')', 'O'), ('in', 'O'), ('the', 'O'), ('T', 'O'), ('+', 'O'), ('A', 'O'), ('group', 'O'), ('and', 'O'), ('1', 'O'), ('.', 'O'), ('0', 'O'), ('%', 'O'), ('(', 'O'), ('1', 'O'), ('/', 'O'), ('104', 'O'), (')', 'O'), ('patients', 'O'), ('in', 'O'), ('the', 'O'), ('A', 'O'), ('group', 'O'), (';', 'O'), ('these', 'O'), ('differences', 'O'), ('did', 'O'), ('not', 'O'), ('reach', 'O'), ('statistical', 'O'), ('significance', 'O'), ('.', 'O'))$$$"
"CONCLUSIONS : Among these Indian patients with stage II hypertension , the FDC of T + A was found to be significantly more effective , with regard to BP reductions , than A , and both treatments were well tolerated .","(('CONCLUSIONS', 'O'), (':', 'O'), ('Among', 'O'), ('these', 'O'), ('Indian', 'O'), ('patients', 'O'), ('with', 'O'), ('stage', 'O'), ('II', 'O'), ('hypertension', 'B'), (',', 'O'), ('the', 'O'), ('FDC', 'O'), ('of', 'O'), ('T', 'O'), ('+', 'O'), ('A', 'O'), ('was', 'O'), ('found', 'O'), ('to', 'O'), ('be', 'O'), ('significantly', 'O'), ('more', 'O'), ('effective', 'O'), (',', 'O'), ('with', 'O'), ('regard', 'O'), ('to', 'O'), ('BP', 'O'), ('reductions', 'O'), (',', 'O'), ('than', 'O'), ('A', 'O'), (',', 'O'), ('and', 'O'), ('both', 'O'), ('treatments', 'O'), ('were', 'O'), ('well', 'O'), ('tolerated', 'O'), ('.', 'O'))$$$"
Hepatotoxicity associated with sulfasalazine in inflammatory arthritis : A case series from a local surveillance of serious adverse events .,"(('Hepatotoxicity', 'B'), ('associated', 'O'), ('with', 'O'), ('sulfasalazine', 'O'), ('in', 'O'), ('inflammatory', 'O'), ('arthritis', 'B'), (':', 'O'), ('A', 'O'), ('case', 'O'), ('series', 'O'), ('from', 'O'), ('a', 'O'), ('local', 'O'), ('surveillance', 'O'), ('of', 'O'), ('serious', 'O'), ('adverse', 'O'), ('events', 'O'), ('.', 'O'))$$$"
We report an investigation from a local surveillance for serious adverse drug reactions associated with disease modifying anti - rheumatic drugs that was triggered by the occurrence of liver failure in two of our patients .,"(('We', 'O'), ('report', 'O'), ('an', 'O'), ('investigation', 'O'), ('from', 'O'), ('a', 'O'), ('local', 'O'), ('surveillance', 'O'), ('for', 'O'), ('serious', 'O'), ('adverse', 'O'), ('drug', 'O'), ('reactions', 'O'), ('associated', 'O'), ('with', 'O'), ('disease', 'O'), ('modifying', 'O'), ('anti', 'O'), ('-', 'O'), ('rheumatic', 'O'), ('drugs', 'O'), ('that', 'O'), ('was', 'O'), ('triggered', 'O'), ('by', 'O'), ('the', 'O'), ('occurrence', 'O'), ('of', 'O'), ('liver', 'B'), ('failure', 'I'), ('in', 'O'), ('two', 'O'), ('of', 'O'), ('our', 'O'), ('patients', 'O'), ('.', 'O'))$$$"
"Patients ' , who had hepatotoxicity on sulfasalazine and met a definition of a serious ADR , were identified .","(('Patients', 'O'), (""'"", 'O'), (',', 'O'), ('who', 'O'), ('had', 'O'), ('hepatotoxicity', 'B'), ('on', 'O'), ('sulfasalazine', 'O'), ('and', 'O'), ('met', 'O'), ('a', 'O'), ('definition', 'O'), ('of', 'O'), ('a', 'O'), ('serious', 'O'), ('ADR', 'O'), (',', 'O'), ('were', 'O'), ('identified', 'O'), ('.', 'O'))$$$"
"Parturients with normal volume status , heart valves and pulmonary vasculature most often respond to this hypotension with a compensatory increase in heart rate and stroke volume .","(('Parturients', 'O'), ('with', 'O'), ('normal', 'O'), ('volume', 'O'), ('status', 'O'), (',', 'O'), ('heart', 'O'), ('valves', 'O'), ('and', 'O'), ('pulmonary', 'O'), ('vasculature', 'O'), ('most', 'O'), ('often', 'O'), ('respond', 'O'), ('to', 'O'), ('this', 'O'), ('hypotension', 'B'), ('with', 'O'), ('a', 'O'), ('compensatory', 'O'), ('increase', 'O'), ('in', 'O'), ('heart', 'O'), ('rate', 'O'), ('and', 'O'), ('stroke', 'B'), ('volume', 'O'), ('.', 'O'))$$$"
"Hypotension in response to oxytocin was associated with a decrease in systemic vascular resistance and a compensatory increase in stroke volume , heart rate and cardiac output .","(('Hypotension', 'B'), ('in', 'O'), ('response', 'O'), ('to', 'O'), ('oxytocin', 'O'), ('was', 'O'), ('associated', 'O'), ('with', 'O'), ('a', 'O'), ('decrease', 'O'), ('in', 'O'), ('systemic', 'O'), ('vascular', 'O'), ('resistance', 'O'), ('and', 'O'), ('a', 'O'), ('compensatory', 'O'), ('increase', 'O'), ('in', 'O'), ('stroke', 'B'), ('volume', 'O'), (',', 'O'), ('heart', 'O'), ('rate', 'O'), ('and', 'O'), ('cardiac', 'O'), ('output', 'O'), ('.', 'O'))$$$"
HIT antibody levels were measured the day before surgery and on POD 7 and 14 .,"(('HIT', 'B'), ('antibody', 'O'), ('levels', 'O'), ('were', 'O'), ('measured', 'O'), ('the', 'O'), ('day', 'O'), ('before', 'O'), ('surgery', 'O'), ('and', 'O'), ('on', 'O'), ('POD', 'O'), ('7', 'O'), ('and', 'O'), ('14', 'O'), ('.', 'O'))$$$"
"Two patients developed hepatic artery thrombosis on POD 11 and 19 , respectively , although they were HIT antibody - negative and their platelet counts were stable .","(('Two', 'O'), ('patients', 'O'), ('developed', 'O'), ('hepatic', 'O'), ('artery', 'O'), ('thrombosis', 'B'), ('on', 'O'), ('POD', 'O'), ('11', 'O'), ('and', 'O'), ('19', 'O'), (',', 'O'), ('respectively', 'O'), (',', 'O'), ('although', 'O'), ('they', 'O'), ('were', 'O'), ('HIT', 'B'), ('antibody', 'O'), ('-', 'O'), ('negative', 'O'), ('and', 'O'), ('their', 'O'), ('platelet', 'O'), ('counts', 'O'), ('were', 'O'), ('stable', 'O'), ('.', 'O'))$$$"
"The percentage of HIT antibody - positive patients was 0 . 5 % preoperatively , 5 . 6 % on POD 7 , and 5 . 6 % on POD 14 .","(('The', 'O'), ('percentage', 'O'), ('of', 'O'), ('HIT', 'B'), ('antibody', 'O'), ('-', 'O'), ('positive', 'O'), ('patients', 'O'), ('was', 'O'), ('0', 'O'), ('.', 'O'), ('5', 'O'), ('%', 'O'), ('preoperatively', 'O'), (',', 'O'), ('5', 'O'), ('.', 'O'), ('6', 'O'), ('%', 'O'), ('on', 'O'), ('POD', 'O'), ('7', 'O'), (',', 'O'), ('and', 'O'), ('5', 'O'), ('.', 'O'), ('6', 'O'), ('%', 'O'), ('on', 'O'), ('POD', 'O'), ('14', 'O'), ('.', 'O'))$$$"
"This was associated with a reduced activation state of AKT , as well as an increased bax / bcl2 ratio in Western blots , indicating cardiac apoptosis .","(('This', 'O'), ('was', 'O'), ('associated', 'O'), ('with', 'O'), ('a', 'O'), ('reduced', 'O'), ('activation', 'O'), ('state', 'O'), ('of', 'O'), ('AKT', 'O'), (',', 'O'), ('as', 'O'), ('well', 'O'), ('as', 'O'), ('an', 'O'), ('increased', 'O'), ('bax', 'O'), ('/', 'O'), ('bcl2', 'O'), ('ratio', 'O'), ('in', 'O'), ('Western', 'O'), ('blots', 'O'), (',', 'O'), ('indicating', 'O'), ('cardiac', 'B'), ('apoptosis', 'I'), ('.', 'O'))$$$"
These findings suggest that B1R is detrimental in DOX cardiomyopathy in that it mediates the inflammatory response and apoptosis .,"(('These', 'O'), ('findings', 'O'), ('suggest', 'O'), ('that', 'O'), ('B1R', 'O'), ('is', 'O'), ('detrimental', 'O'), ('in', 'O'), ('DOX', 'O'), ('cardiomyopathy', 'B'), ('in', 'O'), ('that', 'O'), ('it', 'O'), ('mediates', 'O'), ('the', 'O'), ('inflammatory', 'O'), ('response', 'O'), ('and', 'O'), ('apoptosis', 'O'), ('.', 'O'))$$$"
These insights might have useful implications for future studies utilizing B1R antagonists for treatment of human DOX cardiomyopathy .,"(('These', 'O'), ('insights', 'O'), ('might', 'O'), ('have', 'O'), ('useful', 'O'), ('implications', 'O'), ('for', 'O'), ('future', 'O'), ('studies', 'O'), ('utilizing', 'O'), ('B1R', 'O'), ('antagonists', 'O'), ('for', 'O'), ('treatment', 'O'), ('of', 'O'), ('human', 'O'), ('DOX', 'O'), ('cardiomyopathy', 'B'), ('.', 'O'))$$$"
Detailed spectral profile analysis of penicillin - induced epileptiform activity in anesthetized rats .,"(('Detailed', 'O'), ('spectral', 'O'), ('profile', 'O'), ('analysis', 'O'), ('of', 'O'), ('penicillin', 'O'), ('-', 'O'), ('induced', 'O'), ('epileptiform', 'B'), ('activity', 'I'), ('in', 'O'), ('anesthetized', 'O'), ('rats', 'O'), ('.', 'O'))$$$"
In the present study we aimed to portray a detailed spectral analysis of penicillin - induced epileptiform activity in comparison with basal brain activity in anesthetized Wistar rats .,"(('In', 'O'), ('the', 'O'), ('present', 'O'), ('study', 'O'), ('we', 'O'), ('aimed', 'O'), ('to', 'O'), ('portray', 'O'), ('a', 'O'), ('detailed', 'O'), ('spectral', 'O'), ('analysis', 'O'), ('of', 'O'), ('penicillin', 'O'), ('-', 'O'), ('induced', 'O'), ('epileptiform', 'B'), ('activity', 'I'), ('in', 'O'), ('comparison', 'O'), ('with', 'O'), ('basal', 'O'), ('brain', 'O'), ('activity', 'O'), ('in', 'O'), ('anesthetized', 'O'), ('Wistar', 'O'), ('rats', 'O'), ('.', 'O'))$$$"
"After a short period of basal activity recording , epileptic focus was induced by injecting 400IU / 2 microl penicillin - G potassium into the left lateral ventricle while the cortical activity was continuously recorded .","(('After', 'O'), ('a', 'O'), ('short', 'O'), ('period', 'O'), ('of', 'O'), ('basal', 'O'), ('activity', 'O'), ('recording', 'O'), (',', 'O'), ('epileptic', 'B'), ('focus', 'O'), ('was', 'O'), ('induced', 'O'), ('by', 'O'), ('injecting', 'O'), ('400IU', 'O'), ('/', 'O'), ('2', 'O'), ('microl', 'O'), ('penicillin', 'O'), ('-', 'O'), ('G', 'O'), ('potassium', 'O'), ('into', 'O'), ('the', 'O'), ('left', 'O'), ('lateral', 'O'), ('ventricle', 'O'), ('while', 'O'), ('the', 'O'), ('cortical', 'O'), ('activity', 'O'), ('was', 'O'), ('continuously', 'O'), ('recorded', 'O'), ('.', 'O'))$$$"
"Basal activity , latent period and the penicillin - induced epileptiform activity periods were then analyzed using both conventional methods and spectral analysis .","(('Basal', 'O'), ('activity', 'O'), (',', 'O'), ('latent', 'O'), ('period', 'O'), ('and', 'O'), ('the', 'O'), ('penicillin', 'O'), ('-', 'O'), ('induced', 'O'), ('epileptiform', 'B'), ('activity', 'I'), ('periods', 'O'), ('were', 'O'), ('then', 'O'), ('analyzed', 'O'), ('using', 'O'), ('both', 'O'), ('conventional', 'O'), ('methods', 'O'), ('and', 'O'), ('spectral', 'O'), ('analysis', 'O'), ('.', 'O'))$$$"
"Our results show that the most affected frequency bands were delta , theta , beta - 2 and gamma - 2 bands during the epileptiform activity and there were marked differences in terms of spectral densities between three investigated episodes ( basal activity , latent period and epileptiform activity ) .","(('Our', 'O'), ('results', 'O'), ('show', 'O'), ('that', 'O'), ('the', 'O'), ('most', 'O'), ('affected', 'O'), ('frequency', 'O'), ('bands', 'O'), ('were', 'O'), ('delta', 'O'), (',', 'O'), ('theta', 'O'), (',', 'O'), ('beta', 'O'), ('-', 'O'), ('2', 'O'), ('and', 'O'), ('gamma', 'O'), ('-', 'O'), ('2', 'O'), ('bands', 'O'), ('during', 'O'), ('the', 'O'), ('epileptiform', 'B'), ('activity', 'I'), ('and', 'O'), ('there', 'O'), ('were', 'O'), ('marked', 'O'), ('differences', 'O'), ('in', 'O'), ('terms', 'O'), ('of', 'O'), ('spectral', 'O'), ('densities', 'O'), ('between', 'O'), ('three', 'O'), ('investigated', 'O'), ('episodes', 'O'), ('(', 'O'), ('basal', 'O'), ('activity', 'O'), (',', 'O'), ('latent', 'O'), ('period', 'O'), ('and', 'O'), ('epileptiform', 'B'), ('activity', 'I'), (')', 'O'), ('.', 'O'))$$$"
"A LD ( 10 ) dose ( 8 mg doxorubicin / kg , ip ) administered on day 43 of the HFD feeding regimen led to higher cardiotoxicity , cardiac dysfunction , lipid peroxidation , and 80 % mortality in the obese ( OB ) rats in the absence of any significant renal or hepatic toxicity .","(('A', 'O'), ('LD', 'O'), ('(', 'O'), ('10', 'O'), (')', 'O'), ('dose', 'O'), ('(', 'O'), ('8', 'O'), ('mg', 'O'), ('doxorubicin', 'O'), ('/', 'O'), ('kg', 'O'), (',', 'O'), ('ip', 'O'), (')', 'O'), ('administered', 'O'), ('on', 'O'), ('day', 'O'), ('43', 'O'), ('of', 'O'), ('the', 'O'), ('HFD', 'O'), ('feeding', 'O'), ('regimen', 'O'), ('led', 'O'), ('to', 'O'), ('higher', 'O'), ('cardiotoxicity', 'B'), (',', 'O'), ('cardiac', 'B'), ('dysfunction', 'I'), (',', 'O'), ('lipid', 'O'), ('peroxidation', 'O'), (',', 'O'), ('and', 'O'), ('80', 'O'), ('%', 'O'), ('mortality', 'O'), ('in', 'O'), ('the', 'O'), ('obese', 'B'), ('(', 'O'), ('OB', 'B'), (')', 'O'), ('rats', 'O'), ('in', 'O'), ('the', 'O'), ('absence', 'O'), ('of', 'O'), ('any', 'O'), ('significant', 'O'), ('renal', 'B'), ('or', 'I'), ('hepatic', 'I'), ('toxicity', 'I'), ('.', 'O'))$$$"
"The mechanism of isoproterenol - induced myocardial damage is unknown , but a mismatch of oxygen supply vs . demand following coronary hypotension and myocardial hyperactivity is the best explanation for the complex morphological alterations observed .","(('The', 'O'), ('mechanism', 'O'), ('of', 'O'), ('isoproterenol', 'O'), ('-', 'O'), ('induced', 'O'), ('myocardial', 'B'), ('damage', 'I'), ('is', 'O'), ('unknown', 'O'), (',', 'O'), ('but', 'O'), ('a', 'O'), ('mismatch', 'O'), ('of', 'O'), ('oxygen', 'O'), ('supply', 'O'), ('vs', 'O'), ('.', 'O'), ('demand', 'O'), ('following', 'O'), ('coronary', 'O'), ('hypotension', 'B'), ('and', 'O'), ('myocardial', 'B'), ('hyperactivity', 'I'), ('is', 'O'), ('the', 'O'), ('best', 'O'), ('explanation', 'O'), ('for', 'O'), ('the', 'O'), ('complex', 'O'), ('morphological', 'O'), ('alterations', 'O'), ('observed', 'O'), ('.', 'O'))$$$"
"At 550 mg / m2 / d , three patients experienced nonurologic toxicity ; confusion ( 1 ) , nausea ( 1 ) , and Grade 2 leukopenia ( 1 ) .","(('At', 'O'), ('550', 'O'), ('mg', 'O'), ('/', 'O'), ('m2', 'O'), ('/', 'O'), ('d', 'O'), (',', 'O'), ('three', 'O'), ('patients', 'O'), ('experienced', 'O'), ('nonurologic', 'O'), ('toxicity', 'B'), (';', 'O'), ('confusion', 'B'), ('(', 'O'), ('1', 'O'), (')', 'O'), (',', 'O'), ('nausea', 'B'), ('(', 'O'), ('1', 'O'), (')', 'O'), (',', 'O'), ('and', 'O'), ('Grade', 'O'), ('2', 'O'), ('leukopenia', 'B'), ('(', 'O'), ('1', 'O'), (')', 'O'), ('.', 'O'))$$$"
We describe a patient with no previous history of cardiac disease or arrhythmia who developed sustained bigeminy and 2 brief runs of ventricular tachycardia after caffeine administration .,"(('We', 'O'), ('describe', 'O'), ('a', 'O'), ('patient', 'O'), ('with', 'O'), ('no', 'O'), ('previous', 'O'), ('history', 'O'), ('of', 'O'), ('cardiac', 'B'), ('disease', 'I'), ('or', 'O'), ('arrhythmia', 'B'), ('who', 'O'), ('developed', 'O'), ('sustained', 'O'), ('bigeminy', 'O'), ('and', 'O'), ('2', 'O'), ('brief', 'O'), ('runs', 'O'), ('of', 'O'), ('ventricular', 'B'), ('tachycardia', 'I'), ('after', 'O'), ('caffeine', 'O'), ('administration', 'O'), ('.', 'O'))$$$"
We report a case of fatal internal haemorrhage in an elderly man who consumed only cranberry juice for two weeks while maintaining his usual dosage of warfarin .,"(('We', 'O'), ('report', 'O'), ('a', 'O'), ('case', 'O'), ('of', 'O'), ('fatal', 'O'), ('internal', 'O'), ('haemorrhage', 'B'), ('in', 'O'), ('an', 'O'), ('elderly', 'O'), ('man', 'O'), ('who', 'O'), ('consumed', 'O'), ('only', 'O'), ('cranberry', 'O'), ('juice', 'O'), ('for', 'O'), ('two', 'O'), ('weeks', 'O'), ('while', 'O'), ('maintaining', 'O'), ('his', 'O'), ('usual', 'O'), ('dosage', 'O'), ('of', 'O'), ('warfarin', 'O'), ('.', 'O'))$$$"
RESULTS : The results showed that IP administration of bupropion HCl 120 mg / kg by bolus injection induced convulsions in 6 out of 10 mice ( 60 % of convulsing mice ) in group 1 .,"(('RESULTS', 'O'), (':', 'O'), ('The', 'O'), ('results', 'O'), ('showed', 'O'), ('that', 'O'), ('IP', 'O'), ('administration', 'O'), ('of', 'O'), ('bupropion', 'O'), ('HCl', 'O'), ('120', 'O'), ('mg', 'O'), ('/', 'O'), ('kg', 'O'), ('by', 'O'), ('bolus', 'O'), ('injection', 'O'), ('induced', 'O'), ('convulsions', 'B'), ('in', 'O'), ('6', 'O'), ('out', 'O'), ('of', 'O'), ('10', 'O'), ('mice', 'O'), ('(', 'O'), ('60', 'O'), ('%', 'O'), ('of', 'O'), ('convulsing', 'O'), ('mice', 'O'), (')', 'O'), ('in', 'O'), ('group', 'O'), ('1', 'O'), ('.', 'O'))$$$"
"Transplantation - associated microangiopathy ( TMA ) occurred in 7 patients ( 29 % ) , with 2 cases of acute renal failure .","(('Transplantation', 'B'), ('-', 'I'), ('associated', 'I'), ('microangiopathy', 'I'), ('(', 'O'), ('TMA', 'B'), (')', 'O'), ('occurred', 'O'), ('in', 'O'), ('7', 'O'), ('patients', 'O'), ('(', 'O'), ('29', 'O'), ('%', 'O'), (')', 'O'), (',', 'O'), ('with', 'O'), ('2', 'O'), ('cases', 'O'), ('of', 'O'), ('acute', 'B'), ('renal', 'I'), ('failure', 'I'), ('.', 'O'))$$$"
"Temporary hearing loss is a known toxicity of treatment with DFMO , thus a comprehensive approach was developed to analyze serial air conduction audiograms .","(('Temporary', 'O'), ('hearing', 'B'), ('loss', 'I'), ('is', 'O'), ('a', 'O'), ('known', 'O'), ('toxicity', 'B'), ('of', 'O'), ('treatment', 'O'), ('with', 'O'), ('DFMO', 'O'), (',', 'O'), ('thus', 'O'), ('a', 'O'), ('comprehensive', 'O'), ('approach', 'O'), ('was', 'O'), ('developed', 'O'), ('to', 'O'), ('analyze', 'O'), ('serial', 'O'), ('air', 'O'), ('conduction', 'O'), ('audiograms', 'O'), ('.', 'O'))$$$"
"Ten consecutive patients ( mean age , 58 . 4 + / - 6 . 8 years ; 7 men , 3 women ) with similar characteristics at the duration of disease ( mean disease time , 8 . 4 + / - 3 . 5 years ) , disabling motor fluctuations ( Hoehn _ Yahr stage 3 - 5 in off - drug phases ) and levodopa - induced dyskinesias were selected .","(('Ten', 'O'), ('consecutive', 'O'), ('patients', 'O'), ('(', 'O'), ('mean', 'O'), ('age', 'O'), (',', 'O'), ('58', 'O'), ('.', 'O'), ('4', 'O'), ('+', 'O'), ('/', 'O'), ('-', 'O'), ('6', 'O'), ('.', 'O'), ('8', 'O'), ('years', 'O'), (';', 'O'), ('7', 'O'), ('men', 'O'), (',', 'O'), ('3', 'O'), ('women', 'O'), (')', 'O'), ('with', 'O'), ('similar', 'O'), ('characteristics', 'O'), ('at', 'O'), ('the', 'O'), ('duration', 'O'), ('of', 'O'), ('disease', 'O'), ('(', 'O'), ('mean', 'O'), ('disease', 'O'), ('time', 'O'), (',', 'O'), ('8', 'O'), ('.', 'O'), ('4', 'O'), ('+', 'O'), ('/', 'O'), ('-', 'O'), ('3', 'O'), ('.', 'O'), ('5', 'O'), ('years', 'O'), (')', 'O'), (',', 'O'), ('disabling', 'O'), ('motor', 'O'), ('fluctuations', 'O'), ('(', 'O'), ('Hoehn', 'O'), ('_', 'O'), ('Yahr', 'O'), ('stage', 'O'), ('3', 'O'), ('-', 'O'), ('5', 'O'), ('in', 'O'), ('off', 'O'), ('-', 'O'), ('drug', 'O'), ('phases', 'O'), (')', 'O'), ('and', 'O'), ('levodopa', 'O'), ('-', 'O'), ('induced', 'O'), ('dyskinesias', 'B'), ('were', 'O'), ('selected', 'O'), ('.', 'O'))$$$"
The apical ballooning syndrome ( ABS ) is a recently described stress - mediated acute cardiac syndrome characterized by transient wall - motion abnormalities involving the apex and midventricle with hyperkinesis of the basal left ventricular ( LV ) segments without obstructive epicardial coronary disease .,"(('The', 'O'), ('apical', 'B'), ('ballooning', 'I'), ('syndrome', 'I'), ('(', 'O'), ('ABS', 'B'), (')', 'O'), ('is', 'O'), ('a', 'O'), ('recently', 'O'), ('described', 'O'), ('stress', 'O'), ('-', 'O'), ('mediated', 'O'), ('acute', 'B'), ('cardiac', 'I'), ('syndrome', 'I'), ('characterized', 'O'), ('by', 'O'), ('transient', 'O'), ('wall', 'O'), ('-', 'O'), ('motion', 'O'), ('abnormalities', 'O'), ('involving', 'O'), ('the', 'O'), ('apex', 'O'), ('and', 'O'), ('midventricle', 'O'), ('with', 'O'), ('hyperkinesis', 'B'), ('of', 'O'), ('the', 'O'), ('basal', 'O'), ('left', 'O'), ('ventricular', 'O'), ('(', 'O'), ('LV', 'O'), (')', 'O'), ('segments', 'O'), ('without', 'O'), ('obstructive', 'O'), ('epicardial', 'B'), ('coronary', 'I'), ('disease', 'I'), ('.', 'O'))$$$"
Echocardiography revealed a wall - motion abnormality involving the apical and periapical segments which appeared akinetic .,"(('Echocardiography', 'O'), ('revealed', 'O'), ('a', 'O'), ('wall', 'O'), ('-', 'O'), ('motion', 'O'), ('abnormality', 'O'), ('involving', 'O'), ('the', 'O'), ('apical', 'O'), ('and', 'O'), ('periapical', 'O'), ('segments', 'O'), ('which', 'O'), ('appeared', 'O'), ('akinetic', 'B'), ('.', 'O'))$$$"
"In our patient , both supraphysiologic levels of plasma catecholamines and stress related neuropeptides caused by cancer diagnosis as well as chemotherapy may have contributed the development of ABS .","(('In', 'O'), ('our', 'O'), ('patient', 'O'), (',', 'O'), ('both', 'O'), ('supraphysiologic', 'O'), ('levels', 'O'), ('of', 'O'), ('plasma', 'O'), ('catecholamines', 'O'), ('and', 'O'), ('stress', 'O'), ('related', 'O'), ('neuropeptides', 'O'), ('caused', 'O'), ('by', 'O'), ('cancer', 'B'), ('diagnosis', 'O'), ('as', 'O'), ('well', 'O'), ('as', 'O'), ('chemotherapy', 'O'), ('may', 'O'), ('have', 'O'), ('contributed', 'O'), ('the', 'O'), ('development', 'O'), ('of', 'O'), ('ABS', 'B'), ('.', 'O'))$$$"
Warfarin - associated intracerebral hemorrhage ( W - ICH ) is a severe type of stroke .,"(('Warfarin', 'O'), ('-', 'O'), ('associated', 'O'), ('intracerebral', 'B'), ('hemorrhage', 'I'), ('(', 'O'), ('W', 'O'), ('-', 'O'), ('ICH', 'B'), (')', 'O'), ('is', 'O'), ('a', 'O'), ('severe', 'O'), ('type', 'O'), ('of', 'O'), ('stroke', 'B'), ('.', 'O'))$$$"
There is no consensus on the optimal treatment for W - ICH .,"(('There', 'O'), ('is', 'O'), ('no', 'O'), ('consensus', 'O'), ('on', 'O'), ('the', 'O'), ('optimal', 'O'), ('treatment', 'O'), ('for', 'O'), ('W', 'O'), ('-', 'O'), ('ICH', 'B'), ('.', 'O'))$$$"
"Twenty - four hours after hemorrhage induction , hemorrhagic blood volume was quantified using a photometric hemoglobin assay .","(('Twenty', 'O'), ('-', 'O'), ('four', 'O'), ('hours', 'O'), ('after', 'O'), ('hemorrhage', 'B'), ('induction', 'O'), (',', 'O'), ('hemorrhagic', 'O'), ('blood', 'O'), ('volume', 'O'), ('was', 'O'), ('quantified', 'O'), ('using', 'O'), ('a', 'O'), ('photometric', 'O'), ('hemoglobin', 'O'), ('assay', 'O'), ('.', 'O'))$$$"
We provide experimental data suggesting PCC to be an effective acute treatment for W - ICH in terms of reducing hemorrhagic blood volume .,"(('We', 'O'), ('provide', 'O'), ('experimental', 'O'), ('data', 'O'), ('suggesting', 'O'), ('PCC', 'O'), ('to', 'O'), ('be', 'O'), ('an', 'O'), ('effective', 'O'), ('acute', 'O'), ('treatment', 'O'), ('for', 'O'), ('W', 'O'), ('-', 'O'), ('ICH', 'B'), ('in', 'O'), ('terms', 'O'), ('of', 'O'), ('reducing', 'O'), ('hemorrhagic', 'O'), ('blood', 'O'), ('volume', 'O'), ('.', 'O'))$$$"
Future studies are needed to assess the therapeutic potential emerging from our finding for human W - ICH .,"(('Future', 'O'), ('studies', 'O'), ('are', 'O'), ('needed', 'O'), ('to', 'O'), ('assess', 'O'), ('the', 'O'), ('therapeutic', 'O'), ('potential', 'O'), ('emerging', 'O'), ('from', 'O'), ('our', 'O'), ('finding', 'O'), ('for', 'O'), ('human', 'O'), ('W', 'O'), ('-', 'O'), ('ICH', 'B'), ('.', 'O'))$$$"
"In relatively healthy women , combined continuous HT significantly increased the risk of venous thrombo - embolism or coronary event ( after one year ' s use ) , stroke ( after three years ) , breast cancer and gallbladder disease .","(('In', 'O'), ('relatively', 'O'), ('healthy', 'O'), ('women', 'O'), (',', 'O'), ('combined', 'O'), ('continuous', 'O'), ('HT', 'O'), ('significantly', 'O'), ('increased', 'O'), ('the', 'O'), ('risk', 'O'), ('of', 'O'), ('venous', 'B'), ('thrombo', 'I'), ('-', 'I'), ('embolism', 'I'), ('or', 'O'), ('coronary', 'O'), ('event', 'O'), ('(', 'O'), ('after', 'O'), ('one', 'O'), ('year', 'O'), (""'"", 'O'), ('s', 'O'), ('use', 'O'), (')', 'O'), (',', 'O'), ('stroke', 'B'), ('(', 'O'), ('after', 'O'), ('three', 'O'), ('years', 'O'), (')', 'O'), (',', 'O'), ('breast', 'B'), ('cancer', 'I'), ('and', 'O'), ('gallbladder', 'B'), ('disease', 'I'), ('.', 'O'))$$$"
Acute renal failure in patients with AIDS on tenofovir while receiving prolonged vancomycin course for osteomyelitis .,"(('Acute', 'B'), ('renal', 'I'), ('failure', 'I'), ('in', 'O'), ('patients', 'O'), ('with', 'O'), ('AIDS', 'B'), ('on', 'O'), ('tenofovir', 'O'), ('while', 'O'), ('receiving', 'O'), ('prolonged', 'O'), ('vancomycin', 'O'), ('course', 'O'), ('for', 'O'), ('osteomyelitis', 'B'), ('.', 'O'))$$$"
"Pyrazinamide can have adverse effects such as hepatic toxicity , hyperuricemia or digestive disorders .","(('Pyrazinamide', 'O'), ('can', 'O'), ('have', 'O'), ('adverse', 'O'), ('effects', 'O'), ('such', 'O'), ('as', 'O'), ('hepatic', 'B'), ('toxicity', 'I'), (',', 'O'), ('hyperuricemia', 'B'), ('or', 'O'), ('digestive', 'O'), ('disorders', 'O'), ('.', 'O'))$$$"
"The current data showed that pilocarpine significantly delayed onset of arrhythmias , decreased the time course of ventricular tachycardia and fibrillation , reduced arrhythmia score , and increased the survival time of arrhythmic rats and guinea pigs .","(('The', 'O'), ('current', 'O'), ('data', 'O'), ('showed', 'O'), ('that', 'O'), ('pilocarpine', 'O'), ('significantly', 'O'), ('delayed', 'O'), ('onset', 'O'), ('of', 'O'), ('arrhythmias', 'B'), (',', 'O'), ('decreased', 'O'), ('the', 'O'), ('time', 'O'), ('course', 'O'), ('of', 'O'), ('ventricular', 'B'), ('tachycardia', 'I'), ('and', 'I'), ('fibrillation', 'I'), (',', 'O'), ('reduced', 'O'), ('arrhythmia', 'B'), ('score', 'O'), (',', 'O'), ('and', 'O'), ('increased', 'O'), ('the', 'O'), ('survival', 'O'), ('time', 'O'), ('of', 'O'), ('arrhythmic', 'B'), ('rats', 'O'), ('and', 'O'), ('guinea', 'O'), ('pigs', 'O'), ('.', 'O'))$$$"
Effect of methanolic extract of Hibiscus rosa sinensis ( 100 - 300 mg / kg ) was studied on reserpine - induced orofacial dyskinesia and neurochemical alterations .,"(('Effect', 'O'), ('of', 'O'), ('methanolic', 'O'), ('extract', 'O'), ('of', 'O'), ('Hibiscus', 'O'), ('rosa', 'O'), ('sinensis', 'O'), ('(', 'O'), ('100', 'O'), ('-', 'O'), ('300', 'O'), ('mg', 'O'), ('/', 'O'), ('kg', 'O'), (')', 'O'), ('was', 'O'), ('studied', 'O'), ('on', 'O'), ('reserpine', 'O'), ('-', 'O'), ('induced', 'O'), ('orofacial', 'O'), ('dyskinesia', 'B'), ('and', 'O'), ('neurochemical', 'O'), ('alterations', 'O'), ('.', 'O'))$$$"
The results of the present study suggested that Hibiscus rosa sinensis had a protective role against reserpine - induced orofacial dyskinesia and oxidative stress .,"(('The', 'O'), ('results', 'O'), ('of', 'O'), ('the', 'O'), ('present', 'O'), ('study', 'O'), ('suggested', 'O'), ('that', 'O'), ('Hibiscus', 'O'), ('rosa', 'O'), ('sinensis', 'O'), ('had', 'O'), ('a', 'O'), ('protective', 'O'), ('role', 'O'), ('against', 'O'), ('reserpine', 'O'), ('-', 'O'), ('induced', 'O'), ('orofacial', 'O'), ('dyskinesia', 'B'), ('and', 'O'), ('oxidative', 'O'), ('stress', 'O'), ('.', 'O'))$$$"
"Initially , allograft rejection was feared ; however , myocardial biopsy samples revealed only interstitial edema and mild myocardial hypertrophy ; neither cellular nor humoral rejection was detected .","(('Initially', 'O'), (',', 'O'), ('allograft', 'O'), ('rejection', 'O'), ('was', 'O'), ('feared', 'O'), (';', 'O'), ('however', 'O'), (',', 'O'), ('myocardial', 'O'), ('biopsy', 'O'), ('samples', 'O'), ('revealed', 'O'), ('only', 'O'), ('interstitial', 'O'), ('edema', 'B'), ('and', 'O'), ('mild', 'O'), ('myocardial', 'B'), ('hypertrophy', 'I'), (';', 'O'), ('neither', 'O'), ('cellular', 'O'), ('nor', 'O'), ('humoral', 'O'), ('rejection', 'O'), ('was', 'O'), ('detected', 'O'), ('.', 'O'))$$$"
BACKGROUND : Hypotension and a resultant decrease in cerebral blood flow have been implicated in the development of cognitive dysfunction .,"(('BACKGROUND', 'O'), (':', 'O'), ('Hypotension', 'B'), ('and', 'O'), ('a', 'O'), ('resultant', 'O'), ('decrease', 'O'), ('in', 'O'), ('cerebral', 'O'), ('blood', 'O'), ('flow', 'O'), ('have', 'O'), ('been', 'O'), ('implicated', 'O'), ('in', 'O'), ('the', 'O'), ('development', 'O'), ('of', 'O'), ('cognitive', 'B'), ('dysfunction', 'I'), ('.', 'O'))$$$"
"CONCLUSION : In a PA retention paradigm , the injection of NTG immediately after learning produced a significant impairment of long - term associative memory in mice , whereas delayed induced hypotension had no effect .","(('CONCLUSION', 'O'), (':', 'O'), ('In', 'O'), ('a', 'O'), ('PA', 'O'), ('retention', 'O'), ('paradigm', 'O'), (',', 'O'), ('the', 'O'), ('injection', 'O'), ('of', 'O'), ('NTG', 'O'), ('immediately', 'O'), ('after', 'O'), ('learning', 'O'), ('produced', 'O'), ('a', 'O'), ('significant', 'O'), ('impairment', 'O'), ('of', 'O'), ('long', 'O'), ('-', 'O'), ('term', 'O'), ('associative', 'O'), ('memory', 'O'), ('in', 'O'), ('mice', 'O'), (',', 'O'), ('whereas', 'O'), ('delayed', 'O'), ('induced', 'O'), ('hypotension', 'B'), ('had', 'O'), ('no', 'O'), ('effect', 'O'), ('.', 'O'))$$$"
NIMO attenuated the disruption in consolidation of long - term memory caused by NTG but did not improve latency in the absence of hypotension .,"(('NIMO', 'O'), ('attenuated', 'O'), ('the', 'O'), ('disruption', 'O'), ('in', 'O'), ('consolidation', 'O'), ('of', 'O'), ('long', 'O'), ('-', 'O'), ('term', 'O'), ('memory', 'O'), ('caused', 'O'), ('by', 'O'), ('NTG', 'O'), ('but', 'O'), ('did', 'O'), ('not', 'O'), ('improve', 'O'), ('latency', 'O'), ('in', 'O'), ('the', 'O'), ('absence', 'O'), ('of', 'O'), ('hypotension', 'B'), ('.', 'O'))$$$"
Addition of oral nicorandil reduced his symptoms and maintained stable angina status .,"(('Addition', 'O'), ('of', 'O'), ('oral', 'O'), ('nicorandil', 'O'), ('reduced', 'O'), ('his', 'O'), ('symptoms', 'O'), ('and', 'O'), ('maintained', 'O'), ('stable', 'B'), ('angina', 'I'), ('status', 'O'), ('.', 'O'))$$$"
"In addition , tacrine - loaded nanoparticles administration induced damage of neuronal cells in CA1 field of the hippocampus in all treated animals , while the saline solution of tacrine only in 60 % of animals .","(('In', 'O'), ('addition', 'O'), (',', 'O'), ('tacrine', 'O'), ('-', 'O'), ('loaded', 'O'), ('nanoparticles', 'O'), ('administration', 'O'), ('induced', 'O'), ('damage', 'B'), ('of', 'I'), ('neuronal', 'I'), ('cells', 'I'), ('in', 'O'), ('CA1', 'O'), ('field', 'O'), ('of', 'O'), ('the', 'O'), ('hippocampus', 'O'), ('in', 'O'), ('all', 'O'), ('treated', 'O'), ('animals', 'O'), (',', 'O'), ('while', 'O'), ('the', 'O'), ('saline', 'O'), ('solution', 'O'), ('of', 'O'), ('tacrine', 'O'), ('only', 'O'), ('in', 'O'), ('60', 'O'), ('%', 'O'), ('of', 'O'), ('animals', 'O'), ('.', 'O'))$$$"
"BACKGROUND : In 2 separate centers , we observed a notable increase in the incidence of postoperative convulsive seizures from 1 . 3 % to 3 . 8 % in patients having undergone major cardiac surgical procedures .","(('BACKGROUND', 'O'), (':', 'O'), ('In', 'O'), ('2', 'O'), ('separate', 'O'), ('centers', 'O'), (',', 'O'), ('we', 'O'), ('observed', 'O'), ('a', 'O'), ('notable', 'O'), ('increase', 'O'), ('in', 'O'), ('the', 'O'), ('incidence', 'O'), ('of', 'O'), ('postoperative', 'O'), ('convulsive', 'B'), ('seizures', 'B'), ('from', 'O'), ('1', 'O'), ('.', 'O'), ('3', 'O'), ('%', 'O'), ('to', 'O'), ('3', 'O'), ('.', 'O'), ('8', 'O'), ('%', 'O'), ('in', 'O'), ('patients', 'O'), ('having', 'O'), ('undergone', 'O'), ('major', 'O'), ('cardiac', 'O'), ('surgical', 'O'), ('procedures', 'O'), ('.', 'O'))$$$"
"No evidence of brain ischemic , metabolic , or hyperthermia - induced causes for their seizures was apparent .","(('No', 'O'), ('evidence', 'O'), ('of', 'O'), ('brain', 'B'), ('ischemic', 'I'), (',', 'O'), ('metabolic', 'O'), (',', 'O'), ('or', 'O'), ('hyperthermia', 'B'), ('-', 'O'), ('induced', 'O'), ('causes', 'O'), ('for', 'O'), ('their', 'O'), ('seizures', 'B'), ('was', 'O'), ('apparent', 'O'), ('.', 'O'))$$$"
Aventyl ( nortriptyline ) and Elavil ( amitriptyline ) each produced left bundle branch block in a 73 year old woman .,"(('Aventyl', 'O'), ('(', 'O'), ('nortriptyline', 'O'), (')', 'O'), ('and', 'O'), ('Elavil', 'O'), ('(', 'O'), ('amitriptyline', 'O'), (')', 'O'), ('each', 'O'), ('produced', 'O'), ('left', 'B'), ('bundle', 'I'), ('branch', 'I'), ('block', 'I'), ('in', 'O'), ('a', 'O'), ('73', 'O'), ('year', 'O'), ('old', 'O'), ('woman', 'O'), ('.', 'O'))$$$"
"We have used a murine model of AIDS , infection of female C57BL / 6 mice with LP - BM5 murine leukaemia ( MuLV ) virus , to determine if AZT - induced anaemia is due , in part , to decreased responsiveness of erythropoietic precursors ( BFU - e ) to erythropoietin ( EPO ) .","(('We', 'O'), ('have', 'O'), ('used', 'O'), ('a', 'O'), ('murine', 'O'), ('model', 'O'), ('of', 'O'), ('AIDS', 'B'), (',', 'O'), ('infection', 'B'), ('of', 'O'), ('female', 'O'), ('C57BL', 'O'), ('/', 'O'), ('6', 'O'), ('mice', 'O'), ('with', 'O'), ('LP', 'O'), ('-', 'O'), ('BM5', 'O'), ('murine', 'O'), ('leukaemia', 'B'), ('(', 'O'), ('MuLV', 'O'), (')', 'O'), ('virus', 'O'), (',', 'O'), ('to', 'O'), ('determine', 'O'), ('if', 'O'), ('AZT', 'O'), ('-', 'O'), ('induced', 'O'), ('anaemia', 'B'), ('is', 'O'), ('due', 'O'), (',', 'O'), ('in', 'O'), ('part', 'O'), (',', 'O'), ('to', 'O'), ('decreased', 'O'), ('responsiveness', 'O'), ('of', 'O'), ('erythropoietic', 'O'), ('precursors', 'O'), ('(', 'O'), ('BFU', 'O'), ('-', 'O'), ('e', 'O'), (')', 'O'), ('to', 'O'), ('erythropoietin', 'O'), ('(', 'O'), ('EPO', 'O'), (')', 'O'), ('.', 'O'))$$$"
"Risk of renal failure , Injury to the kidney , Failure of kidney function , Loss of kidney function , and End - stage renal damage ( RIFLE criteria ) were used to define CIN and its incidence in the study population .","(('Risk', 'O'), ('of', 'O'), ('renal', 'B'), ('failure', 'I'), (',', 'O'), ('Injury', 'B'), ('to', 'I'), ('the', 'I'), ('kidney', 'I'), (',', 'O'), ('Failure', 'B'), ('of', 'I'), ('kidney', 'I'), ('function', 'I'), (',', 'O'), ('Loss', 'B'), ('of', 'I'), ('kidney', 'I'), ('function', 'I'), (',', 'O'), ('and', 'O'), ('End', 'O'), ('-', 'O'), ('stage', 'O'), ('renal', 'B'), ('damage', 'I'), ('(', 'O'), ('RIFLE', 'O'), ('criteria', 'O'), (')', 'O'), ('were', 'O'), ('used', 'O'), ('to', 'O'), ('define', 'O'), ('CIN', 'B'), ('and', 'O'), ('its', 'O'), ('incidence', 'O'), ('in', 'O'), ('the', 'O'), ('study', 'O'), ('population', 'O'), ('.', 'O'))$$$"
"Among the 15 patients with CIN , 6 had cyanotic congenital heart diseases , but the incidence did not differ significantly from that for the noncyanotic patients ( p = 0 . 243 ) .","(('Among', 'O'), ('the', 'O'), ('15', 'O'), ('patients', 'O'), ('with', 'O'), ('CIN', 'B'), (',', 'O'), ('6', 'O'), ('had', 'O'), ('cyanotic', 'O'), ('congenital', 'B'), ('heart', 'I'), ('diseases', 'I'), (',', 'O'), ('but', 'O'), ('the', 'O'), ('incidence', 'O'), ('did', 'O'), ('not', 'O'), ('differ', 'O'), ('significantly', 'O'), ('from', 'O'), ('that', 'O'), ('for', 'O'), ('the', 'O'), ('noncyanotic', 'O'), ('patients', 'O'), ('(', 'O'), ('p', 'O'), ('=', 'O'), ('0', 'O'), ('.', 'O'), ('243', 'O'), (')', 'O'), ('.', 'O'))$$$"
Vasoconstriction appears to be the common mechanism of action leading to a wide range of fetal anomalies .,"(('Vasoconstriction', 'O'), ('appears', 'O'), ('to', 'O'), ('be', 'O'), ('the', 'O'), ('common', 'O'), ('mechanism', 'O'), ('of', 'O'), ('action', 'O'), ('leading', 'O'), ('to', 'O'), ('a', 'O'), ('wide', 'O'), ('range', 'O'), ('of', 'O'), ('fetal', 'B'), ('anomalies', 'I'), ('.', 'O'))$$$"
"We report on an infant with multiple cranial - nerve involvement attributable to brainstem dysgenesis , born to a cocaine - addicted mother .","(('We', 'O'), ('report', 'O'), ('on', 'O'), ('an', 'O'), ('infant', 'O'), ('with', 'O'), ('multiple', 'B'), ('cranial', 'I'), ('-', 'I'), ('nerve', 'I'), ('involvement', 'I'), ('attributable', 'O'), ('to', 'O'), ('brainstem', 'B'), ('dysgenesis', 'I'), (',', 'O'), ('born', 'O'), ('to', 'O'), ('a', 'O'), ('cocaine', 'B'), ('-', 'I'), ('addicted', 'I'), ('mother', 'O'), ('.', 'O'))$$$"
"RATIONALE AND OBJECTIVES : The light - enhanced startle paradigm ( LES ) is suggested to model anxiety , because of the non - specific cue and the long - term effect .","(('RATIONALE', 'O'), ('AND', 'O'), ('OBJECTIVES', 'O'), (':', 'O'), ('The', 'O'), ('light', 'O'), ('-', 'O'), ('enhanced', 'O'), ('startle', 'B'), ('paradigm', 'O'), ('(', 'O'), ('LES', 'O'), (')', 'O'), ('is', 'O'), ('suggested', 'O'), ('to', 'O'), ('model', 'O'), ('anxiety', 'B'), (',', 'O'), ('because', 'O'), ('of', 'O'), ('the', 'O'), ('non', 'O'), ('-', 'O'), ('specific', 'O'), ('cue', 'O'), ('and', 'O'), ('the', 'O'), ('long', 'O'), ('-', 'O'), ('term', 'O'), ('effect', 'O'), ('.', 'O'))$$$"
Rosaceiform dermatitis associated with topical tacrolimus treatment .,"(('Rosaceiform', 'O'), ('dermatitis', 'B'), ('associated', 'O'), ('with', 'O'), ('topical', 'O'), ('tacrolimus', 'O'), ('treatment', 'O'), ('.', 'O'))$$$"
We describe herein 3 patients who developed rosacea - like dermatitis eruptions while using 0 . 03 % or 0 . 1 % tacrolimus ointment for facial dermatitis .,"(('We', 'O'), ('describe', 'O'), ('herein', 'O'), ('3', 'O'), ('patients', 'O'), ('who', 'O'), ('developed', 'O'), ('rosacea', 'B'), ('-', 'O'), ('like', 'O'), ('dermatitis', 'B'), ('eruptions', 'B'), ('while', 'O'), ('using', 'O'), ('0', 'O'), ('.', 'O'), ('03', 'O'), ('%', 'O'), ('or', 'O'), ('0', 'O'), ('.', 'O'), ('1', 'O'), ('%', 'O'), ('tacrolimus', 'O'), ('ointment', 'O'), ('for', 'O'), ('facial', 'B'), ('dermatitis', 'I'), ('.', 'O'))$$$"
"Continuous topical use of immunomodulators such as tacrolimus or pimecrolimus should be regarded as a potential cause of rosaceiform dermatitis , although many cases have not been reported .","(('Continuous', 'O'), ('topical', 'O'), ('use', 'O'), ('of', 'O'), ('immunomodulators', 'O'), ('such', 'O'), ('as', 'O'), ('tacrolimus', 'O'), ('or', 'O'), ('pimecrolimus', 'O'), ('should', 'O'), ('be', 'O'), ('regarded', 'O'), ('as', 'O'), ('a', 'O'), ('potential', 'O'), ('cause', 'O'), ('of', 'O'), ('rosaceiform', 'O'), ('dermatitis', 'B'), (',', 'O'), ('although', 'O'), ('many', 'O'), ('cases', 'O'), ('have', 'O'), ('not', 'O'), ('been', 'O'), ('reported', 'O'), ('.', 'O'))$$$"
"Coenzyme Q10 significantly compensated deficits in the antioxidant defense mechanisms ( reduced glutathione level and superoxide dismutase activity ) , suppressed lipid peroxidation , decreased the elevations of tumor necrosis factor - alpha , nitric oxide and platinum ion concentration , and attenuated the reductions of selenium and zinc ions in renal tissue resulted from cisplatin administration .","(('Coenzyme', 'O'), ('Q10', 'O'), ('significantly', 'O'), ('compensated', 'O'), ('deficits', 'O'), ('in', 'O'), ('the', 'O'), ('antioxidant', 'O'), ('defense', 'O'), ('mechanisms', 'O'), ('(', 'O'), ('reduced', 'O'), ('glutathione', 'O'), ('level', 'O'), ('and', 'O'), ('superoxide', 'O'), ('dismutase', 'O'), ('activity', 'O'), (')', 'O'), (',', 'O'), ('suppressed', 'O'), ('lipid', 'O'), ('peroxidation', 'O'), (',', 'O'), ('decreased', 'O'), ('the', 'O'), ('elevations', 'O'), ('of', 'O'), ('tumor', 'B'), ('necrosis', 'B'), ('factor', 'O'), ('-', 'O'), ('alpha', 'O'), (',', 'O'), ('nitric', 'O'), ('oxide', 'O'), ('and', 'O'), ('platinum', 'O'), ('ion', 'O'), ('concentration', 'O'), (',', 'O'), ('and', 'O'), ('attenuated', 'O'), ('the', 'O'), ('reductions', 'O'), ('of', 'O'), ('selenium', 'O'), ('and', 'O'), ('zinc', 'O'), ('ions', 'O'), ('in', 'O'), ('renal', 'O'), ('tissue', 'O'), ('resulted', 'O'), ('from', 'O'), ('cisplatin', 'O'), ('administration', 'O'), ('.', 'O'))$$$"
"A 67 - year - old patient , with primary polymyositis and without previous evidence of liver disease , developed clinical and biochemical features of severe cholestasis 3 months after initiation of azathioprine therapy .","(('A', 'O'), ('67', 'O'), ('-', 'O'), ('year', 'O'), ('-', 'O'), ('old', 'O'), ('patient', 'O'), (',', 'O'), ('with', 'O'), ('primary', 'O'), ('polymyositis', 'B'), ('and', 'O'), ('without', 'O'), ('previous', 'O'), ('evidence', 'O'), ('of', 'O'), ('liver', 'B'), ('disease', 'I'), (',', 'O'), ('developed', 'O'), ('clinical', 'O'), ('and', 'O'), ('biochemical', 'O'), ('features', 'O'), ('of', 'O'), ('severe', 'O'), ('cholestasis', 'B'), ('3', 'O'), ('months', 'O'), ('after', 'O'), ('initiation', 'O'), ('of', 'O'), ('azathioprine', 'O'), ('therapy', 'O'), ('.', 'O'))$$$"
Here we show that the recently reported ability of L - dihydroxyphenylalanine to reverse the protective effect of alpha - methyl - para - tyrosine on METH - induced DA neurotoxicity is also confounded by drug effects on body temperature .,"(('Here', 'O'), ('we', 'O'), ('show', 'O'), ('that', 'O'), ('the', 'O'), ('recently', 'O'), ('reported', 'O'), ('ability', 'O'), ('of', 'O'), ('L', 'O'), ('-', 'O'), ('dihydroxyphenylalanine', 'O'), ('to', 'O'), ('reverse', 'O'), ('the', 'O'), ('protective', 'O'), ('effect', 'O'), ('of', 'O'), ('alpha', 'O'), ('-', 'O'), ('methyl', 'O'), ('-', 'O'), ('para', 'O'), ('-', 'O'), ('tyrosine', 'O'), ('on', 'O'), ('METH', 'O'), ('-', 'O'), ('induced', 'O'), ('DA', 'O'), ('neurotoxicity', 'B'), ('is', 'O'), ('also', 'O'), ('confounded', 'O'), ('by', 'O'), ('drug', 'O'), ('effects', 'O'), ('on', 'O'), ('body', 'O'), ('temperature', 'O'), ('.', 'O'))$$$"
"In addition , we demonstrate that mice genetically engineered to have unilateral brain DA deficits develop METH - induced dopaminergic deficits that are of comparable magnitude on both sides of the brain .","(('In', 'O'), ('addition', 'O'), (',', 'O'), ('we', 'O'), ('demonstrate', 'O'), ('that', 'O'), ('mice', 'O'), ('genetically', 'O'), ('engineered', 'O'), ('to', 'O'), ('have', 'O'), ('unilateral', 'O'), ('brain', 'O'), ('DA', 'O'), ('deficits', 'O'), ('develop', 'O'), ('METH', 'O'), ('-', 'O'), ('induced', 'O'), ('dopaminergic', 'B'), ('deficits', 'I'), ('that', 'O'), ('are', 'O'), ('of', 'O'), ('comparable', 'O'), ('magnitude', 'O'), ('on', 'O'), ('both', 'O'), ('sides', 'O'), ('of', 'O'), ('the', 'O'), ('brain', 'O'), ('.', 'O'))$$$"
"Taken together , these findings demonstrate that DA is not essential for the development of METH - induced dopaminergic neurotoxicity and suggest that mechanisms independent of DA warrant more intense investigation .","(('Taken', 'O'), ('together', 'O'), (',', 'O'), ('these', 'O'), ('findings', 'O'), ('demonstrate', 'O'), ('that', 'O'), ('DA', 'O'), ('is', 'O'), ('not', 'O'), ('essential', 'O'), ('for', 'O'), ('the', 'O'), ('development', 'O'), ('of', 'O'), ('METH', 'O'), ('-', 'O'), ('induced', 'O'), ('dopaminergic', 'O'), ('neurotoxicity', 'B'), ('and', 'O'), ('suggest', 'O'), ('that', 'O'), ('mechanisms', 'O'), ('independent', 'O'), ('of', 'O'), ('DA', 'O'), ('warrant', 'O'), ('more', 'O'), ('intense', 'O'), ('investigation', 'O'), ('.', 'O'))$$$"
Swallowing - induced atrial tachyarrhythmia triggered by salbutamol : case report and review of the literature .,"(('Swallowing', 'O'), ('-', 'O'), ('induced', 'O'), ('atrial', 'B'), ('tachyarrhythmia', 'I'), ('triggered', 'O'), ('by', 'O'), ('salbutamol', 'O'), (':', 'O'), ('case', 'O'), ('report', 'O'), ('and', 'O'), ('review', 'O'), ('of', 'O'), ('the', 'O'), ('literature', 'O'), ('.', 'O'))$$$"
"Diabetes of 2 months duration resulted in decreases in body weight and increases in fluid consumption , urine volume , frequency of micturition , and average volume per micturition ; effects which were prevented by insulin treatment .","(('Diabetes', 'B'), ('of', 'O'), ('2', 'O'), ('months', 'O'), ('duration', 'O'), ('resulted', 'O'), ('in', 'O'), ('decreases', 'O'), ('in', 'O'), ('body', 'O'), ('weight', 'O'), ('and', 'O'), ('increases', 'O'), ('in', 'O'), ('fluid', 'O'), ('consumption', 'O'), (',', 'O'), ('urine', 'O'), ('volume', 'O'), (',', 'O'), ('frequency', 'O'), ('of', 'O'), ('micturition', 'O'), (',', 'O'), ('and', 'O'), ('average', 'O'), ('volume', 'O'), ('per', 'O'), ('micturition', 'O'), (';', 'O'), ('effects', 'O'), ('which', 'O'), ('were', 'O'), ('prevented', 'O'), ('by', 'O'), ('insulin', 'O'), ('treatment', 'O'), ('.', 'O'))$$$"
"Diabetes of 4 months duration also resulted in decreases in body weight , and increases in fluid consumption , urine volume , frequency of micturition , and average volume per micturition , effects which were reversed by insulin treatment for the final 2 months of the study .","(('Diabetes', 'B'), ('of', 'O'), ('4', 'O'), ('months', 'O'), ('duration', 'O'), ('also', 'O'), ('resulted', 'O'), ('in', 'O'), ('decreases', 'O'), ('in', 'O'), ('body', 'O'), ('weight', 'O'), (',', 'O'), ('and', 'O'), ('increases', 'O'), ('in', 'O'), ('fluid', 'O'), ('consumption', 'O'), (',', 'O'), ('urine', 'O'), ('volume', 'O'), (',', 'O'), ('frequency', 'O'), ('of', 'O'), ('micturition', 'O'), (',', 'O'), ('and', 'O'), ('average', 'O'), ('volume', 'O'), ('per', 'O'), ('micturition', 'O'), (',', 'O'), ('effects', 'O'), ('which', 'O'), ('were', 'O'), ('reversed', 'O'), ('by', 'O'), ('insulin', 'O'), ('treatment', 'O'), ('for', 'O'), ('the', 'O'), ('final', 'O'), ('2', 'O'), ('months', 'O'), ('of', 'O'), ('the', 'O'), ('study', 'O'), ('.', 'O'))$$$"
Severe congestive heart failure patient on amiodarone presenting with myxedemic coma : a case report .,"(('Severe', 'O'), ('congestive', 'B'), ('heart', 'I'), ('failure', 'I'), ('patient', 'O'), ('on', 'O'), ('amiodarone', 'O'), ('presenting', 'O'), ('with', 'O'), ('myxedemic', 'B'), ('coma', 'I'), (':', 'O'), ('a', 'O'), ('case', 'O'), ('report', 'O'), ('.', 'O'))$$$"
"The myriad clinical presentation of myxedema coma and its serious morbidity and mortality stresses the need to suspect this clinical syndrome among CHF patients presenting with hypotension , weakness or other unexplained symptoms .","(('The', 'O'), ('myriad', 'O'), ('clinical', 'O'), ('presentation', 'O'), ('of', 'O'), ('myxedema', 'B'), ('coma', 'I'), ('and', 'O'), ('its', 'O'), ('serious', 'O'), ('morbidity', 'O'), ('and', 'O'), ('mortality', 'O'), ('stresses', 'O'), ('the', 'O'), ('need', 'O'), ('to', 'O'), ('suspect', 'O'), ('this', 'O'), ('clinical', 'O'), ('syndrome', 'O'), ('among', 'O'), ('CHF', 'B'), ('patients', 'O'), ('presenting', 'O'), ('with', 'O'), ('hypotension', 'B'), (',', 'O'), ('weakness', 'B'), ('or', 'O'), ('other', 'O'), ('unexplained', 'O'), ('symptoms', 'O'), ('.', 'O'))$$$"
The symptoms of methamphetamine ( METH ) - induced psychosis are similar to those of paranoid type schizophrenia .,"(('The', 'O'), ('symptoms', 'O'), ('of', 'O'), ('methamphetamine', 'O'), ('(', 'O'), ('METH', 'O'), (')', 'O'), ('-', 'O'), ('induced', 'O'), ('psychosis', 'B'), ('are', 'O'), ('similar', 'O'), ('to', 'O'), ('those', 'O'), ('of', 'O'), ('paranoid', 'B'), ('type', 'I'), ('schizophrenia', 'I'), ('.', 'O'))$$$"
"METHOD : Using five tagging SNPs ( rs6693503 , rs1805054 , rs4912138 , rs3790757 and rs9659997 ) , we conducted a genetic association analysis of case - control samples ( 197 METH - induced psychosis patients and 337 controls ) in the Japanese population .","(('METHOD', 'O'), (':', 'O'), ('Using', 'O'), ('five', 'O'), ('tagging', 'O'), ('SNPs', 'O'), ('(', 'O'), ('rs6693503', 'O'), (',', 'O'), ('rs1805054', 'O'), (',', 'O'), ('rs4912138', 'O'), (',', 'O'), ('rs3790757', 'O'), ('and', 'O'), ('rs9659997', 'O'), (')', 'O'), (',', 'O'), ('we', 'O'), ('conducted', 'O'), ('a', 'O'), ('genetic', 'O'), ('association', 'O'), ('analysis', 'O'), ('of', 'O'), ('case', 'O'), ('-', 'O'), ('control', 'O'), ('samples', 'O'), ('(', 'O'), ('197', 'O'), ('METH', 'O'), ('-', 'O'), ('induced', 'O'), ('psychosis', 'B'), ('patients', 'O'), ('and', 'O'), ('337', 'O'), ('controls', 'O'), (')', 'O'), ('in', 'O'), ('the', 'O'), ('Japanese', 'O'), ('population', 'O'), ('.', 'O'))$$$"
"In patients with schizophrenia , ketamine exacerbates the core symptoms of illness , supporting the hypothesis of a glutamatergic dysfunction .","(('In', 'O'), ('patients', 'O'), ('with', 'O'), ('schizophrenia', 'B'), (',', 'O'), ('ketamine', 'O'), ('exacerbates', 'O'), ('the', 'O'), ('core', 'O'), ('symptoms', 'O'), ('of', 'O'), ('illness', 'O'), (',', 'O'), ('supporting', 'O'), ('the', 'O'), ('hypothesis', 'O'), ('of', 'O'), ('a', 'O'), ('glutamatergic', 'B'), ('dysfunction', 'I'), ('.', 'O'))$$$"
Effects of the hippocampal deep brain stimulation on cortical epileptic discharges in penicillin - induced epilepsy model in rats .,"(('Effects', 'O'), ('of', 'O'), ('the', 'O'), ('hippocampal', 'O'), ('deep', 'O'), ('brain', 'O'), ('stimulation', 'O'), ('on', 'O'), ('cortical', 'O'), ('epileptic', 'B'), ('discharges', 'O'), ('in', 'O'), ('penicillin', 'O'), ('-', 'O'), ('induced', 'O'), ('epilepsy', 'B'), ('model', 'O'), ('in', 'O'), ('rats', 'O'), ('.', 'O'))$$$"
The aim was to evaluate the effects of high frequency hippocampal stimulation on cortical epileptic activity in penicillin - induced epilepsy model .,"(('The', 'O'), ('aim', 'O'), ('was', 'O'), ('to', 'O'), ('evaluate', 'O'), ('the', 'O'), ('effects', 'O'), ('of', 'O'), ('high', 'O'), ('frequency', 'O'), ('hippocampal', 'O'), ('stimulation', 'O'), ('on', 'O'), ('cortical', 'O'), ('epileptic', 'B'), ('activity', 'O'), ('in', 'O'), ('penicillin', 'O'), ('-', 'O'), ('induced', 'O'), ('epilepsy', 'B'), ('model', 'O'), ('.', 'O'))$$$"
RESULTS : High frequency hippocampal DBS suppressed the acute penicillin - induced cortical epileptic activity independent from stimulus intensity .,"(('RESULTS', 'O'), (':', 'O'), ('High', 'O'), ('frequency', 'O'), ('hippocampal', 'O'), ('DBS', 'O'), ('suppressed', 'O'), ('the', 'O'), ('acute', 'O'), ('penicillin', 'O'), ('-', 'O'), ('induced', 'O'), ('cortical', 'O'), ('epileptic', 'B'), ('activity', 'O'), ('independent', 'O'), ('from', 'O'), ('stimulus', 'O'), ('intensity', 'O'), ('.', 'O'))$$$"
CONCLUSION : Our results revealed that continuous high frequency stimulation of the hippocampus suppressed acute cortical epileptic activity effectively without causing secondary epileptic discharges .,"(('CONCLUSION', 'O'), (':', 'O'), ('Our', 'O'), ('results', 'O'), ('revealed', 'O'), ('that', 'O'), ('continuous', 'O'), ('high', 'O'), ('frequency', 'O'), ('stimulation', 'O'), ('of', 'O'), ('the', 'O'), ('hippocampus', 'O'), ('suppressed', 'O'), ('acute', 'O'), ('cortical', 'O'), ('epileptic', 'B'), ('activity', 'O'), ('effectively', 'O'), ('without', 'O'), ('causing', 'O'), ('secondary', 'O'), ('epileptic', 'B'), ('discharges', 'O'), ('.', 'O'))$$$"
These results are important in terms of defining the optimal parameters of hippocampal DBS in patients with epilepsy .,"(('These', 'O'), ('results', 'O'), ('are', 'O'), ('important', 'O'), ('in', 'O'), ('terms', 'O'), ('of', 'O'), ('defining', 'O'), ('the', 'O'), ('optimal', 'O'), ('parameters', 'O'), ('of', 'O'), ('hippocampal', 'O'), ('DBS', 'O'), ('in', 'O'), ('patients', 'O'), ('with', 'O'), ('epilepsy', 'B'), ('.', 'O'))$$$"
"OBJECTIVE : To describe the incidence of haematological , renal , hepatic and gastrointestinal toxicities in tumour - bearing dogs receiving 1 - ( 2 - chloroethyl ) - 3 - cyclohexyl - 1 - nitrosourea ( CCNU ) .","(('OBJECTIVE', 'O'), (':', 'O'), ('To', 'O'), ('describe', 'O'), ('the', 'O'), ('incidence', 'O'), ('of', 'O'), ('haematological', 'B'), (',', 'I'), ('renal', 'I'), (',', 'I'), ('hepatic', 'I'), ('and', 'I'), ('gastrointestinal', 'I'), ('toxicities', 'I'), ('in', 'O'), ('tumour', 'O'), ('-', 'O'), ('bearing', 'O'), ('dogs', 'O'), ('receiving', 'O'), ('1', 'O'), ('-', 'O'), ('(', 'O'), ('2', 'O'), ('-', 'O'), ('chloroethyl', 'O'), (')', 'O'), ('-', 'O'), ('3', 'O'), ('-', 'O'), ('cyclohexyl', 'O'), ('-', 'O'), ('1', 'O'), ('-', 'O'), ('nitrosourea', 'O'), ('(', 'O'), ('CCNU', 'O'), (')', 'O'), ('.', 'O'))$$$"
"Potential renal toxicity and elevated alanine transaminase ( ALT ) concentration were reported in 12 . 2 % and 48 . 8 % of dogs , respectively .","(('Potential', 'O'), ('renal', 'O'), ('toxicity', 'B'), ('and', 'O'), ('elevated', 'O'), ('alanine', 'O'), ('transaminase', 'O'), ('(', 'O'), ('ALT', 'O'), (')', 'O'), ('concentration', 'O'), ('were', 'O'), ('reported', 'O'), ('in', 'O'), ('12', 'O'), ('.', 'O'), ('2', 'O'), ('%', 'O'), ('and', 'O'), ('48', 'O'), ('.', 'O'), ('8', 'O'), ('%', 'O'), ('of', 'O'), ('dogs', 'O'), (',', 'O'), ('respectively', 'O'), ('.', 'O'))$$$"
A report is given on an 83 - year - old female who acquired central vein thrombosis in her seeing eye one day after having started topical medication with dipivalyl epinephrine for advanced glaucoma discovered in the other eye .,"(('A', 'O'), ('report', 'O'), ('is', 'O'), ('given', 'O'), ('on', 'O'), ('an', 'O'), ('83', 'O'), ('-', 'O'), ('year', 'O'), ('-', 'O'), ('old', 'O'), ('female', 'O'), ('who', 'O'), ('acquired', 'O'), ('central', 'O'), ('vein', 'B'), ('thrombosis', 'I'), ('in', 'O'), ('her', 'O'), ('seeing', 'O'), ('eye', 'O'), ('one', 'O'), ('day', 'O'), ('after', 'O'), ('having', 'O'), ('started', 'O'), ('topical', 'O'), ('medication', 'O'), ('with', 'O'), ('dipivalyl', 'O'), ('epinephrine', 'O'), ('for', 'O'), ('advanced', 'O'), ('glaucoma', 'B'), ('discovered', 'O'), ('in', 'O'), ('the', 'O'), ('other', 'O'), ('eye', 'O'), ('.', 'O'))$$$"
Benzylacyclouridine reverses azidothymidine - induced marrow suppression without impairment of anti - human immunodeficiency virus activity .,"(('Benzylacyclouridine', 'O'), ('reverses', 'O'), ('azidothymidine', 'O'), ('-', 'O'), ('induced', 'O'), ('marrow', 'B'), ('suppression', 'I'), ('without', 'O'), ('impairment', 'O'), ('of', 'O'), ('anti', 'O'), ('-', 'O'), ('human', 'O'), ('immunodeficiency', 'B'), ('virus', 'O'), ('activity', 'O'), ('.', 'O'))$$$"
"A prerenal component could have contributed to renal failure because of a transient hypotension , due to an increasing ascitis , occurring just before anuria .","(('A', 'O'), ('prerenal', 'O'), ('component', 'O'), ('could', 'O'), ('have', 'O'), ('contributed', 'O'), ('to', 'O'), ('renal', 'B'), ('failure', 'I'), ('because', 'O'), ('of', 'O'), ('a', 'O'), ('transient', 'O'), ('hypotension', 'B'), (',', 'O'), ('due', 'O'), ('to', 'O'), ('an', 'O'), ('increasing', 'O'), ('ascitis', 'O'), (',', 'O'), ('occurring', 'O'), ('just', 'O'), ('before', 'O'), ('anuria', 'B'), ('.', 'O'))$$$"
We describe a 42 - year - old woman who developed superior sagittal and left transverse sinus thrombosis associated with prolonged epsilon - aminocaproic acid therapy for menorrhagia .,"(('We', 'O'), ('describe', 'O'), ('a', 'O'), ('42', 'O'), ('-', 'O'), ('year', 'O'), ('-', 'O'), ('old', 'O'), ('woman', 'O'), ('who', 'O'), ('developed', 'O'), ('superior', 'O'), ('sagittal', 'B'), ('and', 'I'), ('left', 'I'), ('transverse', 'I'), ('sinus', 'I'), ('thrombosis', 'I'), ('associated', 'O'), ('with', 'O'), ('prolonged', 'O'), ('epsilon', 'O'), ('-', 'O'), ('aminocaproic', 'O'), ('acid', 'O'), ('therapy', 'O'), ('for', 'O'), ('menorrhagia', 'B'), ('.', 'O'))$$$"
"Because cibenzoline had only weak hypotensive and sinus node depressive effects and was found to be orally active when given to coronary ligation arrhythmia dogs , its clinical usefulness is expected .","(('Because', 'O'), ('cibenzoline', 'O'), ('had', 'O'), ('only', 'O'), ('weak', 'O'), ('hypotensive', 'B'), ('and', 'O'), ('sinus', 'O'), ('node', 'O'), ('depressive', 'B'), ('effects', 'O'), ('and', 'O'), ('was', 'O'), ('found', 'O'), ('to', 'O'), ('be', 'O'), ('orally', 'O'), ('active', 'O'), ('when', 'O'), ('given', 'O'), ('to', 'O'), ('coronary', 'O'), ('ligation', 'O'), ('arrhythmia', 'B'), ('dogs', 'O'), (',', 'O'), ('its', 'O'), ('clinical', 'O'), ('usefulness', 'O'), ('is', 'O'), ('expected', 'O'), ('.', 'O'))$$$"
We prospectively performed continuous ambulatory ECG monitoring on 25 patients undergoing 5 - FU infusion for treatment of solid tumors in order to assess the incidence of ischemic ST changes .,"(('We', 'O'), ('prospectively', 'O'), ('performed', 'O'), ('continuous', 'O'), ('ambulatory', 'O'), ('ECG', 'O'), ('monitoring', 'O'), ('on', 'O'), ('25', 'O'), ('patients', 'O'), ('undergoing', 'O'), ('5', 'O'), ('-', 'O'), ('FU', 'O'), ('infusion', 'O'), ('for', 'O'), ('treatment', 'O'), ('of', 'O'), ('solid', 'O'), ('tumors', 'B'), ('in', 'O'), ('order', 'O'), ('to', 'O'), ('assess', 'O'), ('the', 'O'), ('incidence', 'O'), ('of', 'O'), ('ischemic', 'B'), ('ST', 'O'), ('changes', 'O'), ('.', 'O'))$$$"
"Our study group consisted of 74 HIV - positive homosexual men belonging to groups II B , III and IV C2 from the Centers for Disease Control ( CDC ) classification of HIV disease .","(('Our', 'O'), ('study', 'O'), ('group', 'O'), ('consisted', 'O'), ('of', 'O'), ('74', 'O'), ('HIV', 'O'), ('-', 'O'), ('positive', 'O'), ('homosexual', 'O'), ('men', 'O'), ('belonging', 'O'), ('to', 'O'), ('groups', 'O'), ('II', 'O'), ('B', 'O'), (',', 'O'), ('III', 'O'), ('and', 'O'), ('IV', 'O'), ('C2', 'O'), ('from', 'O'), ('the', 'O'), ('Centers', 'O'), ('for', 'O'), ('Disease', 'O'), ('Control', 'O'), ('(', 'O'), ('CDC', 'O'), (')', 'O'), ('classification', 'O'), ('of', 'O'), ('HIV', 'B'), ('disease', 'I'), ('.', 'O'))$$$"
National project on the prevention of mother - to - infant infection by hepatitis B virus in Japan .,"(('National', 'O'), ('project', 'O'), ('on', 'O'), ('the', 'O'), ('prevention', 'O'), ('of', 'O'), ('mother', 'O'), ('-', 'O'), ('to', 'O'), ('-', 'O'), ('infant', 'O'), ('infection', 'B'), ('by', 'I'), ('hepatitis', 'I'), ('B', 'I'), ('virus', 'I'), ('in', 'O'), ('Japan', 'O'), ('.', 'O'))$$$"
"In Japan , a nationwide prevention program against mother - to - infant infection by hepatitis B virus ( HBV ) started in 1985 .","(('In', 'O'), ('Japan', 'O'), (',', 'O'), ('a', 'O'), ('nationwide', 'O'), ('prevention', 'O'), ('program', 'O'), ('against', 'O'), ('mother', 'O'), ('-', 'O'), ('to', 'O'), ('-', 'O'), ('infant', 'O'), ('infection', 'B'), ('by', 'I'), ('hepatitis', 'I'), ('B', 'I'), ('virus', 'I'), ('(', 'O'), ('HBV', 'O'), (')', 'O'), ('started', 'O'), ('in', 'O'), ('1985', 'O'), ('.', 'O'))$$$"
These infants are treated with two injections of hepatitis B immune globulin ( HBIG ) and at least three injections of plasma derived hepatitis B vaccine .,"(('These', 'O'), ('infants', 'O'), ('are', 'O'), ('treated', 'O'), ('with', 'O'), ('two', 'O'), ('injections', 'O'), ('of', 'O'), ('hepatitis', 'B'), ('B', 'I'), ('immune', 'O'), ('globulin', 'O'), ('(', 'O'), ('HBIG', 'O'), (')', 'O'), ('and', 'O'), ('at', 'O'), ('least', 'O'), ('three', 'O'), ('injections', 'O'), ('of', 'O'), ('plasma', 'O'), ('derived', 'O'), ('hepatitis', 'O'), ('B', 'O'), ('vaccine', 'O'), ('.', 'O'))$$$"
"The high - dose D - MED animals were flaccid , akinetic , and lacked a startle response during the entire experimental period . ( ABSTRACT TRUNCATED AT 250 WORDS )","(('The', 'O'), ('high', 'O'), ('-', 'O'), ('dose', 'O'), ('D', 'O'), ('-', 'O'), ('MED', 'O'), ('animals', 'O'), ('were', 'O'), ('flaccid', 'O'), (',', 'O'), ('akinetic', 'B'), (',', 'O'), ('and', 'O'), ('lacked', 'O'), ('a', 'O'), ('startle', 'B'), ('response', 'O'), ('during', 'O'), ('the', 'O'), ('entire', 'O'), ('experimental', 'O'), ('period', 'O'), ('.', 'O'), ('(', 'O'), ('ABSTRACT', 'O'), ('TRUNCATED', 'O'), ('AT', 'O'), ('250', 'O'), ('WORDS', 'O'), (')', 'O'))$$$"
"Administration of the local anaesthetic bupivacaine ( 1 . 5 or 2 mg / kg , i . v . ) to rats elicited a marked decrease of mean arterial blood pressure ( MBP ) and heart rate ( HR ) leading to death ( in 67 % or 90 % of animals respectively ) .","(('Administration', 'O'), ('of', 'O'), ('the', 'O'), ('local', 'O'), ('anaesthetic', 'O'), ('bupivacaine', 'O'), ('(', 'O'), ('1', 'O'), ('.', 'O'), ('5', 'O'), ('or', 'O'), ('2', 'O'), ('mg', 'O'), ('/', 'O'), ('kg', 'O'), (',', 'O'), ('i', 'O'), ('.', 'O'), ('v', 'O'), ('.', 'O'), (')', 'O'), ('to', 'O'), ('rats', 'O'), ('elicited', 'O'), ('a', 'O'), ('marked', 'O'), ('decrease', 'B'), ('of', 'I'), ('mean', 'I'), ('arterial', 'I'), ('blood', 'I'), ('pressure', 'I'), ('(', 'I'), ('MBP', 'I'), (')', 'I'), ('and', 'I'), ('heart', 'I'), ('rate', 'I'), ('(', 'I'), ('HR', 'I'), (')', 'I'), ('leading', 'O'), ('to', 'O'), ('death', 'O'), ('(', 'O'), ('in', 'O'), ('67', 'O'), ('%', 'O'), ('or', 'O'), ('90', 'O'), ('%', 'O'), ('of', 'O'), ('animals', 'O'), ('respectively', 'O'), (')', 'O'), ('.', 'O'))$$$"
The epidemiology of the acute flank pain syndrome from suprofen .,"(('The', 'O'), ('epidemiology', 'O'), ('of', 'O'), ('the', 'O'), ('acute', 'O'), ('flank', 'B'), ('pain', 'I'), ('syndrome', 'O'), ('from', 'O'), ('suprofen', 'O'), ('.', 'O'))$$$"
"Until physicians began reporting an unusual acute flank pain syndrome to the spontaneous reporting system , 700 , 000 persons used the drug in the United States .","(('Until', 'O'), ('physicians', 'O'), ('began', 'O'), ('reporting', 'O'), ('an', 'O'), ('unusual', 'O'), ('acute', 'O'), ('flank', 'B'), ('pain', 'I'), ('syndrome', 'O'), ('to', 'O'), ('the', 'O'), ('spontaneous', 'O'), ('reporting', 'O'), ('system', 'O'), (',', 'O'), ('700', 'O'), (',', 'O'), ('000', 'O'), ('persons', 'O'), ('used', 'O'), ('the', 'O'), ('drug', 'O'), ('in', 'O'), ('the', 'O'), ('United', 'O'), ('States', 'O'), ('.', 'O'))$$$"
DM rats with mild glycosuria ( similar in degree to that of the P treated animals ) were also studied .,"(('DM', 'B'), ('rats', 'O'), ('with', 'O'), ('mild', 'O'), ('glycosuria', 'B'), ('(', 'O'), ('similar', 'O'), ('in', 'O'), ('degree', 'O'), ('to', 'O'), ('that', 'O'), ('of', 'O'), ('the', 'O'), ('P', 'O'), ('treated', 'O'), ('animals', 'O'), (')', 'O'), ('were', 'O'), ('also', 'O'), ('studied', 'O'), ('.', 'O'))$$$"
"In Group I , P induced a moderate and stable glycosuria ( 3 . 9 + / - 0 . 1 g / day , SE ) , and no functional or morphologic evidence of renal dysfunction ( baseline CCr 2 . 1 + / - 0 . 1 ml / min , undetectable lysozymuria ) or damage ( tubular necrosis score [ maximum 4 ] , zero ) .","(('In', 'O'), ('Group', 'O'), ('I', 'O'), (',', 'O'), ('P', 'O'), ('induced', 'O'), ('a', 'O'), ('moderate', 'O'), ('and', 'O'), ('stable', 'O'), ('glycosuria', 'B'), ('(', 'O'), ('3', 'O'), ('.', 'O'), ('9', 'O'), ('+', 'O'), ('/', 'O'), ('-', 'O'), ('0', 'O'), ('.', 'O'), ('1', 'O'), ('g', 'O'), ('/', 'O'), ('day', 'O'), (',', 'O'), ('SE', 'O'), (')', 'O'), (',', 'O'), ('and', 'O'), ('no', 'O'), ('functional', 'O'), ('or', 'O'), ('morphologic', 'O'), ('evidence', 'O'), ('of', 'O'), ('renal', 'B'), ('dysfunction', 'I'), ('(', 'O'), ('baseline', 'O'), ('CCr', 'O'), ('2', 'O'), ('.', 'O'), ('1', 'O'), ('+', 'O'), ('/', 'O'), ('-', 'O'), ('0', 'O'), ('.', 'O'), ('1', 'O'), ('ml', 'O'), ('/', 'O'), ('min', 'O'), (',', 'O'), ('undetectable', 'O'), ('lysozymuria', 'O'), (')', 'O'), ('or', 'O'), ('damage', 'O'), ('(', 'O'), ('tubular', 'B'), ('necrosis', 'I'), ('score', 'O'), ('[', 'O'), ('maximum', 'O'), ('4', 'O'), (']', 'O'), (',', 'O'), ('zero', 'O'), (')', 'O'), ('.', 'O'))$$$"
Previous studies demonstrated that both ketamine and morphine induced analgesia and catalepsy in the rat .,"(('Previous', 'O'), ('studies', 'O'), ('demonstrated', 'O'), ('that', 'O'), ('both', 'O'), ('ketamine', 'O'), ('and', 'O'), ('morphine', 'O'), ('induced', 'O'), ('analgesia', 'B'), ('and', 'O'), ('catalepsy', 'B'), ('in', 'O'), ('the', 'O'), ('rat', 'O'), ('.', 'O'))$$$"
"Latency to the loss of righting reflex , rigidity and behavior on recovery , reflected the relative predominance of ketamine or morphine in each combination .","(('Latency', 'O'), ('to', 'O'), ('the', 'O'), ('loss', 'O'), ('of', 'O'), ('righting', 'O'), ('reflex', 'O'), (',', 'O'), ('rigidity', 'B'), ('and', 'O'), ('behavior', 'O'), ('on', 'O'), ('recovery', 'O'), (',', 'O'), ('reflected', 'O'), ('the', 'O'), ('relative', 'O'), ('predominance', 'O'), ('of', 'O'), ('ketamine', 'O'), ('or', 'O'), ('morphine', 'O'), ('in', 'O'), ('each', 'O'), ('combination', 'O'), ('.', 'O'))$$$"
"Although diastolic blood pressure remained unchanged , systolic blood pressure increased from 119 to 135 mm Hg ( SED + / - 3 . 4 , p less than 0 . 01 ) , associated with an increased cardiac output ( 5 . 85 - 7 . 73 l / min , SED + / - 0 . 46 , p less than 0 . 01 ) .","(('Although', 'O'), ('diastolic', 'O'), ('blood', 'O'), ('pressure', 'O'), ('remained', 'O'), ('unchanged', 'O'), (',', 'O'), ('systolic', 'O'), ('blood', 'O'), ('pressure', 'O'), ('increased', 'O'), ('from', 'O'), ('119', 'O'), ('to', 'O'), ('135', 'O'), ('mm', 'O'), ('Hg', 'O'), ('(', 'O'), ('SED', 'O'), ('+', 'O'), ('/', 'O'), ('-', 'O'), ('3', 'O'), ('.', 'O'), ('4', 'O'), (',', 'O'), ('p', 'O'), ('less', 'O'), ('than', 'O'), ('0', 'O'), ('.', 'O'), ('01', 'O'), (')', 'O'), (',', 'O'), ('associated', 'O'), ('with', 'O'), ('an', 'O'), ('increased', 'B'), ('cardiac', 'I'), ('output', 'I'), ('(', 'O'), ('5', 'O'), ('.', 'O'), ('85', 'O'), ('-', 'O'), ('7', 'O'), ('.', 'O'), ('73', 'O'), ('l', 'O'), ('/', 'O'), ('min', 'O'), (',', 'O'), ('SED', 'O'), ('+', 'O'), ('/', 'O'), ('-', 'O'), ('0', 'O'), ('.', 'O'), ('46', 'O'), (',', 'O'), ('p', 'O'), ('less', 'O'), ('than', 'O'), ('0', 'O'), ('.', 'O'), ('01', 'O'), (')', 'O'), ('.', 'O'))$$$"
The rise in resting blood pressure with hydrocortisone is associated with an increased cardiac output ( presumably due to increased blood volume ) . ( ABSTRACT TRUNCATED AT 250 WORDS ),"(('The', 'O'), ('rise', 'B'), ('in', 'I'), ('resting', 'I'), ('blood', 'I'), ('pressure', 'I'), ('with', 'O'), ('hydrocortisone', 'O'), ('is', 'O'), ('associated', 'O'), ('with', 'O'), ('an', 'O'), ('increased', 'B'), ('cardiac', 'I'), ('output', 'I'), ('(', 'O'), ('presumably', 'O'), ('due', 'O'), ('to', 'O'), ('increased', 'O'), ('blood', 'O'), ('volume', 'O'), (')', 'O'), ('.', 'O'), ('(', 'O'), ('ABSTRACT', 'O'), ('TRUNCATED', 'O'), ('AT', 'O'), ('250', 'O'), ('WORDS', 'O'), (')', 'O'))$$$"
"Magnetic resonance imaging of cerebral venous thrombosis secondary to "" low - dose "" birth control pills .","(('Magnetic', 'O'), ('resonance', 'O'), ('imaging', 'O'), ('of', 'O'), ('cerebral', 'O'), ('venous', 'B'), ('thrombosis', 'I'), ('secondary', 'O'), ('to', 'O'), ('""', 'O'), ('low', 'O'), ('-', 'O'), ('dose', 'O'), ('""', 'O'), ('birth', 'O'), ('control', 'O'), ('pills', 'O'), ('.', 'O'))$$$"
A dystonia - like syndrome after neuropeptide ( MSH / ACTH ) stimulation of the rat locus ceruleus .,"(('A', 'O'), ('dystonia', 'B'), ('-', 'O'), ('like', 'O'), ('syndrome', 'O'), ('after', 'O'), ('neuropeptide', 'O'), ('(', 'O'), ('MSH', 'O'), ('/', 'O'), ('ACTH', 'O'), (')', 'O'), ('stimulation', 'O'), ('of', 'O'), ('the', 'O'), ('rat', 'O'), ('locus', 'O'), ('ceruleus', 'O'), ('.', 'O'))$$$"
"The movement disorder investigated in these studies has some features in common with human idiopathic dystonia , and information obtained in these studies may be of potential clinical benefit .","(('The', 'O'), ('movement', 'B'), ('disorder', 'I'), ('investigated', 'O'), ('in', 'O'), ('these', 'O'), ('studies', 'O'), ('has', 'O'), ('some', 'O'), ('features', 'O'), ('in', 'O'), ('common', 'O'), ('with', 'O'), ('human', 'O'), ('idiopathic', 'O'), ('dystonia', 'B'), (',', 'O'), ('and', 'O'), ('information', 'O'), ('obtained', 'O'), ('in', 'O'), ('these', 'O'), ('studies', 'O'), ('may', 'O'), ('be', 'O'), ('of', 'O'), ('potential', 'O'), ('clinical', 'O'), ('benefit', 'O'), ('.', 'O'))$$$"
"However , it is not certain as to the following : ( a ) what receptors were stimulated by the ACTH N - terminal fragments at the LC that resulted in this disorder ; ( b ) whether NE , released onto Purkinje cell synapses located at terminals of the ceruleo - cerebellar pathway , did indeed cause the long - term depression at Purkinje cell synapses ( previously described by others ) that resulted in the long duration of the movement disorder ; ( c ) whether the inhibition of inhibitory Purkinje cells resulted in disinhibition or","(('However', 'O'), (',', 'O'), ('it', 'O'), ('is', 'O'), ('not', 'O'), ('certain', 'O'), ('as', 'O'), ('to', 'O'), ('the', 'O'), ('following', 'O'), (':', 'O'), ('(', 'O'), ('a', 'O'), (')', 'O'), ('what', 'O'), ('receptors', 'O'), ('were', 'O'), ('stimulated', 'O'), ('by', 'O'), ('the', 'O'), ('ACTH', 'O'), ('N', 'O'), ('-', 'O'), ('terminal', 'O'), ('fragments', 'O'), ('at', 'O'), ('the', 'O'), ('LC', 'O'), ('that', 'O'), ('resulted', 'O'), ('in', 'O'), ('this', 'O'), ('disorder', 'O'), (';', 'O'), ('(', 'O'), ('b', 'O'), (')', 'O'), ('whether', 'O'), ('NE', 'O'), (',', 'O'), ('released', 'O'), ('onto', 'O'), ('Purkinje', 'O'), ('cell', 'O'), ('synapses', 'O'), ('located', 'O'), ('at', 'O'), ('terminals', 'O'), ('of', 'O'), ('the', 'O'), ('ceruleo', 'O'), ('-', 'O'), ('cerebellar', 'O'), ('pathway', 'O'), (',', 'O'), ('did', 'O'), ('indeed', 'O'), ('cause', 'O'), ('the', 'O'), ('long', 'O'), ('-', 'O'), ('term', 'O'), ('depression', 'B'), ('at', 'O'), ('Purkinje', 'O'), ('cell', 'O'), ('synapses', 'O'), ('(', 'O'), ('previously', 'O'), ('described', 'O'), ('by', 'O'), ('others', 'O'), (')', 'O'), ('that', 'O'), ('resulted', 'O'), ('in', 'O'), ('the', 'O'), ('long', 'O'), ('duration', 'O'), ('of', 'O'), ('the', 'O'), ('movement', 'B'), ('disorder', 'I'), (';', 'O'), ('(', 'O'), ('c', 'O'), (')', 'O'), ('whether', 'O'), ('the', 'O'), ('inhibition', 'O'), ('of', 'O'), ('inhibitory', 'O'), ('Purkinje', 'O'), ('cells', 'O'), ('resulted', 'O'), ('in', 'O'), ('disinhibition', 'O'), ('or', 'O'))$$$"
"Naloxone ( 2 . 5 mg / kg , i . v . ) reversed respiratory paralysis , glutamate and GABA levels to control values in brain stem and cortex with no changes in caudate or cerebellum .","(('Naloxone', 'O'), ('(', 'O'), ('2', 'O'), ('.', 'O'), ('5', 'O'), ('mg', 'O'), ('/', 'O'), ('kg', 'O'), (',', 'O'), ('i', 'O'), ('.', 'O'), ('v', 'O'), ('.', 'O'), (')', 'O'), ('reversed', 'O'), ('respiratory', 'B'), ('paralysis', 'I'), (',', 'O'), ('glutamate', 'O'), ('and', 'O'), ('GABA', 'O'), ('levels', 'O'), ('to', 'O'), ('control', 'O'), ('values', 'O'), ('in', 'O'), ('brain', 'O'), ('stem', 'O'), ('and', 'O'), ('cortex', 'O'), ('with', 'O'), ('no', 'O'), ('changes', 'O'), ('in', 'O'), ('caudate', 'O'), ('or', 'O'), ('cerebellum', 'O'), ('.', 'O'))$$$"
Initial potassium loss and hypokalaemia during chlorthalidone administration in patients with essential hypertension : the influence of dietary sodium restriction .,"(('Initial', 'O'), ('potassium', 'O'), ('loss', 'O'), ('and', 'O'), ('hypokalaemia', 'B'), ('during', 'O'), ('chlorthalidone', 'O'), ('administration', 'O'), ('in', 'O'), ('patients', 'O'), ('with', 'O'), ('essential', 'O'), ('hypertension', 'B'), (':', 'O'), ('the', 'O'), ('influence', 'O'), ('of', 'O'), ('dietary', 'O'), ('sodium', 'O'), ('restriction', 'O'), ('.', 'O'))$$$"
"To investigate the initial potassium loss and development of hypokalaemia during the administration of an oral diuretic , metabolic balance studies were performed in ten patients with essential hypertension who had shown hypokalaemia under prior oral diuretic treatment .","(('To', 'O'), ('investigate', 'O'), ('the', 'O'), ('initial', 'O'), ('potassium', 'O'), ('loss', 'O'), ('and', 'O'), ('development', 'O'), ('of', 'O'), ('hypokalaemia', 'B'), ('during', 'O'), ('the', 'O'), ('administration', 'O'), ('of', 'O'), ('an', 'O'), ('oral', 'O'), ('diuretic', 'O'), (',', 'O'), ('metabolic', 'O'), ('balance', 'O'), ('studies', 'O'), ('were', 'O'), ('performed', 'O'), ('in', 'O'), ('ten', 'O'), ('patients', 'O'), ('with', 'O'), ('essential', 'O'), ('hypertension', 'B'), ('who', 'O'), ('had', 'O'), ('shown', 'O'), ('hypokalaemia', 'B'), ('under', 'O'), ('prior', 'O'), ('oral', 'O'), ('diuretic', 'O'), ('treatment', 'O'), ('.', 'O'))$$$"
"Multicenter , double - blind , multiple - dose , parallel - groups efficacy and safety trial of azelastine , chlorpheniramine , and placebo in the treatment of spring allergic rhinitis .","(('Multicenter', 'O'), (',', 'O'), ('double', 'O'), ('-', 'O'), ('blind', 'O'), (',', 'O'), ('multiple', 'O'), ('-', 'O'), ('dose', 'O'), (',', 'O'), ('parallel', 'O'), ('-', 'O'), ('groups', 'O'), ('efficacy', 'O'), ('and', 'O'), ('safety', 'O'), ('trial', 'O'), ('of', 'O'), ('azelastine', 'O'), (',', 'O'), ('chlorpheniramine', 'O'), (',', 'O'), ('and', 'O'), ('placebo', 'O'), ('in', 'O'), ('the', 'O'), ('treatment', 'O'), ('of', 'O'), ('spring', 'B'), ('allergic', 'I'), ('rhinitis', 'I'), ('.', 'O'))$$$"
"Azelastine , a novel antiallergic medication , was compared with chlorpheniramine maleate and placebo for efficacy and safety in the treatment of spring allergic rhinitis in a multicenter , double - blind , multiple - dose , parallel - groups study .","(('Azelastine', 'O'), (',', 'O'), ('a', 'O'), ('novel', 'O'), ('antiallergic', 'O'), ('medication', 'O'), (',', 'O'), ('was', 'O'), ('compared', 'O'), ('with', 'O'), ('chlorpheniramine', 'O'), ('maleate', 'O'), ('and', 'O'), ('placebo', 'O'), ('for', 'O'), ('efficacy', 'O'), ('and', 'O'), ('safety', 'O'), ('in', 'O'), ('the', 'O'), ('treatment', 'O'), ('of', 'O'), ('spring', 'B'), ('allergic', 'I'), ('rhinitis', 'I'), ('in', 'O'), ('a', 'O'), ('multicenter', 'O'), (',', 'O'), ('double', 'O'), ('-', 'O'), ('blind', 'O'), (',', 'O'), ('multiple', 'O'), ('-', 'O'), ('dose', 'O'), (',', 'O'), ('parallel', 'O'), ('-', 'O'), ('groups', 'O'), ('study', 'O'), ('.', 'O'))$$$"
"Subjects ranged in age from 18 to 60 years of age and had at least a 2 - year history of spring allergic rhinitis , confirmed by positive skin test to spring aeroallergens .","(('Subjects', 'O'), ('ranged', 'O'), ('in', 'O'), ('age', 'O'), ('from', 'O'), ('18', 'O'), ('to', 'O'), ('60', 'O'), ('years', 'O'), ('of', 'O'), ('age', 'O'), ('and', 'O'), ('had', 'O'), ('at', 'O'), ('least', 'O'), ('a', 'O'), ('2', 'O'), ('-', 'O'), ('year', 'O'), ('history', 'O'), ('of', 'O'), ('spring', 'B'), ('allergic', 'I'), ('rhinitis', 'I'), (',', 'O'), ('confirmed', 'O'), ('by', 'O'), ('positive', 'O'), ('skin', 'O'), ('test', 'O'), ('to', 'O'), ('spring', 'O'), ('aeroallergens', 'O'), ('.', 'O'))$$$"
Drowsiness and altered taste perception were increased significantly over placebo only in the high - dose azelastine group .,"(('Drowsiness', 'B'), ('and', 'O'), ('altered', 'B'), ('taste', 'I'), ('perception', 'I'), ('were', 'O'), ('increased', 'O'), ('significantly', 'O'), ('over', 'O'), ('placebo', 'O'), ('only', 'O'), ('in', 'O'), ('the', 'O'), ('high', 'O'), ('-', 'O'), ('dose', 'O'), ('azelastine', 'O'), ('group', 'O'), ('.', 'O'))$$$"
"Azelastine appears to be a safe , efficacious medication for seasonal allergic rhinitis .","(('Azelastine', 'O'), ('appears', 'O'), ('to', 'O'), ('be', 'O'), ('a', 'O'), ('safe', 'O'), (',', 'O'), ('efficacious', 'O'), ('medication', 'O'), ('for', 'O'), ('seasonal', 'B'), ('allergic', 'I'), ('rhinitis', 'I'), ('.', 'O'))$$$"
Transient contralateral rotation following unilateral substantia nigra lesion reflects susceptibility of the nigrostriatal system to exhaustion by amphetamine .,"(('Transient', 'O'), ('contralateral', 'B'), ('rotation', 'I'), ('following', 'O'), ('unilateral', 'O'), ('substantia', 'B'), ('nigra', 'I'), ('lesion', 'I'), ('reflects', 'O'), ('susceptibility', 'O'), ('of', 'O'), ('the', 'O'), ('nigrostriatal', 'O'), ('system', 'O'), ('to', 'O'), ('exhaustion', 'O'), ('by', 'O'), ('amphetamine', 'O'), ('.', 'O'))$$$"
"Following unilateral 6 - OHDA induced SN lesion , a transient period of contralateral rotation has been reported to precede the predominant ipsilateral circling .","(('Following', 'O'), ('unilateral', 'O'), ('6', 'O'), ('-', 'O'), ('OHDA', 'O'), ('induced', 'O'), ('SN', 'B'), ('lesion', 'I'), (',', 'O'), ('a', 'O'), ('transient', 'O'), ('period', 'O'), ('of', 'O'), ('contralateral', 'B'), ('rotation', 'I'), ('has', 'O'), ('been', 'O'), ('reported', 'O'), ('to', 'O'), ('precede', 'O'), ('the', 'O'), ('predominant', 'O'), ('ipsilateral', 'B'), ('circling', 'I'), ('.', 'O'))$$$"
"In order to clarify the nature of this initial contralateral rotation we examined the effect of the duration of recovery period after the lesion , on amphetamine - induced rotational behavior .","(('In', 'O'), ('order', 'O'), ('to', 'O'), ('clarify', 'O'), ('the', 'O'), ('nature', 'O'), ('of', 'O'), ('this', 'O'), ('initial', 'O'), ('contralateral', 'B'), ('rotation', 'I'), ('we', 'O'), ('examined', 'O'), ('the', 'O'), ('effect', 'O'), ('of', 'O'), ('the', 'O'), ('duration', 'O'), ('of', 'O'), ('recovery', 'O'), ('period', 'O'), ('after', 'O'), ('the', 'O'), ('lesion', 'O'), (',', 'O'), ('on', 'O'), ('amphetamine', 'O'), ('-', 'O'), ('induced', 'O'), ('rotational', 'B'), ('behavior', 'I'), ('.', 'O'))$$$"
"It consists of microangiopathic hemolytic anemia , thrombocytopenia and progressive renal failure associated with mitomycin C treatment and affects about 10 % of patients treated with this agent .","(('It', 'O'), ('consists', 'O'), ('of', 'O'), ('microangiopathic', 'O'), ('hemolytic', 'B'), ('anemia', 'I'), (',', 'O'), ('thrombocytopenia', 'B'), ('and', 'O'), ('progressive', 'O'), ('renal', 'B'), ('failure', 'I'), ('associated', 'O'), ('with', 'O'), ('mitomycin', 'O'), ('C', 'O'), ('treatment', 'O'), ('and', 'O'), ('affects', 'O'), ('about', 'O'), ('10', 'O'), ('%', 'O'), ('of', 'O'), ('patients', 'O'), ('treated', 'O'), ('with', 'O'), ('this', 'O'), ('agent', 'O'), ('.', 'O'))$$$"
"Renal lesions are similar to those seen in idiopathic HUS and include arteriolar fibrin thrombi , expanded subendothelial zones in glomerular capillary walls , ischemic wrinkling of glomerular basement membranes and mesangiolysis .","(('Renal', 'B'), ('lesions', 'I'), ('are', 'O'), ('similar', 'O'), ('to', 'O'), ('those', 'O'), ('seen', 'O'), ('in', 'O'), ('idiopathic', 'O'), ('HUS', 'B'), ('and', 'O'), ('include', 'O'), ('arteriolar', 'O'), ('fibrin', 'O'), ('thrombi', 'B'), (',', 'O'), ('expanded', 'O'), ('subendothelial', 'O'), ('zones', 'O'), ('in', 'O'), ('glomerular', 'O'), ('capillary', 'O'), ('walls', 'O'), (',', 'O'), ('ischemic', 'B'), ('wrinkling', 'O'), ('of', 'O'), ('glomerular', 'O'), ('basement', 'O'), ('membranes', 'O'), ('and', 'O'), ('mesangiolysis', 'O'), ('.', 'O'))$$$"
"Despite the absence of rigidity , animals that received ketanserin ( greater than 0 . 31 mg / kg i . p . ) followed by alfentanil were motionless , flaccid , and less responsive to external stimuli than were animals receiving alfentanil alone .","(('Despite', 'O'), ('the', 'O'), ('absence', 'O'), ('of', 'O'), ('rigidity', 'B'), (',', 'O'), ('animals', 'O'), ('that', 'O'), ('received', 'O'), ('ketanserin', 'O'), ('(', 'O'), ('greater', 'O'), ('than', 'O'), ('0', 'O'), ('.', 'O'), ('31', 'O'), ('mg', 'O'), ('/', 'O'), ('kg', 'O'), ('i', 'O'), ('.', 'O'), ('p', 'O'), ('.', 'O'), (')', 'O'), ('followed', 'O'), ('by', 'O'), ('alfentanil', 'O'), ('were', 'O'), ('motionless', 'O'), (',', 'O'), ('flaccid', 'O'), (',', 'O'), ('and', 'O'), ('less', 'O'), ('responsive', 'O'), ('to', 'O'), ('external', 'O'), ('stimuli', 'O'), ('than', 'O'), ('were', 'O'), ('animals', 'O'), ('receiving', 'O'), ('alfentanil', 'O'), ('alone', 'O'), ('.', 'O'))$$$"
Co - carcinogenic effect of retinyl acetate on forestomach carcinogenesis of male F344 rats induced with butylated hydroxyanisole .,"(('Co', 'O'), ('-', 'O'), ('carcinogenic', 'B'), ('effect', 'O'), ('of', 'O'), ('retinyl', 'O'), ('acetate', 'O'), ('on', 'O'), ('forestomach', 'B'), ('carcinogenesis', 'I'), ('of', 'O'), ('male', 'O'), ('F344', 'O'), ('rats', 'O'), ('induced', 'O'), ('with', 'O'), ('butylated', 'O'), ('hydroxyanisole', 'O'), ('.', 'O'))$$$"
"In groups given 2 % BHA , although marked hyperplastic changes of the forestomach epithelium were observed in all animals , co - administration of 0 . 25 % RA significantly ( P less than 0 . 05 ) increased the incidence of forestomach tumors ( squamous cell papilloma and carcinoma ) to 60 % ( 9 / 15 , 2 rats with carcinoma ) from 15 % ( 3 / 20 , one rat with carcinoma ) in the group given RA - free water .","(('In', 'O'), ('groups', 'O'), ('given', 'O'), ('2', 'O'), ('%', 'O'), ('BHA', 'O'), (',', 'O'), ('although', 'O'), ('marked', 'O'), ('hyperplastic', 'O'), ('changes', 'O'), ('of', 'O'), ('the', 'O'), ('forestomach', 'O'), ('epithelium', 'O'), ('were', 'O'), ('observed', 'O'), ('in', 'O'), ('all', 'O'), ('animals', 'O'), (',', 'O'), ('co', 'O'), ('-', 'O'), ('administration', 'O'), ('of', 'O'), ('0', 'O'), ('.', 'O'), ('25', 'O'), ('%', 'O'), ('RA', 'O'), ('significantly', 'O'), ('(', 'O'), ('P', 'O'), ('less', 'O'), ('than', 'O'), ('0', 'O'), ('.', 'O'), ('05', 'O'), (')', 'O'), ('increased', 'O'), ('the', 'O'), ('incidence', 'O'), ('of', 'O'), ('forestomach', 'B'), ('tumors', 'I'), ('(', 'O'), ('squamous', 'B'), ('cell', 'I'), ('papilloma', 'I'), ('and', 'O'), ('carcinoma', 'B'), (')', 'O'), ('to', 'O'), ('60', 'O'), ('%', 'O'), ('(', 'O'), ('9', 'O'), ('/', 'O'), ('15', 'O'), (',', 'O'), ('2', 'O'), ('rats', 'O'), ('with', 'O'), ('carcinoma', 'B'), (')', 'O'), ('from', 'O'), ('15', 'O'), ('%', 'O'), ('(', 'O'), ('3', 'O'), ('/', 'O'), ('20', 'O'), (',', 'O'), ('one', 'O'), ('rat', 'O'), ('with', 'O'), ('carcinoma', 'B'), (')', 'O'), ('in', 'O'), ('the', 'O'), ('group', 'O'), ('given', 'O'), ('RA', 'O'), ('-', 'O'), ('free', 'O'), ('water', 'O'), ('.', 'O'))$$$"
These findings indicate that RA acted as a co - carcinogen in the BHA forestomach carcinogenesis of the rat .,"(('These', 'O'), ('findings', 'O'), ('indicate', 'O'), ('that', 'O'), ('RA', 'O'), ('acted', 'O'), ('as', 'O'), ('a', 'O'), ('co', 'O'), ('-', 'O'), ('carcinogen', 'O'), ('in', 'O'), ('the', 'O'), ('BHA', 'O'), ('forestomach', 'B'), ('carcinogenesis', 'I'), ('of', 'O'), ('the', 'O'), ('rat', 'O'), ('.', 'O'))$$$"
St .,"(('St', 'B'), ('.', 'I'))$$$"
"Anthony ' s fire , then and now : a case report and historical review .","(('Anthony', 'B'), (""'"", 'I'), ('s', 'I'), ('fire', 'I'), (',', 'O'), ('then', 'O'), ('and', 'O'), ('now', 'O'), (':', 'O'), ('a', 'O'), ('case', 'O'), ('report', 'O'), ('and', 'O'), ('historical', 'O'), ('review', 'O'), ('.', 'O'))$$$"
"A discussion of the history of ergot includes its original discovery , the epidemics of gangrene that it has caused through the ages and its past and present role in the management of migraine headache .","(('A', 'O'), ('discussion', 'O'), ('of', 'O'), ('the', 'O'), ('history', 'O'), ('of', 'O'), ('ergot', 'O'), ('includes', 'O'), ('its', 'O'), ('original', 'O'), ('discovery', 'O'), (',', 'O'), ('the', 'O'), ('epidemics', 'O'), ('of', 'O'), ('gangrene', 'B'), ('that', 'O'), ('it', 'O'), ('has', 'O'), ('caused', 'O'), ('through', 'O'), ('the', 'O'), ('ages', 'O'), ('and', 'O'), ('its', 'O'), ('past', 'O'), ('and', 'O'), ('present', 'O'), ('role', 'O'), ('in', 'O'), ('the', 'O'), ('management', 'O'), ('of', 'O'), ('migraine', 'B'), ('headache', 'I'), ('.', 'O'))$$$"
"Despite the advent of calcium channel blockers and beta - adrenergic antagonists , ergot preparations continue to play a major role in migraine therapy , so that the danger of St .","(('Despite', 'O'), ('the', 'O'), ('advent', 'O'), ('of', 'O'), ('calcium', 'O'), ('channel', 'O'), ('blockers', 'O'), ('and', 'O'), ('beta', 'O'), ('-', 'O'), ('adrenergic', 'O'), ('antagonists', 'O'), (',', 'O'), ('ergot', 'O'), ('preparations', 'O'), ('continue', 'O'), ('to', 'O'), ('play', 'O'), ('a', 'O'), ('major', 'O'), ('role', 'O'), ('in', 'O'), ('migraine', 'B'), ('therapy', 'O'), (',', 'O'), ('so', 'O'), ('that', 'O'), ('the', 'O'), ('danger', 'O'), ('of', 'O'), ('St', 'B'), ('.', 'I'))$$$"
Anthony ' s fire persists .,"(('Anthony', 'B'), (""'"", 'I'), ('s', 'I'), ('fire', 'I'), ('persists', 'O'), ('.', 'O'))$$$"
"However , benztropine treated patients had a significant increase in tardive dyskinesia compared to their condition during procyclindine treatment , and significantly more anxiety and depression than ethopropazine treated patients .","(('However', 'O'), (',', 'O'), ('benztropine', 'O'), ('treated', 'O'), ('patients', 'O'), ('had', 'O'), ('a', 'O'), ('significant', 'O'), ('increase', 'O'), ('in', 'O'), ('tardive', 'B'), ('dyskinesia', 'I'), ('compared', 'O'), ('to', 'O'), ('their', 'O'), ('condition', 'O'), ('during', 'O'), ('procyclindine', 'O'), ('treatment', 'O'), (',', 'O'), ('and', 'O'), ('significantly', 'O'), ('more', 'O'), ('anxiety', 'B'), ('and', 'O'), ('depression', 'B'), ('than', 'O'), ('ethopropazine', 'O'), ('treated', 'O'), ('patients', 'O'), ('.', 'O'))$$$"
Quinidine phenylethylbarbiturate - induced fulminant hepatitis in a pregnant woman .,"(('Quinidine', 'O'), ('phenylethylbarbiturate', 'O'), ('-', 'O'), ('induced', 'O'), ('fulminant', 'O'), ('hepatitis', 'B'), ('in', 'O'), ('a', 'O'), ('pregnant', 'O'), ('woman', 'O'), ('.', 'O'))$$$"
We report the case of a 19 - year - old Laotian patient affected by fulminant hepatitis during the third trimester of her pregnancy after a 1 - month administration of quinidine phenylethylbarbiturate .,"(('We', 'O'), ('report', 'O'), ('the', 'O'), ('case', 'O'), ('of', 'O'), ('a', 'O'), ('19', 'O'), ('-', 'O'), ('year', 'O'), ('-', 'O'), ('old', 'O'), ('Laotian', 'O'), ('patient', 'O'), ('affected', 'O'), ('by', 'O'), ('fulminant', 'O'), ('hepatitis', 'B'), ('during', 'O'), ('the', 'O'), ('third', 'O'), ('trimester', 'O'), ('of', 'O'), ('her', 'O'), ('pregnancy', 'O'), ('after', 'O'), ('a', 'O'), ('1', 'O'), ('-', 'O'), ('month', 'O'), ('administration', 'O'), ('of', 'O'), ('quinidine', 'O'), ('phenylethylbarbiturate', 'O'), ('.', 'O'))$$$"
Quinidine itself or phenylethylbarbiturate may be responsible for fulminant hepatitis in this patient .,"(('Quinidine', 'O'), ('itself', 'O'), ('or', 'O'), ('phenylethylbarbiturate', 'O'), ('may', 'O'), ('be', 'O'), ('responsible', 'O'), ('for', 'O'), ('fulminant', 'O'), ('hepatitis', 'B'), ('in', 'O'), ('this', 'O'), ('patient', 'O'), ('.', 'O'))$$$"
"Toxicities included hepatotoxicity , malaise , and dose - limiting nephrotoxicity .","(('Toxicities', 'B'), ('included', 'O'), ('hepatotoxicity', 'B'), (',', 'O'), ('malaise', 'B'), (',', 'O'), ('and', 'O'), ('dose', 'O'), ('-', 'O'), ('limiting', 'O'), ('nephrotoxicity', 'B'), ('.', 'O'))$$$"
Type B hepatitis after needle - stick exposure : prevention with hepatitis B immune globulin .,"(('Type', 'B'), ('B', 'I'), ('hepatitis', 'I'), ('after', 'O'), ('needle', 'O'), ('-', 'O'), ('stick', 'O'), ('exposure', 'O'), (':', 'O'), ('prevention', 'O'), ('with', 'O'), ('hepatitis', 'B'), ('B', 'I'), ('immune', 'O'), ('globulin', 'O'), ('.', 'O'))$$$"
The efficacy of ISG in preventing type B hepatitis cannot be ascertained because a true placebo group was not included .,"(('The', 'O'), ('efficacy', 'O'), ('of', 'O'), ('ISG', 'O'), ('in', 'O'), ('preventing', 'O'), ('type', 'B'), ('B', 'I'), ('hepatitis', 'I'), ('cannot', 'O'), ('be', 'O'), ('ascertained', 'O'), ('because', 'O'), ('a', 'O'), ('true', 'O'), ('placebo', 'O'), ('group', 'O'), ('was', 'O'), ('not', 'O'), ('included', 'O'), ('.', 'O'))$$$"
We prospectively compared the efficacy and safety of netilmicin sulfate or tobramycin sulfate in conjunction with piperacillin sodium in 118 immunocompromised patients with presumed severe infections .,"(('We', 'O'), ('prospectively', 'O'), ('compared', 'O'), ('the', 'O'), ('efficacy', 'O'), ('and', 'O'), ('safety', 'O'), ('of', 'O'), ('netilmicin', 'O'), ('sulfate', 'O'), ('or', 'O'), ('tobramycin', 'O'), ('sulfate', 'O'), ('in', 'O'), ('conjunction', 'O'), ('with', 'O'), ('piperacillin', 'O'), ('sodium', 'O'), ('in', 'O'), ('118', 'O'), ('immunocompromised', 'O'), ('patients', 'O'), ('with', 'O'), ('presumed', 'O'), ('severe', 'O'), ('infections', 'B'), ('.', 'O'))$$$"
Urinary enzymes and protein patterns as indicators of injury to different regions of the kidney .,"(('Urinary', 'O'), ('enzymes', 'O'), ('and', 'O'), ('protein', 'O'), ('patterns', 'O'), ('as', 'O'), ('indicators', 'O'), ('of', 'O'), ('injury', 'B'), ('to', 'I'), ('different', 'I'), ('regions', 'I'), ('of', 'I'), ('the', 'I'), ('kidney', 'I'), ('.', 'O'))$$$"
"Acute experimental models of renal damage to the proximal tubular , glomerular , and papillary regions of the rat were produced by administration of hexachloro - 1 : 3 - butadiene ( HCBD ) , puromycin aminonucleoside ( PAN ) , and 2 - bromoethylamine ( BEA ) , respectively .","(('Acute', 'B'), ('experimental', 'I'), ('models', 'I'), ('of', 'I'), ('renal', 'I'), ('damage', 'I'), ('to', 'O'), ('the', 'O'), ('proximal', 'O'), ('tubular', 'O'), (',', 'O'), ('glomerular', 'O'), (',', 'O'), ('and', 'O'), ('papillary', 'O'), ('regions', 'O'), ('of', 'O'), ('the', 'O'), ('rat', 'O'), ('were', 'O'), ('produced', 'O'), ('by', 'O'), ('administration', 'O'), ('of', 'O'), ('hexachloro', 'O'), ('-', 'O'), ('1', 'O'), (':', 'O'), ('3', 'O'), ('-', 'O'), ('butadiene', 'O'), ('(', 'O'), ('HCBD', 'O'), (')', 'O'), (',', 'O'), ('puromycin', 'O'), ('aminonucleoside', 'O'), ('(', 'O'), ('PAN', 'O'), (')', 'O'), (',', 'O'), ('and', 'O'), ('2', 'O'), ('-', 'O'), ('bromoethylamine', 'O'), ('(', 'O'), ('BEA', 'O'), (')', 'O'), (',', 'O'), ('respectively', 'O'), ('.', 'O'))$$$"
"Several routine indicators of nephrotoxicity , the enzymes alkaline phosphatase and N - acetyl - beta - glucosaminidase , and the molecular weight of protein excretion were determined on urine samples .","(('Several', 'O'), ('routine', 'O'), ('indicators', 'O'), ('of', 'O'), ('nephrotoxicity', 'B'), (',', 'O'), ('the', 'O'), ('enzymes', 'O'), ('alkaline', 'O'), ('phosphatase', 'O'), ('and', 'O'), ('N', 'O'), ('-', 'O'), ('acetyl', 'O'), ('-', 'O'), ('beta', 'O'), ('-', 'O'), ('glucosaminidase', 'O'), (',', 'O'), ('and', 'O'), ('the', 'O'), ('molecular', 'O'), ('weight', 'O'), ('of', 'O'), ('protein', 'B'), ('excretion', 'I'), ('were', 'O'), ('determined', 'O'), ('on', 'O'), ('urine', 'O'), ('samples', 'O'), ('.', 'O'))$$$"
Tubular damage produced by HCBD or BEA was discriminated both quantitatively and qualitatively from glomerular damage produced by PAN .,"(('Tubular', 'O'), ('damage', 'O'), ('produced', 'O'), ('by', 'O'), ('HCBD', 'O'), ('or', 'O'), ('BEA', 'O'), ('was', 'O'), ('discriminated', 'O'), ('both', 'O'), ('quantitatively', 'O'), ('and', 'O'), ('qualitatively', 'O'), ('from', 'O'), ('glomerular', 'B'), ('damage', 'I'), ('produced', 'O'), ('by', 'O'), ('PAN', 'O'), ('.', 'O'))$$$"
"In contrast , protein excretion in tubular damage was raised only slightly and characterized by excretion of proteins of a wide range of molecular weights .","(('In', 'O'), ('contrast', 'O'), (',', 'O'), ('protein', 'B'), ('excretion', 'I'), ('in', 'O'), ('tubular', 'O'), ('damage', 'O'), ('was', 'O'), ('raised', 'O'), ('only', 'O'), ('slightly', 'O'), ('and', 'O'), ('characterized', 'O'), ('by', 'O'), ('excretion', 'B'), ('of', 'I'), ('proteins', 'I'), ('of', 'O'), ('a', 'O'), ('wide', 'O'), ('range', 'O'), ('of', 'O'), ('molecular', 'O'), ('weights', 'O'), ('.', 'O'))$$$"
Postpartum psychosis induced by bromocriptine .,"(('Postpartum', 'O'), ('psychosis', 'B'), ('induced', 'O'), ('by', 'O'), ('bromocriptine', 'O'), ('.', 'O'))$$$"
"Two multigravida patients with no prior psychiatric history were seen with postpartum psychosis , having received bromocriptine for inhibition of lactation .","(('Two', 'O'), ('multigravida', 'O'), ('patients', 'O'), ('with', 'O'), ('no', 'O'), ('prior', 'O'), ('psychiatric', 'B'), ('history', 'O'), ('were', 'O'), ('seen', 'O'), ('with', 'O'), ('postpartum', 'O'), ('psychosis', 'B'), (',', 'O'), ('having', 'O'), ('received', 'O'), ('bromocriptine', 'O'), ('for', 'O'), ('inhibition', 'B'), ('of', 'I'), ('lactation', 'I'), ('.', 'O'))$$$"
Hyperglycemic acidotic coma and death in Kearns - Sayre syndrome .,"(('Hyperglycemic', 'B'), ('acidotic', 'I'), ('coma', 'I'), ('and', 'O'), ('death', 'O'), ('in', 'O'), ('Kearns', 'B'), ('-', 'I'), ('Sayre', 'I'), ('syndrome', 'I'), ('.', 'O'))$$$"
Nonketotic lactic acidosis was present in one and ketosis without a known serum lactate level was present in the other .,"(('Nonketotic', 'O'), ('lactic', 'B'), ('acidosis', 'I'), ('was', 'O'), ('present', 'O'), ('in', 'O'), ('one', 'O'), ('and', 'O'), ('ketosis', 'B'), ('without', 'O'), ('a', 'O'), ('known', 'O'), ('serum', 'O'), ('lactate', 'O'), ('level', 'O'), ('was', 'O'), ('present', 'O'), ('in', 'O'), ('the', 'O'), ('other', 'O'), ('.', 'O'))$$$"
"Diuretics , potassium and arrhythmias in hypertensive coronary disease .","(('Diuretics', 'O'), (',', 'O'), ('potassium', 'O'), ('and', 'O'), ('arrhythmias', 'B'), ('in', 'O'), ('hypertensive', 'B'), ('coronary', 'B'), ('disease', 'I'), ('.', 'O'))$$$"
"Thus , myocardial electrical excitability was measured in patients with mild essential hypertension and known coronary artery disease after 8 weeks of treatment with a potassium - conserving diuretic ( amiloride ) and a similar period on a potassium - losing diuretic ( chlorthalidone ) in a randomised study .","(('Thus', 'O'), (',', 'O'), ('myocardial', 'O'), ('electrical', 'O'), ('excitability', 'O'), ('was', 'O'), ('measured', 'O'), ('in', 'O'), ('patients', 'O'), ('with', 'O'), ('mild', 'O'), ('essential', 'O'), ('hypertension', 'B'), ('and', 'O'), ('known', 'O'), ('coronary', 'B'), ('artery', 'I'), ('disease', 'I'), ('after', 'O'), ('8', 'O'), ('weeks', 'O'), ('of', 'O'), ('treatment', 'O'), ('with', 'O'), ('a', 'O'), ('potassium', 'O'), ('-', 'O'), ('conserving', 'O'), ('diuretic', 'O'), ('(', 'O'), ('amiloride', 'O'), (')', 'O'), ('and', 'O'), ('a', 'O'), ('similar', 'O'), ('period', 'O'), ('on', 'O'), ('a', 'O'), ('potassium', 'O'), ('-', 'O'), ('losing', 'O'), ('diuretic', 'O'), ('(', 'O'), ('chlorthalidone', 'O'), (')', 'O'), ('in', 'O'), ('a', 'O'), ('randomised', 'O'), ('study', 'O'), ('.', 'O'))$$$"
"We studied a thiamine - dependent enzyme , transketolase , from fibroblasts of a diabetic patient who developed Wernicke ' s encephalopathy when treated with tolazamide , in order to delineate if this patient also had transketolase abnormality [ high Km for thiamine pyrophosphate ( TPP ) ] , as previously reported in postalcoholic Wernicke - Korsakoff syndrome .","(('We', 'O'), ('studied', 'O'), ('a', 'O'), ('thiamine', 'O'), ('-', 'O'), ('dependent', 'O'), ('enzyme', 'O'), (',', 'O'), ('transketolase', 'O'), (',', 'O'), ('from', 'O'), ('fibroblasts', 'O'), ('of', 'O'), ('a', 'O'), ('diabetic', 'B'), ('patient', 'O'), ('who', 'O'), ('developed', 'O'), ('Wernicke', 'B'), (""'"", 'I'), ('s', 'I'), ('encephalopathy', 'I'), ('when', 'O'), ('treated', 'O'), ('with', 'O'), ('tolazamide', 'O'), (',', 'O'), ('in', 'O'), ('order', 'O'), ('to', 'O'), ('delineate', 'O'), ('if', 'O'), ('this', 'O'), ('patient', 'O'), ('also', 'O'), ('had', 'O'), ('transketolase', 'O'), ('abnormality', 'O'), ('[', 'O'), ('high', 'O'), ('Km', 'O'), ('for', 'O'), ('thiamine', 'O'), ('pyrophosphate', 'O'), ('(', 'O'), ('TPP', 'O'), (')', 'O'), (']', 'O'), (',', 'O'), ('as', 'O'), ('previously', 'O'), ('reported', 'O'), ('in', 'O'), ('postalcoholic', 'O'), ('Wernicke', 'B'), ('-', 'I'), ('Korsakoff', 'I'), ('syndrome', 'I'), ('.', 'O'))$$$"
"The patient developed , paradoxically , sinus bradycardia .","(('The', 'O'), ('patient', 'O'), ('developed', 'O'), (',', 'O'), ('paradoxically', 'O'), (',', 'O'), ('sinus', 'O'), ('bradycardia', 'B'), ('.', 'O'))$$$"
This antidyskinetic drug is widely used in clinical psychiatric practice and physicians should be aware of this side effect .,"(('This', 'O'), ('antidyskinetic', 'O'), ('drug', 'O'), ('is', 'O'), ('widely', 'O'), ('used', 'O'), ('in', 'O'), ('clinical', 'O'), ('psychiatric', 'B'), ('practice', 'O'), ('and', 'O'), ('physicians', 'O'), ('should', 'O'), ('be', 'O'), ('aware', 'O'), ('of', 'O'), ('this', 'O'), ('side', 'O'), ('effect', 'O'), ('.', 'O'))$$$"
A case of thoraco - abdominal rigidity leading to respiratory failure is described in the post - operative period in an elderly patient who received a moderate dose of fentanyl .,"(('A', 'O'), ('case', 'O'), ('of', 'O'), ('thoraco', 'O'), ('-', 'O'), ('abdominal', 'O'), ('rigidity', 'B'), ('leading', 'O'), ('to', 'O'), ('respiratory', 'B'), ('failure', 'I'), ('is', 'O'), ('described', 'O'), ('in', 'O'), ('the', 'O'), ('post', 'O'), ('-', 'O'), ('operative', 'O'), ('period', 'O'), ('in', 'O'), ('an', 'O'), ('elderly', 'O'), ('patient', 'O'), ('who', 'O'), ('received', 'O'), ('a', 'O'), ('moderate', 'O'), ('dose', 'O'), ('of', 'O'), ('fentanyl', 'O'), ('.', 'O'))$$$"
This ' anti - carcinogen ' effect acts on the initiation as well as on the promotion of the precancerous lesions .,"(('This', 'O'), (""'"", 'O'), ('anti', 'O'), ('-', 'O'), ('carcinogen', 'O'), (""'"", 'O'), ('effect', 'O'), ('acts', 'O'), ('on', 'O'), ('the', 'O'), ('initiation', 'O'), ('as', 'O'), ('well', 'O'), ('as', 'O'), ('on', 'O'), ('the', 'O'), ('promotion', 'O'), ('of', 'O'), ('the', 'O'), ('precancerous', 'B'), ('lesions', 'I'), ('.', 'O'))$$$"
Bilateral optic neuropathy due to combined ethambutol and isoniazid treatment .,"(('Bilateral', 'B'), ('optic', 'I'), ('neuropathy', 'I'), ('due', 'O'), ('to', 'O'), ('combined', 'O'), ('ethambutol', 'O'), ('and', 'O'), ('isoniazid', 'O'), ('treatment', 'O'), ('.', 'O'))$$$"
A bilateral retrobulbar neuropathy with an unusual central bitemporal hemianopic scotoma was found .,"(('A', 'O'), ('bilateral', 'B'), ('retrobulbar', 'I'), ('neuropathy', 'I'), ('with', 'O'), ('an', 'O'), ('unusual', 'O'), ('central', 'O'), ('bitemporal', 'O'), ('hemianopic', 'O'), ('scotoma', 'B'), ('was', 'O'), ('found', 'O'), ('.', 'O'))$$$"
The hazards of optic nerve toxicity due to ethambutol are known .,"(('The', 'O'), ('hazards', 'O'), ('of', 'O'), ('optic', 'O'), ('nerve', 'O'), ('toxicity', 'B'), ('due', 'O'), ('to', 'O'), ('ethambutol', 'O'), ('are', 'O'), ('known', 'O'), ('.', 'O'))$$$"
We report a case of a patient with colon carcinoma and liver metastasis who presented chest pain after 5 - fluorouracil ( 5 - FU ) administration .,"(('We', 'O'), ('report', 'O'), ('a', 'O'), ('case', 'O'), ('of', 'O'), ('a', 'O'), ('patient', 'O'), ('with', 'O'), ('colon', 'B'), ('carcinoma', 'I'), ('and', 'O'), ('liver', 'O'), ('metastasis', 'B'), ('who', 'O'), ('presented', 'O'), ('chest', 'B'), ('pain', 'I'), ('after', 'O'), ('5', 'O'), ('-', 'O'), ('fluorouracil', 'O'), ('(', 'O'), ('5', 'O'), ('-', 'O'), ('FU', 'O'), (')', 'O'), ('administration', 'O'), ('.', 'O'))$$$"
Dose - related beneficial and adverse effects of dietary corticosterone on organophosphorus - induced delayed neuropathy in chickens .,"(('Dose', 'O'), ('-', 'O'), ('related', 'O'), ('beneficial', 'O'), ('and', 'O'), ('adverse', 'O'), ('effects', 'O'), ('of', 'O'), ('dietary', 'O'), ('corticosterone', 'O'), ('on', 'O'), ('organophosphorus', 'O'), ('-', 'O'), ('induced', 'O'), ('delayed', 'O'), ('neuropathy', 'B'), ('in', 'O'), ('chickens', 'O'), ('.', 'O'))$$$"
Supplemented diets were continued until clinical signs and lesions of delayed neuropathy appeared .,"(('Supplemented', 'O'), ('diets', 'O'), ('were', 'O'), ('continued', 'O'), ('until', 'O'), ('clinical', 'O'), ('signs', 'O'), ('and', 'O'), ('lesions', 'O'), ('of', 'O'), ('delayed', 'O'), ('neuropathy', 'B'), ('appeared', 'O'), ('.', 'O'))$$$"
Amiodarone has proved very effective in the treatment of otherwise resistant cardiac tachyarrhythmias .,"(('Amiodarone', 'O'), ('has', 'O'), ('proved', 'O'), ('very', 'O'), ('effective', 'O'), ('in', 'O'), ('the', 'O'), ('treatment', 'O'), ('of', 'O'), ('otherwise', 'O'), ('resistant', 'O'), ('cardiac', 'O'), ('tachyarrhythmias', 'B'), ('.', 'O'))$$$"
"It is concluded that solid evidence exists of hepatic injury due to amiodarone treatment , including steatosis , alterations resembling alcoholic hepatitis , cholestatic hepatitis and micronodular cirrhosis of the liver .","(('It', 'O'), ('is', 'O'), ('concluded', 'O'), ('that', 'O'), ('solid', 'O'), ('evidence', 'O'), ('exists', 'O'), ('of', 'O'), ('hepatic', 'B'), ('injury', 'I'), ('due', 'O'), ('to', 'O'), ('amiodarone', 'O'), ('treatment', 'O'), (',', 'O'), ('including', 'O'), ('steatosis', 'B'), (',', 'O'), ('alterations', 'O'), ('resembling', 'O'), ('alcoholic', 'B'), ('hepatitis', 'I'), (',', 'O'), ('cholestatic', 'B'), ('hepatitis', 'I'), ('and', 'O'), ('micronodular', 'O'), ('cirrhosis', 'B'), ('of', 'I'), ('the', 'I'), ('liver', 'I'), ('.', 'O'))$$$"
Promotional effects of testosterone and dietary fat on prostate carcinogenesis in genetically susceptible rats .,"(('Promotional', 'O'), ('effects', 'O'), ('of', 'O'), ('testosterone', 'O'), ('and', 'O'), ('dietary', 'O'), ('fat', 'O'), ('on', 'O'), ('prostate', 'O'), ('carcinogenesis', 'B'), ('in', 'O'), ('genetically', 'O'), ('susceptible', 'O'), ('rats', 'O'), ('.', 'O'))$$$"
Significant QTC prolongation occurred in 30 seconds to one minute in association with marked hypotension and elevation of cardiac output .,"(('Significant', 'O'), ('QTC', 'B'), ('prolongation', 'I'), ('occurred', 'O'), ('in', 'O'), ('30', 'O'), ('seconds', 'O'), ('to', 'O'), ('one', 'O'), ('minute', 'O'), ('in', 'O'), ('association', 'O'), ('with', 'O'), ('marked', 'O'), ('hypotension', 'B'), ('and', 'O'), ('elevation', 'O'), ('of', 'O'), ('cardiac', 'O'), ('output', 'O'), ('.', 'O'))$$$"
"With these findings in rats , it is hypothesized that the temporary diplopia sometimes seen in patients after ophthalmic surgery might be due to anesthetic - induced damage to the extraocular muscles .","(('With', 'O'), ('these', 'O'), ('findings', 'O'), ('in', 'O'), ('rats', 'O'), (',', 'O'), ('it', 'O'), ('is', 'O'), ('hypothesized', 'O'), ('that', 'O'), ('the', 'O'), ('temporary', 'O'), ('diplopia', 'B'), ('sometimes', 'O'), ('seen', 'O'), ('in', 'O'), ('patients', 'O'), ('after', 'O'), ('ophthalmic', 'O'), ('surgery', 'O'), ('might', 'O'), ('be', 'O'), ('due', 'O'), ('to', 'O'), ('anesthetic', 'O'), ('-', 'O'), ('induced', 'O'), ('damage', 'O'), ('to', 'O'), ('the', 'O'), ('extraocular', 'O'), ('muscles', 'O'), ('.', 'O'))$$$"
"Papillomas of the transitional epithelium of the bladder developed in all paracetamol - treated groups , and three rats bore bladder carcinomas .","(('Papillomas', 'B'), ('of', 'O'), ('the', 'O'), ('transitional', 'O'), ('epithelium', 'O'), ('of', 'O'), ('the', 'O'), ('bladder', 'O'), ('developed', 'O'), ('in', 'O'), ('all', 'O'), ('paracetamol', 'O'), ('-', 'O'), ('treated', 'O'), ('groups', 'O'), (',', 'O'), ('and', 'O'), ('three', 'O'), ('rats', 'O'), ('bore', 'O'), ('bladder', 'B'), ('carcinomas', 'I'), ('.', 'O'))$$$"
"Additionally , 20 to 25 % of paracetamol - treated rats developed hyperplasia of the bladder epithelium , which was not coincident with the presence of bladder calculi .","(('Additionally', 'O'), (',', 'O'), ('20', 'O'), ('to', 'O'), ('25', 'O'), ('%', 'O'), ('of', 'O'), ('paracetamol', 'O'), ('-', 'O'), ('treated', 'O'), ('rats', 'O'), ('developed', 'O'), ('hyperplasia', 'B'), ('of', 'O'), ('the', 'O'), ('bladder', 'O'), ('epithelium', 'O'), (',', 'O'), ('which', 'O'), ('was', 'O'), ('not', 'O'), ('coincident', 'O'), ('with', 'O'), ('the', 'O'), ('presence', 'O'), ('of', 'O'), ('bladder', 'B'), ('calculi', 'I'), ('.', 'O'))$$$"
Transient hemiparesis : a rare manifestation of diphenylhydantoin toxicity .,"(('Transient', 'O'), ('hemiparesis', 'B'), (':', 'O'), ('a', 'O'), ('rare', 'O'), ('manifestation', 'O'), ('of', 'O'), ('diphenylhydantoin', 'O'), ('toxicity', 'B'), ('.', 'O'))$$$"
Two patients are presented who suffered progressive hemiparesis due to DPH overdose .,"(('Two', 'O'), ('patients', 'O'), ('are', 'O'), ('presented', 'O'), ('who', 'O'), ('suffered', 'O'), ('progressive', 'O'), ('hemiparesis', 'B'), ('due', 'O'), ('to', 'O'), ('DPH', 'O'), ('overdose', 'B'), ('.', 'O'))$$$"
Liver biopsy showed active hepatitis .,"(('Liver', 'O'), ('biopsy', 'O'), ('showed', 'O'), ('active', 'O'), ('hepatitis', 'B'), ('.', 'O'))$$$"
Arterial thromboembolism in patients receiving systemic heparin therapy : a complication associated with heparin - induced thrombocytopenia .,"(('Arterial', 'O'), ('thromboembolism', 'B'), ('in', 'O'), ('patients', 'O'), ('receiving', 'O'), ('systemic', 'O'), ('heparin', 'O'), ('therapy', 'O'), (':', 'O'), ('a', 'O'), ('complication', 'O'), ('associated', 'O'), ('with', 'O'), ('heparin', 'O'), ('-', 'O'), ('induced', 'O'), ('thrombocytopenia', 'B'), ('.', 'O'))$$$"
"Characteristic of the entity is arterial occlusion by platelet - fibrin thrombi with distal ischemia occurring four to twenty days after the initiation of heparin therapy , preceded by profound thrombocytopenia with platelet counts in the range of 30 , 000 to 40 , 000 per cubic millimeter .","(('Characteristic', 'O'), ('of', 'O'), ('the', 'O'), ('entity', 'O'), ('is', 'O'), ('arterial', 'B'), ('occlusion', 'I'), ('by', 'O'), ('platelet', 'O'), ('-', 'O'), ('fibrin', 'O'), ('thrombi', 'B'), ('with', 'O'), ('distal', 'O'), ('ischemia', 'B'), ('occurring', 'O'), ('four', 'O'), ('to', 'O'), ('twenty', 'O'), ('days', 'O'), ('after', 'O'), ('the', 'O'), ('initiation', 'O'), ('of', 'O'), ('heparin', 'O'), ('therapy', 'O'), (',', 'O'), ('preceded', 'O'), ('by', 'O'), ('profound', 'O'), ('thrombocytopenia', 'B'), ('with', 'O'), ('platelet', 'O'), ('counts', 'O'), ('in', 'O'), ('the', 'O'), ('range', 'O'), ('of', 'O'), ('30', 'O'), (',', 'O'), ('000', 'O'), ('to', 'O'), ('40', 'O'), (',', 'O'), ('000', 'O'), ('per', 'O'), ('cubic', 'O'), ('millimeter', 'O'), ('.', 'O'))$$$"
"The clinically apparent occlusion may be preceded by gastrointestinal and musculoskeletal symptoms that appear to be ischemic in origin , and might serve to warn the clinician of these complications .","(('The', 'O'), ('clinically', 'O'), ('apparent', 'O'), ('occlusion', 'O'), ('may', 'O'), ('be', 'O'), ('preceded', 'O'), ('by', 'O'), ('gastrointestinal', 'B'), ('and', 'I'), ('musculoskeletal', 'I'), ('symptoms', 'I'), ('that', 'O'), ('appear', 'O'), ('to', 'O'), ('be', 'O'), ('ischemic', 'B'), ('in', 'O'), ('origin', 'O'), (',', 'O'), ('and', 'O'), ('might', 'O'), ('serve', 'O'), ('to', 'O'), ('warn', 'O'), ('the', 'O'), ('clinician', 'O'), ('of', 'O'), ('these', 'O'), ('complications', 'O'), ('.', 'O'))$$$"
"Nineteen patients had Zollinger - Ellison syndrome , one patient had systemic mastocytosis , and two patients had idiopathic hypersecretion .","(('Nineteen', 'O'), ('patients', 'O'), ('had', 'O'), ('Zollinger', 'B'), ('-', 'I'), ('Ellison', 'I'), ('syndrome', 'I'), (',', 'O'), ('one', 'O'), ('patient', 'O'), ('had', 'O'), ('systemic', 'B'), ('mastocytosis', 'I'), (',', 'O'), ('and', 'O'), ('two', 'O'), ('patients', 'O'), ('had', 'O'), ('idiopathic', 'O'), ('hypersecretion', 'O'), ('.', 'O'))$$$"
Sixty percent of the males developed breast changes or impotence while taking cimetidine and in all cases these changes disappeared when cimetidine was replaced by ranitidine .,"(('Sixty', 'O'), ('percent', 'O'), ('of', 'O'), ('the', 'O'), ('males', 'O'), ('developed', 'O'), ('breast', 'O'), ('changes', 'O'), ('or', 'O'), ('impotence', 'B'), ('while', 'O'), ('taking', 'O'), ('cimetidine', 'O'), ('and', 'O'), ('in', 'O'), ('all', 'O'), ('cases', 'O'), ('these', 'O'), ('changes', 'O'), ('disappeared', 'O'), ('when', 'O'), ('cimetidine', 'O'), ('was', 'O'), ('replaced', 'O'), ('by', 'O'), ('ranitidine', 'O'), ('.', 'O'))$$$"
"On the other hand , enflurane may prove to be a safe fast acting activator of epileptic foci during corticography or depth electrode intraoperative recordings .","(('On', 'O'), ('the', 'O'), ('other', 'O'), ('hand', 'O'), (',', 'O'), ('enflurane', 'O'), ('may', 'O'), ('prove', 'O'), ('to', 'O'), ('be', 'O'), ('a', 'O'), ('safe', 'O'), ('fast', 'O'), ('acting', 'O'), ('activator', 'O'), ('of', 'O'), ('epileptic', 'B'), ('foci', 'O'), ('during', 'O'), ('corticography', 'O'), ('or', 'O'), ('depth', 'O'), ('electrode', 'O'), ('intraoperative', 'O'), ('recordings', 'O'), ('.', 'O'))$$$"
"The skin lesion resembled elastosis perforans serpiginosa , which has been reported as a rare side effect in patients with Wilson ' s disease but not in patients with rheumatoid arthritis treated with penicillamine .","(('The', 'O'), ('skin', 'B'), ('lesion', 'I'), ('resembled', 'O'), ('elastosis', 'B'), ('perforans', 'I'), ('serpiginosa', 'I'), (',', 'O'), ('which', 'O'), ('has', 'O'), ('been', 'O'), ('reported', 'O'), ('as', 'O'), ('a', 'O'), ('rare', 'O'), ('side', 'O'), ('effect', 'O'), ('in', 'O'), ('patients', 'O'), ('with', 'O'), ('Wilson', 'B'), (""'"", 'I'), ('s', 'I'), ('disease', 'I'), ('but', 'O'), ('not', 'O'), ('in', 'O'), ('patients', 'O'), ('with', 'O'), ('rheumatoid', 'B'), ('arthritis', 'I'), ('treated', 'O'), ('with', 'O'), ('penicillamine', 'O'), ('.', 'O'))$$$"
Two children with Wilms tumor of the left kidney experienced severe anthracycline cardiomyopathy after irradiation to the tumor bed and conventional dosage of doxorubicin .,"(('Two', 'O'), ('children', 'O'), ('with', 'O'), ('Wilms', 'B'), ('tumor', 'I'), ('of', 'O'), ('the', 'O'), ('left', 'O'), ('kidney', 'O'), ('experienced', 'O'), ('severe', 'O'), ('anthracycline', 'O'), ('cardiomyopathy', 'B'), ('after', 'O'), ('irradiation', 'O'), ('to', 'O'), ('the', 'O'), ('tumor', 'B'), ('bed', 'O'), ('and', 'O'), ('conventional', 'O'), ('dosage', 'O'), ('of', 'O'), ('doxorubicin', 'O'), ('.', 'O'))$$$"
It is recommended that doxorubicin dosage be sharply restricted in children with Wilms tumor of the left kidney who receive postoperative irradiation .,"(('It', 'O'), ('is', 'O'), ('recommended', 'O'), ('that', 'O'), ('doxorubicin', 'O'), ('dosage', 'O'), ('be', 'O'), ('sharply', 'O'), ('restricted', 'O'), ('in', 'O'), ('children', 'O'), ('with', 'O'), ('Wilms', 'B'), ('tumor', 'I'), ('of', 'O'), ('the', 'O'), ('left', 'O'), ('kidney', 'O'), ('who', 'O'), ('receive', 'O'), ('postoperative', 'O'), ('irradiation', 'O'), ('.', 'O'))$$$"
"Pretreatment with naloxazone significantly blocked morphine analgesia , catalepsy and hypothermia at a dose which completely eliminated high - affinity binding in brain membranes .","(('Pretreatment', 'O'), ('with', 'O'), ('naloxazone', 'O'), ('significantly', 'O'), ('blocked', 'O'), ('morphine', 'O'), ('analgesia', 'B'), (',', 'O'), ('catalepsy', 'B'), ('and', 'O'), ('hypothermia', 'B'), ('at', 'O'), ('a', 'O'), ('dose', 'O'), ('which', 'O'), ('completely', 'O'), ('eliminated', 'O'), ('high', 'O'), ('-', 'O'), ('affinity', 'O'), ('binding', 'O'), ('in', 'O'), ('brain', 'O'), ('membranes', 'O'), ('.', 'O'))$$$"
Levodopa - induced dyskinesia and thalamotomy .,"(('Levodopa', 'O'), ('-', 'O'), ('induced', 'O'), ('dyskinesia', 'B'), ('and', 'O'), ('thalamotomy', 'O'), ('.', 'O'))$$$"
Control of levodopa - induced dyskinesias by thalamic lesions in the course of routine treatment of Parkinsonism is discussed .,"(('Control', 'O'), ('of', 'O'), ('levodopa', 'O'), ('-', 'O'), ('induced', 'O'), ('dyskinesias', 'B'), ('by', 'O'), ('thalamic', 'B'), ('lesions', 'I'), ('in', 'O'), ('the', 'O'), ('course', 'O'), ('of', 'O'), ('routine', 'O'), ('treatment', 'O'), ('of', 'O'), ('Parkinsonism', 'B'), ('is', 'O'), ('discussed', 'O'), ('.', 'O'))$$$"
"Five children , aged 3 to 11 years , treated with carbamazepine for epilepsy , had an acute aberrant reaction characterized by the onset of myoclonic , atypical absence and / or atonic ( minor motor ) seizures within a few days .","(('Five', 'O'), ('children', 'O'), (',', 'O'), ('aged', 'O'), ('3', 'O'), ('to', 'O'), ('11', 'O'), ('years', 'O'), (',', 'O'), ('treated', 'O'), ('with', 'O'), ('carbamazepine', 'O'), ('for', 'O'), ('epilepsy', 'B'), (',', 'O'), ('had', 'O'), ('an', 'O'), ('acute', 'O'), ('aberrant', 'O'), ('reaction', 'O'), ('characterized', 'O'), ('by', 'O'), ('the', 'O'), ('onset', 'O'), ('of', 'O'), ('myoclonic', 'B'), (',', 'I'), ('atypical', 'I'), ('absence', 'I'), ('and', 'I'), ('/', 'I'), ('or', 'I'), ('atonic', 'I'), ('(', 'I'), ('minor', 'I'), ('motor', 'I'), (')', 'I'), ('seizures', 'I'), ('within', 'O'), ('a', 'O'), ('few', 'O'), ('days', 'O'), ('.', 'O'))$$$"
The child in whom the seizures persisted was later found to have ceroid lipofuscinosis .,"(('The', 'O'), ('child', 'O'), ('in', 'O'), ('whom', 'O'), ('the', 'O'), ('seizures', 'B'), ('persisted', 'O'), ('was', 'O'), ('later', 'O'), ('found', 'O'), ('to', 'O'), ('have', 'O'), ('ceroid', 'B'), ('lipofuscinosis', 'I'), ('.', 'O'))$$$"
Phenobarbital - induced dyskinesia in a neurologically - impaired child .,"(('Phenobarbital', 'O'), ('-', 'O'), ('induced', 'O'), ('dyskinesia', 'B'), ('in', 'O'), ('a', 'O'), ('neurologically', 'B'), ('-', 'I'), ('impaired', 'I'), ('child', 'O'), ('.', 'O'))$$$"
"Laboratory testing has revealed a falling platelet count , increased resistance to heparin , and aggregation of platelets by the patient ' s plasma when heparin is added .","(('Laboratory', 'O'), ('testing', 'O'), ('has', 'O'), ('revealed', 'O'), ('a', 'B'), ('falling', 'I'), ('platelet', 'I'), ('count', 'I'), (',', 'O'), ('increased', 'O'), ('resistance', 'O'), ('to', 'O'), ('heparin', 'O'), (',', 'O'), ('and', 'O'), ('aggregation', 'O'), ('of', 'O'), ('platelets', 'O'), ('by', 'O'), ('the', 'O'), ('patient', 'O'), (""'"", 'O'), ('s', 'O'), ('plasma', 'O'), ('when', 'O'), ('heparin', 'O'), ('is', 'O'), ('added', 'O'), ('.', 'O'))$$$"
"The 20 deaths , 52 hemorrhagic and thromboembolic complications , and 21 surgical procedures to manage the complications confirm the seriousness of the disorder .","(('The', 'O'), ('20', 'O'), ('deaths', 'O'), (',', 'O'), ('52', 'O'), ('hemorrhagic', 'B'), ('and', 'I'), ('thromboembolic', 'I'), ('complications', 'I'), (',', 'O'), ('and', 'O'), ('21', 'O'), ('surgical', 'O'), ('procedures', 'O'), ('to', 'O'), ('manage', 'O'), ('the', 'O'), ('complications', 'O'), ('confirm', 'O'), ('the', 'O'), ('seriousness', 'O'), ('of', 'O'), ('the', 'O'), ('disorder', 'O'), ('.', 'O'))$$$"
"The most common symptomatic adverse reactions were tremor or ataxia ( 35 % ) , nausea and anorexia ( 8 % ) , visual halos or blurring ( 6 % ) , thyroid function abnormalities ( 6 % ) and pulmonary interstitial infiltrates ( 5 % ) .","(('The', 'O'), ('most', 'O'), ('common', 'O'), ('symptomatic', 'O'), ('adverse', 'O'), ('reactions', 'O'), ('were', 'O'), ('tremor', 'B'), ('or', 'O'), ('ataxia', 'B'), ('(', 'O'), ('35', 'O'), ('%', 'O'), (')', 'O'), (',', 'O'), ('nausea', 'B'), ('and', 'O'), ('anorexia', 'B'), ('(', 'O'), ('8', 'O'), ('%', 'O'), (')', 'O'), (',', 'O'), ('visual', 'B'), ('halos', 'I'), ('or', 'I'), ('blurring', 'I'), ('(', 'O'), ('6', 'O'), ('%', 'O'), (')', 'O'), (',', 'O'), ('thyroid', 'B'), ('function', 'I'), ('abnormalities', 'I'), ('(', 'O'), ('6', 'O'), ('%', 'O'), (')', 'O'), ('and', 'O'), ('pulmonary', 'B'), ('interstitial', 'I'), ('infiltrates', 'I'), ('(', 'O'), ('5', 'O'), ('%', 'O'), (')', 'O'), ('.', 'O'))$$$"
"Although large - dose amiodarone is highly effective in the long - term treatment of VT or VF refractory to conventional antiarrhythmic drugs , it causes significant toxicity in approximately 50 % of patients .","(('Although', 'O'), ('large', 'O'), ('-', 'O'), ('dose', 'O'), ('amiodarone', 'O'), ('is', 'O'), ('highly', 'O'), ('effective', 'O'), ('in', 'O'), ('the', 'O'), ('long', 'O'), ('-', 'O'), ('term', 'O'), ('treatment', 'O'), ('of', 'O'), ('VT', 'B'), ('or', 'O'), ('VF', 'B'), ('refractory', 'O'), ('to', 'O'), ('conventional', 'O'), ('antiarrhythmic', 'O'), ('drugs', 'O'), (',', 'O'), ('it', 'O'), ('causes', 'O'), ('significant', 'O'), ('toxicity', 'B'), ('in', 'O'), ('approximately', 'O'), ('50', 'O'), ('%', 'O'), ('of', 'O'), ('patients', 'O'), ('.', 'O'))$$$"
A case of necrotizing myopathy due to a short epsilon - aminocaproic acid ( EACA ) treatment in a 72 year - old patient with subarachnoid haemorrhage ( SAH ) is described .,"(('A', 'O'), ('case', 'O'), ('of', 'O'), ('necrotizing', 'B'), ('myopathy', 'I'), ('due', 'O'), ('to', 'O'), ('a', 'O'), ('short', 'O'), ('epsilon', 'O'), ('-', 'O'), ('aminocaproic', 'O'), ('acid', 'O'), ('(', 'O'), ('EACA', 'O'), (')', 'O'), ('treatment', 'O'), ('in', 'O'), ('a', 'O'), ('72', 'O'), ('year', 'O'), ('-', 'O'), ('old', 'O'), ('patient', 'O'), ('with', 'O'), ('subarachnoid', 'B'), ('haemorrhage', 'I'), ('(', 'O'), ('SAH', 'B'), (')', 'O'), ('is', 'O'), ('described', 'O'), ('.', 'O'))$$$"
"Thus , aminoglycosides may act as nephrotoxicants at glomerular and / or tubular level inducing impairment of renal reabsorption and accumulation of proteins .","(('Thus', 'O'), (',', 'O'), ('aminoglycosides', 'O'), ('may', 'O'), ('act', 'O'), ('as', 'O'), ('nephrotoxicants', 'O'), ('at', 'O'), ('glomerular', 'O'), ('and', 'O'), ('/', 'O'), ('or', 'O'), ('tubular', 'O'), ('level', 'O'), ('inducing', 'O'), ('impairment', 'B'), ('of', 'I'), ('renal', 'I'), ('reabsorption', 'I'), ('and', 'O'), ('accumulation', 'O'), ('of', 'O'), ('proteins', 'O'), ('.', 'O'))$$$"
We documented airway occlusion during sleep and an abnormally high supraglottic resistance while awake in a 54 - yr - old woman who had developed physical changes and the syndrome of obstructive sleep apnea while being administered exogenous androgens .,"(('We', 'O'), ('documented', 'O'), ('airway', 'O'), ('occlusion', 'O'), ('during', 'O'), ('sleep', 'O'), ('and', 'O'), ('an', 'O'), ('abnormally', 'O'), ('high', 'O'), ('supraglottic', 'O'), ('resistance', 'O'), ('while', 'O'), ('awake', 'O'), ('in', 'O'), ('a', 'O'), ('54', 'O'), ('-', 'O'), ('yr', 'O'), ('-', 'O'), ('old', 'O'), ('woman', 'O'), ('who', 'O'), ('had', 'O'), ('developed', 'O'), ('physical', 'O'), ('changes', 'O'), ('and', 'O'), ('the', 'O'), ('syndrome', 'B'), ('of', 'I'), ('obstructive', 'I'), ('sleep', 'I'), ('apnea', 'I'), ('while', 'O'), ('being', 'O'), ('administered', 'O'), ('exogenous', 'O'), ('androgens', 'O'), ('.', 'O'))$$$"
"Our results suggest that adriamycin is a more potent cardiotoxin in monkeys than in man , and that leukemia may be a consequence of prolonged treatment with this drug .","(('Our', 'O'), ('results', 'O'), ('suggest', 'O'), ('that', 'O'), ('adriamycin', 'O'), ('is', 'O'), ('a', 'O'), ('more', 'O'), ('potent', 'O'), ('cardiotoxin', 'O'), ('in', 'O'), ('monkeys', 'O'), ('than', 'O'), ('in', 'O'), ('man', 'O'), (',', 'O'), ('and', 'O'), ('that', 'O'), ('leukemia', 'B'), ('may', 'O'), ('be', 'O'), ('a', 'O'), ('consequence', 'O'), ('of', 'O'), ('prolonged', 'O'), ('treatment', 'O'), ('with', 'O'), ('this', 'O'), ('drug', 'O'), ('.', 'O'))$$$"
"The effect of aniracetam ( Ro 13 - 5057 , 1 - anisoyl - 2 - pyrrolidinone ) was studied on various forms of experimentally impaired cognitive functions ( learning and memory ) in rodents and produced the following effects : ( 1 ) almost complete prevention of the incapacity to learn a discrete escape response in rats exposed to sublethal hypercapnia immediately before the acquisition session ; ( 2 ) partial ( rats ) or complete ( mice ) prevention of the scopolamine - induced short - term amnesia for a passive avoidance task ; ( 3","(('The', 'O'), ('effect', 'O'), ('of', 'O'), ('aniracetam', 'O'), ('(', 'O'), ('Ro', 'O'), ('13', 'O'), ('-', 'O'), ('5057', 'O'), (',', 'O'), ('1', 'O'), ('-', 'O'), ('anisoyl', 'O'), ('-', 'O'), ('2', 'O'), ('-', 'O'), ('pyrrolidinone', 'O'), (')', 'O'), ('was', 'O'), ('studied', 'O'), ('on', 'O'), ('various', 'O'), ('forms', 'O'), ('of', 'O'), ('experimentally', 'O'), ('impaired', 'B'), ('cognitive', 'I'), ('functions', 'I'), ('(', 'O'), ('learning', 'O'), ('and', 'O'), ('memory', 'O'), (')', 'O'), ('in', 'O'), ('rodents', 'O'), ('and', 'O'), ('produced', 'O'), ('the', 'O'), ('following', 'O'), ('effects', 'O'), (':', 'O'), ('(', 'O'), ('1', 'O'), (')', 'O'), ('almost', 'O'), ('complete', 'O'), ('prevention', 'O'), ('of', 'O'), ('the', 'O'), ('incapacity', 'O'), ('to', 'O'), ('learn', 'O'), ('a', 'O'), ('discrete', 'O'), ('escape', 'O'), ('response', 'O'), ('in', 'O'), ('rats', 'O'), ('exposed', 'O'), ('to', 'O'), ('sublethal', 'O'), ('hypercapnia', 'B'), ('immediately', 'O'), ('before', 'O'), ('the', 'O'), ('acquisition', 'O'), ('session', 'O'), (';', 'O'), ('(', 'O'), ('2', 'O'), (')', 'O'), ('partial', 'O'), ('(', 'O'), ('rats', 'O'), (')', 'O'), ('or', 'O'), ('complete', 'O'), ('(', 'O'), ('mice', 'O'), (')', 'O'), ('prevention', 'O'), ('of', 'O'), ('the', 'O'), ('scopolamine', 'O'), ('-', 'O'), ('induced', 'O'), ('short', 'O'), ('-', 'O'), ('term', 'O'), ('amnesia', 'B'), ('for', 'O'), ('a', 'O'), ('passive', 'O'), ('avoidance', 'O'), ('task', 'O'), (';', 'O'), ('(', 'O'), ('3', 'O'))$$$"
"The effect of calcium chloride injected into the cerebral ventricles of group - housed unanaesthetized cats upon vocalization ( rage , hissing and snarling ) , fighting ( attack with paws and claws , defense with paws and claws and biting ) , mydriasis , tremor and clonic - tonic convulsions produced by carbachol and eserine injected similarly was investigated .","(('The', 'O'), ('effect', 'O'), ('of', 'O'), ('calcium', 'O'), ('chloride', 'O'), ('injected', 'O'), ('into', 'O'), ('the', 'O'), ('cerebral', 'O'), ('ventricles', 'O'), ('of', 'O'), ('group', 'O'), ('-', 'O'), ('housed', 'O'), ('unanaesthetized', 'O'), ('cats', 'O'), ('upon', 'O'), ('vocalization', 'O'), ('(', 'O'), ('rage', 'O'), (',', 'O'), ('hissing', 'O'), ('and', 'O'), ('snarling', 'O'), (')', 'O'), (',', 'O'), ('fighting', 'O'), ('(', 'O'), ('attack', 'O'), ('with', 'O'), ('paws', 'O'), ('and', 'O'), ('claws', 'O'), (',', 'O'), ('defense', 'O'), ('with', 'O'), ('paws', 'O'), ('and', 'O'), ('claws', 'O'), ('and', 'O'), ('biting', 'O'), (')', 'O'), (',', 'O'), ('mydriasis', 'B'), (',', 'O'), ('tremor', 'B'), ('and', 'O'), ('clonic', 'B'), ('-', 'I'), ('tonic', 'I'), ('convulsions', 'I'), ('produced', 'O'), ('by', 'O'), ('carbachol', 'O'), ('and', 'O'), ('eserine', 'O'), ('injected', 'O'), ('similarly', 'O'), ('was', 'O'), ('investigated', 'O'), ('.', 'O'))$$$"
"On the other hand , mydriasis , tremor and clonic - tonic convulsions evoked by carbachol and eserine were not significantly changed by calcium chloride .","(('On', 'O'), ('the', 'O'), ('other', 'O'), ('hand', 'O'), (',', 'O'), ('mydriasis', 'B'), (',', 'O'), ('tremor', 'B'), ('and', 'O'), ('clonic', 'B'), ('-', 'I'), ('tonic', 'I'), ('convulsions', 'I'), ('evoked', 'O'), ('by', 'O'), ('carbachol', 'O'), ('and', 'O'), ('eserine', 'O'), ('were', 'O'), ('not', 'O'), ('significantly', 'O'), ('changed', 'O'), ('by', 'O'), ('calcium', 'O'), ('chloride', 'O'), ('.', 'O'))$$$"
"It is apparent that calcium chloride can "" dissociate "" vocalization and fighting from autonomic and motor phenomena such as mydriasis , tremor and clonic - tonic convulsions caused by carbachol and eserine .","(('It', 'O'), ('is', 'O'), ('apparent', 'O'), ('that', 'O'), ('calcium', 'O'), ('chloride', 'O'), ('can', 'O'), ('""', 'O'), ('dissociate', 'O'), ('""', 'O'), ('vocalization', 'O'), ('and', 'O'), ('fighting', 'O'), ('from', 'O'), ('autonomic', 'O'), ('and', 'O'), ('motor', 'O'), ('phenomena', 'O'), ('such', 'O'), ('as', 'O'), ('mydriasis', 'B'), (',', 'O'), ('tremor', 'B'), ('and', 'O'), ('clonic', 'B'), ('-', 'I'), ('tonic', 'I'), ('convulsions', 'I'), ('caused', 'O'), ('by', 'O'), ('carbachol', 'O'), ('and', 'O'), ('eserine', 'O'), ('.', 'O'))$$$"
"This case presented a unique opportunity to observe the histologic features of clinically reversible hepatic veno - occlusive disease over time , and may be the first case of veno - occlusive related solely to 6 - thioguanine .","(('This', 'O'), ('case', 'O'), ('presented', 'O'), ('a', 'O'), ('unique', 'O'), ('opportunity', 'O'), ('to', 'O'), ('observe', 'O'), ('the', 'O'), ('histologic', 'O'), ('features', 'O'), ('of', 'O'), ('clinically', 'O'), ('reversible', 'O'), ('hepatic', 'B'), ('veno', 'I'), ('-', 'I'), ('occlusive', 'I'), ('disease', 'I'), ('over', 'O'), ('time', 'O'), (',', 'O'), ('and', 'O'), ('may', 'O'), ('be', 'O'), ('the', 'O'), ('first', 'O'), ('case', 'O'), ('of', 'O'), ('veno', 'O'), ('-', 'O'), ('occlusive', 'O'), ('related', 'O'), ('solely', 'O'), ('to', 'O'), ('6', 'O'), ('-', 'O'), ('thioguanine', 'O'), ('.', 'O'))$$$"
A 65 - year - old woman with adult - onset diabetes treated with chlorpropamide ( Diabenese ) had a toxic optic neuropathy that resolved with discontinuation of chlorpropamide therapy .,"(('A', 'O'), ('65', 'O'), ('-', 'O'), ('year', 'O'), ('-', 'O'), ('old', 'O'), ('woman', 'O'), ('with', 'O'), ('adult', 'B'), ('-', 'I'), ('onset', 'I'), ('diabetes', 'I'), ('treated', 'O'), ('with', 'O'), ('chlorpropamide', 'O'), ('(', 'O'), ('Diabenese', 'O'), (')', 'O'), ('had', 'O'), ('a', 'O'), ('toxic', 'B'), ('optic', 'I'), ('neuropathy', 'I'), ('that', 'O'), ('resolved', 'O'), ('with', 'O'), ('discontinuation', 'O'), ('of', 'O'), ('chlorpropamide', 'O'), ('therapy', 'O'), ('.', 'O'))$$$"
"This was the second report of fatal aplastic anemia after topical treatment with chloramphenicol for ocular conditions , although two cases of reversible bone marrow hypoplasia have also been reported .","(('This', 'O'), ('was', 'O'), ('the', 'O'), ('second', 'O'), ('report', 'O'), ('of', 'O'), ('fatal', 'O'), ('aplastic', 'B'), ('anemia', 'I'), ('after', 'O'), ('topical', 'O'), ('treatment', 'O'), ('with', 'O'), ('chloramphenicol', 'O'), ('for', 'O'), ('ocular', 'O'), ('conditions', 'O'), (',', 'O'), ('although', 'O'), ('two', 'O'), ('cases', 'O'), ('of', 'O'), ('reversible', 'O'), ('bone', 'B'), ('marrow', 'I'), ('hypoplasia', 'I'), ('have', 'O'), ('also', 'O'), ('been', 'O'), ('reported', 'O'), ('.', 'O'))$$$"
Deaths from local anesthetic - induced convulsions in mice .,"(('Deaths', 'O'), ('from', 'O'), ('local', 'O'), ('anesthetic', 'O'), ('-', 'O'), ('induced', 'O'), ('convulsions', 'B'), ('in', 'O'), ('mice', 'O'), ('.', 'O'))$$$"
"Convulsions always preceded death , except after precipitous cardiopulmonary arrest from extreme doses .","(('Convulsions', 'B'), ('always', 'O'), ('preceded', 'O'), ('death', 'O'), (',', 'O'), ('except', 'O'), ('after', 'O'), ('precipitous', 'O'), ('cardiopulmonary', 'B'), ('arrest', 'I'), ('from', 'O'), ('extreme', 'O'), ('doses', 'O'), ('.', 'O'))$$$"
REM sleep deprivation changes behavioral response to catecholaminergic and serotonergic receptor activation in rats .,"(('REM', 'B'), ('sleep', 'I'), ('deprivation', 'I'), ('changes', 'O'), ('behavioral', 'O'), ('response', 'O'), ('to', 'O'), ('catecholaminergic', 'O'), ('and', 'O'), ('serotonergic', 'O'), ('receptor', 'O'), ('activation', 'O'), ('in', 'O'), ('rats', 'O'), ('.', 'O'))$$$"
The effects of REM sleep deprivation ( REMD ) on apomorphine - induced aggressiveness and quipazine - induced head twitches in rats were determined .,"(('The', 'O'), ('effects', 'O'), ('of', 'O'), ('REM', 'B'), ('sleep', 'I'), ('deprivation', 'I'), ('(', 'O'), ('REMD', 'B'), (')', 'O'), ('on', 'O'), ('apomorphine', 'O'), ('-', 'O'), ('induced', 'O'), ('aggressiveness', 'B'), ('and', 'O'), ('quipazine', 'O'), ('-', 'O'), ('induced', 'O'), ('head', 'B'), ('twitches', 'I'), ('in', 'O'), ('rats', 'O'), ('were', 'O'), ('determined', 'O'), ('.', 'O'))$$$"
"Forty - eight hr of REMD increased apomorphine - induced aggressiveness , and reduced ( immediately after completing of REMD ) or increased ( 96 hr after completing of REMD ) quipazine - induced head twitches .","(('Forty', 'O'), ('-', 'O'), ('eight', 'O'), ('hr', 'O'), ('of', 'O'), ('REMD', 'B'), ('increased', 'O'), ('apomorphine', 'O'), ('-', 'O'), ('induced', 'O'), ('aggressiveness', 'B'), (',', 'O'), ('and', 'O'), ('reduced', 'O'), ('(', 'O'), ('immediately', 'O'), ('after', 'O'), ('completing', 'O'), ('of', 'O'), ('REMD', 'B'), (')', 'O'), ('or', 'O'), ('increased', 'O'), ('(', 'O'), ('96', 'O'), ('hr', 'O'), ('after', 'O'), ('completing', 'O'), ('of', 'O'), ('REMD', 'B'), (')', 'O'), ('quipazine', 'O'), ('-', 'O'), ('induced', 'O'), ('head', 'B'), ('twitches', 'I'), ('.', 'O'))$$$"
"In DXR - CM myocardial damage is proportional to the degree of cytotoxic insult ( DXR dose ) while myocardial function is preserved until a critical dose or degree of damage is reached , after which myocardial performance deteriorates rapidly .","(('In', 'O'), ('DXR', 'O'), ('-', 'O'), ('CM', 'B'), ('myocardial', 'B'), ('damage', 'I'), ('is', 'O'), ('proportional', 'O'), ('to', 'O'), ('the', 'O'), ('degree', 'O'), ('of', 'O'), ('cytotoxic', 'O'), ('insult', 'O'), ('(', 'O'), ('DXR', 'O'), ('dose', 'O'), (')', 'O'), ('while', 'O'), ('myocardial', 'O'), ('function', 'O'), ('is', 'O'), ('preserved', 'O'), ('until', 'O'), ('a', 'O'), ('critical', 'O'), ('dose', 'O'), ('or', 'O'), ('degree', 'O'), ('of', 'O'), ('damage', 'O'), ('is', 'O'), ('reached', 'O'), (',', 'O'), ('after', 'O'), ('which', 'O'), ('myocardial', 'O'), ('performance', 'O'), ('deteriorates', 'O'), ('rapidly', 'O'), ('.', 'O'))$$$"
Massive cerebral edema associated with fulminant hepatic failure in acetaminophen overdose : possible role of cranial decompression .,"(('Massive', 'O'), ('cerebral', 'B'), ('edema', 'I'), ('associated', 'O'), ('with', 'O'), ('fulminant', 'O'), ('hepatic', 'B'), ('failure', 'I'), ('in', 'O'), ('acetaminophen', 'O'), ('overdose', 'B'), (':', 'O'), ('possible', 'O'), ('role', 'O'), ('of', 'O'), ('cranial', 'O'), ('decompression', 'O'), ('.', 'O'))$$$"
"Tests used to evaluate the changes in sexual behavior showed a significant decrease in sexual desire , sexual excitement phase ( erection ) , and frequency of sexual relations in the study group .","(('Tests', 'O'), ('used', 'O'), ('to', 'O'), ('evaluate', 'O'), ('the', 'O'), ('changes', 'O'), ('in', 'O'), ('sexual', 'O'), ('behavior', 'O'), ('showed', 'O'), ('a', 'O'), ('significant', 'O'), ('decrease', 'B'), ('in', 'I'), ('sexual', 'I'), ('desire', 'I'), (',', 'O'), ('sexual', 'O'), ('excitement', 'O'), ('phase', 'O'), ('(', 'O'), ('erection', 'O'), (')', 'O'), (',', 'O'), ('and', 'O'), ('frequency', 'O'), ('of', 'O'), ('sexual', 'O'), ('relations', 'O'), ('in', 'O'), ('the', 'O'), ('study', 'O'), ('group', 'O'), ('.', 'O'))$$$"
"A case of acute inflammatory myopathy associated with the use of pravastatin , a new hydrophilic 3 - hydroxy - 3 methylglutaril coenzyme A reductase inhibitor , is reported .","(('A', 'O'), ('case', 'O'), ('of', 'O'), ('acute', 'O'), ('inflammatory', 'B'), ('myopathy', 'I'), ('associated', 'O'), ('with', 'O'), ('the', 'O'), ('use', 'O'), ('of', 'O'), ('pravastatin', 'O'), (',', 'O'), ('a', 'O'), ('new', 'O'), ('hydrophilic', 'O'), ('3', 'O'), ('-', 'O'), ('hydroxy', 'O'), ('-', 'O'), ('3', 'O'), ('methylglutaril', 'O'), ('coenzyme', 'O'), ('A', 'O'), ('reductase', 'O'), ('inhibitor', 'O'), (',', 'O'), ('is', 'O'), ('reported', 'O'), ('.', 'O'))$$$"
"The patient , a 69 - year - old man was affected by non - insulin - dependent diabetes mellitus and hypertension .","(('The', 'O'), ('patient', 'O'), (',', 'O'), ('a', 'O'), ('69', 'O'), ('-', 'O'), ('year', 'O'), ('-', 'O'), ('old', 'O'), ('man', 'O'), ('was', 'O'), ('affected', 'O'), ('by', 'O'), ('non', 'B'), ('-', 'I'), ('insulin', 'I'), ('-', 'I'), ('dependent', 'I'), ('diabetes', 'I'), ('mellitus', 'I'), ('and', 'O'), ('hypertension', 'B'), ('.', 'O'))$$$"
"A previously unknown hypothyroidism , probably due to chronic autoimmune thyroiditis , was evidenced .","(('A', 'O'), ('previously', 'O'), ('unknown', 'O'), ('hypothyroidism', 'B'), (',', 'O'), ('probably', 'O'), ('due', 'O'), ('to', 'O'), ('chronic', 'O'), ('autoimmune', 'B'), ('thyroiditis', 'I'), (',', 'O'), ('was', 'O'), ('evidenced', 'O'), ('.', 'O'))$$$"
"While lovastatin and simvastatin have been associated with toxic myopathy , pravastatin - associated myopathy could represent a distinct , inflammatory entity .","(('While', 'O'), ('lovastatin', 'O'), ('and', 'O'), ('simvastatin', 'O'), ('have', 'O'), ('been', 'O'), ('associated', 'O'), ('with', 'O'), ('toxic', 'O'), ('myopathy', 'B'), (',', 'O'), ('pravastatin', 'O'), ('-', 'O'), ('associated', 'O'), ('myopathy', 'B'), ('could', 'O'), ('represent', 'O'), ('a', 'O'), ('distinct', 'O'), (',', 'O'), ('inflammatory', 'O'), ('entity', 'O'), ('.', 'O'))$$$"
"Thus , the reduction in blood and brain ammonia and the prevention of ammonia coma after L - dopa , can be accounted for by the peripheral effect of dopamine on renal function rather than its central action .","(('Thus', 'O'), (',', 'O'), ('the', 'O'), ('reduction', 'O'), ('in', 'O'), ('blood', 'O'), ('and', 'O'), ('brain', 'O'), ('ammonia', 'O'), ('and', 'O'), ('the', 'O'), ('prevention', 'O'), ('of', 'O'), ('ammonia', 'O'), ('coma', 'B'), ('after', 'O'), ('L', 'O'), ('-', 'O'), ('dopa', 'O'), (',', 'O'), ('can', 'O'), ('be', 'O'), ('accounted', 'O'), ('for', 'O'), ('by', 'O'), ('the', 'O'), ('peripheral', 'O'), ('effect', 'O'), ('of', 'O'), ('dopamine', 'O'), ('on', 'O'), ('renal', 'O'), ('function', 'O'), ('rather', 'O'), ('than', 'O'), ('its', 'O'), ('central', 'O'), ('action', 'O'), ('.', 'O'))$$$"
"Two halogenated anesthetics , enflurane and isoflurane , have been associated with an allergic - type hepatic injury both alone and following previous exposure to halothane .","(('Two', 'O'), ('halogenated', 'O'), ('anesthetics', 'O'), (',', 'O'), ('enflurane', 'O'), ('and', 'O'), ('isoflurane', 'O'), (',', 'O'), ('have', 'O'), ('been', 'O'), ('associated', 'O'), ('with', 'O'), ('an', 'O'), ('allergic', 'O'), ('-', 'O'), ('type', 'O'), ('hepatic', 'B'), ('injury', 'I'), ('both', 'O'), ('alone', 'O'), ('and', 'O'), ('following', 'O'), ('previous', 'O'), ('exposure', 'O'), ('to', 'O'), ('halothane', 'O'), ('.', 'O'))$$$"
Halothane hepatitis appears to involve an aberrant immune response .,"(('Halothane', 'O'), ('hepatitis', 'B'), ('appears', 'O'), ('to', 'O'), ('involve', 'O'), ('an', 'O'), ('aberrant', 'O'), ('immune', 'O'), ('response', 'O'), ('.', 'O'))$$$"
An antibody response to a protein - bound biotransformation product ( trifluoroacetyl adduct ) has been detected on halothane hepatitis patients .,"(('An', 'O'), ('antibody', 'O'), ('response', 'O'), ('to', 'O'), ('a', 'O'), ('protein', 'O'), ('-', 'O'), ('bound', 'O'), ('biotransformation', 'O'), ('product', 'O'), ('(', 'O'), ('trifluoroacetyl', 'O'), ('adduct', 'O'), (')', 'O'), ('has', 'O'), ('been', 'O'), ('detected', 'O'), ('on', 'O'), ('halothane', 'O'), ('hepatitis', 'B'), ('patients', 'O'), ('.', 'O'))$$$"
This supports and extends previous evidence for a mechanism by which enflurane and / or isoflurane could produce a hypersensitivity condition similar to that of halothane hepatitis either alone or subsequent to halothane administration .,"(('This', 'O'), ('supports', 'O'), ('and', 'O'), ('extends', 'O'), ('previous', 'O'), ('evidence', 'O'), ('for', 'O'), ('a', 'O'), ('mechanism', 'O'), ('by', 'O'), ('which', 'O'), ('enflurane', 'O'), ('and', 'O'), ('/', 'O'), ('or', 'O'), ('isoflurane', 'O'), ('could', 'O'), ('produce', 'O'), ('a', 'O'), ('hypersensitivity', 'B'), ('condition', 'O'), ('similar', 'O'), ('to', 'O'), ('that', 'O'), ('of', 'O'), ('halothane', 'O'), ('hepatitis', 'B'), ('either', 'O'), ('alone', 'O'), ('or', 'O'), ('subsequent', 'O'), ('to', 'O'), ('halothane', 'O'), ('administration', 'O'), ('.', 'O'))$$$"
Cholinergic toxicity resulting from ocular instillation of echothiophate iodide eye drops .,"(('Cholinergic', 'O'), ('toxicity', 'B'), ('resulting', 'O'), ('from', 'O'), ('ocular', 'O'), ('instillation', 'O'), ('of', 'O'), ('echothiophate', 'O'), ('iodide', 'O'), ('eye', 'O'), ('drops', 'O'), ('.', 'O'))$$$"
"A patient developed a severe cholinergic syndrome from the use of echothiophate iodide ophthalmic drops , presented with profound muscle weakness and was initially given the diagnosis of myasthenia gravis .","(('A', 'O'), ('patient', 'O'), ('developed', 'O'), ('a', 'O'), ('severe', 'O'), ('cholinergic', 'O'), ('syndrome', 'O'), ('from', 'O'), ('the', 'O'), ('use', 'O'), ('of', 'O'), ('echothiophate', 'O'), ('iodide', 'O'), ('ophthalmic', 'O'), ('drops', 'O'), (',', 'O'), ('presented', 'O'), ('with', 'O'), ('profound', 'O'), ('muscle', 'B'), ('weakness', 'I'), ('and', 'O'), ('was', 'O'), ('initially', 'O'), ('given', 'O'), ('the', 'O'), ('diagnosis', 'O'), ('of', 'O'), ('myasthenia', 'B'), ('gravis', 'I'), ('.', 'O'))$$$"
Incomplete cerebral ischemia ( 30 min ) was induced in the rat by bilaterally clamping the common carotid arteries .,"(('Incomplete', 'O'), ('cerebral', 'B'), ('ischemia', 'I'), ('(', 'O'), ('30', 'O'), ('min', 'O'), (')', 'O'), ('was', 'O'), ('induced', 'O'), ('in', 'O'), ('the', 'O'), ('rat', 'O'), ('by', 'O'), ('bilaterally', 'O'), ('clamping', 'O'), ('the', 'O'), ('common', 'O'), ('carotid', 'O'), ('arteries', 'O'), ('.', 'O'))$$$"
"Peripheral venous blood samples were withdrawn from the femoral vein four times ( once every 5 min ) before ischemia ( 0 time ) and 5 , 15 , and 30 min after ischemia .","(('Peripheral', 'O'), ('venous', 'O'), ('blood', 'O'), ('samples', 'O'), ('were', 'O'), ('withdrawn', 'O'), ('from', 'O'), ('the', 'O'), ('femoral', 'O'), ('vein', 'O'), ('four', 'O'), ('times', 'O'), ('(', 'O'), ('once', 'O'), ('every', 'O'), ('5', 'O'), ('min', 'O'), (')', 'O'), ('before', 'O'), ('ischemia', 'B'), ('(', 'O'), ('0', 'O'), ('time', 'O'), (')', 'O'), ('and', 'O'), ('5', 'O'), (',', 'O'), ('15', 'O'), (',', 'O'), ('and', 'O'), ('30', 'O'), ('min', 'O'), ('after', 'O'), ('ischemia', 'B'), ('.', 'O'))$$$"
"The present data indicate that the determination of malondialdehyde , oxypurines , and nucleosides in peripheral blood , may be used to monitor the metabolic alterations of tissues occurring during ischemic phenomena . ( ABSTRACT TRUNCATED AT 250 WORDS )","(('The', 'O'), ('present', 'O'), ('data', 'O'), ('indicate', 'O'), ('that', 'O'), ('the', 'O'), ('determination', 'O'), ('of', 'O'), ('malondialdehyde', 'O'), (',', 'O'), ('oxypurines', 'O'), (',', 'O'), ('and', 'O'), ('nucleosides', 'O'), ('in', 'O'), ('peripheral', 'O'), ('blood', 'O'), (',', 'O'), ('may', 'O'), ('be', 'O'), ('used', 'O'), ('to', 'O'), ('monitor', 'O'), ('the', 'O'), ('metabolic', 'O'), ('alterations', 'O'), ('of', 'O'), ('tissues', 'O'), ('occurring', 'O'), ('during', 'O'), ('ischemic', 'B'), ('phenomena', 'O'), ('.', 'O'), ('(', 'O'), ('ABSTRACT', 'O'), ('TRUNCATED', 'O'), ('AT', 'O'), ('250', 'O'), ('WORDS', 'O'), (')', 'O'))$$$"
"Prostanoids may , via release of tachykinins , contribute to both urge and bladder hyperactivity seen in inflammatory conditions of the lower urinary tract .","(('Prostanoids', 'O'), ('may', 'O'), (',', 'O'), ('via', 'O'), ('release', 'O'), ('of', 'O'), ('tachykinins', 'O'), (',', 'O'), ('contribute', 'O'), ('to', 'O'), ('both', 'O'), ('urge', 'O'), ('and', 'O'), ('bladder', 'B'), ('hyperactivity', 'I'), ('seen', 'O'), ('in', 'O'), ('inflammatory', 'O'), ('conditions', 'O'), ('of', 'O'), ('the', 'O'), ('lower', 'O'), ('urinary', 'O'), ('tract', 'O'), ('.', 'O'))$$$"
"The drug is known to cause a variety of acute toxic effects , ranging from nausea , restlessness , insomnia , ataxia , slurred speech and nystagmus to mood changes , perceptual alterations , inattention , disorientation and aggressive behavior ( Rammer et al 1988 ; Katona and Watson 1986 ; Isbell and Fraser 1953 ; Devlin et al 1985 ; McCarthy 1971 ; Dodds and Revai 1967 ; Degkwitz 1964 ; Hildebrand et al 1989 ) .","(('The', 'O'), ('drug', 'O'), ('is', 'O'), ('known', 'O'), ('to', 'O'), ('cause', 'O'), ('a', 'O'), ('variety', 'O'), ('of', 'O'), ('acute', 'O'), ('toxic', 'O'), ('effects', 'O'), (',', 'O'), ('ranging', 'O'), ('from', 'O'), ('nausea', 'B'), (',', 'O'), ('restlessness', 'B'), (',', 'O'), ('insomnia', 'B'), (',', 'O'), ('ataxia', 'B'), (',', 'O'), ('slurred', 'O'), ('speech', 'O'), ('and', 'O'), ('nystagmus', 'B'), ('to', 'O'), ('mood', 'O'), ('changes', 'O'), (',', 'O'), ('perceptual', 'O'), ('alterations', 'O'), (',', 'O'), ('inattention', 'O'), (',', 'O'), ('disorientation', 'O'), ('and', 'O'), ('aggressive', 'B'), ('behavior', 'I'), ('(', 'O'), ('Rammer', 'O'), ('et', 'O'), ('al', 'O'), ('1988', 'O'), (';', 'O'), ('Katona', 'O'), ('and', 'O'), ('Watson', 'O'), ('1986', 'O'), (';', 'O'), ('Isbell', 'O'), ('and', 'O'), ('Fraser', 'O'), ('1953', 'O'), (';', 'O'), ('Devlin', 'O'), ('et', 'O'), ('al', 'O'), ('1985', 'O'), (';', 'O'), ('McCarthy', 'O'), ('1971', 'O'), (';', 'O'), ('Dodds', 'O'), ('and', 'O'), ('Revai', 'O'), ('1967', 'O'), (';', 'O'), ('Degkwitz', 'O'), ('1964', 'O'), (';', 'O'), ('Hildebrand', 'O'), ('et', 'O'), ('al', 'O'), ('1989', 'O'), (')', 'O'), ('.', 'O'))$$$"
Effects of ouabain on myocardial oxygen supply and demand in patients with chronic coronary artery disease .,"(('Effects', 'O'), ('of', 'O'), ('ouabain', 'O'), ('on', 'O'), ('myocardial', 'O'), ('oxygen', 'O'), ('supply', 'O'), ('and', 'O'), ('demand', 'O'), ('in', 'O'), ('patients', 'O'), ('with', 'O'), ('chronic', 'O'), ('coronary', 'B'), ('artery', 'I'), ('disease', 'I'), ('.', 'O'))$$$"
"The effects of digitalis glycosides on myocardial oxygen supply and demand are of particular interest in the presence of obstructive coronary artery disease , but have not been measured previously in man .","(('The', 'O'), ('effects', 'O'), ('of', 'O'), ('digitalis', 'O'), ('glycosides', 'O'), ('on', 'O'), ('myocardial', 'O'), ('oxygen', 'O'), ('supply', 'O'), ('and', 'O'), ('demand', 'O'), ('are', 'O'), ('of', 'O'), ('particular', 'O'), ('interest', 'O'), ('in', 'O'), ('the', 'O'), ('presence', 'O'), ('of', 'O'), ('obstructive', 'O'), ('coronary', 'B'), ('artery', 'I'), ('disease', 'I'), (',', 'O'), ('but', 'O'), ('have', 'O'), ('not', 'O'), ('been', 'O'), ('measured', 'O'), ('previously', 'O'), ('in', 'O'), ('man', 'O'), ('.', 'O'))$$$"
"We assessed the effects of ouabain ( 0 . 015 mg / kg body weight ) on hemodynamic , volumetric , and metabolic parameters in 11 patients with severe chronic coronary artery disease without clinical congestive heart failure .","(('We', 'O'), ('assessed', 'O'), ('the', 'O'), ('effects', 'O'), ('of', 'O'), ('ouabain', 'O'), ('(', 'O'), ('0', 'O'), ('.', 'O'), ('015', 'O'), ('mg', 'O'), ('/', 'O'), ('kg', 'O'), ('body', 'O'), ('weight', 'O'), (')', 'O'), ('on', 'O'), ('hemodynamic', 'O'), (',', 'O'), ('volumetric', 'O'), (',', 'O'), ('and', 'O'), ('metabolic', 'O'), ('parameters', 'O'), ('in', 'O'), ('11', 'O'), ('patients', 'O'), ('with', 'O'), ('severe', 'O'), ('chronic', 'O'), ('coronary', 'B'), ('artery', 'I'), ('disease', 'I'), ('without', 'O'), ('clinical', 'O'), ('congestive', 'B'), ('heart', 'I'), ('failure', 'I'), ('.', 'O'))$$$"
We conclude that in patients with chronic coronary artery disease who are not in clinical congestive heart failure left ventricular end - diastolic volume falls after ouabain administration even when it is initially normal .,"(('We', 'O'), ('conclude', 'O'), ('that', 'O'), ('in', 'O'), ('patients', 'O'), ('with', 'O'), ('chronic', 'O'), ('coronary', 'B'), ('artery', 'I'), ('disease', 'I'), ('who', 'O'), ('are', 'O'), ('not', 'O'), ('in', 'O'), ('clinical', 'O'), ('congestive', 'B'), ('heart', 'I'), ('failure', 'I'), ('left', 'B'), ('ventricular', 'I'), ('end', 'I'), ('-', 'I'), ('diastolic', 'I'), ('volume', 'I'), ('falls', 'I'), ('after', 'O'), ('ouabain', 'O'), ('administration', 'O'), ('even', 'O'), ('when', 'O'), ('it', 'O'), ('is', 'O'), ('initially', 'O'), ('normal', 'O'), ('.', 'O'))$$$"
PURPOSE : Glucocorticoid administration can lead to the development of ocular hypertension and corticosteroid glaucoma in a subset of the population through a decrease in the aqueous humor outflow facility .,"(('PURPOSE', 'O'), (':', 'O'), ('Glucocorticoid', 'O'), ('administration', 'O'), ('can', 'O'), ('lead', 'O'), ('to', 'O'), ('the', 'O'), ('development', 'O'), ('of', 'O'), ('ocular', 'B'), ('hypertension', 'I'), ('and', 'O'), ('corticosteroid', 'B'), ('glaucoma', 'I'), ('in', 'O'), ('a', 'O'), ('subset', 'O'), ('of', 'O'), ('the', 'O'), ('population', 'O'), ('through', 'O'), ('a', 'O'), ('decrease', 'O'), ('in', 'O'), ('the', 'O'), ('aqueous', 'O'), ('humor', 'O'), ('outflow', 'O'), ('facility', 'O'), ('.', 'O'))$$$"
"In contrast , the dexamethasone - treated hypertensive eyes had thickened trabecular beams , decreased intertrabecular spaces , thickened juxtacanalicular tissue , activated trabecular meshwork cells , and increased amounts of amorphogranular extracellular material , especially in the juxtacanalicular tissue and beneath the endothelial lining of the canal of Schlemm .","(('In', 'O'), ('contrast', 'O'), (',', 'O'), ('the', 'O'), ('dexamethasone', 'O'), ('-', 'O'), ('treated', 'O'), ('hypertensive', 'B'), ('eyes', 'I'), ('had', 'O'), ('thickened', 'O'), ('trabecular', 'O'), ('beams', 'O'), (',', 'O'), ('decreased', 'O'), ('intertrabecular', 'O'), ('spaces', 'O'), (',', 'O'), ('thickened', 'O'), ('juxtacanalicular', 'O'), ('tissue', 'O'), (',', 'O'), ('activated', 'O'), ('trabecular', 'O'), ('meshwork', 'O'), ('cells', 'O'), (',', 'O'), ('and', 'O'), ('increased', 'O'), ('amounts', 'O'), ('of', 'O'), ('amorphogranular', 'O'), ('extracellular', 'O'), ('material', 'O'), (',', 'O'), ('especially', 'O'), ('in', 'O'), ('the', 'O'), ('juxtacanalicular', 'O'), ('tissue', 'O'), ('and', 'O'), ('beneath', 'O'), ('the', 'O'), ('endothelial', 'O'), ('lining', 'O'), ('of', 'O'), ('the', 'O'), ('canal', 'O'), ('of', 'O'), ('Schlemm', 'O'), ('.', 'O'))$$$"
This system may provide an acute model in which to study the pathogenic mechanisms involved in steroid glaucoma and primary open angle glaucoma .,"(('This', 'O'), ('system', 'O'), ('may', 'O'), ('provide', 'O'), ('an', 'O'), ('acute', 'O'), ('model', 'O'), ('in', 'O'), ('which', 'O'), ('to', 'O'), ('study', 'O'), ('the', 'O'), ('pathogenic', 'O'), ('mechanisms', 'O'), ('involved', 'O'), ('in', 'O'), ('steroid', 'B'), ('glaucoma', 'I'), ('and', 'O'), ('primary', 'B'), ('open', 'I'), ('angle', 'I'), ('glaucoma', 'I'), ('.', 'O'))$$$"
We report 3 patients ( age 37 - 52 years ) with acute respiratory insufficiency who developed prolonged weakness following the discontinuation of ND - NMBAs .,"(('We', 'O'), ('report', 'O'), ('3', 'O'), ('patients', 'O'), ('(', 'O'), ('age', 'O'), ('37', 'O'), ('-', 'O'), ('52', 'O'), ('years', 'O'), (')', 'O'), ('with', 'O'), ('acute', 'O'), ('respiratory', 'B'), ('insufficiency', 'I'), ('who', 'O'), ('developed', 'O'), ('prolonged', 'O'), ('weakness', 'B'), ('following', 'O'), ('the', 'O'), ('discontinuation', 'O'), ('of', 'O'), ('ND', 'O'), ('-', 'O'), ('NMBAs', 'O'), ('.', 'O'))$$$"
"A muscle biopsy in this patient showed loss of thick , myosin filaments .","(('A', 'O'), ('muscle', 'O'), ('biopsy', 'O'), ('in', 'O'), ('this', 'O'), ('patient', 'O'), ('showed', 'O'), ('loss', 'B'), ('of', 'I'), ('thick', 'I'), (',', 'I'), ('myosin', 'I'), ('filaments', 'I'), ('.', 'O'))$$$"
The weakness in these patients is due to pathology at both the neuromuscular junction ( most likely due to ND - NMBA ) and muscle ( most likely due to corticosteroids ) .,"(('The', 'O'), ('weakness', 'B'), ('in', 'O'), ('these', 'O'), ('patients', 'O'), ('is', 'O'), ('due', 'O'), ('to', 'O'), ('pathology', 'B'), ('at', 'I'), ('both', 'I'), ('the', 'I'), ('neuromuscular', 'I'), ('junction', 'I'), ('(', 'O'), ('most', 'O'), ('likely', 'O'), ('due', 'O'), ('to', 'O'), ('ND', 'O'), ('-', 'O'), ('NMBA', 'O'), (')', 'O'), ('and', 'O'), ('muscle', 'O'), ('(', 'O'), ('most', 'O'), ('likely', 'O'), ('due', 'O'), ('to', 'O'), ('corticosteroids', 'O'), (')', 'O'), ('.', 'O'))$$$"
Failure of ancrod in the treatment of heparin - induced arterial thrombosis .,"(('Failure', 'O'), ('of', 'O'), ('ancrod', 'O'), ('in', 'O'), ('the', 'O'), ('treatment', 'O'), ('of', 'O'), ('heparin', 'O'), ('-', 'O'), ('induced', 'O'), ('arterial', 'O'), ('thrombosis', 'B'), ('.', 'O'))$$$"
"Ancrod has been used successfully for prophylaxis against development of thrombosis in patients with heparin induced platelet aggregation who require brief reexposure to heparin , but its success in patients who have developed the thrombosis syndrome is not well defined .","(('Ancrod', 'O'), ('has', 'O'), ('been', 'O'), ('used', 'O'), ('successfully', 'O'), ('for', 'O'), ('prophylaxis', 'O'), ('against', 'O'), ('development', 'O'), ('of', 'O'), ('thrombosis', 'B'), ('in', 'O'), ('patients', 'O'), ('with', 'O'), ('heparin', 'O'), ('induced', 'O'), ('platelet', 'B'), ('aggregation', 'I'), ('who', 'O'), ('require', 'O'), ('brief', 'O'), ('reexposure', 'O'), ('to', 'O'), ('heparin', 'O'), (',', 'O'), ('but', 'O'), ('its', 'O'), ('success', 'O'), ('in', 'O'), ('patients', 'O'), ('who', 'O'), ('have', 'O'), ('developed', 'O'), ('the', 'O'), ('thrombosis', 'B'), ('syndrome', 'O'), ('is', 'O'), ('not', 'O'), ('well', 'O'), ('defined', 'O'), ('.', 'O'))$$$"
Water intoxication associated with oxytocin administration during saline - induced abortion .,"(('Water', 'B'), ('intoxication', 'I'), ('associated', 'O'), ('with', 'O'), ('oxytocin', 'O'), ('administration', 'O'), ('during', 'O'), ('saline', 'O'), ('-', 'O'), ('induced', 'O'), ('abortion', 'B'), ('.', 'O'))$$$"
Four cases of water intoxication in connection with oxytocin administration during saline - induced abortions are described .,"(('Four', 'O'), ('cases', 'O'), ('of', 'O'), ('water', 'B'), ('intoxication', 'I'), ('in', 'O'), ('connection', 'O'), ('with', 'O'), ('oxytocin', 'O'), ('administration', 'O'), ('during', 'O'), ('saline', 'O'), ('-', 'O'), ('induced', 'O'), ('abortions', 'B'), ('are', 'O'), ('described', 'O'), ('.', 'O'))$$$"
The mechanism of water intoxication is discussed in regard to these cases .,"(('The', 'O'), ('mechanism', 'O'), ('of', 'O'), ('water', 'B'), ('intoxication', 'I'), ('is', 'O'), ('discussed', 'O'), ('in', 'O'), ('regard', 'O'), ('to', 'O'), ('these', 'O'), ('cases', 'O'), ('.', 'O'))$$$"
"Oxytocin administration during midtrimester - induced abortions is advocated only if it can be carried out under careful observations of an alert nursing staff , aware of the symptoms of water intoxication and instructed to watch the diuresis and report such early signs of the syndrome as asthenia , muscular irritability , or headaches .","(('Oxytocin', 'O'), ('administration', 'O'), ('during', 'O'), ('midtrimester', 'O'), ('-', 'O'), ('induced', 'O'), ('abortions', 'B'), ('is', 'O'), ('advocated', 'O'), ('only', 'O'), ('if', 'O'), ('it', 'O'), ('can', 'O'), ('be', 'O'), ('carried', 'O'), ('out', 'O'), ('under', 'O'), ('careful', 'O'), ('observations', 'O'), ('of', 'O'), ('an', 'O'), ('alert', 'O'), ('nursing', 'O'), ('staff', 'O'), (',', 'O'), ('aware', 'O'), ('of', 'O'), ('the', 'O'), ('symptoms', 'O'), ('of', 'O'), ('water', 'B'), ('intoxication', 'I'), ('and', 'O'), ('instructed', 'O'), ('to', 'O'), ('watch', 'O'), ('the', 'O'), ('diuresis', 'O'), ('and', 'O'), ('report', 'O'), ('such', 'O'), ('early', 'O'), ('signs', 'O'), ('of', 'O'), ('the', 'O'), ('syndrome', 'O'), ('as', 'O'), ('asthenia', 'B'), (',', 'O'), ('muscular', 'O'), ('irritability', 'B'), (',', 'O'), ('or', 'O'), ('headaches', 'B'), ('.', 'O'))$$$"
A series of agents acting primarily on neurotransmitters other than dopamine were then tested in combination with L - DOPA to see if the dyskinetic movements would be modified .,"(('A', 'O'), ('series', 'O'), ('of', 'O'), ('agents', 'O'), ('acting', 'O'), ('primarily', 'O'), ('on', 'O'), ('neurotransmitters', 'O'), ('other', 'O'), ('than', 'O'), ('dopamine', 'O'), ('were', 'O'), ('then', 'O'), ('tested', 'O'), ('in', 'O'), ('combination', 'O'), ('with', 'O'), ('L', 'O'), ('-', 'O'), ('DOPA', 'O'), ('to', 'O'), ('see', 'O'), ('if', 'O'), ('the', 'O'), ('dyskinetic', 'B'), ('movements', 'O'), ('would', 'O'), ('be', 'O'), ('modified', 'O'), ('.', 'O'))$$$"
"Several drugs , including clonidine , physostigmine , methysergide , 5 - MDOT , propranolol , and MK - 801 , markedly reduced the dyskinetic movements but at the cost of a return of parkinsonian symptomatology .","(('Several', 'O'), ('drugs', 'O'), (',', 'O'), ('including', 'O'), ('clonidine', 'O'), (',', 'O'), ('physostigmine', 'O'), (',', 'O'), ('methysergide', 'O'), (',', 'O'), ('5', 'O'), ('-', 'O'), ('MDOT', 'O'), (',', 'O'), ('propranolol', 'O'), (',', 'O'), ('and', 'O'), ('MK', 'O'), ('-', 'O'), ('801', 'O'), (',', 'O'), ('markedly', 'O'), ('reduced', 'O'), ('the', 'O'), ('dyskinetic', 'B'), ('movements', 'O'), ('but', 'O'), ('at', 'O'), ('the', 'O'), ('cost', 'O'), ('of', 'O'), ('a', 'O'), ('return', 'O'), ('of', 'O'), ('parkinsonian', 'B'), ('symptomatology', 'O'), ('.', 'O'))$$$"
"However , yohimbine and meperidine reduced predominantly the dyskinetic movements .","(('However', 'O'), (',', 'O'), ('yohimbine', 'O'), ('and', 'O'), ('meperidine', 'O'), ('reduced', 'O'), ('predominantly', 'O'), ('the', 'O'), ('dyskinetic', 'B'), ('movements', 'O'), ('.', 'O'))$$$"
Neither patient complained of photosensitivity or flushing .,"(('Neither', 'O'), ('patient', 'O'), ('complained', 'O'), ('of', 'O'), ('photosensitivity', 'O'), ('or', 'O'), ('flushing', 'B'), ('.', 'O'))$$$"
"Although only few clinical descriptions of the relationship between hyperalgesia / myoclonus and high doses of morphine are available , experimental support from animal studies indicates that morphine , or its metabolites , plays a causative role for the observed behavioural syndrome .","(('Although', 'O'), ('only', 'O'), ('few', 'O'), ('clinical', 'O'), ('descriptions', 'O'), ('of', 'O'), ('the', 'O'), ('relationship', 'O'), ('between', 'O'), ('hyperalgesia', 'B'), ('/', 'O'), ('myoclonus', 'B'), ('and', 'O'), ('high', 'O'), ('doses', 'O'), ('of', 'O'), ('morphine', 'O'), ('are', 'O'), ('available', 'O'), (',', 'O'), ('experimental', 'O'), ('support', 'O'), ('from', 'O'), ('animal', 'O'), ('studies', 'O'), ('indicates', 'O'), ('that', 'O'), ('morphine', 'O'), (',', 'O'), ('or', 'O'), ('its', 'O'), ('metabolites', 'O'), (',', 'O'), ('plays', 'O'), ('a', 'O'), ('causative', 'O'), ('role', 'O'), ('for', 'O'), ('the', 'O'), ('observed', 'O'), ('behavioural', 'O'), ('syndrome', 'O'), ('.', 'O'))$$$"
"The main problem encountered was haematological toxicity , with three subjects experiencing severe neutropenia ( neutrophil count < 0 . 5 x 10 ( 9 ) / l ) .","(('The', 'O'), ('main', 'O'), ('problem', 'O'), ('encountered', 'O'), ('was', 'O'), ('haematological', 'O'), ('toxicity', 'B'), (',', 'O'), ('with', 'O'), ('three', 'O'), ('subjects', 'O'), ('experiencing', 'O'), ('severe', 'O'), ('neutropenia', 'B'), ('(', 'O'), ('neutrophil', 'O'), ('count', 'O'), ('<', 'O'), ('0', 'O'), ('.', 'O'), ('5', 'O'), ('x', 'O'), ('10', 'O'), ('(', 'O'), ('9', 'O'), (')', 'O'), ('/', 'O'), ('l', 'O'), (')', 'O'), ('.', 'O'))$$$"
The patients were interviewed with emphasis on neuropathic symptoms .,"(('The', 'O'), ('patients', 'O'), ('were', 'O'), ('interviewed', 'O'), ('with', 'O'), ('emphasis', 'O'), ('on', 'O'), ('neuropathic', 'B'), ('symptoms', 'I'), ('.', 'O'))$$$"
Hepatic adenomas and focal nodular hyperplasia of the liver in young women on oral contraceptives : case reports .,"(('Hepatic', 'O'), ('adenomas', 'B'), ('and', 'O'), ('focal', 'B'), ('nodular', 'I'), ('hyperplasia', 'I'), ('of', 'O'), ('the', 'O'), ('liver', 'O'), ('in', 'O'), ('young', 'O'), ('women', 'O'), ('on', 'O'), ('oral', 'O'), ('contraceptives', 'O'), (':', 'O'), ('case', 'O'), ('reports', 'O'), ('.', 'O'))$$$"
"Two cases of hepatic adenoma and one of focal nodular hyperplasia presumably associated with the use of oral contraceptives , are reported .","(('Two', 'O'), ('cases', 'O'), ('of', 'O'), ('hepatic', 'O'), ('adenoma', 'B'), ('and', 'O'), ('one', 'O'), ('of', 'O'), ('focal', 'B'), ('nodular', 'I'), ('hyperplasia', 'I'), ('presumably', 'O'), ('associated', 'O'), ('with', 'O'), ('the', 'O'), ('use', 'O'), ('of', 'O'), ('oral', 'O'), ('contraceptives', 'O'), (',', 'O'), ('are', 'O'), ('reported', 'O'), ('.', 'O'))$$$"
Histologic differences and clinical similarities between hepatic adenoma and focal nodular hyperplasia of the liver are discussed .,"(('Histologic', 'O'), ('differences', 'O'), ('and', 'O'), ('clinical', 'O'), ('similarities', 'O'), ('between', 'O'), ('hepatic', 'O'), ('adenoma', 'B'), ('and', 'O'), ('focal', 'B'), ('nodular', 'I'), ('hyperplasia', 'I'), ('of', 'O'), ('the', 'O'), ('liver', 'O'), ('are', 'O'), ('discussed', 'O'), ('.', 'O'))$$$"
"Additional neuronanatomical studies , including cresyl violet staining , neuronal degeneration methods , and histochemical localization of glial fibrillary acidic protein , suggested that the decrease in the number of GAD mRNA - containing neurons was related to neuronal loss rather than to a decrease in GAD mRNA levels .","(('Additional', 'O'), ('neuronanatomical', 'O'), ('studies', 'O'), (',', 'O'), ('including', 'O'), ('cresyl', 'O'), ('violet', 'O'), ('staining', 'O'), (',', 'O'), ('neuronal', 'B'), ('degeneration', 'I'), ('methods', 'O'), (',', 'O'), ('and', 'O'), ('histochemical', 'O'), ('localization', 'O'), ('of', 'O'), ('glial', 'O'), ('fibrillary', 'O'), ('acidic', 'O'), ('protein', 'O'), (',', 'O'), ('suggested', 'O'), ('that', 'O'), ('the', 'O'), ('decrease', 'O'), ('in', 'O'), ('the', 'O'), ('number', 'O'), ('of', 'O'), ('GAD', 'O'), ('mRNA', 'O'), ('-', 'O'), ('containing', 'O'), ('neurons', 'O'), ('was', 'O'), ('related', 'O'), ('to', 'O'), ('neuronal', 'B'), ('loss', 'I'), ('rather', 'O'), ('than', 'O'), ('to', 'O'), ('a', 'O'), ('decrease', 'O'), ('in', 'O'), ('GAD', 'O'), ('mRNA', 'O'), ('levels', 'O'), ('.', 'O'))$$$"
Case report : pentamidine and polymorphic ventricular tachycardia revisited .,"(('Case', 'O'), ('report', 'O'), (':', 'O'), ('pentamidine', 'O'), ('and', 'O'), ('polymorphic', 'O'), ('ventricular', 'B'), ('tachycardia', 'I'), ('revisited', 'O'), ('.', 'O'))$$$"
Pentamidine - induced torsade de pointes may be related to serum magnesium levels and hypomagnesemia may synergistically induce torsade .,"(('Pentamidine', 'O'), ('-', 'O'), ('induced', 'O'), ('torsade', 'B'), ('de', 'I'), ('pointes', 'I'), ('may', 'O'), ('be', 'O'), ('related', 'O'), ('to', 'O'), ('serum', 'O'), ('magnesium', 'O'), ('levels', 'O'), ('and', 'O'), ('hypomagnesemia', 'B'), ('may', 'O'), ('synergistically', 'O'), ('induce', 'O'), ('torsade', 'O'), ('.', 'O'))$$$"
"When QTc interval prolongation is observed , early magnesium supplementation is advocated .","(('When', 'O'), ('QTc', 'B'), ('interval', 'I'), ('prolongation', 'I'), ('is', 'O'), ('observed', 'O'), (',', 'O'), ('early', 'O'), ('magnesium', 'O'), ('supplementation', 'O'), ('is', 'O'), ('advocated', 'O'), ('.', 'O'))$$$"
Venous complications of midazolam versus diazepam .,"(('Venous', 'B'), ('complications', 'I'), ('of', 'O'), ('midazolam', 'O'), ('versus', 'O'), ('diazepam', 'O'), ('.', 'O'))$$$"
"Although some studies have suggested fewer venous complications are associated with midazolam than with diazepam for endoscopic procedures , this variable has not been well documented .","(('Although', 'O'), ('some', 'O'), ('studies', 'O'), ('have', 'O'), ('suggested', 'O'), ('fewer', 'O'), ('venous', 'B'), ('complications', 'I'), ('are', 'O'), ('associated', 'O'), ('with', 'O'), ('midazolam', 'O'), ('than', 'O'), ('with', 'O'), ('diazepam', 'O'), ('for', 'O'), ('endoscopic', 'O'), ('procedures', 'O'), (',', 'O'), ('this', 'O'), ('variable', 'O'), ('has', 'O'), ('not', 'O'), ('been', 'O'), ('well', 'O'), ('documented', 'O'), ('.', 'O'))$$$"
"Overall , venous complications were more frequent with diazepam ( 22 of 62 patients ) than with midazolam ( 4 of 60 patients ) ( p < 0 . 001 ) .","(('Overall', 'O'), (',', 'O'), ('venous', 'B'), ('complications', 'I'), ('were', 'O'), ('more', 'O'), ('frequent', 'O'), ('with', 'O'), ('diazepam', 'O'), ('(', 'O'), ('22', 'O'), ('of', 'O'), ('62', 'O'), ('patients', 'O'), (')', 'O'), ('than', 'O'), ('with', 'O'), ('midazolam', 'O'), ('(', 'O'), ('4', 'O'), ('of', 'O'), ('60', 'O'), ('patients', 'O'), (')', 'O'), ('(', 'O'), ('p', 'O'), ('<', 'O'), ('0', 'O'), ('.', 'O'), ('001', 'O'), (')', 'O'), ('.', 'O'))$$$"
"The combination of a relatively high dose of clarithromycin in face of chronic renal failure in a functionally anephric patient , with underlying aluminum intoxication , may have facilitated the appearance of this neurotoxic side effect .","(('The', 'O'), ('combination', 'O'), ('of', 'O'), ('a', 'O'), ('relatively', 'O'), ('high', 'O'), ('dose', 'O'), ('of', 'O'), ('clarithromycin', 'O'), ('in', 'O'), ('face', 'O'), ('of', 'O'), ('chronic', 'B'), ('renal', 'I'), ('failure', 'I'), ('in', 'O'), ('a', 'O'), ('functionally', 'O'), ('anephric', 'O'), ('patient', 'O'), (',', 'O'), ('with', 'O'), ('underlying', 'O'), ('aluminum', 'O'), ('intoxication', 'O'), (',', 'O'), ('may', 'O'), ('have', 'O'), ('facilitated', 'O'), ('the', 'O'), ('appearance', 'O'), ('of', 'O'), ('this', 'O'), ('neurotoxic', 'B'), ('side', 'O'), ('effect', 'O'), ('.', 'O'))$$$"
Peroxisomes in hepatomas and hyperplastic preneoplastic liver lesions induced in mice by 500 ppm alpha - benzene hexachloride were examined histochemically and electron microscopically .,"(('Peroxisomes', 'O'), ('in', 'O'), ('hepatomas', 'B'), ('and', 'O'), ('hyperplastic', 'O'), ('preneoplastic', 'O'), ('liver', 'B'), ('lesions', 'I'), ('induced', 'O'), ('in', 'O'), ('mice', 'O'), ('by', 'O'), ('500', 'O'), ('ppm', 'O'), ('alpha', 'O'), ('-', 'O'), ('benzene', 'O'), ('hexachloride', 'O'), ('were', 'O'), ('examined', 'O'), ('histochemically', 'O'), ('and', 'O'), ('electron', 'O'), ('microscopically', 'O'), ('.', 'O'))$$$"
Intravenous infusion of the ganglionic blocker hexamethonium resulted in a rapid decline in MAP that eliminated the dietary sodium chloride - induced increase in MAP in both groups .,"(('Intravenous', 'O'), ('infusion', 'O'), ('of', 'O'), ('the', 'O'), ('ganglionic', 'O'), ('blocker', 'O'), ('hexamethonium', 'O'), ('resulted', 'O'), ('in', 'O'), ('a', 'O'), ('rapid', 'O'), ('decline', 'O'), ('in', 'O'), ('MAP', 'O'), ('that', 'O'), ('eliminated', 'O'), ('the', 'O'), ('dietary', 'O'), ('sodium', 'O'), ('chloride', 'O'), ('-', 'O'), ('induced', 'O'), ('increase', 'B'), ('in', 'I'), ('MAP', 'I'), ('in', 'O'), ('both', 'O'), ('groups', 'O'), ('.', 'O'))$$$"
"Angioedema , also known as angioneurotic edema or Quincke ' s disease , is a well - demarcated , localized edema involving the subcutaneous tissues that may cause upper - airway obstruction .","(('Angioedema', 'B'), (',', 'O'), ('also', 'O'), ('known', 'O'), ('as', 'O'), ('angioneurotic', 'B'), ('edema', 'I'), ('or', 'O'), ('Quincke', 'B'), (""'"", 'I'), ('s', 'I'), ('disease', 'I'), (',', 'O'), ('is', 'O'), ('a', 'O'), ('well', 'O'), ('-', 'O'), ('demarcated', 'O'), (',', 'O'), ('localized', 'O'), ('edema', 'B'), ('involving', 'O'), ('the', 'O'), ('subcutaneous', 'O'), ('tissues', 'O'), ('that', 'O'), ('may', 'O'), ('cause', 'O'), ('upper', 'B'), ('-', 'I'), ('airway', 'I'), ('obstruction', 'I'), ('.', 'O'))$$$"
We report the case of a previously healthy 19 - year - old man with no known drug allergies in whom angioedema with significant tongue swelling and protrusion developed within 10 minutes of the administration of a single IV dose of droperidol .,"(('We', 'O'), ('report', 'O'), ('the', 'O'), ('case', 'O'), ('of', 'O'), ('a', 'O'), ('previously', 'O'), ('healthy', 'O'), ('19', 'O'), ('-', 'O'), ('year', 'O'), ('-', 'O'), ('old', 'O'), ('man', 'O'), ('with', 'O'), ('no', 'O'), ('known', 'O'), ('drug', 'B'), ('allergies', 'I'), ('in', 'O'), ('whom', 'O'), ('angioedema', 'B'), ('with', 'O'), ('significant', 'O'), ('tongue', 'B'), ('swelling', 'I'), ('and', 'O'), ('protrusion', 'O'), ('developed', 'O'), ('within', 'O'), ('10', 'O'), ('minutes', 'O'), ('of', 'O'), ('the', 'O'), ('administration', 'O'), ('of', 'O'), ('a', 'O'), ('single', 'O'), ('IV', 'O'), ('dose', 'O'), ('of', 'O'), ('droperidol', 'O'), ('.', 'O'))$$$"
Late cardiotoxicity after treatment for a malignant bone tumor .,"(('Late', 'O'), ('cardiotoxicity', 'B'), ('after', 'O'), ('treatment', 'O'), ('for', 'O'), ('a', 'O'), ('malignant', 'O'), ('bone', 'B'), ('tumor', 'I'), ('.', 'O'))$$$"
"Cardiac function was assessed in long - term survivors of malignant bone tumors who were treated according to Rosen ' s T5 or T10 protocol , both including doxorubicin .","(('Cardiac', 'O'), ('function', 'O'), ('was', 'O'), ('assessed', 'O'), ('in', 'O'), ('long', 'O'), ('-', 'O'), ('term', 'O'), ('survivors', 'O'), ('of', 'O'), ('malignant', 'O'), ('bone', 'B'), ('tumors', 'I'), ('who', 'O'), ('were', 'O'), ('treated', 'O'), ('according', 'O'), ('to', 'O'), ('Rosen', 'O'), (""'"", 'O'), ('s', 'O'), ('T5', 'O'), ('or', 'O'), ('T10', 'O'), ('protocol', 'O'), (',', 'O'), ('both', 'O'), ('including', 'O'), ('doxorubicin', 'O'), ('.', 'O'))$$$"
"Eighteen of 31 ( 58 % ) patients showed cardiac toxicity , defined as having one or more of the following abnormalities : late potentials , complex ventricular arrhythmias , left ventricular dilation , decreased shortening fraction , or decreased ejection fraction .","(('Eighteen', 'O'), ('of', 'O'), ('31', 'O'), ('(', 'O'), ('58', 'O'), ('%', 'O'), (')', 'O'), ('patients', 'O'), ('showed', 'O'), ('cardiac', 'B'), ('toxicity', 'I'), (',', 'O'), ('defined', 'O'), ('as', 'O'), ('having', 'O'), ('one', 'O'), ('or', 'O'), ('more', 'O'), ('of', 'O'), ('the', 'O'), ('following', 'O'), ('abnormalities', 'O'), (':', 'O'), ('late', 'O'), ('potentials', 'O'), (',', 'O'), ('complex', 'O'), ('ventricular', 'B'), ('arrhythmias', 'I'), (',', 'O'), ('left', 'O'), ('ventricular', 'B'), ('dilation', 'I'), (',', 'O'), ('decreased', 'O'), ('shortening', 'O'), ('fraction', 'O'), (',', 'O'), ('or', 'O'), ('decreased', 'O'), ('ejection', 'O'), ('fraction', 'O'), ('.', 'O'))$$$"
Acute blood pressure elevations with caffeine in men with borderline systemic hypertension .,"(('Acute', 'O'), ('blood', 'O'), ('pressure', 'O'), ('elevations', 'O'), ('with', 'O'), ('caffeine', 'O'), ('in', 'O'), ('men', 'O'), ('with', 'O'), ('borderline', 'O'), ('systemic', 'O'), ('hypertension', 'B'), ('.', 'O'))$$$"
Coexistence of cerebral venous sinus and internal carotid artery thrombosis associated with exogenous sex hormones .,"(('Coexistence', 'O'), ('of', 'O'), ('cerebral', 'B'), ('venous', 'I'), ('sinus', 'I'), ('and', 'I'), ('internal', 'I'), ('carotid', 'I'), ('artery', 'I'), ('thrombosis', 'I'), ('associated', 'O'), ('with', 'O'), ('exogenous', 'O'), ('sex', 'O'), ('hormones', 'O'), ('.', 'O'))$$$"
"A forty - six year - old premenopausal woman developed headache , nausea and vomiting , left hemiparesis and seizure two days after parenteral use of progesterone and estradiol .","(('A', 'O'), ('forty', 'O'), ('-', 'O'), ('six', 'O'), ('year', 'O'), ('-', 'O'), ('old', 'O'), ('premenopausal', 'O'), ('woman', 'O'), ('developed', 'O'), ('headache', 'B'), (',', 'O'), ('nausea', 'B'), ('and', 'O'), ('vomiting', 'B'), (',', 'O'), ('left', 'O'), ('hemiparesis', 'B'), ('and', 'O'), ('seizure', 'B'), ('two', 'O'), ('days', 'O'), ('after', 'O'), ('parenteral', 'O'), ('use', 'O'), ('of', 'O'), ('progesterone', 'O'), ('and', 'O'), ('estradiol', 'O'), ('.', 'O'))$$$"
Computed tomography showed a hemorrhagic infarct in the right frontal lobe and increased density in the superior sagittal sinus ( SSS ) .,"(('Computed', 'O'), ('tomography', 'O'), ('showed', 'O'), ('a', 'O'), ('hemorrhagic', 'B'), ('infarct', 'I'), ('in', 'O'), ('the', 'O'), ('right', 'O'), ('frontal', 'O'), ('lobe', 'O'), ('and', 'O'), ('increased', 'O'), ('density', 'O'), ('in', 'O'), ('the', 'O'), ('superior', 'O'), ('sagittal', 'O'), ('sinus', 'O'), ('(', 'O'), ('SSS', 'O'), (')', 'O'), ('.', 'O'))$$$"
Left carotid angiography found occlusion of the left internal carotid artery ( ICA ) .,"(('Left', 'O'), ('carotid', 'O'), ('angiography', 'O'), ('found', 'O'), ('occlusion', 'B'), ('of', 'I'), ('the', 'I'), ('left', 'I'), ('internal', 'I'), ('carotid', 'I'), ('artery', 'I'), ('(', 'O'), ('ICA', 'O'), (')', 'O'), ('.', 'O'))$$$"
Coexistence of the cerebral artery and the venous sinus occlusion has been described infrequently .,"(('Coexistence', 'O'), ('of', 'O'), ('the', 'O'), ('cerebral', 'B'), ('artery', 'I'), ('and', 'I'), ('the', 'I'), ('venous', 'I'), ('sinus', 'I'), ('occlusion', 'I'), ('has', 'O'), ('been', 'O'), ('described', 'O'), ('infrequently', 'O'), ('.', 'O'))$$$"
"In this case , the authors postulate that the use of estradiol and progesterone and the underlying DM increased vascular thrombogenicity , which provided a common denominator for thrombosis of both the ICA and the venous sinus .","(('In', 'O'), ('this', 'O'), ('case', 'O'), (',', 'O'), ('the', 'O'), ('authors', 'O'), ('postulate', 'O'), ('that', 'O'), ('the', 'O'), ('use', 'O'), ('of', 'O'), ('estradiol', 'O'), ('and', 'O'), ('progesterone', 'O'), ('and', 'O'), ('the', 'O'), ('underlying', 'O'), ('DM', 'B'), ('increased', 'O'), ('vascular', 'O'), ('thrombogenicity', 'O'), (',', 'O'), ('which', 'O'), ('provided', 'O'), ('a', 'O'), ('common', 'O'), ('denominator', 'O'), ('for', 'O'), ('thrombosis', 'B'), ('of', 'I'), ('both', 'I'), ('the', 'I'), ('ICA', 'I'), ('and', 'I'), ('the', 'I'), ('venous', 'I'), ('sinus', 'I'), ('.', 'O'))$$$"
"Nausea and vomiting were infrequent , with 14 % of patients experiencing grade 1 or 2 and only 2 % experiencing grade 3 or 4 .","(('Nausea', 'B'), ('and', 'O'), ('vomiting', 'B'), ('were', 'O'), ('infrequent', 'O'), (',', 'O'), ('with', 'O'), ('14', 'O'), ('%', 'O'), ('of', 'O'), ('patients', 'O'), ('experiencing', 'O'), ('grade', 'O'), ('1', 'O'), ('or', 'O'), ('2', 'O'), ('and', 'O'), ('only', 'O'), ('2', 'O'), ('%', 'O'), ('experiencing', 'O'), ('grade', 'O'), ('3', 'O'), ('or', 'O'), ('4', 'O'), ('.', 'O'))$$$"
"Nutritional intake , measured daily in 15 animals , showed a significant reduction of food intake in the steroid - treated groups ( - 50 and - 79 % in M and T , respectively ) .","(('Nutritional', 'O'), ('intake', 'O'), (',', 'O'), ('measured', 'O'), ('daily', 'O'), ('in', 'O'), ('15', 'O'), ('animals', 'O'), (',', 'O'), ('showed', 'O'), ('a', 'O'), ('significant', 'O'), ('reduction', 'B'), ('of', 'I'), ('food', 'I'), ('intake', 'I'), ('in', 'O'), ('the', 'O'), ('steroid', 'O'), ('-', 'O'), ('treated', 'O'), ('groups', 'O'), ('(', 'O'), ('-', 'O'), ('50', 'O'), ('and', 'O'), ('-', 'O'), ('79', 'O'), ('%', 'O'), ('in', 'O'), ('M', 'O'), ('and', 'O'), ('T', 'O'), (',', 'O'), ('respectively', 'O'), (')', 'O'), ('.', 'O'))$$$"
This was associated with a similar loss in body weight .,"(('This', 'O'), ('was', 'O'), ('associated', 'O'), ('with', 'O'), ('a', 'O'), ('similar', 'O'), ('loss', 'B'), ('in', 'I'), ('body', 'I'), ('weight', 'I'), ('.', 'O'))$$$"
"Half - relaxation time was prolonged in both steroid groups , and time to peak tension was longer with M , whereas tetanic tensions were similar .","(('Half', 'O'), ('-', 'O'), ('relaxation', 'O'), ('time', 'O'), ('was', 'O'), ('prolonged', 'O'), ('in', 'O'), ('both', 'O'), ('steroid', 'O'), ('groups', 'O'), (',', 'O'), ('and', 'O'), ('time', 'O'), ('to', 'O'), ('peak', 'O'), ('tension', 'O'), ('was', 'O'), ('longer', 'O'), ('with', 'O'), ('M', 'O'), (',', 'O'), ('whereas', 'O'), ('tetanic', 'B'), ('tensions', 'O'), ('were', 'O'), ('similar', 'O'), ('.', 'O'))$$$"
"We conclude that ( 1 ) short - term treatment with massive doses of steroids induced severe respiratory and limb muscle wasting ; ( 2 ) both types of steroids induced predominantly type IIb atrophy , resulting in the expected alterations in diaphragm contractile properties ; ( 3 ) neither steroid caused muscle necrosis ; ( 4 ) type IIb atrophy was not caused by acute nutritional deprivation alone .","(('We', 'O'), ('conclude', 'O'), ('that', 'O'), ('(', 'O'), ('1', 'O'), (')', 'O'), ('short', 'O'), ('-', 'O'), ('term', 'O'), ('treatment', 'O'), ('with', 'O'), ('massive', 'O'), ('doses', 'O'), ('of', 'O'), ('steroids', 'O'), ('induced', 'O'), ('severe', 'O'), ('respiratory', 'O'), ('and', 'O'), ('limb', 'O'), ('muscle', 'O'), ('wasting', 'O'), (';', 'O'), ('(', 'O'), ('2', 'O'), (')', 'O'), ('both', 'O'), ('types', 'O'), ('of', 'O'), ('steroids', 'O'), ('induced', 'O'), ('predominantly', 'O'), ('type', 'O'), ('IIb', 'O'), ('atrophy', 'B'), (',', 'O'), ('resulting', 'O'), ('in', 'O'), ('the', 'O'), ('expected', 'O'), ('alterations', 'O'), ('in', 'O'), ('diaphragm', 'O'), ('contractile', 'O'), ('properties', 'O'), (';', 'O'), ('(', 'O'), ('3', 'O'), (')', 'O'), ('neither', 'O'), ('steroid', 'O'), ('caused', 'O'), ('muscle', 'O'), ('necrosis', 'B'), (';', 'O'), ('(', 'O'), ('4', 'O'), (')', 'O'), ('type', 'O'), ('IIb', 'O'), ('atrophy', 'B'), ('was', 'O'), ('not', 'O'), ('caused', 'O'), ('by', 'O'), ('acute', 'O'), ('nutritional', 'O'), ('deprivation', 'O'), ('alone', 'O'), ('.', 'O'))$$$"
Thirteen of these patients experienced pain in the legs and / or back after recovery from anaesthesia .,"(('Thirteen', 'O'), ('of', 'O'), ('these', 'O'), ('patients', 'O'), ('experienced', 'O'), ('pain', 'B'), ('in', 'I'), ('the', 'I'), ('legs', 'I'), ('and', 'I'), ('/', 'I'), ('or', 'I'), ('back', 'I'), ('after', 'O'), ('recovery', 'O'), ('from', 'O'), ('anaesthesia', 'O'), ('.', 'O'))$$$"
"The present study investigates the effects of a diet free of precursors of NAD , the substrate on which PARP acts , in female NMRI mice with AAP hepatitis and evaluates the influence of simultaneous ethanol consumption in these animals .","(('The', 'O'), ('present', 'O'), ('study', 'O'), ('investigates', 'O'), ('the', 'O'), ('effects', 'O'), ('of', 'O'), ('a', 'O'), ('diet', 'O'), ('free', 'O'), ('of', 'O'), ('precursors', 'O'), ('of', 'O'), ('NAD', 'O'), (',', 'O'), ('the', 'O'), ('substrate', 'O'), ('on', 'O'), ('which', 'O'), ('PARP', 'O'), ('acts', 'O'), (',', 'O'), ('in', 'O'), ('female', 'O'), ('NMRI', 'O'), ('mice', 'O'), ('with', 'O'), ('AAP', 'O'), ('hepatitis', 'B'), ('and', 'O'), ('evaluates', 'O'), ('the', 'O'), ('influence', 'O'), ('of', 'O'), ('simultaneous', 'O'), ('ethanol', 'O'), ('consumption', 'O'), ('in', 'O'), ('these', 'O'), ('animals', 'O'), ('.', 'O'))$$$"
Nightmares and hallucinations after long - term intake of tramadol combined with antidepressants .,"(('Nightmares', 'O'), ('and', 'O'), ('hallucinations', 'B'), ('after', 'O'), ('long', 'O'), ('-', 'O'), ('term', 'O'), ('intake', 'O'), ('of', 'O'), ('tramadol', 'O'), ('combined', 'O'), ('with', 'O'), ('antidepressants', 'O'), ('.', 'O'))$$$"
Tramadol is a weak opioid with effects on adrenergic and serotonergic neurotransmission that is used to treat cancer pain and chronic non malignant pain .,"(('Tramadol', 'O'), ('is', 'O'), ('a', 'O'), ('weak', 'O'), ('opioid', 'O'), ('with', 'O'), ('effects', 'O'), ('on', 'O'), ('adrenergic', 'O'), ('and', 'O'), ('serotonergic', 'O'), ('neurotransmission', 'O'), ('that', 'O'), ('is', 'O'), ('used', 'O'), ('to', 'O'), ('treat', 'O'), ('cancer', 'B'), ('pain', 'B'), ('and', 'O'), ('chronic', 'O'), ('non', 'O'), ('malignant', 'O'), ('pain', 'B'), ('.', 'O'))$$$"
"The case report questions the long term use of pain killers combined with psycho - active drugs in chronic non malignant pain , especially if pain is under control .","(('The', 'O'), ('case', 'O'), ('report', 'O'), ('questions', 'O'), ('the', 'O'), ('long', 'O'), ('term', 'O'), ('use', 'O'), ('of', 'O'), ('pain', 'B'), ('killers', 'O'), ('combined', 'O'), ('with', 'O'), ('psycho', 'O'), ('-', 'O'), ('active', 'O'), ('drugs', 'O'), ('in', 'O'), ('chronic', 'O'), ('non', 'O'), ('malignant', 'O'), ('pain', 'B'), (',', 'O'), ('especially', 'O'), ('if', 'O'), ('pain', 'B'), ('is', 'O'), ('under', 'O'), ('control', 'O'), ('.', 'O'))$$$"
"Anesthetized rats received the tricyclic antidepressant desipramine IP to produce hypotension , QRS prolongation , and bradycardia .","(('Anesthetized', 'O'), ('rats', 'O'), ('received', 'O'), ('the', 'O'), ('tricyclic', 'O'), ('antidepressant', 'O'), ('desipramine', 'O'), ('IP', 'O'), ('to', 'O'), ('produce', 'O'), ('hypotension', 'B'), (',', 'O'), ('QRS', 'O'), ('prolongation', 'O'), (',', 'O'), ('and', 'O'), ('bradycardia', 'B'), ('.', 'O'))$$$"
RESULTS : NaHCO3 briefly ( 5 min ) reversed hypotension and QRS prolongation .,"(('RESULTS', 'O'), (':', 'O'), ('NaHCO3', 'O'), ('briefly', 'O'), ('(', 'O'), ('5', 'O'), ('min', 'O'), (')', 'O'), ('reversed', 'O'), ('hypotension', 'B'), ('and', 'O'), ('QRS', 'O'), ('prolongation', 'O'), ('.', 'O'))$$$"
"Valsartan , a new angiotensin II antagonist for the treatment of essential hypertension : a comparative study of the efficacy and safety against amlodipine .","(('Valsartan', 'O'), (',', 'O'), ('a', 'O'), ('new', 'O'), ('angiotensin', 'O'), ('II', 'O'), ('antagonist', 'O'), ('for', 'O'), ('the', 'O'), ('treatment', 'O'), ('of', 'O'), ('essential', 'O'), ('hypertension', 'B'), (':', 'O'), ('a', 'O'), ('comparative', 'O'), ('study', 'O'), ('of', 'O'), ('the', 'O'), ('efficacy', 'O'), ('and', 'O'), ('safety', 'O'), ('against', 'O'), ('amlodipine', 'O'), ('.', 'O'))$$$"
"Excessive stimulation of serotonin 5HT1A receptors causes a syndrome of serotonin excess that consists of shivering , muscle rigidity , salivation , confusion , agitation and hyperthermia .","(('Excessive', 'O'), ('stimulation', 'O'), ('of', 'O'), ('serotonin', 'O'), ('5HT1A', 'O'), ('receptors', 'O'), ('causes', 'O'), ('a', 'O'), ('syndrome', 'O'), ('of', 'O'), ('serotonin', 'O'), ('excess', 'O'), ('that', 'O'), ('consists', 'O'), ('of', 'O'), ('shivering', 'O'), (',', 'O'), ('muscle', 'B'), ('rigidity', 'I'), (',', 'O'), ('salivation', 'B'), (',', 'O'), ('confusion', 'B'), (',', 'O'), ('agitation', 'B'), ('and', 'O'), ('hyperthermia', 'B'), ('.', 'O'))$$$"
"Within 2 h he became confused with jerking movements of his extremities , tremors and rigidity .","(('Within', 'O'), ('2', 'O'), ('h', 'O'), ('he', 'O'), ('became', 'O'), ('confused', 'O'), ('with', 'O'), ('jerking', 'O'), ('movements', 'O'), ('of', 'O'), ('his', 'O'), ('extremities', 'O'), (',', 'O'), ('tremors', 'B'), ('and', 'O'), ('rigidity', 'B'), ('.', 'O'))$$$"
"He was brought directly to a hospital where he was found to be agitated and confused with shivering , myoclonic jerks , rigidity , salivation and diaphoresis .","(('He', 'O'), ('was', 'O'), ('brought', 'O'), ('directly', 'O'), ('to', 'O'), ('a', 'O'), ('hospital', 'O'), ('where', 'O'), ('he', 'O'), ('was', 'O'), ('found', 'O'), ('to', 'O'), ('be', 'O'), ('agitated', 'O'), ('and', 'O'), ('confused', 'O'), ('with', 'O'), ('shivering', 'O'), (',', 'O'), ('myoclonic', 'B'), ('jerks', 'I'), (',', 'O'), ('rigidity', 'B'), (',', 'O'), ('salivation', 'B'), ('and', 'O'), ('diaphoresis', 'O'), ('.', 'O'))$$$"
After 180 mg of diazepam i . v . he remained tremulous with muscle rigidity and clenched jaws .,"(('After', 'O'), ('180', 'O'), ('mg', 'O'), ('of', 'O'), ('diazepam', 'O'), ('i', 'O'), ('.', 'O'), ('v', 'O'), ('.', 'O'), ('he', 'O'), ('remained', 'O'), ('tremulous', 'O'), ('with', 'O'), ('muscle', 'B'), ('rigidity', 'I'), ('and', 'O'), ('clenched', 'O'), ('jaws', 'O'), ('.', 'O'))$$$"
"He was intubated for airway protection and because of hypoventilation , and was paralyzed to control muscle rigidity .","(('He', 'O'), ('was', 'O'), ('intubated', 'O'), ('for', 'O'), ('airway', 'O'), ('protection', 'O'), ('and', 'O'), ('because', 'O'), ('of', 'O'), ('hypoventilation', 'B'), (',', 'O'), ('and', 'O'), ('was', 'O'), ('paralyzed', 'B'), ('to', 'O'), ('control', 'O'), ('muscle', 'B'), ('rigidity', 'I'), ('.', 'O'))$$$"
This patient survived without sequelae due to the aggressive sedation and neuromuscular paralysis .,"(('This', 'O'), ('patient', 'O'), ('survived', 'O'), ('without', 'O'), ('sequelae', 'O'), ('due', 'O'), ('to', 'O'), ('the', 'O'), ('aggressive', 'O'), ('sedation', 'O'), ('and', 'O'), ('neuromuscular', 'O'), ('paralysis', 'B'), ('.', 'O'))$$$"
RESULTS : All tumors were grade 3 or 4 transitional cell carcinoma .,"(('RESULTS', 'O'), (':', 'O'), ('All', 'O'), ('tumors', 'B'), ('were', 'O'), ('grade', 'O'), ('3', 'O'), ('or', 'O'), ('4', 'O'), ('transitional', 'O'), ('cell', 'O'), ('carcinoma', 'B'), ('.', 'O'))$$$"
"We describe an outbreak of deaths from cocaine - induced excited delirium ( EDDs ) in Dade County , Florida between 1979 and 1990 .","(('We', 'O'), ('describe', 'O'), ('an', 'O'), ('outbreak', 'O'), ('of', 'O'), ('deaths', 'O'), ('from', 'O'), ('cocaine', 'O'), ('-', 'O'), ('induced', 'O'), ('excited', 'O'), ('delirium', 'B'), ('(', 'O'), ('EDDs', 'B'), (')', 'O'), ('in', 'O'), ('Dade', 'O'), ('County', 'O'), (',', 'O'), ('Florida', 'O'), ('between', 'O'), ('1979', 'O'), ('and', 'O'), ('1990', 'O'), ('.', 'O'))$$$"
"From a registry of all cocaine - related deaths in Dade County , Florida , from 1969 - 1990 , 58 EDDs were compared with 125 victims of accidental cocaine overdose without excited delirium .","(('From', 'O'), ('a', 'O'), ('registry', 'O'), ('of', 'O'), ('all', 'O'), ('cocaine', 'O'), ('-', 'O'), ('related', 'O'), ('deaths', 'O'), ('in', 'O'), ('Dade', 'O'), ('County', 'O'), (',', 'O'), ('Florida', 'O'), (',', 'O'), ('from', 'O'), ('1969', 'O'), ('-', 'O'), ('1990', 'O'), (',', 'O'), ('58', 'O'), ('EDDs', 'B'), ('were', 'O'), ('compared', 'O'), ('with', 'O'), ('125', 'O'), ('victims', 'O'), ('of', 'O'), ('accidental', 'O'), ('cocaine', 'O'), ('overdose', 'B'), ('without', 'O'), ('excited', 'O'), ('delirium', 'B'), ('.', 'O'))$$$"
"They were less likely to have a low body mass index , and more likely to have died in police custody , to have received medical treatment immediately before death , to have survived for a longer period , to have developed hyperthermia , and to have died in summer months .","(('They', 'O'), ('were', 'O'), ('less', 'O'), ('likely', 'O'), ('to', 'O'), ('have', 'O'), ('a', 'O'), ('low', 'O'), ('body', 'O'), ('mass', 'O'), ('index', 'O'), (',', 'O'), ('and', 'O'), ('more', 'O'), ('likely', 'O'), ('to', 'O'), ('have', 'O'), ('died', 'O'), ('in', 'O'), ('police', 'O'), ('custody', 'O'), (',', 'O'), ('to', 'O'), ('have', 'O'), ('received', 'O'), ('medical', 'O'), ('treatment', 'O'), ('immediately', 'O'), ('before', 'O'), ('death', 'O'), (',', 'O'), ('to', 'O'), ('have', 'O'), ('survived', 'O'), ('for', 'O'), ('a', 'O'), ('longer', 'O'), ('period', 'O'), (',', 'O'), ('to', 'O'), ('have', 'O'), ('developed', 'O'), ('hyperthermia', 'B'), (',', 'O'), ('and', 'O'), ('to', 'O'), ('have', 'O'), ('died', 'O'), ('in', 'O'), ('summer', 'O'), ('months', 'O'), ('.', 'O'))$$$"
The children received gastrointestinal decontamination and high doses of intravenous benzodiazepines in an attempt to control the choreoathetoid movements .,"(('The', 'O'), ('children', 'O'), ('received', 'O'), ('gastrointestinal', 'O'), ('decontamination', 'O'), ('and', 'O'), ('high', 'O'), ('doses', 'O'), ('of', 'O'), ('intravenous', 'O'), ('benzodiazepines', 'O'), ('in', 'O'), ('an', 'O'), ('attempt', 'O'), ('to', 'O'), ('control', 'O'), ('the', 'O'), ('choreoathetoid', 'B'), ('movements', 'O'), ('.', 'O'))$$$"
The possibility of choreoathetoid movements should be considered in patients presenting after pemoline overdose .,"(('The', 'O'), ('possibility', 'O'), ('of', 'O'), ('choreoathetoid', 'B'), ('movements', 'O'), ('should', 'O'), ('be', 'O'), ('considered', 'O'), ('in', 'O'), ('patients', 'O'), ('presenting', 'O'), ('after', 'O'), ('pemoline', 'O'), ('overdose', 'B'), ('.', 'O'))$$$"
"During the follow - up , 3 patients ( 12 % ) developed steroid - induced elevated intraocular pressure ( IOP ) that resolved after corticosteroid therapy was discontinued .","(('During', 'O'), ('the', 'O'), ('follow', 'O'), ('-', 'O'), ('up', 'O'), (',', 'O'), ('3', 'O'), ('patients', 'O'), ('(', 'O'), ('12', 'O'), ('%', 'O'), (')', 'O'), ('developed', 'O'), ('steroid', 'O'), ('-', 'O'), ('induced', 'O'), ('elevated', 'B'), ('intraocular', 'I'), ('pressure', 'I'), ('(', 'O'), ('IOP', 'O'), (')', 'O'), ('that', 'O'), ('resolved', 'O'), ('after', 'O'), ('corticosteroid', 'O'), ('therapy', 'O'), ('was', 'O'), ('discontinued', 'O'), ('.', 'O'))$$$"
Superoxide and hydrogen peroxide production by ALF neutrophils stimulated with zymosan opsonized with ALF serum was significantly reduced compared with the control subjects ( P < 0 . 01 ) .,"(('Superoxide', 'O'), ('and', 'O'), ('hydrogen', 'O'), ('peroxide', 'O'), ('production', 'O'), ('by', 'O'), ('ALF', 'B'), ('neutrophils', 'O'), ('stimulated', 'O'), ('with', 'O'), ('zymosan', 'O'), ('opsonized', 'O'), ('with', 'O'), ('ALF', 'B'), ('serum', 'O'), ('was', 'O'), ('significantly', 'O'), ('reduced', 'O'), ('compared', 'O'), ('with', 'O'), ('the', 'O'), ('control', 'O'), ('subjects', 'O'), ('(', 'O'), ('P', 'O'), ('<', 'O'), ('0', 'O'), ('.', 'O'), ('01', 'O'), (')', 'O'), ('.', 'O'))$$$"
Neuroactive steroids protect against pilocarpine - and kainic acid - induced limbic seizures and status epilepticus in mice .,"(('Neuroactive', 'O'), ('steroids', 'O'), ('protect', 'O'), ('against', 'O'), ('pilocarpine', 'O'), ('-', 'O'), ('and', 'O'), ('kainic', 'O'), ('acid', 'O'), ('-', 'O'), ('induced', 'O'), ('limbic', 'O'), ('seizures', 'B'), ('and', 'O'), ('status', 'B'), ('epilepticus', 'I'), ('in', 'O'), ('mice', 'O'), ('.', 'O'))$$$"
"Steroids with the 3 - hydroxy group in the alpha - position and 5 - H in the alpha - or beta - configurations were highly effective in protecting against pilocarpine ( 416 mg / kg , s . c . ) - induced limbic motor seizures and status epilepticus ( ED50 values , 7 . 0 - 18 . 7 mg / kg , i . p . ) .","(('Steroids', 'O'), ('with', 'O'), ('the', 'O'), ('3', 'O'), ('-', 'O'), ('hydroxy', 'O'), ('group', 'O'), ('in', 'O'), ('the', 'O'), ('alpha', 'O'), ('-', 'O'), ('position', 'O'), ('and', 'O'), ('5', 'O'), ('-', 'O'), ('H', 'O'), ('in', 'O'), ('the', 'O'), ('alpha', 'O'), ('-', 'O'), ('or', 'O'), ('beta', 'O'), ('-', 'O'), ('configurations', 'O'), ('were', 'O'), ('highly', 'O'), ('effective', 'O'), ('in', 'O'), ('protecting', 'O'), ('against', 'O'), ('pilocarpine', 'O'), ('(', 'O'), ('416', 'O'), ('mg', 'O'), ('/', 'O'), ('kg', 'O'), (',', 'O'), ('s', 'O'), ('.', 'O'), ('c', 'O'), ('.', 'O'), (')', 'O'), ('-', 'O'), ('induced', 'O'), ('limbic', 'O'), ('motor', 'O'), ('seizures', 'B'), ('and', 'O'), ('status', 'B'), ('epilepticus', 'I'), ('(', 'O'), ('ED50', 'O'), ('values', 'O'), (',', 'O'), ('7', 'O'), ('.', 'O'), ('0', 'O'), ('-', 'O'), ('18', 'O'), ('.', 'O'), ('7', 'O'), ('mg', 'O'), ('/', 'O'), ('kg', 'O'), (',', 'O'), ('i', 'O'), ('.', 'O'), ('p', 'O'), ('.', 'O'), (')', 'O'), ('.', 'O'))$$$"
"Although the neuroactive steroids were considerably less potent than the benzodiazepine clonazepam in protecting against pilocarpine seizures , steroids with the 5 alpha , 3 alpha - configuration had comparable or higher protective index values ( TD50 for motor impairment divided by ED50 for seizure protection ) than clonazepam , indicating that some neuroactive steroids may have lower relative toxicity .","(('Although', 'O'), ('the', 'O'), ('neuroactive', 'O'), ('steroids', 'O'), ('were', 'O'), ('considerably', 'O'), ('less', 'O'), ('potent', 'O'), ('than', 'O'), ('the', 'O'), ('benzodiazepine', 'O'), ('clonazepam', 'O'), ('in', 'O'), ('protecting', 'O'), ('against', 'O'), ('pilocarpine', 'O'), ('seizures', 'B'), (',', 'O'), ('steroids', 'O'), ('with', 'O'), ('the', 'O'), ('5', 'O'), ('alpha', 'O'), (',', 'O'), ('3', 'O'), ('alpha', 'O'), ('-', 'O'), ('configuration', 'O'), ('had', 'O'), ('comparable', 'O'), ('or', 'O'), ('higher', 'O'), ('protective', 'O'), ('index', 'O'), ('values', 'O'), ('(', 'O'), ('TD50', 'O'), ('for', 'O'), ('motor', 'O'), ('impairment', 'O'), ('divided', 'O'), ('by', 'O'), ('ED50', 'O'), ('for', 'O'), ('seizure', 'B'), ('protection', 'O'), (')', 'O'), ('than', 'O'), ('clonazepam', 'O'), (',', 'O'), ('indicating', 'O'), ('that', 'O'), ('some', 'O'), ('neuroactive', 'O'), ('steroids', 'O'), ('may', 'O'), ('have', 'O'), ('lower', 'O'), ('relative', 'O'), ('toxicity', 'B'), ('.', 'O'))$$$"
"Steroids with the 5 alpha , 3 alpha - or 5 beta , 3 alpha - configurations also produced a dose - dependent delay in the onset of limbic seizures induced by kainic acid ( 32 mg / kg , s . c . ) , but did not completely protect against the seizures .","(('Steroids', 'O'), ('with', 'O'), ('the', 'O'), ('5', 'O'), ('alpha', 'O'), (',', 'O'), ('3', 'O'), ('alpha', 'O'), ('-', 'O'), ('or', 'O'), ('5', 'O'), ('beta', 'O'), (',', 'O'), ('3', 'O'), ('alpha', 'O'), ('-', 'O'), ('configurations', 'O'), ('also', 'O'), ('produced', 'O'), ('a', 'O'), ('dose', 'O'), ('-', 'O'), ('dependent', 'O'), ('delay', 'O'), ('in', 'O'), ('the', 'O'), ('onset', 'O'), ('of', 'O'), ('limbic', 'O'), ('seizures', 'B'), ('induced', 'O'), ('by', 'O'), ('kainic', 'O'), ('acid', 'O'), ('(', 'O'), ('32', 'O'), ('mg', 'O'), ('/', 'O'), ('kg', 'O'), (',', 'O'), ('s', 'O'), ('.', 'O'), ('c', 'O'), ('.', 'O'), (')', 'O'), (',', 'O'), ('but', 'O'), ('did', 'O'), ('not', 'O'), ('completely', 'O'), ('protect', 'O'), ('against', 'O'), ('the', 'O'), ('seizures', 'B'), ('.', 'O'))$$$"
"However , when a second dose of the steroid was administered 1 hr after the first dose , complete protection from the kainic acid - induced limbic seizures and status epilepticus was obtained .","(('However', 'O'), (',', 'O'), ('when', 'O'), ('a', 'O'), ('second', 'O'), ('dose', 'O'), ('of', 'O'), ('the', 'O'), ('steroid', 'O'), ('was', 'O'), ('administered', 'O'), ('1', 'O'), ('hr', 'O'), ('after', 'O'), ('the', 'O'), ('first', 'O'), ('dose', 'O'), (',', 'O'), ('complete', 'O'), ('protection', 'O'), ('from', 'O'), ('the', 'O'), ('kainic', 'O'), ('acid', 'O'), ('-', 'O'), ('induced', 'O'), ('limbic', 'O'), ('seizures', 'B'), ('and', 'O'), ('status', 'B'), ('epilepticus', 'I'), ('was', 'O'), ('obtained', 'O'), ('.', 'O'))$$$"
Hepatic and extrahepatic angiotensinogen gene expression in rats with acute nephrotic syndrome .,"(('Hepatic', 'O'), ('and', 'O'), ('extrahepatic', 'O'), ('angiotensinogen', 'O'), ('gene', 'O'), ('expression', 'O'), ('in', 'O'), ('rats', 'O'), ('with', 'O'), ('acute', 'O'), ('nephrotic', 'B'), ('syndrome', 'I'), ('.', 'O'))$$$"
"With this low frequency of extrapyramidal symptoms , it was thought the frequency of neuroleptic malignant syndrome might also be lowered .","(('With', 'O'), ('this', 'O'), ('low', 'O'), ('frequency', 'O'), ('of', 'O'), ('extrapyramidal', 'B'), ('symptoms', 'I'), (',', 'O'), ('it', 'O'), ('was', 'O'), ('thought', 'O'), ('the', 'O'), ('frequency', 'O'), ('of', 'O'), ('neuroleptic', 'B'), ('malignant', 'I'), ('syndrome', 'I'), ('might', 'O'), ('also', 'O'), ('be', 'O'), ('lowered', 'O'), ('.', 'O'))$$$"
A 73 - year - old woman developed neuroleptic malignant syndrome after monotherapy with risperidone .,"(('A', 'O'), ('73', 'O'), ('-', 'O'), ('year', 'O'), ('-', 'O'), ('old', 'O'), ('woman', 'O'), ('developed', 'O'), ('neuroleptic', 'B'), ('malignant', 'I'), ('syndrome', 'I'), ('after', 'O'), ('monotherapy', 'O'), ('with', 'O'), ('risperidone', 'O'), ('.', 'O'))$$$"
It appears that the protection from extrapyramidal side effects observed with risperidone does not ensure protection from neuroleptic malignant syndrome .,"(('It', 'O'), ('appears', 'O'), ('that', 'O'), ('the', 'O'), ('protection', 'O'), ('from', 'O'), ('extrapyramidal', 'O'), ('side', 'O'), ('effects', 'O'), ('observed', 'O'), ('with', 'O'), ('risperidone', 'O'), ('does', 'O'), ('not', 'O'), ('ensure', 'O'), ('protection', 'O'), ('from', 'O'), ('neuroleptic', 'B'), ('malignant', 'I'), ('syndrome', 'I'), ('.', 'O'))$$$"
Carteolol did not evoke postsynaptic dopamine receptor - stimulating behavioral signs such as stereotypy and hyperlocomotion in rats .,"(('Carteolol', 'O'), ('did', 'O'), ('not', 'O'), ('evoke', 'O'), ('postsynaptic', 'O'), ('dopamine', 'O'), ('receptor', 'O'), ('-', 'O'), ('stimulating', 'O'), ('behavioral', 'O'), ('signs', 'O'), ('such', 'O'), ('as', 'O'), ('stereotypy', 'O'), ('and', 'O'), ('hyperlocomotion', 'B'), ('in', 'O'), ('rats', 'O'), ('.', 'O'))$$$"
Review of the literature reveals an association between tamoxifen use and gynecologic tumors .,"(('Review', 'O'), ('of', 'O'), ('the', 'O'), ('literature', 'O'), ('reveals', 'O'), ('an', 'O'), ('association', 'O'), ('between', 'O'), ('tamoxifen', 'O'), ('use', 'O'), ('and', 'O'), ('gynecologic', 'O'), ('tumors', 'B'), ('.', 'O'))$$$"
AZT has induced a macrocytic anemia in AIDS patients on long term AZT therapy .,"(('AZT', 'O'), ('has', 'O'), ('induced', 'O'), ('a', 'O'), ('macrocytic', 'B'), ('anemia', 'I'), ('in', 'O'), ('AIDS', 'B'), ('patients', 'O'), ('on', 'O'), ('long', 'O'), ('term', 'O'), ('AZT', 'O'), ('therapy', 'O'), ('.', 'O'))$$$"
"There were two cases of hypocellular myelodysplasia , two cases of hypersegmented myelodysplastic granulocytosis , two cases of hypercellular marrow with abnormal megakaryocytes with bizarre nuclei , one case of megakaryocytic myelosis associated with a hyperplastic marrow , dysmyelopoiesis and a hypocellular marrow and two cases of myelodysplasia with dyserythropoiesis , hemosiderosis and a hypocellular marrow .","(('There', 'O'), ('were', 'O'), ('two', 'O'), ('cases', 'O'), ('of', 'O'), ('hypocellular', 'O'), ('myelodysplasia', 'B'), (',', 'O'), ('two', 'O'), ('cases', 'O'), ('of', 'O'), ('hypersegmented', 'O'), ('myelodysplastic', 'B'), ('granulocytosis', 'O'), (',', 'O'), ('two', 'O'), ('cases', 'O'), ('of', 'O'), ('hypercellular', 'O'), ('marrow', 'O'), ('with', 'O'), ('abnormal', 'O'), ('megakaryocytes', 'O'), ('with', 'O'), ('bizarre', 'O'), ('nuclei', 'O'), (',', 'O'), ('one', 'O'), ('case', 'O'), ('of', 'O'), ('megakaryocytic', 'O'), ('myelosis', 'O'), ('associated', 'O'), ('with', 'O'), ('a', 'O'), ('hyperplastic', 'B'), ('marrow', 'I'), (',', 'O'), ('dysmyelopoiesis', 'B'), ('and', 'O'), ('a', 'O'), ('hypocellular', 'B'), ('marrow', 'I'), ('and', 'O'), ('two', 'O'), ('cases', 'O'), ('of', 'O'), ('myelodysplasia', 'B'), ('with', 'O'), ('dyserythropoiesis', 'B'), (',', 'O'), ('hemosiderosis', 'B'), ('and', 'O'), ('a', 'O'), ('hypocellular', 'B'), ('marrow', 'I'), ('.', 'O'))$$$"
"Above mentioned AZT incorporation may have induced an ineffective hemopoiesis in the primitive hemopoietic progenitor cells , which is known to be seen commonly in the myelodysplastic syndrome .","(('Above', 'O'), ('mentioned', 'O'), ('AZT', 'O'), ('incorporation', 'O'), ('may', 'O'), ('have', 'O'), ('induced', 'O'), ('an', 'O'), ('ineffective', 'O'), ('hemopoiesis', 'O'), ('in', 'O'), ('the', 'O'), ('primitive', 'O'), ('hemopoietic', 'O'), ('progenitor', 'O'), ('cells', 'O'), (',', 'O'), ('which', 'O'), ('is', 'O'), ('known', 'O'), ('to', 'O'), ('be', 'O'), ('seen', 'O'), ('commonly', 'O'), ('in', 'O'), ('the', 'O'), ('myelodysplastic', 'B'), ('syndrome', 'I'), ('.', 'O'))$$$"
We report the case of a patient who developed severe hypernatraemic dehydration following a head injury .,"(('We', 'O'), ('report', 'O'), ('the', 'O'), ('case', 'O'), ('of', 'O'), ('a', 'O'), ('patient', 'O'), ('who', 'O'), ('developed', 'O'), ('severe', 'O'), ('hypernatraemic', 'O'), ('dehydration', 'B'), ('following', 'O'), ('a', 'O'), ('head', 'B'), ('injury', 'I'), ('.', 'O'))$$$"
"He remained thirsty and polyuric despite cessation of lithium and investigations on admission showed him to have normal osmoregulated thirst and vasopressin secretion , with clear evidence of nephrogenic diabetes insipidus .","(('He', 'O'), ('remained', 'O'), ('thirsty', 'O'), ('and', 'O'), ('polyuric', 'B'), ('despite', 'O'), ('cessation', 'O'), ('of', 'O'), ('lithium', 'O'), ('and', 'O'), ('investigations', 'O'), ('on', 'O'), ('admission', 'O'), ('showed', 'O'), ('him', 'O'), ('to', 'O'), ('have', 'O'), ('normal', 'O'), ('osmoregulated', 'O'), ('thirst', 'O'), ('and', 'O'), ('vasopressin', 'O'), ('secretion', 'O'), (',', 'O'), ('with', 'O'), ('clear', 'O'), ('evidence', 'O'), ('of', 'O'), ('nephrogenic', 'B'), ('diabetes', 'I'), ('insipidus', 'I'), ('.', 'O'))$$$"
Effect of glyceryl trinitrate on the sphincter of Oddi spasm evoked by prostigmine - morphine administration .,"(('Effect', 'O'), ('of', 'O'), ('glyceryl', 'O'), ('trinitrate', 'O'), ('on', 'O'), ('the', 'O'), ('sphincter', 'B'), ('of', 'I'), ('Oddi', 'I'), ('spasm', 'I'), ('evoked', 'O'), ('by', 'O'), ('prostigmine', 'O'), ('-', 'O'), ('morphine', 'O'), ('administration', 'O'), ('.', 'O'))$$$"
OBJECTIVE : In this study the effect of glyceryl trinitrate on the prostigmine - morphine - induced sphincter of Oddi spasm was evaluated in nine female patients with sphincter of Oddi dyskinesia .,"(('OBJECTIVE', 'O'), (':', 'O'), ('In', 'O'), ('this', 'O'), ('study', 'O'), ('the', 'O'), ('effect', 'O'), ('of', 'O'), ('glyceryl', 'O'), ('trinitrate', 'O'), ('on', 'O'), ('the', 'O'), ('prostigmine', 'O'), ('-', 'O'), ('morphine', 'O'), ('-', 'O'), ('induced', 'O'), ('sphincter', 'B'), ('of', 'I'), ('Oddi', 'I'), ('spasm', 'I'), ('was', 'O'), ('evaluated', 'O'), ('in', 'O'), ('nine', 'O'), ('female', 'O'), ('patients', 'O'), ('with', 'O'), ('sphincter', 'B'), ('of', 'I'), ('Oddi', 'I'), ('dyskinesia', 'I'), ('.', 'O'))$$$"
METHOD : Sphincter of Oddi spasm was induced by prostigmine - morphine administration ( 0 . 5 mg prostigmine intramuscularly and 10 mg morphine subcutaneously ) and visualized by quantitative hepatobiliary scintigraphy .,"(('METHOD', 'O'), (':', 'O'), ('Sphincter', 'B'), ('of', 'I'), ('Oddi', 'I'), ('spasm', 'I'), ('was', 'O'), ('induced', 'O'), ('by', 'O'), ('prostigmine', 'O'), ('-', 'O'), ('morphine', 'O'), ('administration', 'O'), ('(', 'O'), ('0', 'O'), ('.', 'O'), ('5', 'O'), ('mg', 'O'), ('prostigmine', 'O'), ('intramuscularly', 'O'), ('and', 'O'), ('10', 'O'), ('mg', 'O'), ('morphine', 'O'), ('subcutaneously', 'O'), (')', 'O'), ('and', 'O'), ('visualized', 'O'), ('by', 'O'), ('quantitative', 'O'), ('hepatobiliary', 'O'), ('scintigraphy', 'O'), ('.', 'O'))$$$"
CONCLUSION : These results provide the first evidence of the effectiveness of glyceryl trinitrate on the morphine - induced sphincter of Oddi spasm in humans .,"(('CONCLUSION', 'O'), (':', 'O'), ('These', 'O'), ('results', 'O'), ('provide', 'O'), ('the', 'O'), ('first', 'O'), ('evidence', 'O'), ('of', 'O'), ('the', 'O'), ('effectiveness', 'O'), ('of', 'O'), ('glyceryl', 'O'), ('trinitrate', 'O'), ('on', 'O'), ('the', 'O'), ('morphine', 'O'), ('-', 'O'), ('induced', 'O'), ('sphincter', 'B'), ('of', 'I'), ('Oddi', 'I'), ('spasm', 'I'), ('in', 'O'), ('humans', 'O'), ('.', 'O'))$$$"
"Since glyceryl trinitrate is able to overcome even the drastic effect of morphine , it might be of relevance in the treatment of sphincter of Oddi dyskinesia .","(('Since', 'O'), ('glyceryl', 'O'), ('trinitrate', 'O'), ('is', 'O'), ('able', 'O'), ('to', 'O'), ('overcome', 'O'), ('even', 'O'), ('the', 'O'), ('drastic', 'O'), ('effect', 'O'), ('of', 'O'), ('morphine', 'O'), (',', 'O'), ('it', 'O'), ('might', 'O'), ('be', 'O'), ('of', 'O'), ('relevance', 'O'), ('in', 'O'), ('the', 'O'), ('treatment', 'O'), ('of', 'O'), ('sphincter', 'B'), ('of', 'I'), ('Oddi', 'I'), ('dyskinesia', 'I'), ('.', 'O'))$$$"
Experimental cranial pain elicited by capsaicin : a PET study .,"(('Experimental', 'O'), ('cranial', 'O'), ('pain', 'B'), ('elicited', 'O'), ('by', 'O'), ('capsaicin', 'O'), (':', 'O'), ('a', 'O'), ('PET', 'O'), ('study', 'O'), ('.', 'O'))$$$"
"Using a positron emission tomography ( PET ) study it was shown recently that in migraine without aura certain areas in the brain stem were activated during the headache state , but not in the headache free interval .","(('Using', 'O'), ('a', 'O'), ('positron', 'O'), ('emission', 'O'), ('tomography', 'O'), ('(', 'O'), ('PET', 'O'), (')', 'O'), ('study', 'O'), ('it', 'O'), ('was', 'O'), ('shown', 'O'), ('recently', 'O'), ('that', 'O'), ('in', 'O'), ('migraine', 'B'), ('without', 'O'), ('aura', 'O'), ('certain', 'O'), ('areas', 'O'), ('in', 'O'), ('the', 'O'), ('brain', 'O'), ('stem', 'O'), ('were', 'O'), ('activated', 'O'), ('during', 'O'), ('the', 'O'), ('headache', 'B'), ('state', 'O'), (',', 'O'), ('but', 'O'), ('not', 'O'), ('in', 'O'), ('the', 'O'), ('headache', 'B'), ('free', 'O'), ('interval', 'O'), ('.', 'O'))$$$"
Using the same stereotactic space limits as in the above mentioned migraine study no brain stem activation was found in the acute pain state compared to the pain free state .,"(('Using', 'O'), ('the', 'O'), ('same', 'O'), ('stereotactic', 'O'), ('space', 'O'), ('limits', 'O'), ('as', 'O'), ('in', 'O'), ('the', 'O'), ('above', 'O'), ('mentioned', 'O'), ('migraine', 'B'), ('study', 'O'), ('no', 'O'), ('brain', 'O'), ('stem', 'O'), ('activation', 'O'), ('was', 'O'), ('found', 'O'), ('in', 'O'), ('the', 'O'), ('acute', 'O'), ('pain', 'B'), ('state', 'O'), ('compared', 'O'), ('to', 'O'), ('the', 'O'), ('pain', 'B'), ('free', 'O'), ('state', 'O'), ('.', 'O'))$$$"
"The increase of activation in the region of the cavernous sinus however , suggests that this structure is more likely to be involved in trigeminal transmitted pain as such , rather than in a specific type of headache as was suggested for cluster headache .","(('The', 'O'), ('increase', 'O'), ('of', 'O'), ('activation', 'O'), ('in', 'O'), ('the', 'O'), ('region', 'O'), ('of', 'O'), ('the', 'O'), ('cavernous', 'O'), ('sinus', 'O'), ('however', 'O'), (',', 'O'), ('suggests', 'O'), ('that', 'O'), ('this', 'O'), ('structure', 'O'), ('is', 'O'), ('more', 'O'), ('likely', 'O'), ('to', 'O'), ('be', 'O'), ('involved', 'O'), ('in', 'O'), ('trigeminal', 'O'), ('transmitted', 'O'), ('pain', 'B'), ('as', 'O'), ('such', 'O'), (',', 'O'), ('rather', 'O'), ('than', 'O'), ('in', 'O'), ('a', 'O'), ('specific', 'O'), ('type', 'O'), ('of', 'O'), ('headache', 'B'), ('as', 'O'), ('was', 'O'), ('suggested', 'O'), ('for', 'O'), ('cluster', 'B'), ('headache', 'I'), ('.', 'O'))$$$"
Value of methylprednisolone in prevention of the arthralgia - myalgia syndrome associated with the total dose infusion of iron dextran : a double blind randomized trial .,"(('Value', 'O'), ('of', 'O'), ('methylprednisolone', 'O'), ('in', 'O'), ('prevention', 'O'), ('of', 'O'), ('the', 'O'), ('arthralgia', 'B'), ('-', 'O'), ('myalgia', 'B'), ('syndrome', 'O'), ('associated', 'O'), ('with', 'O'), ('the', 'O'), ('total', 'O'), ('dose', 'O'), ('infusion', 'O'), ('of', 'O'), ('iron', 'O'), ('dextran', 'O'), (':', 'O'), ('a', 'O'), ('double', 'O'), ('blind', 'O'), ('randomized', 'O'), ('trial', 'O'), ('.', 'O'))$$$"
"In 40 % of treated patients , an arthralgia - myalgia syndrome develops .","(('In', 'O'), ('40', 'O'), ('%', 'O'), ('of', 'O'), ('treated', 'O'), ('patients', 'O'), (',', 'O'), ('an', 'O'), ('arthralgia', 'B'), ('-', 'O'), ('myalgia', 'B'), ('syndrome', 'O'), ('develops', 'O'), ('.', 'O'))$$$"
These data demonstrate that administration of MP before and after TDI reduces the frequency and severity of the arthralgia - myalgia syndrome .,"(('These', 'O'), ('data', 'O'), ('demonstrate', 'O'), ('that', 'O'), ('administration', 'O'), ('of', 'O'), ('MP', 'O'), ('before', 'O'), ('and', 'O'), ('after', 'O'), ('TDI', 'O'), ('reduces', 'O'), ('the', 'O'), ('frequency', 'O'), ('and', 'O'), ('severity', 'O'), ('of', 'O'), ('the', 'O'), ('arthralgia', 'B'), ('-', 'O'), ('myalgia', 'B'), ('syndrome', 'O'), ('.', 'O'))$$$"
Prolongation of the QT interval related to cisapride - diltiazem interaction .,"(('Prolongation', 'B'), ('of', 'I'), ('the', 'I'), ('QT', 'I'), ('interval', 'I'), ('related', 'O'), ('to', 'O'), ('cisapride', 'O'), ('-', 'O'), ('diltiazem', 'O'), ('interaction', 'O'), ('.', 'O'))$$$"
Cortical motor overactivation in parkinsonian patients with L - dopa - induced peak - dose dyskinesia .,"(('Cortical', 'O'), ('motor', 'O'), ('overactivation', 'O'), ('in', 'O'), ('parkinsonian', 'B'), ('patients', 'O'), ('with', 'O'), ('L', 'O'), ('-', 'O'), ('dopa', 'O'), ('-', 'O'), ('induced', 'O'), ('peak', 'O'), ('-', 'O'), ('dose', 'O'), ('dyskinesia', 'B'), ('.', 'O'))$$$"
"The dyskinetic parkinsonian patients exhibited a pattern of response which was markedly different from those of the normal subjects and non - dyskinetic parkinsonian patients , with a significant overactivation in the supplementary motor area and the ipsi - and contralateral primary motor areas .","(('The', 'O'), ('dyskinetic', 'B'), ('parkinsonian', 'B'), ('patients', 'O'), ('exhibited', 'O'), ('a', 'O'), ('pattern', 'O'), ('of', 'O'), ('response', 'O'), ('which', 'O'), ('was', 'O'), ('markedly', 'O'), ('different', 'O'), ('from', 'O'), ('those', 'O'), ('of', 'O'), ('the', 'O'), ('normal', 'O'), ('subjects', 'O'), ('and', 'O'), ('non', 'O'), ('-', 'O'), ('dyskinetic', 'B'), ('parkinsonian', 'B'), ('patients', 'O'), (',', 'O'), ('with', 'O'), ('a', 'O'), ('significant', 'O'), ('overactivation', 'O'), ('in', 'O'), ('the', 'O'), ('supplementary', 'O'), ('motor', 'O'), ('area', 'O'), ('and', 'O'), ('the', 'O'), ('ipsi', 'O'), ('-', 'O'), ('and', 'O'), ('contralateral', 'O'), ('primary', 'O'), ('motor', 'O'), ('areas', 'O'), ('.', 'O'))$$$"
Women who had endometrial cancer and had received tamoxifen had more advanced disease and poorer prognosis than those with endometrial cancer who had not received this treatment .,"(('Women', 'O'), ('who', 'O'), ('had', 'O'), ('endometrial', 'B'), ('cancer', 'I'), ('and', 'O'), ('had', 'O'), ('received', 'O'), ('tamoxifen', 'O'), ('had', 'O'), ('more', 'O'), ('advanced', 'B'), ('disease', 'I'), ('and', 'O'), ('poorer', 'O'), ('prognosis', 'O'), ('than', 'O'), ('those', 'O'), ('with', 'O'), ('endometrial', 'B'), ('cancer', 'I'), ('who', 'O'), ('had', 'O'), ('not', 'O'), ('received', 'O'), ('this', 'O'), ('treatment', 'O'), ('.', 'O'))$$$"
"5 , 7 - dichlorokynurenic acid ( 5 , 7 - DCKA ) , a selective glycine site antagonist , injected in doses of 2 . 5 and 4 . 5 microg / 0 . 5 microl bilaterally , into the rostral region of the striatum , decreased both the haloperidol - induced muscle rigidity ( MMG ) and the enhanced electromyographic activity ( EMG ) .","(('5', 'O'), (',', 'O'), ('7', 'O'), ('-', 'O'), ('dichlorokynurenic', 'O'), ('acid', 'O'), ('(', 'O'), ('5', 'O'), (',', 'O'), ('7', 'O'), ('-', 'O'), ('DCKA', 'O'), (')', 'O'), (',', 'O'), ('a', 'O'), ('selective', 'O'), ('glycine', 'O'), ('site', 'O'), ('antagonist', 'O'), (',', 'O'), ('injected', 'O'), ('in', 'O'), ('doses', 'O'), ('of', 'O'), ('2', 'O'), ('.', 'O'), ('5', 'O'), ('and', 'O'), ('4', 'O'), ('.', 'O'), ('5', 'O'), ('microg', 'O'), ('/', 'O'), ('0', 'O'), ('.', 'O'), ('5', 'O'), ('microl', 'O'), ('bilaterally', 'O'), (',', 'O'), ('into', 'O'), ('the', 'O'), ('rostral', 'O'), ('region', 'O'), ('of', 'O'), ('the', 'O'), ('striatum', 'O'), (',', 'O'), ('decreased', 'O'), ('both', 'O'), ('the', 'O'), ('haloperidol', 'O'), ('-', 'O'), ('induced', 'O'), ('muscle', 'B'), ('rigidity', 'I'), ('(', 'O'), ('MMG', 'O'), (')', 'O'), ('and', 'O'), ('the', 'O'), ('enhanced', 'O'), ('electromyographic', 'O'), ('activity', 'O'), ('(', 'O'), ('EMG', 'O'), (')', 'O'), ('.', 'O'))$$$"
BACKGROUND : Irritable bowel syndrome is a common cause of abdominal pain and discomfort and may be related to disordered gastrointestinal motility .,"(('BACKGROUND', 'O'), (':', 'O'), ('Irritable', 'B'), ('bowel', 'I'), ('syndrome', 'I'), ('is', 'O'), ('a', 'O'), ('common', 'O'), ('cause', 'O'), ('of', 'O'), ('abdominal', 'B'), ('pain', 'I'), ('and', 'O'), ('discomfort', 'O'), ('and', 'O'), ('may', 'O'), ('be', 'O'), ('related', 'O'), ('to', 'O'), ('disordered', 'B'), ('gastrointestinal', 'I'), ('motility', 'I'), ('.', 'O'))$$$"
"METHODS : Thirty - eight patients with IBS ( constipation - predominant , n = 17 ; diarrhoea - predominant , n = 21 ) underwent 24 - h ambulatory jejunal manometry before and after 12 week ' s treatment [ cisapride , 5 mg three times daily ( n = 19 ) or placebo ( n = 19 ) ] .","(('METHODS', 'O'), (':', 'O'), ('Thirty', 'O'), ('-', 'O'), ('eight', 'O'), ('patients', 'O'), ('with', 'O'), ('IBS', 'B'), ('(', 'O'), ('constipation', 'B'), ('-', 'O'), ('predominant', 'O'), (',', 'O'), ('n', 'O'), ('=', 'O'), ('17', 'O'), (';', 'O'), ('diarrhoea', 'B'), ('-', 'O'), ('predominant', 'O'), (',', 'O'), ('n', 'O'), ('=', 'O'), ('21', 'O'), (')', 'O'), ('underwent', 'O'), ('24', 'O'), ('-', 'O'), ('h', 'O'), ('ambulatory', 'O'), ('jejunal', 'O'), ('manometry', 'O'), ('before', 'O'), ('and', 'O'), ('after', 'O'), ('12', 'O'), ('week', 'O'), (""'"", 'O'), ('s', 'O'), ('treatment', 'O'), ('[', 'O'), ('cisapride', 'O'), (',', 'O'), ('5', 'O'), ('mg', 'O'), ('three', 'O'), ('times', 'O'), ('daily', 'O'), ('(', 'O'), ('n', 'O'), ('=', 'O'), ('19', 'O'), (')', 'O'), ('or', 'O'), ('placebo', 'O'), ('(', 'O'), ('n', 'O'), ('=', 'O'), ('19', 'O'), (')', 'O'), (']', 'O'), ('.', 'O'))$$$"
"In cisapride - treated diarrhoea - predominant patients the mean contraction amplitude was higher ( 29 . 3 + / - 3 . 2 versus 24 . 9 + / - 2 . 6 mm Hg , cisapride versus placebo ( P < 0 . 001 ) ; pretreatment , 25 . 7 + / - 6 . 0 mm Hg ) , the mean contraction duration longer ( 3 . 4 + / - 0 . 2 versus 3 . 0 + / - 0 . 2 sec , cisapride versus placebo ( P < 0 . 001 ) ;","(('In', 'O'), ('cisapride', 'O'), ('-', 'O'), ('treated', 'O'), ('diarrhoea', 'B'), ('-', 'O'), ('predominant', 'O'), ('patients', 'O'), ('the', 'O'), ('mean', 'O'), ('contraction', 'O'), ('amplitude', 'O'), ('was', 'O'), ('higher', 'O'), ('(', 'O'), ('29', 'O'), ('.', 'O'), ('3', 'O'), ('+', 'O'), ('/', 'O'), ('-', 'O'), ('3', 'O'), ('.', 'O'), ('2', 'O'), ('versus', 'O'), ('24', 'O'), ('.', 'O'), ('9', 'O'), ('+', 'O'), ('/', 'O'), ('-', 'O'), ('2', 'O'), ('.', 'O'), ('6', 'O'), ('mm', 'O'), ('Hg', 'O'), (',', 'O'), ('cisapride', 'O'), ('versus', 'O'), ('placebo', 'O'), ('(', 'O'), ('P', 'O'), ('<', 'O'), ('0', 'O'), ('.', 'O'), ('001', 'O'), (')', 'O'), (';', 'O'), ('pretreatment', 'O'), (',', 'O'), ('25', 'O'), ('.', 'O'), ('7', 'O'), ('+', 'O'), ('/', 'O'), ('-', 'O'), ('6', 'O'), ('.', 'O'), ('0', 'O'), ('mm', 'O'), ('Hg', 'O'), (')', 'O'), (',', 'O'), ('the', 'O'), ('mean', 'O'), ('contraction', 'O'), ('duration', 'O'), ('longer', 'O'), ('(', 'O'), ('3', 'O'), ('.', 'O'), ('4', 'O'), ('+', 'O'), ('/', 'O'), ('-', 'O'), ('0', 'O'), ('.', 'O'), ('2', 'O'), ('versus', 'O'), ('3', 'O'), ('.', 'O'), ('0', 'O'), ('+', 'O'), ('/', 'O'), ('-', 'O'), ('0', 'O'), ('.', 'O'), ('2', 'O'), ('sec', 'O'), (',', 'O'), ('cisapride', 'O'), ('versus', 'O'), ('placebo', 'O'), ('(', 'O'), ('P', 'O'), ('<', 'O'), ('0', 'O'), ('.', 'O'), ('001', 'O'), (')', 'O'), (';', 'O'))$$$"
"Diarrhoea - predominant IBS patients had a higher pain score after cisapride therapy [ score , 55 + / - 15 versus 34 + / - 12 mm , cisapride versus placebo ( P < 0 . 05 ) ; pretreatment , 67 + / - 19 mm ] .","(('Diarrhoea', 'B'), ('-', 'O'), ('predominant', 'O'), ('IBS', 'B'), ('patients', 'O'), ('had', 'O'), ('a', 'O'), ('higher', 'O'), ('pain', 'B'), ('score', 'O'), ('after', 'O'), ('cisapride', 'O'), ('therapy', 'O'), ('[', 'O'), ('score', 'O'), (',', 'O'), ('55', 'O'), ('+', 'O'), ('/', 'O'), ('-', 'O'), ('15', 'O'), ('versus', 'O'), ('34', 'O'), ('+', 'O'), ('/', 'O'), ('-', 'O'), ('12', 'O'), ('mm', 'O'), (',', 'O'), ('cisapride', 'O'), ('versus', 'O'), ('placebo', 'O'), ('(', 'O'), ('P', 'O'), ('<', 'O'), ('0', 'O'), ('.', 'O'), ('05', 'O'), (')', 'O'), (';', 'O'), ('pretreatment', 'O'), (',', 'O'), ('67', 'O'), ('+', 'O'), ('/', 'O'), ('-', 'O'), ('19', 'O'), ('mm', 'O'), (']', 'O'), ('.', 'O'))$$$"
The primary endpoints are the occurrence of and deaths from breast cancer .,"(('The', 'O'), ('primary', 'O'), ('endpoints', 'O'), ('are', 'O'), ('the', 'O'), ('occurrence', 'O'), ('of', 'O'), ('and', 'O'), ('deaths', 'O'), ('from', 'O'), ('breast', 'B'), ('cancer', 'I'), ('.', 'O'))$$$"
41 cases of breast cancer occurred so far ; there have been no deaths from breast cancer .,"(('41', 'O'), ('cases', 'O'), ('of', 'O'), ('breast', 'B'), ('cancer', 'I'), ('occurred', 'O'), ('so', 'O'), ('far', 'O'), (';', 'O'), ('there', 'O'), ('have', 'O'), ('been', 'O'), ('no', 'O'), ('deaths', 'O'), ('from', 'O'), ('breast', 'B'), ('cancer', 'I'), ('.', 'O'))$$$"
"Compared with the placebo group , there was a significantly increased risk of vascular events and hypertriglyceridaemia among women on tamoxifen .","(('Compared', 'O'), ('with', 'O'), ('the', 'O'), ('placebo', 'O'), ('group', 'O'), (',', 'O'), ('there', 'O'), ('was', 'O'), ('a', 'O'), ('significantly', 'O'), ('increased', 'O'), ('risk', 'O'), ('of', 'O'), ('vascular', 'B'), ('events', 'I'), ('and', 'O'), ('hypertriglyceridaemia', 'B'), ('among', 'O'), ('women', 'O'), ('on', 'O'), ('tamoxifen', 'O'), ('.', 'O'))$$$"
There were no deaths from breast cancer recorded in women in the study .,"(('There', 'O'), ('were', 'O'), ('no', 'O'), ('deaths', 'O'), ('from', 'O'), ('breast', 'B'), ('cancer', 'I'), ('recorded', 'O'), ('in', 'O'), ('women', 'O'), ('in', 'O'), ('the', 'O'), ('study', 'O'), ('.', 'O'))$$$"
The association of cocaine and amphetamine use with hemorrhagic and ischemic stroke is based almost solely on data from case series .,"(('The', 'O'), ('association', 'O'), ('of', 'O'), ('cocaine', 'O'), ('and', 'O'), ('amphetamine', 'O'), ('use', 'O'), ('with', 'O'), ('hemorrhagic', 'O'), ('and', 'O'), ('ischemic', 'B'), ('stroke', 'B'), ('is', 'O'), ('based', 'O'), ('almost', 'O'), ('solely', 'O'), ('on', 'O'), ('data', 'O'), ('from', 'O'), ('case', 'O'), ('series', 'O'), ('.', 'O'))$$$"
"The stage of olig - anuria lasted for 1 - 3 weeks , and five of the patients were treated by hemodialysis .","(('The', 'O'), ('stage', 'O'), ('of', 'O'), ('olig', 'O'), ('-', 'O'), ('anuria', 'B'), ('lasted', 'O'), ('for', 'O'), ('1', 'O'), ('-', 'O'), ('3', 'O'), ('weeks', 'O'), (',', 'O'), ('and', 'O'), ('five', 'O'), ('of', 'O'), ('the', 'O'), ('patients', 'O'), ('were', 'O'), ('treated', 'O'), ('by', 'O'), ('hemodialysis', 'O'), ('.', 'O'))$$$"
"Although in the acute stage the renal lesions histologically appeared toxic , evidence suggestive of an immunological mechanism cannot be excluded .","(('Although', 'O'), ('in', 'O'), ('the', 'O'), ('acute', 'O'), ('stage', 'O'), ('the', 'O'), ('renal', 'B'), ('lesions', 'I'), ('histologically', 'O'), ('appeared', 'O'), ('toxic', 'O'), (',', 'O'), ('evidence', 'O'), ('suggestive', 'O'), ('of', 'O'), ('an', 'O'), ('immunological', 'O'), ('mechanism', 'O'), ('cannot', 'O'), ('be', 'O'), ('excluded', 'O'), ('.', 'O'))$$$"
"Animals which received over six courses of doxorubicin demonstrated the electrocardiogram ( ECG ) changes , decrease of blood pressure and high - grade histopathological cardiomyopathy , while animals which were terminally sacrificed after the SM - 5887 administration did not show any changes in ECG , blood pressure and histopathological examinations .","(('Animals', 'O'), ('which', 'O'), ('received', 'O'), ('over', 'O'), ('six', 'O'), ('courses', 'O'), ('of', 'O'), ('doxorubicin', 'O'), ('demonstrated', 'O'), ('the', 'O'), ('electrocardiogram', 'O'), ('(', 'O'), ('ECG', 'O'), (')', 'O'), ('changes', 'O'), (',', 'O'), ('decrease', 'O'), ('of', 'O'), ('blood', 'O'), ('pressure', 'O'), ('and', 'O'), ('high', 'O'), ('-', 'O'), ('grade', 'O'), ('histopathological', 'O'), ('cardiomyopathy', 'B'), (',', 'O'), ('while', 'O'), ('animals', 'O'), ('which', 'O'), ('were', 'O'), ('terminally', 'O'), ('sacrificed', 'O'), ('after', 'O'), ('the', 'O'), ('SM', 'O'), ('-', 'O'), ('5887', 'O'), ('administration', 'O'), ('did', 'O'), ('not', 'O'), ('show', 'O'), ('any', 'O'), ('changes', 'O'), ('in', 'O'), ('ECG', 'O'), (',', 'O'), ('blood', 'O'), ('pressure', 'O'), ('and', 'O'), ('histopathological', 'O'), ('examinations', 'O'), ('.', 'O'))$$$"
One had baseline bicuspid aortic valve and mild aortic regurgitation that progressed to moderate regurgitation .,"(('One', 'O'), ('had', 'O'), ('baseline', 'O'), ('bicuspid', 'B'), ('aortic', 'I'), ('valve', 'I'), ('and', 'O'), ('mild', 'O'), ('aortic', 'B'), ('regurgitation', 'I'), ('that', 'O'), ('progressed', 'O'), ('to', 'O'), ('moderate', 'O'), ('regurgitation', 'O'), ('.', 'O'))$$$"
"Increased serum creatinine was observed in 73 % of patients in OD versus 57 % of patients in TD , without evidence of nephrotoxicity .","(('Increased', 'O'), ('serum', 'O'), ('creatinine', 'O'), ('was', 'O'), ('observed', 'O'), ('in', 'O'), ('73', 'O'), ('%', 'O'), ('of', 'O'), ('patients', 'O'), ('in', 'O'), ('OD', 'O'), ('versus', 'O'), ('57', 'O'), ('%', 'O'), ('of', 'O'), ('patients', 'O'), ('in', 'O'), ('TD', 'O'), (',', 'O'), ('without', 'O'), ('evidence', 'O'), ('of', 'O'), ('nephrotoxicity', 'B'), ('.', 'O'))$$$"
"In TD group , three patients developed decreased auditory function , of which one presented with an auditory loss of - 30 dB , whereas in the OD group only one patient presented decreased auditory function .","(('In', 'O'), ('TD', 'O'), ('group', 'O'), (',', 'O'), ('three', 'O'), ('patients', 'O'), ('developed', 'O'), ('decreased', 'B'), ('auditory', 'I'), ('function', 'I'), (',', 'O'), ('of', 'O'), ('which', 'O'), ('one', 'O'), ('presented', 'O'), ('with', 'O'), ('an', 'O'), ('auditory', 'B'), ('loss', 'I'), ('of', 'O'), ('-', 'O'), ('30', 'O'), ('dB', 'O'), (',', 'O'), ('whereas', 'O'), ('in', 'O'), ('the', 'O'), ('OD', 'O'), ('group', 'O'), ('only', 'O'), ('one', 'O'), ('patient', 'O'), ('presented', 'O'), ('decreased', 'B'), ('auditory', 'I'), ('function', 'I'), ('.', 'O'))$$$"
Structural and functional impairment of mitochondria in adriamycin - induced cardiomyopathy in mice : suppression of cytochrome c oxidase II gene expression .,"(('Structural', 'B'), ('and', 'I'), ('functional', 'I'), ('impairment', 'I'), ('of', 'I'), ('mitochondria', 'I'), ('in', 'O'), ('adriamycin', 'O'), ('-', 'O'), ('induced', 'O'), ('cardiomyopathy', 'B'), ('in', 'O'), ('mice', 'O'), (':', 'O'), ('suppression', 'O'), ('of', 'O'), ('cytochrome', 'O'), ('c', 'O'), ('oxidase', 'O'), ('II', 'O'), ('gene', 'O'), ('expression', 'O'), ('.', 'O'))$$$"
"Our results indicated that 1 ) treatment of mice with ADR caused cardiovascular arrhythmias characterized by bradycardia , extension of ventricular depolarization time ( tQRS ) , and failure of QRS at high concentrations ( 10 - 14 mg / kg body weight cumulative dose ) ; 2 ) the heart mitochondria underwent swelling , fusion , dissolution , and / or disruption of mitochondrial cristae after several weeks of treatment .","(('Our', 'O'), ('results', 'O'), ('indicated', 'O'), ('that', 'O'), ('1', 'O'), (')', 'O'), ('treatment', 'O'), ('of', 'O'), ('mice', 'O'), ('with', 'O'), ('ADR', 'O'), ('caused', 'O'), ('cardiovascular', 'B'), ('arrhythmias', 'I'), ('characterized', 'O'), ('by', 'O'), ('bradycardia', 'B'), (',', 'O'), ('extension', 'O'), ('of', 'O'), ('ventricular', 'O'), ('depolarization', 'O'), ('time', 'O'), ('(', 'O'), ('tQRS', 'O'), (')', 'O'), (',', 'O'), ('and', 'O'), ('failure', 'O'), ('of', 'O'), ('QRS', 'O'), ('at', 'O'), ('high', 'O'), ('concentrations', 'O'), ('(', 'O'), ('10', 'O'), ('-', 'O'), ('14', 'O'), ('mg', 'O'), ('/', 'O'), ('kg', 'O'), ('body', 'O'), ('weight', 'O'), ('cumulative', 'O'), ('dose', 'O'), (')', 'O'), (';', 'O'), ('2', 'O'), (')', 'O'), ('the', 'O'), ('heart', 'O'), ('mitochondria', 'O'), ('underwent', 'O'), ('swelling', 'B'), (',', 'O'), ('fusion', 'O'), (',', 'O'), ('dissolution', 'O'), (',', 'O'), ('and', 'O'), ('/', 'O'), ('or', 'O'), ('disruption', 'O'), ('of', 'O'), ('mitochondrial', 'O'), ('cristae', 'O'), ('after', 'O'), ('several', 'O'), ('weeks', 'O'), ('of', 'O'), ('treatment', 'O'), ('.', 'O'))$$$"
"Knowing that heart mitochondria represent almost 40 % of heart muscle by weight , we conclude that the deteriorating effects of ADR on cardiovascular function involve mitochondrial structural and functional impairment .","(('Knowing', 'O'), ('that', 'O'), ('heart', 'O'), ('mitochondria', 'O'), ('represent', 'O'), ('almost', 'O'), ('40', 'O'), ('%', 'O'), ('of', 'O'), ('heart', 'O'), ('muscle', 'O'), ('by', 'O'), ('weight', 'O'), (',', 'O'), ('we', 'O'), ('conclude', 'O'), ('that', 'O'), ('the', 'O'), ('deteriorating', 'O'), ('effects', 'O'), ('of', 'O'), ('ADR', 'O'), ('on', 'O'), ('cardiovascular', 'O'), ('function', 'O'), ('involve', 'O'), ('mitochondrial', 'B'), ('structural', 'I'), ('and', 'I'), ('functional', 'I'), ('impairment', 'I'), ('.', 'O'))$$$"
